




Analysis Type:	PANTHER Overrepresentation Test (Released 20200728)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.4081749 Released 2020-10-09
Analyzed List:	upload_1 (Drosophila melanogaster)
Reference List:	fly_background.txt (Drosophila melanogaster)	There are duplicate IDs in the file. The unique set of IDs will be used.
Test Type:	BINOMIAL
Correction:	NONE
GO biological process complete	fly_background.txt - REFLIST (5878)	upload_1 (1025)	upload_1 (expected)	upload_1 (over/under)	upload_1 (fold Enrichment)	upload_1 (raw P-value)
peptidyl-serine acetylation (GO:0030920)	1	1	.17	+	5.73	1.60E-01
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	1	1	.17	+	5.73	1.60E-01
protein splicing (GO:0030908)	1	1	.17	+	5.73	1.60E-01
extracellular transport (GO:0006858)	1	1	.17	+	5.73	1.60E-01
drug transmembrane transport (GO:0006855)	1	1	.17	+	5.73	1.60E-01
water transport (GO:0006833)	2	2	.35	+	5.73	4.83E-02
positive regulation of mitochondrial membrane permeability (GO:0035794)	1	1	.17	+	5.73	1.60E-01
nitric oxide biosynthetic process (GO:0006809)	1	1	.17	+	5.73	1.60E-01
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	1	1	.17	+	5.73	1.60E-01
mitochondrial outer membrane translocase complex assembly (GO:0070096)	1	1	.17	+	5.73	1.60E-01
negative regulation of vesicle fusion (GO:0031339)	1	1	.17	+	5.73	1.60E-01
proprioception (GO:0019230)	2	2	.35	+	5.73	4.83E-02
gamma-aminobutyric acid biosynthetic process (GO:0009449)	1	1	.17	+	5.73	1.60E-01
negative regulation of cytokine-mediated signaling pathway (GO:0001960)	1	1	.17	+	5.73	1.60E-01
NAD biosynthetic process (GO:0009435)	1	1	.17	+	5.73	1.60E-01
cytoplasmic sequestering of NF-kappaB (GO:0007253)	1	1	.17	+	5.73	1.60E-01
positive regulation of miRNA mediated inhibition of translation (GO:1905618)	1	1	.17	+	5.73	1.60E-01
regulation of miRNA mediated inhibition of translation (GO:1905616)	1	1	.17	+	5.73	1.60E-01
negative regulation of synaptic vesicle recycling (GO:1903422)	1	1	.17	+	5.73	1.60E-01
protein-tetrapyrrole linkage (GO:0017006)	1	1	.17	+	5.73	1.60E-01
protein-heme linkage (GO:0017003)	1	1	.17	+	5.73	1.60E-01
positive regulation of receptor recycling (GO:0001921)	1	1	.17	+	5.73	1.60E-01
reactive oxygen species biosynthetic process (GO:1903409)	2	2	.35	+	5.73	4.83E-02
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	1	1	.17	+	5.73	1.60E-01
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	1	1	.17	+	5.73	1.60E-01
inner dynein arm assembly (GO:0036159)	2	2	.35	+	5.73	4.83E-02
protein arginylation (GO:0016598)	1	1	.17	+	5.73	1.60E-01
phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845)	1	1	.17	+	5.73	1.60E-01
positive regulation of amyloid precursor protein catabolic process (GO:1902993)	1	1	.17	+	5.73	1.60E-01
regulation of amyloid precursor protein catabolic process (GO:1902991)	1	1	.17	+	5.73	1.60E-01
heme oxidation (GO:0006788)	1	1	.17	+	5.73	1.60E-01
porphyrin-containing compound catabolic process (GO:0006787)	1	1	.17	+	5.73	1.60E-01
regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)	1	1	.17	+	5.73	1.60E-01
intein-mediated protein splicing (GO:0016539)	1	1	.17	+	5.73	1.60E-01
NADH regeneration (GO:0006735)	1	1	.17	+	5.73	1.60E-01
protein K33-linked deubiquitination (GO:1990168)	1	1	.17	+	5.73	1.60E-01
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738)	2	2	.35	+	5.73	4.83E-02
regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736)	2	2	.35	+	5.73	4.83E-02
inactivation of MAPK activity (GO:0000188)	2	2	.35	+	5.73	4.83E-02
juvenile hormone catabolic process (GO:0006719)	2	2	.35	+	5.73	4.83E-02
cholesterol catabolic process (GO:0006707)	1	1	.17	+	5.73	1.60E-01
steroid catabolic process (GO:0006706)	2	2	.35	+	5.73	4.83E-02
clathrin-coated vesicle cargo loading (GO:0035652)	1	1	.17	+	5.73	1.60E-01
messenger ribonucleoprotein complex assembly (GO:1990120)	1	1	.17	+	5.73	1.60E-01
sulfate assimilation (GO:0000103)	1	1	.17	+	5.73	1.60E-01
regulation of formation of translation initiation ternary complex (GO:1901190)	1	1	.17	+	5.73	1.60E-01
protein localization to basolateral plasma membrane (GO:1903361)	1	1	.17	+	5.73	1.60E-01
negative regulation of posttranscriptional gene silencing (GO:0060149)	1	1	.17	+	5.73	1.60E-01
positive regulation of protein folding (GO:1903334)	1	1	.17	+	5.73	1.60E-01
regulation of protein folding (GO:1903332)	1	1	.17	+	5.73	1.60E-01
R3/R4 development (GO:0048057)	1	1	.17	+	5.73	1.60E-01
drinking behavior (GO:0042756)	1	1	.17	+	5.73	1.60E-01
insulin catabolic process (GO:1901143)	1	1	.17	+	5.73	1.60E-01
insulin metabolic process (GO:1901142)	1	1	.17	+	5.73	1.60E-01
exogenous drug catabolic process (GO:0042738)	2	2	.35	+	5.73	4.83E-02
drug catabolic process (GO:0042737)	2	2	.35	+	5.73	4.83E-02
cytokine production (GO:0001816)	1	1	.17	+	5.73	1.60E-01
positive regulation of phagocytosis, engulfment (GO:0060100)	1	1	.17	+	5.73	1.60E-01
ocellus photoreceptor cell differentiation (GO:0042705)	2	2	.35	+	5.73	4.83E-02
negative regulation of activin receptor signaling pathway (GO:0032926)	1	1	.17	+	5.73	1.60E-01
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)	1	1	.17	+	5.73	1.60E-01
negative regulation of neuronal signal transduction (GO:1902848)	1	1	.17	+	5.73	1.60E-01
regulation of neuronal signal transduction (GO:1902847)	1	1	.17	+	5.73	1.60E-01
positive regulation of mitotic spindle elongation (GO:1902846)	1	1	.17	+	5.73	1.60E-01
diacylglycerol biosynthetic process (GO:0006651)	1	1	.17	+	5.73	1.60E-01
myeloid leukocyte activation (GO:0002274)	1	1	.17	+	5.73	1.60E-01
protein processing involved in protein targeting to mitochondrion (GO:0006627)	1	1	.17	+	5.73	1.60E-01
sequestering of extracellular ligand from receptor (GO:0035581)	1	1	.17	+	5.73	1.60E-01
stress fiber assembly (GO:0043149)	1	1	.17	+	5.73	1.60E-01
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	1	1	.17	+	5.73	1.60E-01
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	1	1	.17	+	5.73	1.60E-01
protein K29-linked deubiquitination (GO:0035523)	1	1	.17	+	5.73	1.60E-01
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509)	1	1	.17	+	5.73	1.60E-01
regulation of myosin-light-chain-phosphatase activity (GO:0035507)	1	1	.17	+	5.73	1.60E-01
regulation of glutamate secretion, neurotransmission (GO:1903294)	1	1	.17	+	5.73	1.60E-01
meiotic spindle assembly checkpoint (GO:0033316)	1	1	.17	+	5.73	1.60E-01
regulation of phagocytosis, engulfment (GO:0060099)	1	1	.17	+	5.73	1.60E-01
snRNA pseudouridine synthesis (GO:0031120)	2	2	.35	+	5.73	4.83E-02
neurofilament cytoskeleton organization (GO:0060052)	1	1	.17	+	5.73	1.60E-01
cardiac muscle contraction (GO:0060048)	1	1	.17	+	5.73	1.60E-01
regulation of organic acid transport (GO:0032890)	1	1	.17	+	5.73	1.60E-01
negative regulation of response to reactive oxygen species (GO:1901032)	1	1	.17	+	5.73	1.60E-01
negative regulation of hydrogen peroxide-induced cell death (GO:1903206)	1	1	.17	+	5.73	1.60E-01
regulation of hydrogen peroxide-induced cell death (GO:1903205)	1	1	.17	+	5.73	1.60E-01
outer mitochondrial membrane organization (GO:0007008)	1	1	.17	+	5.73	1.60E-01
histone H3-K27 demethylation (GO:0071557)	1	1	.17	+	5.73	1.60E-01
positive regulation of chromosome segregation (GO:0051984)	1	1	.17	+	5.73	1.60E-01
positive regulation of telomerase activity (GO:0051973)	1	1	.17	+	5.73	1.60E-01
regulation of telomerase activity (GO:0051972)	1	1	.17	+	5.73	1.60E-01
regulation of choline O-acetyltransferase activity (GO:1902769)	2	2	.35	+	5.73	4.83E-02
isoprenoid biosynthetic process via mevalonate (GO:1902767)	1	1	.17	+	5.73	1.60E-01
late endosomal microautophagy (GO:0061738)	1	1	.17	+	5.73	1.60E-01
calcium-dependent cell-matrix adhesion (GO:0016340)	1	1	.17	+	5.73	1.60E-01
regulation of amino acid transport (GO:0051955)	1	1	.17	+	5.73	1.60E-01
glucose catabolic process to pyruvate (GO:0061718)	1	1	.17	+	5.73	1.60E-01
histidine catabolic process (GO:0006548)	1	1	.17	+	5.73	1.60E-01
histidine metabolic process (GO:0006547)	1	1	.17	+	5.73	1.60E-01
glutamine catabolic process (GO:0006543)	1	1	.17	+	5.73	1.60E-01
cytoplasmic translational termination (GO:0002184)	1	1	.17	+	5.73	1.60E-01
SNARE complex assembly (GO:0035493)	2	2	.35	+	5.73	4.83E-02
establishment of pigment granule localization (GO:0051905)	1	1	.17	+	5.73	1.60E-01
pigment granule transport (GO:0051904)	1	1	.17	+	5.73	1.60E-01
meiotic metaphase I plate congression (GO:0043060)	1	1	.17	+	5.73	1.60E-01
mitochondrial mRNA 3'-end processing (GO:0090616)	1	1	.17	+	5.73	1.60E-01
mitochondrial mRNA processing (GO:0090615)	1	1	.17	+	5.73	1.60E-01
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271)	1	1	.17	+	5.73	1.60E-01
zonula adherens maintenance (GO:0045218)	1	1	.17	+	5.73	1.60E-01
ribonucleoside diphosphate biosynthetic process (GO:0009188)	1	1	.17	+	5.73	1.60E-01
purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	1	1	.17	+	5.73	1.60E-01
histamine biosynthetic process (GO:0001694)	2	2	.35	+	5.73	4.83E-02
meiotic spindle checkpoint (GO:0044779)	1	1	.17	+	5.73	1.60E-01
microtubule organizing center attachment site organization (GO:0034994)	1	1	.17	+	5.73	1.60E-01
mitochondrial protein processing (GO:0034982)	1	1	.17	+	5.73	1.60E-01
retinol metabolic process (GO:0042572)	1	1	.17	+	5.73	1.60E-01
purine nucleoside diphosphate biosynthetic process (GO:0009136)	1	1	.17	+	5.73	1.60E-01
sequestering of BMP from receptor via BMP binding (GO:0038098)	1	1	.17	+	5.73	1.60E-01
nucleoside diphosphate biosynthetic process (GO:0009133)	1	1	.17	+	5.73	1.60E-01
box H/ACA snoRNA processing (GO:0034964)	1	1	.17	+	5.73	1.60E-01
positive regulation of cytoplasmic translation (GO:2000767)	1	1	.17	+	5.73	1.60E-01
regulation of mitochondrial transcription (GO:1903108)	3	3	.52	+	5.73	1.62E-02
cellular response to high light intensity (GO:0071486)	1	1	.17	+	5.73	1.60E-01
cellular response to light intensity (GO:0071484)	3	3	.52	+	5.73	1.62E-02
cellular response to blue light (GO:0071483)	1	1	.17	+	5.73	1.60E-01
negative regulation of SMAD protein complex assembly (GO:0010991)	1	1	.17	+	5.73	1.60E-01
cellular response to anoxia (GO:0071454)	2	2	.35	+	5.73	4.83E-02
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	1	1	.17	+	5.73	1.60E-01
gap junction assembly (GO:0016264)	1	1	.17	+	5.73	1.60E-01
magnesium ion homeostasis (GO:0010960)	1	1	.17	+	5.73	1.60E-01
pigment granule localization (GO:0051875)	1	1	.17	+	5.73	1.60E-01
canonical glycolysis (GO:0061621)	1	1	.17	+	5.73	1.60E-01
glycolytic process through glucose-6-phosphate (GO:0061620)	1	1	.17	+	5.73	1.60E-01
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	1	.17	+	5.73	1.60E-01
regulation of glutamate secretion (GO:0014048)	1	1	.17	+	5.73	1.60E-01
glutamate secretion (GO:0014047)	1	1	.17	+	5.73	1.60E-01
glycolytic process through fructose-6-phosphate (GO:0061615)	1	1	.17	+	5.73	1.60E-01
positive regulation of mitochondrial membrane potential (GO:0010918)	1	1	.17	+	5.73	1.60E-01
transepithelial water transport (GO:0035377)	1	1	.17	+	5.73	1.60E-01
response to hydroperoxide (GO:0033194)	1	1	.17	+	5.73	1.60E-01
snRNA export from nucleus (GO:0006408)	1	1	.17	+	5.73	1.60E-01
desensitization of G protein-coupled receptor signaling pathway by arrestin (GO:0002032)	2	2	.35	+	5.73	4.83E-02
regulation of histone H2B conserved C-terminal lysine ubiquitination (GO:2001173)	1	1	.17	+	5.73	1.60E-01
trehalose transport (GO:0015771)	1	1	.17	+	5.73	1.60E-01
positive regulation of protein dephosphorylation (GO:0035307)	1	1	.17	+	5.73	1.60E-01
positive regulation of dephosphorylation (GO:0035306)	1	1	.17	+	5.73	1.60E-01
positive regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905273)	1	1	.17	+	5.73	1.60E-01
regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905271)	1	1	.17	+	5.73	1.60E-01
positive regulation of mitotic sister chromatid segregation (GO:0062033)	1	1	.17	+	5.73	1.60E-01
positive regulation of stress granule assembly (GO:0062029)	1	1	.17	+	5.73	1.60E-01
regulation of stress granule assembly (GO:0062028)	1	1	.17	+	5.73	1.60E-01
ocellus photoreceptor cell development (GO:0042463)	2	2	.35	+	5.73	4.83E-02
positive regulation of transcription regulatory region DNA binding (GO:2000679)	1	1	.17	+	5.73	1.60E-01
hormone catabolic process (GO:0042447)	3	3	.52	+	5.73	1.62E-02
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	1	.17	+	5.73	1.60E-01
regulation of early endosome to late endosome transport (GO:2000641)	1	1	.17	+	5.73	1.60E-01
cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	1	1	.17	+	5.73	1.60E-01
synaptic vesicle to endosome fusion (GO:0016189)	1	1	.17	+	5.73	1.60E-01
peristalsis (GO:0030432)	1	1	.17	+	5.73	1.60E-01
sterol catabolic process (GO:0016127)	1	1	.17	+	5.73	1.60E-01
centriole elongation (GO:0061511)	1	1	.17	+	5.73	1.60E-01
terpenoid catabolic process (GO:0016115)	2	2	.35	+	5.73	4.83E-02
sesquiterpenoid catabolic process (GO:0016107)	2	2	.35	+	5.73	4.83E-02
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804)	1	1	.17	+	5.73	1.60E-01
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)	1	1	.17	+	5.73	1.60E-01
protein import into peroxisome membrane (GO:0045046)	2	2	.35	+	5.73	4.83E-02
protein insertion into mitochondrial inner membrane (GO:0045039)	2	2	.35	+	5.73	4.83E-02
reactive nitrogen species metabolic process (GO:2001057)	1	1	.17	+	5.73	1.60E-01
tetrapyrrole catabolic process (GO:0033015)	1	1	.17	+	5.73	1.60E-01
positive regulation of membrane invagination (GO:1905155)	1	1	.17	+	5.73	1.60E-01
regulation of membrane invagination (GO:1905153)	1	1	.17	+	5.73	1.60E-01
negative regulation of meiotic chromosome separation (GO:1905133)	1	1	.17	+	5.73	1.60E-01
regulation of meiotic chromosome separation (GO:1905132)	1	1	.17	+	5.73	1.60E-01
regulation of mitochondrial mRNA stability (GO:0044528)	2	2	.35	+	5.73	4.83E-02
protein exit from endoplasmic reticulum (GO:0032527)	1	1	.17	+	5.73	1.60E-01
pointed-end actin filament capping (GO:0051694)	1	1	.17	+	5.73	1.60E-01
meiotic mismatch repair involved in reciprocal meiotic recombination (GO:0010777)	1	1	.17	+	5.73	1.60E-01
transepithelial chloride transport (GO:0030321)	1	1	.17	+	5.73	1.60E-01
negative regulation of histone H3-K27 trimethylation (GO:1902465)	1	1	.17	+	5.73	1.60E-01
regulation of histone H3-K27 trimethylation (GO:1902464)	1	1	.17	+	5.73	1.60E-01
connective tissue development (GO:0061448)	1	1	.17	+	5.73	1.60E-01
regulation of long-term synaptic potentiation (GO:1900271)	1	1	.17	+	5.73	1.60E-01
mitochondrial RNA 3'-end processing (GO:0000965)	1	1	.17	+	5.73	1.60E-01
absorption of UV light (GO:0016039)	1	1	.17	+	5.73	1.60E-01
absorption of visible light (GO:0016038)	1	1	.17	+	5.73	1.60E-01
light absorption (GO:0016037)	2	2	.35	+	5.73	4.83E-02
tRNA import into mitochondrion (GO:0016031)	1	1	.17	+	5.73	1.60E-01
negative regulation of extracellular matrix disassembly (GO:0010716)	1	1	.17	+	5.73	1.60E-01
regulation of extracellular matrix disassembly (GO:0010715)	1	1	.17	+	5.73	1.60E-01
negative regulation of meiotic cell cycle phase transition (GO:1901994)	1	1	.17	+	5.73	1.60E-01
negative regulation of gene silencing by miRNA (GO:0060965)	1	1	.17	+	5.73	1.60E-01
plus-end-directed endosome transport along mitotic spindle midzone microtubule (GO:0140024)	1	1	.17	+	5.73	1.60E-01
negative regulation of insulin secretion (GO:0046676)	1	1	.17	+	5.73	1.60E-01
mitochondrial outer membrane permeabilization (GO:0097345)	1	1	.17	+	5.73	1.60E-01
ocellus morphogenesis (GO:0048816)	1	1	.17	+	5.73	1.60E-01
peptidyl-aspartic acid hydroxylation (GO:0042264)	1	1	.17	+	5.73	1.60E-01
mature ribosome assembly (GO:0042256)	1	1	.17	+	5.73	1.60E-01
peptidyl-aspartic acid modification (GO:0018197)	1	1	.17	+	5.73	1.60E-01
polar body extrusion after meiotic divisions (GO:0040038)	1	1	.17	+	5.73	1.60E-01
RNA acetylation (GO:1990884)	1	1	.17	+	5.73	1.60E-01
rRNA acetylation (GO:1990882)	1	1	.17	+	5.73	1.60E-01
positive regulation of apoptotic cell clearance (GO:2000427)	2	2	.35	+	5.73	4.83E-02
regulation of apoptotic cell clearance (GO:2000425)	2	2	.35	+	5.73	4.83E-02
peptidyl-pyrromethane cofactor linkage (GO:0018160)	1	1	.17	+	5.73	1.60E-01
light-induced release of internally sequestered calcium ion (GO:0008377)	2	2	.35	+	5.73	4.83E-02
melanosome transport (GO:0032402)	1	1	.17	+	5.73	1.60E-01
establishment of melanosome localization (GO:0032401)	1	1	.17	+	5.73	1.60E-01
melanosome localization (GO:0032400)	1	1	.17	+	5.73	1.60E-01
chondroitin sulfate biosynthetic process (GO:0030206)	1	1	.17	+	5.73	1.60E-01
ADP biosynthetic process (GO:0006172)	1	1	.17	+	5.73	1.60E-01
cell communication by electrical coupling (GO:0010644)	1	1	.17	+	5.73	1.60E-01
cell morphogenesis involved in Malpighian tubule morphogenesis (GO:0061336)	1	1	.17	+	5.73	1.60E-01
regulation of actomyosin contractile ring contraction (GO:0031991)	1	1	.17	+	5.73	1.60E-01
ecdysone-mediated polytene chromosome puffing (GO:0035077)	1	1	.17	+	5.73	1.60E-01
extracellular negative regulation of signal transduction (GO:1900116)	1	1	.17	+	5.73	1.60E-01
extracellular regulation of signal transduction (GO:1900115)	1	1	.17	+	5.73	1.60E-01
fumarate metabolic process (GO:0006106)	1	1	.17	+	5.73	1.60E-01
isocitrate metabolic process (GO:0006102)	1	1	.17	+	5.73	1.60E-01
nuclear speck organization (GO:0035063)	1	1	.17	+	5.73	1.60E-01
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)	1	1	.17	+	5.73	1.60E-01
regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	1	1	.17	+	5.73	1.60E-01
protein localization to nuclear pore (GO:0090204)	1	1	.17	+	5.73	1.60E-01
ketone catabolic process (GO:0042182)	1	1	.17	+	5.73	1.60E-01
positive regulation of calcineurin-mediated signaling (GO:0106058)	1	1	.17	+	5.73	1.60E-01
mitochondrial mRNA polyadenylation (GO:0097222)	1	1	.17	+	5.73	1.60E-01
positive regulation of ubiquitin-dependent endocytosis (GO:2000397)	1	1	.17	+	5.73	1.60E-01
regulation of ubiquitin-dependent endocytosis (GO:2000395)	1	1	.17	+	5.73	1.60E-01
heme catabolic process (GO:0042167)	1	1	.17	+	5.73	1.60E-01
negative regulation of blood coagulation (GO:0030195)	1	1	.17	+	5.73	1.60E-01
regulation of blood coagulation (GO:0030193)	1	1	.17	+	5.73	1.60E-01
macrophage activation (GO:0042116)	1	1	.17	+	5.73	1.60E-01
cytochrome c-heme linkage (GO:0018063)	1	1	.17	+	5.73	1.60E-01
regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway (GO:0010578)	1	1	.17	+	5.73	1.60E-01
positive regulation of ceramide biosynthetic process (GO:2000304)	1	1	.17	+	5.73	1.60E-01
glycerol metabolic process (GO:0006071)	1	1	.17	+	5.73	1.60E-01
response to magnetism (GO:0071000)	1	1	.17	+	5.73	1.60E-01
N-terminal peptidyl-glutamic acid acetylation (GO:0018002)	1	1	.17	+	5.73	1.60E-01
negative regulation of hemostasis (GO:1900047)	1	1	.17	+	5.73	1.60E-01
regulation of hemostasis (GO:1900046)	1	1	.17	+	5.73	1.60E-01
negative regulation of cellular response to hypoxia (GO:1900038)	1	1	.17	+	5.73	1.60E-01
positive regulation of sphingolipid biosynthetic process (GO:0090154)	2	2	.35	+	5.73	4.83E-02
establishment of protein localization to mitochondrial membrane (GO:0090151)	2	2	.35	+	5.73	4.83E-02
positive regulation of ruffle assembly (GO:1900029)	1	1	.17	+	5.73	1.60E-01
regulation of ruffle assembly (GO:1900027)	1	1	.17	+	5.73	1.60E-01
regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138)	1	1	.17	+	5.73	1.60E-01
cellular water homeostasis (GO:0009992)	1	1	.17	+	5.73	1.60E-01
fructose 2,6-bisphosphate metabolic process (GO:0006003)	1	1	.17	+	5.73	1.60E-01
positive regulation of synapse maturation (GO:0090129)	1	1	.17	+	5.73	1.60E-01
negative regulation of response to cytokine stimulus (GO:0060761)	1	1	.17	+	5.73	1.60E-01
detection of light stimulus involved in magnetoreception (GO:0050980)	1	1	.17	+	5.73	1.60E-01
negative regulation of histone H4-K20 methylation (GO:0070511)	1	1	.17	+	5.73	1.60E-01
regulation of histone H4-K20 methylation (GO:0070510)	1	1	.17	+	5.73	1.60E-01
magnetoreception (GO:0050958)	1	1	.17	+	5.73	1.60E-01
circadian regulation of translation (GO:0097167)	1	1	.17	+	5.73	1.60E-01
positive regulation of extracellular matrix constituent secretion (GO:0003331)	2	2	.35	+	5.73	4.83E-02
regulation of extracellular matrix constituent secretion (GO:0003330)	2	2	.35	+	5.73	4.83E-02
negative regulation of synaptic transmission, GABAergic (GO:0032229)	1	1	.17	+	5.73	1.60E-01
regulation of synaptic transmission, GABAergic (GO:0032228)	1	1	.17	+	5.73	1.60E-01
actin modification (GO:0030047)	1	1	.17	+	5.73	1.60E-01
contractile actin filament bundle assembly (GO:0030038)	2	2	.35	+	5.73	4.83E-02
microvillar actin bundle assembly (GO:0030034)	1	1	.17	+	5.73	1.60E-01
microvillus assembly (GO:0030033)	1	1	.17	+	5.73	1.60E-01
positive regulation of telomere maintenance (GO:0032206)	1	1	.17	+	5.73	1.60E-01
regulation of telomere maintenance (GO:0032204)	2	2	.35	+	5.73	4.83E-02
positive regulation of telomere capping (GO:1904355)	1	1	.17	+	5.73	1.60E-01
phasic smooth muscle contraction (GO:0014821)	1	1	.17	+	5.73	1.60E-01
regulation of telomere capping (GO:1904353)	1	1	.17	+	5.73	1.60E-01
positive regulation of calcium ion-dependent exocytosis (GO:0045956)	1	1	.17	+	5.73	1.60E-01
box H/ACA snoRNA metabolic process (GO:0033979)	1	1	.17	+	5.73	1.60E-01
negative regulation of translational elongation (GO:0045900)	1	1	.17	+	5.73	1.60E-01
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	1	1	.17	+	5.73	1.60E-01
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	1	1	.17	+	5.73	1.60E-01
glyceraldehyde-3-phosphate metabolic process (GO:0019682)	1	1	.17	+	5.73	1.60E-01
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	1	1	.17	+	5.73	1.60E-01
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	1	1	.17	+	5.73	1.60E-01
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	1	1	.17	+	5.73	1.60E-01
ecdysteroid catabolic process (GO:0046344)	1	1	.17	+	5.73	1.60E-01
negative regulation of coagulation (GO:0050819)	1	1	.17	+	5.73	1.60E-01
regulation of coagulation (GO:0050818)	1	1	.17	+	5.73	1.60E-01
regulation of timing of cell differentiation (GO:0048505)	1	1	.17	+	5.73	1.60E-01
negative regulation of antifungal peptide production (GO:0002789)	1	1	.17	+	5.73	1.60E-01
negative regulation of rhodopsin gene expression (GO:0045871)	1	1	.17	+	5.73	1.60E-01
establishment of blood-nerve barrier (GO:0008065)	1	1	.17	+	5.73	1.60E-01
regulation of transcription from RNA polymerase II promoter involved in spermatogenesis (GO:1902064)	1	1	.17	+	5.73	1.60E-01
MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	1	1	.17	+	5.73	1.60E-01
negative regulation of hematopoietic stem cell differentiation (GO:1902037)	1	1	.17	+	5.73	1.60E-01
regulation of hematopoietic stem cell differentiation (GO:1902036)	2	2	.35	+	5.73	4.83E-02
negative regulation of glycogen catabolic process (GO:0045818)	1	1	.17	+	5.73	1.60E-01
spindle disassembly (GO:0051230)	1	1	.17	+	5.73	1.60E-01
mitotic spindle disassembly (GO:0051228)	1	1	.17	+	5.73	1.60E-01
negative regulation of eclosion (GO:0045804)	1	1	.17	+	5.73	1.60E-01
cellular response to sucrose starvation (GO:0043617)	1	1	.17	+	5.73	1.60E-01
positive regulation of amyloid-beta formation (GO:1902004)	1	1	.17	+	5.73	1.60E-01
regulation of amyloid-beta formation (GO:1902003)	1	1	.17	+	5.73	1.60E-01
protein insertion into mitochondrial membrane (GO:0051204)	2	2	.35	+	5.73	4.83E-02
glycerol catabolic process (GO:0019563)	1	1	.17	+	5.73	1.60E-01
blue light signaling pathway (GO:0009785)	1	1	.17	+	5.73	1.60E-01
negative regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031631)	1	1	.17	+	5.73	1.60E-01
glutamate catabolic process to 2-oxoglutarate (GO:0019551)	1	1	.17	+	5.73	1.60E-01
carbohydrate utilization (GO:0009758)	1	1	.17	+	5.73	1.60E-01
response to paclitaxel (GO:1901555)	1	1	.17	+	5.73	1.60E-01
cellular response to hydrogen peroxide (GO:0070301)	1	1	.17	+	5.73	1.60E-01
IRE1-mediated unfolded protein response (GO:0036498)	1	1	.17	+	5.73	1.60E-01
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	1	1	.17	+	5.73	1.60E-01
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	2	2	.35	+	5.73	4.83E-02
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)	1	1	.17	+	5.73	1.60E-01
regulation of anion transport (GO:0044070)	1	1	.17	+	5.73	1.60E-01
cell death in response to hydrogen peroxide (GO:0036474)	1	1	.17	+	5.73	1.60E-01
cell death in response to oxidative stress (GO:0036473)	1	1	.17	+	5.73	1.60E-01
response to food (GO:0032094)	1	1	.17	+	5.73	1.60E-01
positive regulation of protein binding (GO:0032092)	1	1	.17	+	5.73	1.60E-01
negative regulation of protein binding (GO:0032091)	2	2	.35	+	5.73	4.83E-02
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	1	1	.17	+	5.73	1.60E-01
nitric oxide metabolic process (GO:0046209)	1	1	.17	+	5.73	1.60E-01
mRNA pseudouridine synthesis (GO:1990481)	1	1	.17	+	5.73	1.60E-01
ARF protein signal transduction (GO:0032011)	1	1	.17	+	5.73	1.60E-01
negative regulation of autophagosome size (GO:0045771)	1	1	.17	+	5.73	1.60E-01
positive regulation of protein localization to cell surface (GO:2000010)	1	1	.17	+	5.73	1.60E-01
box H/ACA snoRNA 3'-end processing (GO:0000495)	1	1	.17	+	5.73	1.60E-01
regulation of protein localization to cell surface (GO:2000008)	1	1	.17	+	5.73	1.60E-01
tendon development (GO:0035989)	1	1	.17	+	5.73	1.60E-01
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)	1	1	.17	+	5.73	1.60E-01
cardiolipin acyl-chain remodeling (GO:0035965)	1	1	.17	+	5.73	1.60E-01
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	2	2	.35	+	5.73	4.83E-02
response to UV-C (GO:0010225)	1	1	.17	+	5.73	1.60E-01
RNA import into mitochondrion (GO:0035927)	1	1	.17	+	5.73	1.60E-01
peptidyl-serine dephosphorylation (GO:0070262)	1	1	.17	+	5.73	1.60E-01
pharynx development (GO:0060465)	1	1	.17	+	5.73	1.60E-01
wing disc proximal/distal pattern formation (GO:0007473)	3	3	.52	+	5.73	1.62E-02
response to high light intensity (GO:0009644)	1	1	.17	+	5.73	1.60E-01
regulation of cytoplasmic transport (GO:1903649)	1	1	.17	+	5.73	1.60E-01
positive regulation of chaperone-mediated protein folding (GO:1903646)	1	1	.17	+	5.73	1.60E-01
regulation of chaperone-mediated protein folding (GO:1903644)	1	1	.17	+	5.73	1.60E-01
renal water transport (GO:0003097)	1	1	.17	+	5.73	1.60E-01
hydrogen peroxide biosynthetic process (GO:0050665)	1	1	.17	+	5.73	1.60E-01
cytokine secretion (GO:0050663)	1	1	.17	+	5.73	1.60E-01
renal water homeostasis (GO:0003091)	1	1	.17	+	5.73	1.60E-01
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	1	1	.17	+	5.73	1.60E-01
muscle tissue morphogenesis (GO:0060415)	2	2	.35	+	5.73	4.83E-02
imidazole-containing compound catabolic process (GO:0052805)	1	1	.17	+	5.73	1.60E-01
circadian regulation of heart rate (GO:0003053)	3	3	.52	+	5.73	1.62E-02
pigment catabolic process (GO:0046149)	1	1	.17	+	5.73	1.60E-01
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	1	1	.17	+	5.73	1.60E-01
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990)	1	1	.17	+	5.73	1.60E-01
response to lipid hydroperoxide (GO:0006982)	1	1	.17	+	5.73	1.60E-01
negative regulation of R8 cell differentiation (GO:0045680)	1	1	.17	+	5.73	1.60E-01
regulation of R8 cell differentiation (GO:0045679)	1	1	.17	+	5.73	1.60E-01
malate-aspartate shuttle (GO:0043490)	2	2	.35	+	5.73	4.83E-02
positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	2	2	.35	+	5.73	4.83E-02
proton-transporting ATP synthase complex assembly (GO:0043461)	1	1	.17	+	5.73	1.60E-01
farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)	1	1	.17	+	5.73	1.60E-01
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	1	1	.17	+	5.73	1.60E-01
regulation of membrane protein ectodomain proteolysis (GO:0051043)	1	1	.17	+	5.73	1.60E-01
response to corticotropin-releasing hormone (GO:0043435)	1	1	.17	+	5.73	1.60E-01
protein localization to pericentriolar material (GO:1905793)	1	1	.17	+	5.73	1.60E-01
protein localization to chromosome, telomeric region (GO:0070198)	1	1	.17	+	5.73	1.60E-01
N-terminal peptidyl-serine acetylation (GO:0017198)	1	1	.17	+	5.73	1.60E-01
UV-A, blue light phototransduction (GO:0009588)	2	2	.35	+	5.73	4.83E-02
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)	1	1	.17	+	5.73	1.60E-01
polycistronic mRNA processing (GO:0031426)	1	1	.17	+	5.73	1.60E-01
chaperone-mediated protein transport (GO:0072321)	1	1	.17	+	5.73	1.60E-01
anterior midgut invagination (GO:0007375)	1	1	.17	+	5.73	1.60E-01
drug metabolic process (GO:0017144)	2	2	.35	+	5.73	4.83E-02
positive regulation of mitochondrial translation (GO:0070131)	2	2	.35	+	5.73	4.83E-02
negative regulation of mitochondrial translation (GO:0070130)	1	1	.17	+	5.73	1.60E-01
anterior region determination (GO:0007355)	1	1	.17	+	5.73	1.60E-01
positive regulation of membrane permeability (GO:1905710)	1	1	.17	+	5.73	1.60E-01
regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905706)	1	1	.17	+	5.73	1.60E-01
endoplasmic reticulum to cytosol transport (GO:1903513)	1	1	.17	+	5.73	1.60E-01
sperm capacitation (GO:0048240)	1	1	.17	+	5.73	1.60E-01
retrograde protein transport, ER to cytosol (GO:0030970)	1	1	.17	+	5.73	1.60E-01
rhabdomere morphogenesis (GO:0061541)	5	5	.87	+	5.73	2.03E-03
acylglycerol biosynthetic process (GO:0046463)	6	5	1.05	+	4.78	4.39E-03
neutral lipid biosynthetic process (GO:0046460)	6	5	1.05	+	4.78	4.39E-03
triglyceride biosynthetic process (GO:0019432)	5	4	.87	+	4.59	1.21E-02
tricarboxylic acid metabolic process (GO:0072350)	5	4	.87	+	4.59	1.21E-02
regulation of mitochondrial translation (GO:0070129)	5	4	.87	+	4.59	1.21E-02
pteridine biosynthetic process (GO:0006728)	4	3	.70	+	4.30	3.38E-02
rRNA pseudouridine synthesis (GO:0031118)	4	3	.70	+	4.30	3.38E-02
pseudouridine synthesis (GO:0001522)	4	3	.70	+	4.30	3.38E-02
citrate metabolic process (GO:0006101)	4	3	.70	+	4.30	3.38E-02
positive regulation of phagocytosis (GO:0050766)	8	6	1.40	+	4.30	3.12E-03
ADP metabolic process (GO:0046031)	13	9	2.27	+	3.97	5.68E-04
ribonucleoside diphosphate metabolic process (GO:0009185)	13	9	2.27	+	3.97	5.68E-04
purine ribonucleoside diphosphate metabolic process (GO:0009179)	13	9	2.27	+	3.97	5.68E-04
purine nucleoside diphosphate metabolic process (GO:0009135)	13	9	2.27	+	3.97	5.68E-04
Golgi vesicle docking (GO:0048211)	3	2	.52	+	3.82	9.73E-02
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433)	3	2	.52	+	3.82	9.73E-02
nitric oxide mediated signal transduction (GO:0007263)	3	2	.52	+	3.82	9.73E-02
gamma-aminobutyric acid signaling pathway (GO:0007214)	3	2	.52	+	3.82	9.73E-02
ATP generation from ADP (GO:0006757)	12	8	2.09	+	3.82	1.43E-03
response to ether (GO:0045472)	3	2	.52	+	3.82	9.73E-02
juvenile hormone metabolic process (GO:0006716)	3	2	.52	+	3.82	9.73E-02
sesquiterpenoid metabolic process (GO:0006714)	3	2	.52	+	3.82	9.73E-02
positive regulation of cuticle pigmentation (GO:0048081)	3	2	.52	+	3.82	9.73E-02
regulation of establishment or maintenance of cell polarity (GO:0032878)	3	2	.52	+	3.82	9.73E-02
post-chaperonin tubulin folding pathway (GO:0007023)	3	2	.52	+	3.82	9.73E-02
SNARE complex disassembly (GO:0035494)	3	2	.52	+	3.82	9.73E-02
sulfation (GO:0051923)	3	2	.52	+	3.82	9.73E-02
histamine metabolic process (GO:0001692)	3	2	.52	+	3.82	9.73E-02
positive phototaxis (GO:0046956)	3	2	.52	+	3.82	9.73E-02
aspartate transmembrane transport (GO:0015810)	3	2	.52	+	3.82	9.73E-02
regulation of mitochondrial gene expression (GO:0062125)	6	4	1.05	+	3.82	2.19E-02
beta-catenin destruction complex disassembly (GO:1904886)	3	2	.52	+	3.82	9.73E-02
assembly of large subunit precursor of preribosome (GO:1902626)	3	2	.52	+	3.82	9.73E-02
G protein-coupled receptor internalization (GO:0002031)	3	2	.52	+	3.82	9.73E-02
desensitization of G protein-coupled receptor signaling pathway (GO:0002029)	3	2	.52	+	3.82	9.73E-02
fatty-acyl-CoA metabolic process (GO:0035337)	3	2	.52	+	3.82	9.73E-02
positive regulation of extracellular matrix organization (GO:1903055)	3	2	.52	+	3.82	9.73E-02
negative regulation of transcription regulatory region DNA binding (GO:2000678)	3	2	.52	+	3.82	9.73E-02
tRNA methylation (GO:0030488)	3	2	.52	+	3.82	9.73E-02
retinoid metabolic process (GO:0001523)	3	2	.52	+	3.82	9.73E-02
dopamine biosynthetic process (GO:0042416)	3	2	.52	+	3.82	9.73E-02
termination of RNA polymerase II transcription (GO:0006369)	3	2	.52	+	3.82	9.73E-02
diterpenoid metabolic process (GO:0016101)	3	2	.52	+	3.82	9.73E-02
double-strand break repair via single-strand annealing (GO:0045002)	3	2	.52	+	3.82	9.73E-02
positive energy taxis (GO:0052128)	3	2	.52	+	3.82	9.73E-02
snRNA modification (GO:0040031)	3	2	.52	+	3.82	9.73E-02
isoprenoid catabolic process (GO:0008300)	3	2	.52	+	3.82	9.73E-02
regulation of centriole replication (GO:0046599)	3	2	.52	+	3.82	9.73E-02
glycolytic process (GO:0006096)	12	8	2.09	+	3.82	1.43E-03
parallel actin filament bundle assembly (GO:0030046)	3	2	.52	+	3.82	9.73E-02
negative adaptation of signaling pathway (GO:0022401)	3	2	.52	+	3.82	9.73E-02
central nervous system projection neuron axonogenesis (GO:0021952)	3	2	.52	+	3.82	9.73E-02
protein desumoylation (GO:0016926)	3	2	.52	+	3.82	9.73E-02
peptidyl-threonine dephosphorylation (GO:0035970)	3	2	.52	+	3.82	9.73E-02
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)	3	2	.52	+	3.82	9.73E-02
regulation of response to endoplasmic reticulum stress (GO:1905897)	3	2	.52	+	3.82	9.73E-02
imidazole-containing compound metabolic process (GO:0052803)	3	2	.52	+	3.82	9.73E-02
smooth muscle contraction (GO:0006939)	3	2	.52	+	3.82	9.73E-02
response to light intensity (GO:0009642)	9	6	1.57	+	3.82	5.47E-03
regulation of phagocytosis (GO:0050764)	11	7	1.92	+	3.65	3.59E-03
detection of light stimulus involved in sensory perception (GO:0050962)	8	5	1.40	+	3.58	1.40E-02
eclosion rhythm (GO:0008062)	8	5	1.40	+	3.58	1.40E-02
maturation of LSU-rRNA (GO:0000470)	13	8	2.27	+	3.53	2.34E-03
positive regulation of developmental pigmentation (GO:0048087)	5	3	.87	+	3.44	5.82E-02
optomotor response (GO:0071632)	5	3	.87	+	3.44	5.82E-02
regulation of neuron projection arborization (GO:0150011)	5	3	.87	+	3.44	5.82E-02
regulation of transcription regulatory region DNA binding (GO:2000677)	5	3	.87	+	3.44	5.82E-02
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	5	3	.87	+	3.44	5.82E-02
pteridine metabolic process (GO:0019889)	5	3	.87	+	3.44	5.82E-02
negative regulation of protein catabolic process (GO:0042177)	10	6	1.74	+	3.44	8.92E-03
optokinetic behavior (GO:0007634)	5	3	.87	+	3.44	5.82E-02
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)	5	3	.87	+	3.44	5.82E-02
morphogenesis of larval imaginal disc epithelium (GO:0016335)	7	4	1.22	+	3.28	3.55E-02
protein deglycosylation (GO:0006517)	7	4	1.22	+	3.28	3.55E-02
inositol metabolic process (GO:0006020)	7	4	1.22	+	3.28	3.55E-02
nucleotide phosphorylation (GO:0046939)	16	9	2.79	+	3.23	2.34E-03
nucleoside diphosphate phosphorylation (GO:0006165)	16	9	2.79	+	3.23	2.34E-03
behavioral response to cocaine (GO:0048148)	9	5	1.57	+	3.19	2.19E-02
terpenoid metabolic process (GO:0006721)	9	5	1.57	+	3.19	2.19E-02
negative regulation of cellular protein catabolic process (GO:1903363)	9	5	1.57	+	3.19	2.19E-02
circadian regulation of gene expression (GO:0032922)	9	5	1.57	+	3.19	2.19E-02
nucleoside diphosphate metabolic process (GO:0009132)	18	10	3.14	+	3.19	1.50E-03
regulation of rhodopsin mediated signaling pathway (GO:0022400)	18	10	3.14	+	3.19	1.50E-03
sperm chromatin decondensation (GO:0035041)	11	6	1.92	+	3.13	1.37E-02
chloride transmembrane transport (GO:1902476)	13	7	2.27	+	3.09	8.62E-03
rhodopsin mediated signaling pathway (GO:0016056)	13	7	2.27	+	3.09	8.62E-03
rhodopsin metabolic process (GO:0046154)	13	7	2.27	+	3.09	8.62E-03
retina homeostasis (GO:0001895)	15	8	2.62	+	3.06	5.45E-03
deactivation of rhodopsin mediated signaling (GO:0016059)	17	9	2.96	+	3.04	3.47E-03
negative regulation of histone H2A K63-linked ubiquitination (GO:1901315)	2	1	.35	+	2.87	2.94E-01
regulation of histone H2A K63-linked ubiquitination (GO:1901314)	2	1	.35	+	2.87	2.94E-01
response to anoxia (GO:0034059)	6	3	1.05	+	2.87	8.89E-02
contractile ring localization (GO:0036214)	2	1	.35	+	2.87	2.94E-01
cell volume homeostasis (GO:0006884)	4	2	.70	+	2.87	1.55E-01
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	2	1	.35	+	2.87	2.94E-01
intracellular sequestering of iron ion (GO:0006880)	2	1	.35	+	2.87	2.94E-01
regulation of protein binding (GO:0043393)	6	3	1.05	+	2.87	8.89E-02
pre-mRNA catabolic process (GO:1990261)	2	1	.35	+	2.87	2.94E-01
manganese ion transport (GO:0006828)	4	2	.70	+	2.87	1.55E-01
regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248)	2	1	.35	+	2.87	2.94E-01
response to iron(II) ion (GO:0010040)	2	1	.35	+	2.87	2.94E-01
clustering of voltage-gated calcium channels (GO:0070073)	2	1	.35	+	2.87	2.94E-01
proton-transporting two-sector ATPase complex assembly (GO:0070071)	2	1	.35	+	2.87	2.94E-01
gamma-aminobutyric acid metabolic process (GO:0009448)	2	1	.35	+	2.87	2.94E-01
alditol phosphate metabolic process (GO:0052646)	2	1	.35	+	2.87	2.94E-01
behavioral response to ether (GO:0048150)	2	1	.35	+	2.87	2.94E-01
patched ligand maturation (GO:0007225)	2	1	.35	+	2.87	2.94E-01
tachykinin receptor signaling pathway (GO:0007217)	4	2	.70	+	2.87	1.55E-01
activation of phospholipase C activity (GO:0007202)	2	1	.35	+	2.87	2.94E-01
outer dynein arm assembly (GO:0036158)	4	2	.70	+	2.87	1.55E-01
somatic stem cell division (GO:0048103)	2	1	.35	+	2.87	2.94E-01
nucleosome positioning (GO:0016584)	2	1	.35	+	2.87	2.94E-01
female analia development (GO:0045497)	2	1	.35	+	2.87	2.94E-01
male analia development (GO:0045496)	2	1	.35	+	2.87	2.94E-01
regulation of p38MAPK cascade (GO:1900744)	2	1	.35	+	2.87	2.94E-01
R8 cell-mediated photoreceptor organization (GO:0045470)	2	1	.35	+	2.87	2.94E-01
NADH metabolic process (GO:0006734)	4	2	.70	+	2.87	1.55E-01
negative regulation of protein polyubiquitination (GO:1902915)	2	1	.35	+	2.87	2.94E-01
protein localization to rhabdomere (GO:1990146)	2	1	.35	+	2.87	2.94E-01
endothelial cell differentiation (GO:0045446)	2	1	.35	+	2.87	2.94E-01
positive regulation of guanylate cyclase activity (GO:0031284)	2	1	.35	+	2.87	2.94E-01
regulation of guanylate cyclase activity (GO:0031282)	2	1	.35	+	2.87	2.94E-01
folic acid-containing compound biosynthetic process (GO:0009396)	2	1	.35	+	2.87	2.94E-01
positive regulation of lipase activity (GO:0060193)	2	1	.35	+	2.87	2.94E-01
regulation of lipase activity (GO:0060191)	2	1	.35	+	2.87	2.94E-01
endothelial cell development (GO:0001885)	2	1	.35	+	2.87	2.94E-01
regulation of Golgi organization (GO:1903358)	2	1	.35	+	2.87	2.94E-01
positive regulation of compound eye pigmentation (GO:0048078)	2	1	.35	+	2.87	2.94E-01
positive regulation of eye pigmentation (GO:0048075)	2	1	.35	+	2.87	2.94E-01
male somatic sex determination (GO:0019102)	2	1	.35	+	2.87	2.94E-01
positive regulation of regulated secretory pathway (GO:1903307)	2	1	.35	+	2.87	2.94E-01
negative regulation of response to oxidative stress (GO:1902883)	2	1	.35	+	2.87	2.94E-01
sphingosine metabolic process (GO:0006670)	6	3	1.05	+	2.87	8.89E-02
acyl-CoA biosynthetic process (GO:0071616)	4	2	.70	+	2.87	1.55E-01
endoplasmic reticulum-plasma membrane tethering (GO:0061817)	2	1	.35	+	2.87	2.94E-01
acyl-CoA metabolic process (GO:0006637)	8	4	1.40	+	2.87	5.30E-02
nucleoside salvage (GO:0043174)	2	1	.35	+	2.87	2.94E-01
farnesyl diphosphate metabolic process (GO:0045338)	2	1	.35	+	2.87	2.94E-01
farnesyl diphosphate biosynthetic process (GO:0045337)	2	1	.35	+	2.87	2.94E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	2	1	.35	+	2.87	2.94E-01
leukocyte activation (GO:0045321)	2	1	.35	+	2.87	2.94E-01
positive regulation of compound eye photoreceptor development (GO:0045315)	2	1	.35	+	2.87	2.94E-01
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)	2	1	.35	+	2.87	2.94E-01
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	6	3	1.05	+	2.87	8.89E-02
protein localization to Golgi membrane (GO:1903292)	2	1	.35	+	2.87	2.94E-01
meiotic cell cycle checkpoint (GO:0033313)	4	2	.70	+	2.87	1.55E-01
circadian temperature homeostasis (GO:0060086)	4	2	.70	+	2.87	1.55E-01
membrane bending (GO:0097753)	2	1	.35	+	2.87	2.94E-01
positive regulation of microtubule depolymerization (GO:0031117)	2	1	.35	+	2.87	2.94E-01
negative regulation of microtubule polymerization (GO:0031115)	2	1	.35	+	2.87	2.94E-01
regulation of vacuole fusion, non-autophagic (GO:0032889)	2	1	.35	+	2.87	2.94E-01
regulation of mitotic spindle elongation (GO:0032888)	2	1	.35	+	2.87	2.94E-01
regulation of spindle elongation (GO:0032887)	2	1	.35	+	2.87	2.94E-01
pericardium development (GO:0060039)	2	1	.35	+	2.87	2.94E-01
positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity (GO:1903220)	2	1	.35	+	2.87	2.94E-01
regulation of malate dehydrogenase (decarboxylating) (NADP+) activity (GO:1903218)	2	1	.35	+	2.87	2.94E-01
regulation of response to reactive oxygen species (GO:1901031)	2	1	.35	+	2.87	2.94E-01
tubulin complex assembly (GO:0007021)	4	2	.70	+	2.87	1.55E-01
inner mitochondrial membrane organization (GO:0007007)	6	3	1.05	+	2.87	8.89E-02
mitochondrial large ribosomal subunit assembly (GO:1902775)	2	1	.35	+	2.87	2.94E-01
dopamine biosynthetic process from tyrosine (GO:0006585)	2	1	.35	+	2.87	2.94E-01
positive regulation of transmission of nerve impulse (GO:0051971)	2	1	.35	+	2.87	2.94E-01
monovalent inorganic anion homeostasis (GO:0055083)	2	1	.35	+	2.87	2.94E-01
establishment or maintenance of polarity of embryonic epithelium (GO:0016332)	6	3	1.05	+	2.87	8.89E-02
chloride ion homeostasis (GO:0055064)	2	1	.35	+	2.87	2.94E-01
endoplasmic reticulum membrane fusion (GO:0016320)	2	1	.35	+	2.87	2.94E-01
glutamate catabolic process (GO:0006538)	4	2	.70	+	2.87	1.55E-01
regulation of GTP cyclohydrolase I activity (GO:0043095)	2	1	.35	+	2.87	2.94E-01
cysteine metabolic process (GO:0006534)	2	1	.35	+	2.87	2.94E-01
negative regulation of calcium ion transport (GO:0051926)	6	3	1.05	+	2.87	8.89E-02
vesicle cargo loading (GO:0035459)	6	3	1.05	+	2.87	8.89E-02
heme transport (GO:0015886)	2	1	.35	+	2.87	2.94E-01
maintenance of neuroblast polarity (GO:0045201)	2	1	.35	+	2.87	2.94E-01
tRNA 5'-leader removal (GO:0001682)	2	1	.35	+	2.87	2.94E-01
L-glutamate transmembrane transport (GO:0015813)	4	2	.70	+	2.87	1.55E-01
modulation by symbiont of entry into host (GO:0052372)	2	1	.35	+	2.87	2.94E-01
fatty-acyl-CoA biosynthetic process (GO:0046949)	2	1	.35	+	2.87	2.94E-01
acidic amino acid transport (GO:0015800)	6	3	1.05	+	2.87	8.89E-02
retinal metabolic process (GO:0042574)	2	1	.35	+	2.87	2.94E-01
temperature homeostasis (GO:0001659)	4	2	.70	+	2.87	1.55E-01
negative regulation of ATPase activity (GO:0032780)	2	1	.35	+	2.87	2.94E-01
superoxide anion generation (GO:0042554)	2	1	.35	+	2.87	2.94E-01
nitric oxide-cGMP-mediated signaling pathway (GO:0038060)	2	1	.35	+	2.87	2.94E-01
regulation of cytoplasmic translation (GO:2000765)	6	3	1.05	+	2.87	8.89E-02
signal transduction in absence of ligand (GO:0038034)	2	1	.35	+	2.87	2.94E-01
cellular response to water stimulus (GO:0071462)	2	1	.35	+	2.87	2.94E-01
regulation of SMAD protein complex assembly (GO:0010990)	2	1	.35	+	2.87	2.94E-01
mitochondrial ribosome assembly (GO:0061668)	2	1	.35	+	2.87	2.94E-01
O-glycan processing, core 1 (GO:0016267)	2	1	.35	+	2.87	2.94E-01
malate transmembrane transport (GO:0071423)	2	1	.35	+	2.87	2.94E-01
succinate transmembrane transport (GO:0071422)	2	1	.35	+	2.87	2.94E-01
regulation of autophagosome size (GO:0016243)	2	1	.35	+	2.87	2.94E-01
regulation of translational elongation (GO:0006448)	2	1	.35	+	2.87	2.94E-01
neuronal ion channel clustering (GO:0045161)	2	1	.35	+	2.87	2.94E-01
thioester biosynthetic process (GO:0035384)	4	2	.70	+	2.87	1.55E-01
thioester metabolic process (GO:0035383)	8	4	1.40	+	2.87	5.30E-02
neuroblast fate specification (GO:0014018)	2	1	.35	+	2.87	2.94E-01
translational termination (GO:0006415)	2	1	.35	+	2.87	2.94E-01
cellular triglyceride homeostasis (GO:0035356)	2	1	.35	+	2.87	2.94E-01
azole transmembrane transport (GO:0045117)	2	1	.35	+	2.87	2.94E-01
regulation of histone H2B ubiquitination (GO:2001166)	2	1	.35	+	2.87	2.94E-01
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	2	1	.35	+	2.87	2.94E-01
intermediate filament cytoskeleton organization (GO:0045104)	2	1	.35	+	2.87	2.94E-01
intermediate filament-based process (GO:0045103)	2	1	.35	+	2.87	2.94E-01
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)	2	1	.35	+	2.87	2.94E-01
negative regulation of neuron projection arborization (GO:0150013)	4	2	.70	+	2.87	1.55E-01
oligosaccharide transport (GO:0015772)	2	1	.35	+	2.87	2.94E-01
disaccharide transport (GO:0015766)	2	1	.35	+	2.87	2.94E-01
homoserine metabolic process (GO:0009092)	2	1	.35	+	2.87	2.94E-01
sequestering of iron ion (GO:0097577)	2	1	.35	+	2.87	2.94E-01
malate transport (GO:0015743)	2	1	.35	+	2.87	2.94E-01
oxaloacetate transport (GO:0015729)	2	1	.35	+	2.87	2.94E-01
pentose-phosphate shunt, non-oxidative branch (GO:0009052)	2	1	.35	+	2.87	2.94E-01
thiosulfate transport (GO:0015709)	2	1	.35	+	2.87	2.94E-01
chorion micropyle formation (GO:0046844)	4	2	.70	+	2.87	1.55E-01
bicarbonate transport (GO:0015701)	2	1	.35	+	2.87	2.94E-01
negative regulation of extracellular matrix organization (GO:1903054)	2	1	.35	+	2.87	2.94E-01
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051)	8	4	1.40	+	2.87	5.30E-02
positive regulation of eye photoreceptor cell development (GO:0042479)	2	1	.35	+	2.87	2.94E-01
negative regulation of protein export from nucleus (GO:0046826)	2	1	.35	+	2.87	2.94E-01
positive regulation of gene silencing by miRNA (GO:2000637)	2	1	.35	+	2.87	2.94E-01
cellular response to epidermal growth factor stimulus (GO:0071364)	2	1	.35	+	2.87	2.94E-01
medium-chain fatty acid biosynthetic process (GO:0051792)	2	1	.35	+	2.87	2.94E-01
positive regulation of phospholipase C activity (GO:0010863)	2	1	.35	+	2.87	2.94E-01
negative regulation of apoptotic process involved in development (GO:1904746)	2	1	.35	+	2.87	2.94E-01
actin crosslink formation (GO:0051764)	2	1	.35	+	2.87	2.94E-01
protein import into mitochondrial intermembrane space (GO:0045041)	2	1	.35	+	2.87	2.94E-01
negative regulation of glycogen metabolic process (GO:0070874)	2	1	.35	+	2.87	2.94E-01
ammonium transport (GO:0015696)	2	1	.35	+	2.87	2.94E-01
magnesium ion transport (GO:0015693)	2	1	.35	+	2.87	2.94E-01
germ cell repulsion (GO:0035233)	2	1	.35	+	2.87	2.94E-01
germ cell attraction (GO:0035232)	2	1	.35	+	2.87	2.94E-01
cytoneme assembly (GO:0035231)	2	1	.35	+	2.87	2.94E-01
response to epidermal growth factor (GO:0070849)	2	1	.35	+	2.87	2.94E-01
bicellular tight junction assembly (GO:0070830)	2	1	.35	+	2.87	2.94E-01
hemolymph coagulation (GO:0042381)	4	2	.70	+	2.87	1.55E-01
protein maturation by iron-sulfur cluster transfer (GO:0097428)	2	1	.35	+	2.87	2.94E-01
fructose 1,6-bisphosphate metabolic process (GO:0030388)	2	1	.35	+	2.87	2.94E-01
regulation of fatty acid biosynthetic process (GO:0042304)	2	1	.35	+	2.87	2.94E-01
rhodopsin biosynthetic process (GO:0016063)	12	6	2.09	+	2.87	2.00E-02
adaptation of rhodopsin mediated signaling (GO:0016062)	4	2	.70	+	2.87	1.55E-01
cellular response to peptidoglycan (GO:0071224)	2	1	.35	+	2.87	2.94E-01
cellular response to lipopolysaccharide (GO:0071222)	2	1	.35	+	2.87	2.94E-01
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	6	3	1.05	+	2.87	8.89E-02
peptidyl-L-cysteine S-palmitoylation (GO:0018230)	6	3	1.05	+	2.87	8.89E-02
nuclear pore localization (GO:0051664)	2	1	.35	+	2.87	2.94E-01
regulation of phospholipase C activity (GO:1900274)	2	1	.35	+	2.87	2.94E-01
DNA replication, synthesis of RNA primer (GO:0006269)	2	1	.35	+	2.87	2.94E-01
RNA 5'-end processing (GO:0000966)	2	1	.35	+	2.87	2.94E-01
mitochondrial RNA processing (GO:0000963)	2	1	.35	+	2.87	2.94E-01
uracil catabolic process (GO:0006212)	2	1	.35	+	2.87	2.94E-01
negative regulation of fusion cell fate specification (GO:0035157)	2	1	.35	+	2.87	2.94E-01
stem cell fate specification (GO:0048866)	2	1	.35	+	2.87	2.94E-01
regulation of oviposition (GO:0046662)	8	4	1.40	+	2.87	5.30E-02
tetrahydrofolate biosynthetic process (GO:0046654)	2	1	.35	+	2.87	2.94E-01
positive regulation of small RNA loading onto RISC (GO:0106161)	2	1	.35	+	2.87	2.94E-01
negative regulation of antifungal innate immune response (GO:1905035)	2	1	.35	+	2.87	2.94E-01
regulation of antifungal innate immune response (GO:1905034)	2	1	.35	+	2.87	2.94E-01
regulation of small RNA loading onto RISC (GO:0106159)	2	1	.35	+	2.87	2.94E-01
response to lipopolysaccharide (GO:0032496)	4	2	.70	+	2.87	1.55E-01
positive regulation of cell proliferation involved in compound eye morphogenesis (GO:2000497)	2	1	.35	+	2.87	2.94E-01
Rap protein signal transduction (GO:0032486)	2	1	.35	+	2.87	2.94E-01
establishment of planar polarity of embryonic epithelium (GO:0042249)	2	1	.35	+	2.87	2.94E-01
peptidyl-glutamine modification (GO:0018199)	2	1	.35	+	2.87	2.94E-01
peptidyl-cysteine modification (GO:0018198)	8	4	1.40	+	2.87	5.30E-02
age-dependent response to oxidative stress (GO:0001306)	4	2	.70	+	2.87	1.55E-01
negative regulation of cellular carbohydrate metabolic process (GO:0010677)	2	1	.35	+	2.87	2.94E-01
peptide cross-linking (GO:0018149)	2	1	.35	+	2.87	2.94E-01
regulation of bicoid mRNA localization (GO:0008359)	2	1	.35	+	2.87	2.94E-01
chondroitin sulfate metabolic process (GO:0030204)	2	1	.35	+	2.87	2.94E-01
cellular response to chloroquine (GO:1902350)	2	1	.35	+	2.87	2.94E-01
purine ribonucleoside salvage (GO:0006166)	2	1	.35	+	2.87	2.94E-01
protein K48-linked deubiquitination (GO:0071108)	2	1	.35	+	2.87	2.94E-01
response to chloroquine (GO:1902349)	2	1	.35	+	2.87	2.94E-01
negative regulation of calcium ion import (GO:0090281)	2	1	.35	+	2.87	2.94E-01
positive regulation of TORC2 signaling (GO:1904515)	2	1	.35	+	2.87	2.94E-01
regulation of calcium ion import (GO:0090279)	2	1	.35	+	2.87	2.94E-01
sperm chromatin condensation (GO:0035092)	4	2	.70	+	2.87	1.55E-01
NADH oxidation (GO:0006116)	2	1	.35	+	2.87	2.94E-01
negative regulation of execution phase of apoptosis (GO:1900118)	2	1	.35	+	2.87	2.94E-01
2-oxoglutarate metabolic process (GO:0006103)	2	1	.35	+	2.87	2.94E-01
uracil metabolic process (GO:0019860)	2	1	.35	+	2.87	2.94E-01
male pronucleus assembly (GO:0035039)	12	6	2.09	+	2.87	2.00E-02
adaptation of signaling pathway (GO:0023058)	6	3	1.05	+	2.87	8.89E-02
positive regulation of viral entry into host cell (GO:0046598)	2	1	.35	+	2.87	2.94E-01
regulation of viral entry into host cell (GO:0046596)	2	1	.35	+	2.87	2.94E-01
sphingoid biosynthetic process (GO:0046520)	6	3	1.05	+	2.87	8.89E-02
sphingoid metabolic process (GO:0046519)	6	3	1.05	+	2.87	8.89E-02
ceramide biosynthetic process (GO:0046513)	6	3	1.05	+	2.87	8.89E-02
sphingosine biosynthetic process (GO:0046512)	6	3	1.05	+	2.87	8.89E-02
mitochondrial respiratory chain complex II assembly (GO:0034553)	2	1	.35	+	2.87	2.94E-01
respiratory chain complex II assembly (GO:0034552)	2	1	.35	+	2.87	2.94E-01
regulation of cholesterol transport (GO:0032374)	2	1	.35	+	2.87	2.94E-01
regulation of sterol transport (GO:0032371)	2	1	.35	+	2.87	2.94E-01
glycerolipid catabolic process (GO:0046503)	4	2	.70	+	2.87	1.55E-01
positive regulation of clathrin-dependent endocytosis (GO:2000370)	6	3	1.05	+	2.87	8.89E-02
retrograde axonal transport of mitochondrion (GO:0098958)	2	1	.35	+	2.87	2.94E-01
positive regulation of neuronal action potential (GO:1904457)	2	1	.35	+	2.87	2.94E-01
acetyl-CoA biosynthetic process (GO:0006085)	2	1	.35	+	2.87	2.94E-01
acetyl-CoA metabolic process (GO:0006084)	4	2	.70	+	2.87	1.55E-01
water homeostasis (GO:0030104)	6	3	1.05	+	2.87	8.89E-02
retrograde trans-synaptic signaling (GO:0098917)	2	1	.35	+	2.87	2.94E-01
glycerol-3-phosphate metabolic process (GO:0006072)	2	1	.35	+	2.87	2.94E-01
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	2	1	.35	+	2.87	2.94E-01
ethanol oxidation (GO:0006069)	2	1	.35	+	2.87	2.94E-01
ethanol metabolic process (GO:0006067)	2	1	.35	+	2.87	2.94E-01
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)	2	1	.35	+	2.87	2.94E-01
regulation of calcium ion transport into cytosol (GO:0010522)	2	1	.35	+	2.87	2.94E-01
positive regulation of phospholipase activity (GO:0010518)	2	1	.35	+	2.87	2.94E-01
regulation of phospholipase activity (GO:0010517)	2	1	.35	+	2.87	2.94E-01
negative regulation of protein K63-linked ubiquitination (GO:1900045)	2	1	.35	+	2.87	2.94E-01
regulation of protein K63-linked ubiquitination (GO:1900044)	2	1	.35	+	2.87	2.94E-01
Golgi to lysosome transport (GO:0090160)	2	1	.35	+	2.87	2.94E-01
endoplasmic reticulum membrane organization (GO:0090158)	2	1	.35	+	2.87	2.94E-01
cholesterol metabolic process (GO:0008203)	2	1	.35	+	2.87	2.94E-01
glucose catabolic process (GO:0006007)	2	1	.35	+	2.87	2.94E-01
achiasmate meiosis I (GO:0000705)	2	1	.35	+	2.87	2.94E-01
fructose 6-phosphate metabolic process (GO:0006002)	4	2	.70	+	2.87	1.55E-01
fructose metabolic process (GO:0006000)	2	1	.35	+	2.87	2.94E-01
regulation of synapse maturation (GO:0090128)	2	1	.35	+	2.87	2.94E-01
COPII-coated vesicle budding (GO:0090114)	6	3	1.05	+	2.87	8.89E-02
COPII-coated vesicle cargo loading (GO:0090110)	4	2	.70	+	2.87	1.55E-01
negative regulation of proteasomal protein catabolic process (GO:1901799)	6	3	1.05	+	2.87	8.89E-02
negative regulation of signal transduction by p53 class mediator (GO:1901797)	2	1	.35	+	2.87	2.94E-01
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	2	1	.35	+	2.87	2.94E-01
cytoneme morphogenesis (GO:0003399)	2	1	.35	+	2.87	2.94E-01
detection of temperature stimulus involved in thermoception (GO:0050960)	2	1	.35	+	2.87	2.94E-01
olefinic compound metabolic process (GO:0120254)	2	1	.35	+	2.87	2.94E-01
thermoception (GO:0050955)	2	1	.35	+	2.87	2.94E-01
sensory perception of light stimulus (GO:0050953)	22	11	3.84	+	2.87	2.03E-03
acylglycerol catabolic process (GO:0046464)	4	2	.70	+	2.87	1.55E-01
neutral lipid catabolic process (GO:0046461)	4	2	.70	+	2.87	1.55E-01
positive regulation of viral life cycle (GO:1903902)	2	1	.35	+	2.87	2.94E-01
negative regulation of endoribonuclease activity (GO:0060702)	2	1	.35	+	2.87	2.94E-01
negative regulation of ribonuclease activity (GO:0060701)	2	1	.35	+	2.87	2.94E-01
regulation of ribonuclease activity (GO:0060700)	2	1	.35	+	2.87	2.94E-01
late endosome to Golgi transport (GO:0034499)	2	1	.35	+	2.87	2.94E-01
early endosome to Golgi transport (GO:0034498)	2	1	.35	+	2.87	2.94E-01
pericardium morphogenesis (GO:0003344)	2	1	.35	+	2.87	2.94E-01
ncRNA 5'-end processing (GO:0034471)	2	1	.35	+	2.87	2.94E-01
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)	2	1	.35	+	2.87	2.94E-01
positive regulation of ligase activity (GO:0051351)	2	1	.35	+	2.87	2.94E-01
regulation of ligase activity (GO:0051340)	2	1	.35	+	2.87	2.94E-01
negative regulation of carbohydrate metabolic process (GO:0045912)	2	1	.35	+	2.87	2.94E-01
regulation of antifungal peptide biosynthetic process (GO:0002810)	2	1	.35	+	2.87	2.94E-01
meiotic metaphase plate congression (GO:0051311)	2	1	.35	+	2.87	2.94E-01
rRNA base methylation (GO:0070475)	2	1	.35	+	2.87	2.94E-01
regulation of endoribonuclease activity (GO:0060699)	2	1	.35	+	2.87	2.94E-01
central nervous system neuron axonogenesis (GO:0021955)	4	2	.70	+	2.87	1.55E-01
multicellular organismal water homeostasis (GO:0050891)	2	1	.35	+	2.87	2.94E-01
neuromuscular process controlling posture (GO:0050884)	6	3	1.05	+	2.87	8.89E-02
iron coordination entity transport (GO:1901678)	2	1	.35	+	2.87	2.94E-01
ncRNA export from nucleus (GO:0097064)	2	1	.35	+	2.87	2.94E-01
dendritic spine maintenance (GO:0097062)	2	1	.35	+	2.87	2.94E-01
regulation of chromosome condensation (GO:0060623)	2	1	.35	+	2.87	2.94E-01
protein localization to cell surface (GO:0034394)	4	2	.70	+	2.87	1.55E-01
coagulation (GO:0050817)	4	2	.70	+	2.87	1.55E-01
positive regulation by symbiont of entry into host (GO:0075294)	2	1	.35	+	2.87	2.94E-01
renal protein absorption (GO:0097017)	2	1	.35	+	2.87	2.94E-01
actomyosin contractile ring localization (GO:0032187)	2	1	.35	+	2.87	2.94E-01
regulation of establishment of cell polarity (GO:2000114)	2	1	.35	+	2.87	2.94E-01
positive regulation of rhodopsin gene expression (GO:0045872)	2	1	.35	+	2.87	2.94E-01
negative regulation of sequestering of calcium ion (GO:0051283)	4	2	.70	+	2.87	1.55E-01
regulation of sequestering of calcium ion (GO:0051282)	4	2	.70	+	2.87	1.55E-01
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	4	2	.70	+	2.87	1.55E-01
negative regulation of wound healing (GO:0061045)	2	1	.35	+	2.87	2.94E-01
negative regulation of nurse cell apoptotic process (GO:0045849)	2	1	.35	+	2.87	2.94E-01
mitochondrial thiamine pyrophosphate transmembrane transport (GO:1990545)	2	1	.35	+	2.87	2.94E-01
iron ion import across plasma membrane (GO:0098711)	2	1	.35	+	2.87	2.94E-01
positive regulation of membrane potential (GO:0045838)	2	1	.35	+	2.87	2.94E-01
sequestering of metal ion (GO:0051238)	2	1	.35	+	2.87	2.94E-01
dense core granule exocytosis (GO:1990504)	2	1	.35	+	2.87	2.94E-01
positive regulation of eclosion (GO:0045805)	2	1	.35	+	2.87	2.94E-01
cortical microtubule organization (GO:0043622)	2	1	.35	+	2.87	2.94E-01
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	4	2	.70	+	2.87	1.55E-01
sequestering of calcium ion (GO:0051208)	2	1	.35	+	2.87	2.94E-01
protein insertion into membrane (GO:0051205)	4	2	.70	+	2.87	1.55E-01
regulation of neuronal synaptic plasticity in response to neurotrophin (GO:0031637)	2	1	.35	+	2.87	2.94E-01
regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630)	2	1	.35	+	2.87	2.94E-01
hemostasis (GO:0007599)	4	2	.70	+	2.87	1.55E-01
regulation of DNA double-strand break processing (GO:1903775)	2	1	.35	+	2.87	2.94E-01
positive regulation of microfilament motor activity (GO:0120081)	2	1	.35	+	2.87	2.94E-01
age-dependent general metabolic decline (GO:0007571)	4	2	.70	+	2.87	1.55E-01
regulation of translation in response to endoplasmic reticulum stress (GO:0036490)	2	1	.35	+	2.87	2.94E-01
negative regulation of inflammatory response (GO:0050728)	2	1	.35	+	2.87	2.94E-01
regulation of inflammatory response (GO:0050727)	2	1	.35	+	2.87	2.94E-01
endothelium development (GO:0003158)	2	1	.35	+	2.87	2.94E-01
tRNA 5'-end processing (GO:0099116)	2	1	.35	+	2.87	2.94E-01
negative regulation of nuclease activity (GO:0032074)	2	1	.35	+	2.87	2.94E-01
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)	6	3	1.05	+	2.87	8.89E-02
cardiolipin biosynthetic process (GO:0032049)	2	1	.35	+	2.87	2.94E-01
cardiolipin metabolic process (GO:0032048)	2	1	.35	+	2.87	2.94E-01
detoxification of iron ion (GO:1990461)	2	1	.35	+	2.87	2.94E-01
positive regulation of action potential (GO:0045760)	2	1	.35	+	2.87	2.94E-01
enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	2	1	.35	+	2.87	2.94E-01
ammonium transmembrane transport (GO:0072488)	2	1	.35	+	2.87	2.94E-01
beta-alanine biosynthetic process (GO:0019483)	2	1	.35	+	2.87	2.94E-01
beta-alanine metabolic process (GO:0019482)	2	1	.35	+	2.87	2.94E-01
renal absorption (GO:0070293)	2	1	.35	+	2.87	2.94E-01
endosomal lumen acidification (GO:0048388)	2	1	.35	+	2.87	2.94E-01
response to blue light (GO:0009637)	2	1	.35	+	2.87	2.94E-01
dorsal/ventral lineage restriction, imaginal disc (GO:0007451)	2	1	.35	+	2.87	2.94E-01
homocysteine metabolic process (GO:0050667)	2	1	.35	+	2.87	2.94E-01
renal sodium ion transport (GO:0003096)	2	1	.35	+	2.87	2.94E-01
protein poly-ADP-ribosylation (GO:0070212)	2	1	.35	+	2.87	2.94E-01
light adaption (GO:0036367)	4	2	.70	+	2.87	1.55E-01
tyramine signaling pathway (GO:0071928)	2	1	.35	+	2.87	2.94E-01
positive regulation of antifungal peptide biosynthetic process (GO:0006967)	2	1	.35	+	2.87	2.94E-01
positive regulation of heterotypic cell-cell adhesion (GO:0034116)	2	1	.35	+	2.87	2.94E-01
regulation of heterotypic cell-cell adhesion (GO:0034114)	2	1	.35	+	2.87	2.94E-01
regulation of homotypic cell-cell adhesion (GO:0034110)	2	1	.35	+	2.87	2.94E-01
positive regulation of locomotor rhythm (GO:1904061)	2	1	.35	+	2.87	2.94E-01
regulation of proton transport (GO:0010155)	2	1	.35	+	2.87	2.94E-01
tRNA transport (GO:0051031)	2	1	.35	+	2.87	2.94E-01
snRNA transport (GO:0051030)	2	1	.35	+	2.87	2.94E-01
negative regulation of MAP kinase activity (GO:0043407)	6	3	1.05	+	2.87	8.89E-02
retrograde transport, vesicle recycling within Golgi (GO:0000301)	2	1	.35	+	2.87	2.94E-01
pyridine nucleotide biosynthetic process (GO:0019363)	2	1	.35	+	2.87	2.94E-01
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	2	1	.35	+	2.87	2.94E-01
peptidyl-lysine hydroxylation (GO:0017185)	2	1	.35	+	2.87	2.94E-01
nicotinamide nucleotide biosynthetic process (GO:0019359)	2	1	.35	+	2.87	2.94E-01
synapse assembly involved in innervation (GO:0060386)	2	1	.35	+	2.87	2.94E-01
transsulfuration (GO:0019346)	2	1	.35	+	2.87	2.94E-01
UDP-galactose transmembrane transport (GO:0072334)	2	1	.35	+	2.87	2.94E-01
cysteine biosynthetic process (GO:0019344)	2	1	.35	+	2.87	2.94E-01
cysteine biosynthetic process via cystathionine (GO:0019343)	2	1	.35	+	2.87	2.94E-01
negative regulation of response to endoplasmic reticulum stress (GO:1903573)	2	1	.35	+	2.87	2.94E-01
negative regulation of receptor-mediated endocytosis (GO:0048261)	2	1	.35	+	2.87	2.94E-01
apical constriction involved in ventral furrow formation (GO:0110072)	2	1	.35	+	2.87	2.94E-01
thiamine pyrophosphate transmembrane transport (GO:0030974)	2	1	.35	+	2.87	2.94E-01
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	26	13	4.53	+	2.87	8.33E-04
cellular response to light stimulus (GO:0071482)	35	17	6.10	+	2.79	2.01E-04
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	29	14	5.06	+	2.77	7.49E-04
pole cell migration (GO:0007280)	21	10	3.66	+	2.73	4.44E-03
phototransduction, visible light (GO:0007603)	21	10	3.66	+	2.73	4.44E-03
alcohol catabolic process (GO:0046164)	15	7	2.62	+	2.68	1.75E-02
photoreceptor cell maintenance (GO:0045494)	13	6	2.27	+	2.65	2.81E-02
response to cocaine (GO:0042220)	13	6	2.27	+	2.65	2.81E-02
photoperiodism (GO:0009648)	13	6	2.27	+	2.65	2.81E-02
rRNA modification (GO:0000154)	11	5	1.92	+	2.61	4.54E-02
N-glycan processing (GO:0006491)	11	5	1.92	+	2.61	4.54E-02
glutamine family amino acid catabolic process (GO:0009065)	11	5	1.92	+	2.61	4.54E-02
diol biosynthetic process (GO:0034312)	11	5	1.92	+	2.61	4.54E-02
diol metabolic process (GO:0034311)	11	5	1.92	+	2.61	4.54E-02
eclosion (GO:0007562)	11	5	1.92	+	2.61	4.54E-02
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	20	9	3.49	+	2.58	9.54E-03
chloride transport (GO:0006821)	18	8	3.14	+	2.55	1.50E-02
response to hydrogen peroxide (GO:0042542)	9	4	1.57	+	2.55	7.45E-02
zonula adherens assembly (GO:0045186)	9	4	1.57	+	2.55	7.45E-02
visual perception (GO:0007601)	18	8	3.14	+	2.55	1.50E-02
inorganic anion transmembrane transport (GO:0098661)	18	8	3.14	+	2.55	1.50E-02
negative regulation of binding (GO:0051100)	9	4	1.57	+	2.55	7.45E-02
response to drug (GO:0042493)	16	7	2.79	+	2.51	2.38E-02
negative regulation of multi-organism process (GO:0043901)	16	7	2.79	+	2.51	2.38E-02
maintenance of cell polarity (GO:0030011)	16	7	2.79	+	2.51	2.38E-02
negative regulation of peptidoglycan recognition protein signaling pathway (GO:0061060)	16	7	2.79	+	2.51	2.38E-02
sulfur amino acid metabolic process (GO:0000096)	7	3	1.22	+	2.46	1.25E-01
protein targeting to mitochondrion (GO:0006626)	21	9	3.66	+	2.46	1.27E-02
protein K48-linked ubiquitination (GO:0070936)	7	3	1.22	+	2.46	1.25E-01
C4-dicarboxylate transport (GO:0015740)	7	3	1.22	+	2.46	1.25E-01
negative regulation of RNA splicing (GO:0033119)	7	3	1.22	+	2.46	1.25E-01
regulation of cell proliferation involved in compound eye morphogenesis (GO:2000495)	7	3	1.22	+	2.46	1.25E-01
cell-cell adhesion mediated by cadherin (GO:0044331)	14	6	2.44	+	2.46	3.80E-02
neuron projection organization (GO:0106027)	7	3	1.22	+	2.46	1.25E-01
protein localization to mitochondrion (GO:0070585)	21	9	3.66	+	2.46	1.27E-02
muscle organ morphogenesis (GO:0048644)	7	3	1.22	+	2.46	1.25E-01
establishment of protein localization to mitochondrion (GO:0072655)	21	9	3.66	+	2.46	1.27E-02
dendritic spine organization (GO:0097061)	7	3	1.22	+	2.46	1.25E-01
adherens junction maintenance (GO:0034334)	7	3	1.22	+	2.46	1.25E-01
negative regulation of defense response to bacterium (GO:1900425)	19	8	3.31	+	2.41	2.00E-02
phototransduction (GO:0007602)	50	21	8.72	+	2.41	2.73E-04
electron transport chain (GO:0022900)	67	28	11.68	+	2.40	3.13E-05
entrainment of circadian clock by photoperiod (GO:0043153)	12	5	2.09	+	2.39	6.12E-02
ectopic germ cell programmed cell death (GO:0035234)	12	5	2.09	+	2.39	6.12E-02
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	12	5	2.09	+	2.39	6.12E-02
tricarboxylic acid cycle (GO:0006099)	12	5	2.09	+	2.39	6.12E-02
glucose metabolic process (GO:0006006)	12	5	2.09	+	2.39	6.12E-02
regulation of body fluid levels (GO:0050878)	12	5	2.09	+	2.39	6.12E-02
ATP metabolic process (GO:0046034)	97	40	16.91	+	2.36	9.67E-07
photoreceptor cell morphogenesis (GO:0008594)	17	7	2.96	+	2.36	3.15E-02
generation of precursor metabolites and energy (GO:0006091)	120	49	20.93	+	2.34	7.99E-08
respiratory electron transport chain (GO:0022904)	64	26	11.16	+	2.33	9.24E-05
cellular respiration (GO:0045333)	74	30	12.90	+	2.32	2.88E-05
detection of visible light (GO:0009584)	25	10	4.36	+	2.29	1.39E-02
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	10	4	1.74	+	2.29	9.97E-02
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	10	4	1.74	+	2.29	9.97E-02
response to iron ion (GO:0010039)	5	2	.87	+	2.29	2.17E-01
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	5	2	.87	+	2.29	2.17E-01
octopamine or tyramine signaling pathway (GO:0007211)	5	2	.87	+	2.29	2.17E-01
establishment of body hair or bristle planar orientation (GO:0048104)	5	2	.87	+	2.29	2.17E-01
regulation of nucleotide biosynthetic process (GO:0030808)	5	2	.87	+	2.29	2.17E-01
tetrahydrobiopterin biosynthetic process (GO:0006729)	5	2	.87	+	2.29	2.17E-01
negative regulation of ion transport (GO:0043271)	10	4	1.74	+	2.29	9.97E-02
response to tumor cell (GO:0002347)	5	2	.87	+	2.29	2.17E-01
adult chitin-containing cuticle pigmentation (GO:0048085)	5	2	.87	+	2.29	2.17E-01
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	60	24	10.46	+	2.29	2.11E-04
cuticle pigmentation (GO:0048067)	10	4	1.74	+	2.29	9.97E-02
inositol phosphate catabolic process (GO:0071545)	10	4	1.74	+	2.29	9.97E-02
establishment or maintenance of polarity of larval imaginal disc epithelium (GO:0016336)	5	2	.87	+	2.29	2.17E-01
negative regulation of neurotransmitter secretion (GO:0046929)	5	2	.87	+	2.29	2.17E-01
negative regulation of stem cell differentiation (GO:2000737)	10	4	1.74	+	2.29	9.97E-02
regulation of mitochondrial membrane potential (GO:0051881)	5	2	.87	+	2.29	2.17E-01
regulation of histone ubiquitination (GO:0033182)	5	2	.87	+	2.29	2.17E-01
protein neddylation (GO:0045116)	5	2	.87	+	2.29	2.17E-01
inositol phosphate dephosphorylation (GO:0046855)	10	4	1.74	+	2.29	9.97E-02
phosphorylated carbohydrate dephosphorylation (GO:0046838)	10	4	1.74	+	2.29	9.97E-02
positive regulation of RNA export from nucleus (GO:0046833)	5	2	.87	+	2.29	2.17E-01
catecholamine biosynthetic process (GO:0042423)	5	2	.87	+	2.29	2.17E-01
regulation of purine nucleotide biosynthetic process (GO:1900371)	5	2	.87	+	2.29	2.17E-01
regulation of centrosome duplication (GO:0010824)	5	2	.87	+	2.29	2.17E-01
organic cation transport (GO:0015695)	5	2	.87	+	2.29	2.17E-01
metarhodopsin inactivation (GO:0016060)	5	2	.87	+	2.29	2.17E-01
cellular response to molecule of bacterial origin (GO:0071219)	5	2	.87	+	2.29	2.17E-01
cellular response to biotic stimulus (GO:0071216)	5	2	.87	+	2.29	2.17E-01
endoplasmic reticulum localization (GO:0051643)	5	2	.87	+	2.29	2.17E-01
dendritic spine morphogenesis (GO:0060997)	5	2	.87	+	2.29	2.17E-01
dendritic spine development (GO:0060996)	5	2	.87	+	2.29	2.17E-01
regulation of gene silencing by miRNA (GO:0060964)	5	2	.87	+	2.29	2.17E-01
regulation of membrane lipid metabolic process (GO:1905038)	5	2	.87	+	2.29	2.17E-01
regulation of centrosome cycle (GO:0046605)	5	2	.87	+	2.29	2.17E-01
negative regulation of neurotransmitter transport (GO:0051589)	5	2	.87	+	2.29	2.17E-01
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	5	2	.87	+	2.29	2.17E-01
renal tubular secretion (GO:0097254)	5	2	.87	+	2.29	2.17E-01
epidermis morphogenesis (GO:0048730)	5	2	.87	+	2.29	2.17E-01
negative regulation of meiotic cell cycle (GO:0051447)	5	2	.87	+	2.29	2.17E-01
regulation of sphingolipid biosynthetic process (GO:0090153)	5	2	.87	+	2.29	2.17E-01
detection of light stimulus involved in visual perception (GO:0050908)	5	2	.87	+	2.29	2.17E-01
perineurial glial growth (GO:0042066)	5	2	.87	+	2.29	2.17E-01
positive regulation of nucleobase-containing compound transport (GO:0032241)	5	2	.87	+	2.29	2.17E-01
positive regulation of exocytosis (GO:0045921)	5	2	.87	+	2.29	2.17E-01
NAD metabolic process (GO:0019674)	5	2	.87	+	2.29	2.17E-01
phototransduction, UV (GO:0007604)	5	2	.87	+	2.29	2.17E-01
primary alcohol metabolic process (GO:0034308)	5	2	.87	+	2.29	2.17E-01
dicarboxylic acid catabolic process (GO:0043649)	5	2	.87	+	2.29	2.17E-01
nucleoside bisphosphate biosynthetic process (GO:0033866)	10	4	1.74	+	2.29	9.97E-02
cytoplasmic sequestering of protein (GO:0051220)	5	2	.87	+	2.29	2.17E-01
positive regulation of nervous system process (GO:0031646)	5	2	.87	+	2.29	2.17E-01
regulation of eclosion (GO:0007563)	5	2	.87	+	2.29	2.17E-01
fatty acid derivative metabolic process (GO:1901568)	5	2	.87	+	2.29	2.17E-01
catechol-containing compound biosynthetic process (GO:0009713)	5	2	.87	+	2.29	2.17E-01
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	5	2	.87	+	2.29	2.17E-01
analia development (GO:0007487)	5	2	.87	+	2.29	2.17E-01
regulation of rhodopsin gene expression (GO:0007468)	5	2	.87	+	2.29	2.17E-01
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	5	2	.87	+	2.29	2.17E-01
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	5	2	.87	+	2.29	2.17E-01
tetrahydrobiopterin metabolic process (GO:0046146)	5	2	.87	+	2.29	2.17E-01
intracellular distribution of mitochondria (GO:0048312)	5	2	.87	+	2.29	2.17E-01
cytoplasmic sequestering of transcription factor (GO:0042994)	5	2	.87	+	2.29	2.17E-01
rRNA processing (GO:0006364)	63	25	10.99	+	2.28	1.77E-04
detection of light stimulus (GO:0009583)	53	21	9.24	+	2.27	5.73E-04
ATP synthesis coupled electron transport (GO:0042773)	61	24	10.64	+	2.26	2.67E-04
mitochondrial translation (GO:0032543)	74	29	12.90	+	2.25	6.96E-05
dorsal/ventral pattern formation, imaginal disc (GO:0007450)	46	18	8.02	+	2.24	1.56E-03
cellular response to decreased oxygen levels (GO:0036294)	23	9	4.01	+	2.24	2.14E-02
ribosomal large subunit biogenesis (GO:0042273)	36	14	6.28	+	2.23	5.18E-03
oxidative phosphorylation (GO:0006119)	67	26	11.68	+	2.23	1.87E-04
rRNA metabolic process (GO:0016072)	70	27	12.21	+	2.21	1.57E-04
isoprenoid metabolic process (GO:0006720)	13	5	2.27	+	2.21	7.97E-02
triglyceride metabolic process (GO:0006641)	13	5	2.27	+	2.21	7.97E-02
energy derivation by oxidation of organic compounds (GO:0015980)	91	35	15.87	+	2.21	1.91E-05
mitochondrial membrane organization (GO:0007006)	13	5	2.27	+	2.21	7.97E-02
regulation of calcium ion transport (GO:0051924)	13	5	2.27	+	2.21	7.97E-02
cellular hormone metabolic process (GO:0034754)	26	10	4.53	+	2.21	1.77E-02
polyol catabolic process (GO:0046174)	13	5	2.27	+	2.21	7.97E-02
wing disc dorsal/ventral pattern formation (GO:0048190)	42	16	7.32	+	2.18	3.57E-03
pyruvate metabolic process (GO:0006090)	21	8	3.66	+	2.18	3.32E-02
locomotor rhythm (GO:0045475)	61	23	10.64	+	2.16	6.28E-04
Golgi to vacuole transport (GO:0006896)	8	3	1.40	+	2.15	1.65E-01
purine nucleoside bisphosphate metabolic process (GO:0034032)	16	6	2.79	+	2.15	6.40E-02
Golgi vesicle budding (GO:0048194)	8	3	1.40	+	2.15	1.65E-01
porphyrin-containing compound metabolic process (GO:0006778)	8	3	1.40	+	2.15	1.65E-01
snoRNA 3'-end processing (GO:0031126)	8	3	1.40	+	2.15	1.65E-01
pteridine-containing compound biosynthetic process (GO:0042559)	8	3	1.40	+	2.15	1.65E-01
cellular response to oxygen levels (GO:0071453)	24	9	4.19	+	2.15	2.71E-02
regulation of sodium ion transport (GO:0002028)	8	3	1.40	+	2.15	1.65E-01
male gonad development (GO:0008584)	8	3	1.40	+	2.15	1.65E-01
tetrapyrrole metabolic process (GO:0033013)	8	3	1.40	+	2.15	1.65E-01
regulation of membrane potential in photoreceptor cell (GO:0016057)	8	3	1.40	+	2.15	1.65E-01
maintenance of apical/basal cell polarity (GO:0035090)	8	3	1.40	+	2.15	1.65E-01
development of primary male sexual characteristics (GO:0046546)	8	3	1.40	+	2.15	1.65E-01
heme metabolic process (GO:0042168)	8	3	1.40	+	2.15	1.65E-01
regulation of clathrin-dependent endocytosis (GO:2000369)	8	3	1.40	+	2.15	1.65E-01
glial cell growth (GO:0042065)	8	3	1.40	+	2.15	1.65E-01
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)	8	3	1.40	+	2.15	1.65E-01
ribonucleoside bisphosphate metabolic process (GO:0033875)	16	6	2.79	+	2.15	6.40E-02
nucleoside bisphosphate metabolic process (GO:0033865)	16	6	2.79	+	2.15	6.40E-02
mitochondrial gene expression (GO:0140053)	81	30	14.12	+	2.12	1.39E-04
organic hydroxy compound catabolic process (GO:1901616)	19	7	3.31	+	2.11	5.16E-02
negative regulation of synaptic transmission (GO:0050805)	19	7	3.31	+	2.11	5.16E-02
cellular response to radiation (GO:0071478)	52	19	9.07	+	2.10	2.51E-03
dicarboxylic acid transport (GO:0006835)	11	4	1.92	+	2.09	1.28E-01
nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	11	4	1.92	+	2.09	1.28E-01
cytochrome complex assembly (GO:0017004)	11	4	1.92	+	2.09	1.28E-01
glutamate metabolic process (GO:0006536)	11	4	1.92	+	2.09	1.28E-01
habituation (GO:0046959)	11	4	1.92	+	2.09	1.28E-01
maintenance of epithelial integrity, open tracheal system (GO:0035160)	11	4	1.92	+	2.09	1.28E-01
dorsal closure, amnioserosa morphology change (GO:0046664)	11	4	1.92	+	2.09	1.28E-01
cell elongation involved in imaginal disc-derived wing morphogenesis (GO:0090254)	11	4	1.92	+	2.09	1.28E-01
establishment of epithelial cell polarity (GO:0090162)	11	4	1.92	+	2.09	1.28E-01
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	22	8	3.84	+	2.09	4.17E-02
negative regulation of Toll signaling pathway (GO:0045751)	11	4	1.92	+	2.09	1.28E-01
larval salivary gland morphogenesis (GO:0007436)	11	4	1.92	+	2.09	1.28E-01
central nervous system morphogenesis (GO:0021551)	14	5	2.44	+	2.05	1.01E-01
regulation of cuticle pigmentation (GO:0048079)	14	5	2.44	+	2.05	1.01E-01
ribosomal small subunit biogenesis (GO:0042274)	31	11	5.41	+	2.03	2.23E-02
polyol metabolic process (GO:0019751)	31	11	5.41	+	2.03	2.23E-02
thermotaxis (GO:0043052)	17	6	2.96	+	2.02	8.01E-02
sulfur compound biosynthetic process (GO:0044272)	17	6	2.96	+	2.02	8.01E-02
polyol biosynthetic process (GO:0046173)	17	6	2.96	+	2.02	8.01E-02
renal system process (GO:0003014)	17	6	2.96	+	2.02	8.01E-02
sensory perception of sound (GO:0007605)	54	19	9.42	+	2.02	3.74E-03
acylglycerol metabolic process (GO:0006639)	20	7	3.49	+	2.01	6.40E-02
neutral lipid metabolic process (GO:0006638)	20	7	3.49	+	2.01	6.40E-02
mitochondrial respiratory chain complex assembly (GO:0033108)	20	7	3.49	+	2.01	6.40E-02
rhabdomere development (GO:0042052)	40	14	6.98	+	2.01	1.22E-02
actin filament bundle assembly (GO:0051017)	20	7	3.49	+	2.01	6.40E-02
autophagic cell death (GO:0048102)	26	9	4.53	+	1.99	4.15E-02
inorganic anion transport (GO:0015698)	26	9	4.53	+	1.99	4.15E-02
fluid transport (GO:0042044)	26	9	4.53	+	1.99	4.15E-02
carbohydrate catabolic process (GO:0016052)	32	11	5.58	+	1.97	2.72E-02
rhythmic behavior (GO:0007622)	70	24	12.21	+	1.97	1.71E-03
mitochondrial transport (GO:0006839)	47	16	8.20	+	1.95	9.87E-03
anion transmembrane transport (GO:0098656)	47	16	8.20	+	1.95	9.87E-03
circadian behavior (GO:0048512)	68	23	11.86	+	1.94	2.49E-03
sulfur compound metabolic process (GO:0006790)	77	26	13.43	+	1.94	1.39E-03
CENP-A containing nucleosome assembly (GO:0034080)	3	1	.52	+	1.91	4.07E-01
mitochondrial calcium ion transmembrane transport (GO:0006851)	3	1	.52	+	1.91	4.07E-01
negative regulation of DNA binding (GO:0043392)	6	2	1.05	+	1.91	2.81E-01
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	3	1	.52	+	1.91	4.07E-01
regulation of sarcomere organization (GO:0060297)	3	1	.52	+	1.91	4.07E-01
respiratory chain complex III assembly (GO:0017062)	3	1	.52	+	1.91	4.07E-01
spermatid nucleus differentiation (GO:0007289)	12	4	2.09	+	1.91	1.60E-01
negative regulation of glial cell proliferation (GO:0060253)	6	2	1.05	+	1.91	2.81E-01
regulation of fatty acid metabolic process (GO:0019217)	3	1	.52	+	1.91	4.07E-01
regulation of cytokine-mediated signaling pathway (GO:0001959)	6	2	1.05	+	1.91	2.81E-01
integrin-mediated signaling pathway (GO:0007229)	6	2	1.05	+	1.91	2.81E-01
regulation of receptor recycling (GO:0001919)	3	1	.52	+	1.91	4.07E-01
protein import into peroxisome matrix, docking (GO:0016560)	3	1	.52	+	1.91	4.07E-01
Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	3	1	.52	+	1.91	4.07E-01
ER-associated misfolded protein catabolic process (GO:0071712)	3	1	.52	+	1.91	4.07E-01
glutathione biosynthetic process (GO:0006750)	3	1	.52	+	1.91	4.07E-01
mucosal immune response (GO:0002385)	12	4	2.09	+	1.91	1.60E-01
one-carbon metabolic process (GO:0006730)	6	2	1.05	+	1.91	2.81E-01
regulation of protein polyubiquitination (GO:1902914)	3	1	.52	+	1.91	4.07E-01
positive regulation of cyclase activity (GO:0031281)	3	1	.52	+	1.91	4.07E-01
regulation of cyclase activity (GO:0031279)	6	2	1.05	+	1.91	2.81E-01
mRNA transcription by RNA polymerase II (GO:0042789)	6	2	1.05	+	1.91	2.81E-01
positive regulation of posttranscriptional gene silencing (GO:0060148)	3	1	.52	+	1.91	4.07E-01
regulation of posttranscriptional gene silencing (GO:0060147)	6	2	1.05	+	1.91	2.81E-01
compound eye corneal lens development (GO:0048058)	3	1	.52	+	1.91	4.07E-01
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	3	1	.52	+	1.91	4.07E-01
cleavage furrow formation (GO:0036089)	3	1	.52	+	1.91	4.07E-01
negative regulation of regulated secretory pathway (GO:1903306)	3	1	.52	+	1.91	4.07E-01
N-glycan fucosylation (GO:0036071)	3	1	.52	+	1.91	4.07E-01
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	3	1	.52	+	1.91	4.07E-01
SREBP signaling pathway (GO:0032933)	6	2	1.05	+	1.91	2.81E-01
anterior/posterior axis specification, follicular epithelium (GO:0030714)	3	1	.52	+	1.91	4.07E-01
dosage compensation complex assembly involved in dosage compensation by hyperactivation of X chromosome (GO:0016457)	3	1	.52	+	1.91	4.07E-01
phosphatidylglycerol biosynthetic process (GO:0006655)	3	1	.52	+	1.91	4.07E-01
fatty acid biosynthetic process (GO:0006633)	24	8	4.19	+	1.91	6.25E-02
sulfur amino acid biosynthetic process (GO:0000097)	6	2	1.05	+	1.91	2.81E-01
protein targeting to peroxisome (GO:0006625)	12	4	2.09	+	1.91	1.60E-01
organ or tissue specific immune response (GO:0002251)	12	4	2.09	+	1.91	1.60E-01
toll-like receptor signaling pathway (GO:0002224)	3	1	.52	+	1.91	4.07E-01
female germ-line sex determination (GO:0019099)	3	1	.52	+	1.91	4.07E-01
replication fork arrest (GO:0043111)	3	1	.52	+	1.91	4.07E-01
mRNA transcription (GO:0009299)	6	2	1.05	+	1.91	2.81E-01
mitochondrion inheritance (GO:0000001)	3	1	.52	+	1.91	4.07E-01
glucosamine-containing compound biosynthetic process (GO:1901073)	3	1	.52	+	1.91	4.07E-01
mitotic G1/S transition checkpoint (GO:0044819)	3	1	.52	+	1.91	4.07E-01
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	3	1	.52	+	1.91	4.07E-01
negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	3	1	.52	+	1.91	4.07E-01
mitochondrion transport along microtubule (GO:0047497)	12	4	2.09	+	1.91	1.60E-01
regulation of transmission of nerve impulse (GO:0051969)	3	1	.52	+	1.91	4.07E-01
fatty acid homeostasis (GO:0055089)	3	1	.52	+	1.91	4.07E-01
anion homeostasis (GO:0055081)	6	2	1.05	+	1.91	2.81E-01
proline catabolic process (GO:0006562)	3	1	.52	+	1.91	4.07E-01
cellular response to sterol depletion (GO:0071501)	6	2	1.05	+	1.91	2.81E-01
regulation of sensory perception (GO:0051931)	3	1	.52	+	1.91	4.07E-01
regulation of sensory perception of pain (GO:0051930)	3	1	.52	+	1.91	4.07E-01
arginine catabolic process (GO:0006527)	3	1	.52	+	1.91	4.07E-01
C-terminal protein lipidation (GO:0006501)	3	1	.52	+	1.91	4.07E-01
drug transport (GO:0015893)	3	1	.52	+	1.91	4.07E-01
neurotransmitter receptor metabolic process (GO:0045213)	3	1	.52	+	1.91	4.07E-01
store-operated calcium entry (GO:0002115)	3	1	.52	+	1.91	4.07E-01
negative regulation of histone methylation (GO:0031061)	6	2	1.05	+	1.91	2.81E-01
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	3	1	.52	+	1.91	4.07E-01
nucleoside transport (GO:0015858)	3	1	.52	+	1.91	4.07E-01
iron import into cell (GO:0033212)	3	1	.52	+	1.91	4.07E-01
negative regulation of calcium ion transmembrane transport (GO:1903170)	3	1	.52	+	1.91	4.07E-01
long-chain fatty acid metabolic process (GO:0001676)	6	2	1.05	+	1.91	2.81E-01
protein folding in endoplasmic reticulum (GO:0034975)	3	1	.52	+	1.91	4.07E-01
regulation of mitochondrial membrane permeability (GO:0046902)	3	1	.52	+	1.91	4.07E-01
negative regulation of cytoplasmic translation (GO:2000766)	3	1	.52	+	1.91	4.07E-01
detoxification of inorganic compound (GO:0061687)	3	1	.52	+	1.91	4.07E-01
negative regulation of cardioblast differentiation (GO:0051892)	3	1	.52	+	1.91	4.07E-01
negative regulation of axon extension (GO:0030517)	3	1	.52	+	1.91	4.07E-01
response to amine (GO:0014075)	3	1	.52	+	1.91	4.07E-01
CENP-A containing chromatin organization (GO:0061641)	3	1	.52	+	1.91	4.07E-01
cellular response to amine stimulus (GO:0071418)	3	1	.52	+	1.91	4.07E-01
carbohydrate transport (GO:0008643)	3	1	.52	+	1.91	4.07E-01
regulation of synapse structural plasticity (GO:0051823)	3	1	.52	+	1.91	4.07E-01
regulation of membrane permeability (GO:0090559)	3	1	.52	+	1.91	4.07E-01
negative regulation of gliogenesis (GO:0014014)	6	2	1.05	+	1.91	2.81E-01
negative regulation of histone ubiquitination (GO:0033183)	3	1	.52	+	1.91	4.07E-01
regulation of ATP biosynthetic process (GO:2001169)	3	1	.52	+	1.91	4.07E-01
maintenance of imaginal disc-derived wing hair orientation (GO:0035321)	3	1	.52	+	1.91	4.07E-01
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	3	1	.52	+	1.91	4.07E-01
carbohydrate phosphorylation (GO:0046835)	3	1	.52	+	1.91	4.07E-01
regulation of RNA export from nucleus (GO:0046831)	6	2	1.05	+	1.91	2.81E-01
negative regulation of response to wounding (GO:1903035)	6	2	1.05	+	1.91	2.81E-01
negative regulation of cardiocyte differentiation (GO:1905208)	3	1	.52	+	1.91	4.07E-01
fatty acid elongation (GO:0030497)	6	2	1.05	+	1.91	2.81E-01
synaptic vesicle maturation (GO:0016188)	3	1	.52	+	1.91	4.07E-01
medium-chain fatty acid catabolic process (GO:0051793)	3	1	.52	+	1.91	4.07E-01
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	3	1	.52	+	1.91	4.07E-01
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	6	2	1.05	+	1.91	2.81E-01
regulation of calcineurin-NFAT signaling cascade (GO:0070884)	3	1	.52	+	1.91	4.07E-01
peptidyl-arginine omega-N-methylation (GO:0035247)	3	1	.52	+	1.91	4.07E-01
glycerolipid biosynthetic process (GO:0045017)	27	9	4.71	+	1.91	5.03E-02
cellular modified amino acid biosynthetic process (GO:0042398)	6	2	1.05	+	1.91	2.81E-01
histone H3-K4 demethylation (GO:0034720)	3	1	.52	+	1.91	4.07E-01
establishment of mitochondrion localization (GO:0051654)	12	4	2.09	+	1.91	1.60E-01
actin filament network formation (GO:0051639)	3	1	.52	+	1.91	4.07E-01
preblastoderm mitotic cell cycle (GO:0035185)	3	1	.52	+	1.91	4.07E-01
larval turning behavior (GO:0035179)	3	1	.52	+	1.91	4.07E-01
turning behavior (GO:0035178)	3	1	.52	+	1.91	4.07E-01
imaginal disc lineage restriction (GO:0035161)	6	2	1.05	+	1.91	2.81E-01
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309)	6	2	1.05	+	1.91	2.81E-01
regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308)	6	2	1.05	+	1.91	2.81E-01
regulation of meiotic cell cycle phase transition (GO:1901993)	3	1	.52	+	1.91	4.07E-01
histone H3-K27 methylation (GO:0070734)	3	1	.52	+	1.91	4.07E-01
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)	3	1	.52	+	1.91	4.07E-01
zymogen inhibition (GO:0097341)	3	1	.52	+	1.91	4.07E-01
inhibition of cysteine-type endopeptidase activity (GO:0097340)	3	1	.52	+	1.91	4.07E-01
motile cilium assembly (GO:0044458)	3	1	.52	+	1.91	4.07E-01
establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	12	4	2.09	+	1.91	1.60E-01
autophagy of peroxisome (GO:0030242)	3	1	.52	+	1.91	4.07E-01
skeletal muscle thin filament assembly (GO:0030240)	3	1	.52	+	1.91	4.07E-01
male sex determination (GO:0030238)	3	1	.52	+	1.91	4.07E-01
meiotic recombination checkpoint (GO:0051598)	3	1	.52	+	1.91	4.07E-01
response to cAMP (GO:0051591)	3	1	.52	+	1.91	4.07E-01
regulation of growth rate (GO:0040009)	3	1	.52	+	1.91	4.07E-01
chitin-based cuticle attachment to epithelium (GO:0040005)	3	1	.52	+	1.91	4.07E-01
adult chitin-based cuticle development (GO:0008365)	6	2	1.05	+	1.91	2.81E-01
histone H3-K9 methylation (GO:0051567)	6	2	1.05	+	1.91	2.81E-01
Malpighian tubule stellate cell differentiation (GO:0061330)	3	1	.52	+	1.91	4.07E-01
negative regulation of mitochondrial fusion (GO:0010637)	3	1	.52	+	1.91	4.07E-01
posterior Malpighian tubule development (GO:0061328)	3	1	.52	+	1.91	4.07E-01
mRNA export from nucleus in response to heat stress (GO:0031990)	6	2	1.05	+	1.91	2.81E-01
positive regulation of protein depolymerization (GO:1901881)	3	1	.52	+	1.91	4.07E-01
positive regulation of Rac protein signal transduction (GO:0035022)	3	1	.52	+	1.91	4.07E-01
transepithelial transport (GO:0070633)	24	8	4.19	+	1.91	6.25E-02
neuronal signal transduction (GO:0023041)	3	1	.52	+	1.91	4.07E-01
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838)	3	1	.52	+	1.91	4.07E-01
regulation of calcineurin-mediated signaling (GO:0106056)	3	1	.52	+	1.91	4.07E-01
assembly of apicomedial cortex actomyosin (GO:0106036)	3	1	.52	+	1.91	4.07E-01
mitochondrial respiratory chain complex III assembly (GO:0034551)	3	1	.52	+	1.91	4.07E-01
regulation of COPII vesicle coating (GO:0003400)	3	1	.52	+	1.91	4.07E-01
protein import into mitochondrial matrix (GO:0030150)	12	4	2.09	+	1.91	1.60E-01
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051)	6	2	1.05	+	1.91	2.81E-01
negative regulation of filopodium assembly (GO:0051490)	3	1	.52	+	1.91	4.07E-01
gluconeogenesis (GO:0006094)	6	2	1.05	+	1.91	2.81E-01
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482)	3	1	.52	+	1.91	4.07E-01
negative regulation of synaptic vesicle exocytosis (GO:2000301)	3	1	.52	+	1.91	4.07E-01
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	3	1	.52	+	1.91	4.07E-01
regulation of neuronal action potential (GO:0098908)	3	1	.52	+	1.91	4.07E-01
regulation of action potential (GO:0098900)	3	1	.52	+	1.91	4.07E-01
microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176)	3	1	.52	+	1.91	4.07E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	3	1	.52	+	1.91	4.07E-01
cuticle chitin biosynthetic process (GO:0006035)	3	1	.52	+	1.91	4.07E-01
chitin biosynthetic process (GO:0006031)	3	1	.52	+	1.91	4.07E-01
regulation of cellular response to hypoxia (GO:1900037)	3	1	.52	+	1.91	4.07E-01
meiotic mismatch repair (GO:0000710)	3	1	.52	+	1.91	4.07E-01
negative regulation of cardioblast cell fate specification (GO:0009997)	3	1	.52	+	1.91	4.07E-01
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113)	3	1	.52	+	1.91	4.07E-01
regulation of signal transduction by p53 class mediator (GO:1901796)	3	1	.52	+	1.91	4.07E-01
Mo-molybdopterin cofactor metabolic process (GO:0019720)	3	1	.52	+	1.91	4.07E-01
protein K63-linked deubiquitination (GO:0070536)	3	1	.52	+	1.91	4.07E-01
protein K63-linked ubiquitination (GO:0070534)	6	2	1.05	+	1.91	2.81E-01
regulation of response to cytokine stimulus (GO:0060759)	6	2	1.05	+	1.91	2.81E-01
extrinsic apoptotic signaling pathway (GO:0097191)	3	1	.52	+	1.91	4.07E-01
nicotinamide nucleotide metabolic process (GO:0046496)	3	1	.52	+	1.91	4.07E-01
regulation of TORC2 signaling (GO:1903939)	3	1	.52	+	1.91	4.07E-01
phosphatidylglycerol metabolic process (GO:0046471)	3	1	.52	+	1.91	4.07E-01
ammonium ion metabolic process (GO:0097164)	6	2	1.05	+	1.91	2.81E-01
negative regulation of muscle organ development (GO:0048635)	3	1	.52	+	1.91	4.07E-01
positive chemotaxis (GO:0050918)	6	2	1.05	+	1.91	2.81E-01
oocyte morphogenesis (GO:0048601)	3	1	.52	+	1.91	4.07E-01
epithelial fluid transport (GO:0042045)	24	8	4.19	+	1.91	6.25E-02
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	3	1	.52	+	1.91	4.07E-01
positive regulation of translational initiation (GO:0045948)	3	1	.52	+	1.91	4.07E-01
positive regulation of transcription by RNA polymerase III (GO:0045945)	3	1	.52	+	1.91	4.07E-01
positive regulation of transcription by RNA polymerase I (GO:0045943)	6	2	1.05	+	1.91	2.81E-01
positive regulation of oxidoreductase activity (GO:0051353)	3	1	.52	+	1.91	4.07E-01
positive regulation of lyase activity (GO:0051349)	3	1	.52	+	1.91	4.07E-01
negative regulation of exocytosis (GO:0045920)	3	1	.52	+	1.91	4.07E-01
regulation of lyase activity (GO:0051339)	6	2	1.05	+	1.91	2.81E-01
positive regulation of ribosome biogenesis (GO:0090070)	3	1	.52	+	1.91	4.07E-01
regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002816)	3	1	.52	+	1.91	4.07E-01
neuroendocrine cell differentiation (GO:0061101)	6	2	1.05	+	1.91	2.81E-01
regulation of trehalose metabolic process (GO:0090062)	3	1	.52	+	1.91	4.07E-01
establishment of protein localization to peroxisome (GO:0072663)	12	4	2.09	+	1.91	1.60E-01
protein localization to peroxisome (GO:0072662)	12	4	2.09	+	1.91	1.60E-01
central nervous system neuron development (GO:0021954)	6	2	1.05	+	1.91	2.81E-01
nucleoside transmembrane transport (GO:1901642)	3	1	.52	+	1.91	4.07E-01
regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	6	2	1.05	+	1.91	2.81E-01
regulation of membrane depolarization (GO:0003254)	3	1	.52	+	1.91	4.07E-01
positive regulation of viral process (GO:0048524)	3	1	.52	+	1.91	4.07E-01
phosphatidylethanolamine metabolic process (GO:0046337)	3	1	.52	+	1.91	4.07E-01
histone H3-K14 acetylation (GO:0044154)	3	1	.52	+	1.91	4.07E-01
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	3	1	.52	+	1.91	4.07E-01
symmetric cell division (GO:0098725)	6	2	1.05	+	1.91	2.81E-01
negative regulation of endocytosis (GO:0045806)	3	1	.52	+	1.91	4.07E-01
regulation of DNA-templated transcription in response to stress (GO:0043620)	6	2	1.05	+	1.91	2.81E-01
protein destabilization (GO:0031648)	3	1	.52	+	1.91	4.07E-01
pyrimidine-containing compound transmembrane transport (GO:0072531)	3	1	.52	+	1.91	4.07E-01
intestinal epithelial cell differentiation (GO:0060575)	3	1	.52	+	1.91	4.07E-01
neuroepithelial cell differentiation (GO:0060563)	6	2	1.05	+	1.91	2.81E-01
regulation of microfilament motor activity (GO:0120079)	3	1	.52	+	1.91	4.07E-01
fatty acid derivative biosynthetic process (GO:1901570)	3	1	.52	+	1.91	4.07E-01
imaginal disc eversion (GO:0007561)	6	2	1.05	+	1.91	2.81E-01
negative regulation of centriole elongation (GO:1903723)	3	1	.52	+	1.91	4.07E-01
regulation of centriole elongation (GO:1903722)	3	1	.52	+	1.91	4.07E-01
mesodermal cell fate determination (GO:0007500)	3	1	.52	+	1.91	4.07E-01
regulation of nuclease activity (GO:0032069)	3	1	.52	+	1.91	4.07E-01
negative regulation of cardiac cell fate specification (GO:2000044)	3	1	.52	+	1.91	4.07E-01
positive regulation of ARF protein signal transduction (GO:0032014)	3	1	.52	+	1.91	4.07E-01
prosthetic group metabolic process (GO:0051189)	3	1	.52	+	1.91	4.07E-01
molybdopterin cofactor metabolic process (GO:0043545)	3	1	.52	+	1.91	4.07E-01
positive regulation of neuron apoptotic process (GO:0043525)	3	1	.52	+	1.91	4.07E-01
protein peptidyl-prolyl isomerization (GO:0000413)	6	2	1.05	+	1.91	2.81E-01
negative regulation of JUN kinase activity (GO:0043508)	3	1	.52	+	1.91	4.07E-01
triglyceride catabolic process (GO:0019433)	3	1	.52	+	1.91	4.07E-01
alditol catabolic process (GO:0019405)	3	1	.52	+	1.91	4.07E-01
alditol metabolic process (GO:0019400)	3	1	.52	+	1.91	4.07E-01
aldehyde biosynthetic process (GO:0046184)	3	1	.52	+	1.91	4.07E-01
organelle inheritance (GO:0048308)	3	1	.52	+	1.91	4.07E-01
regulation of imaginal disc-derived wing vein specification (GO:0110107)	3	1	.52	+	1.91	4.07E-01
response to sterol depletion (GO:0006991)	6	2	1.05	+	1.91	2.81E-01
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0006965)	3	1	.52	+	1.91	4.07E-01
determination of digestive tract left/right asymmetry (GO:0071907)	6	2	1.05	+	1.91	2.81E-01
mitotic cleavage furrow ingression (GO:1990386)	3	1	.52	+	1.91	4.07E-01
substrate-dependent cell migration, cell extension (GO:0006930)	3	1	.52	+	1.91	4.07E-01
positive regulation of sensory perception of pain (GO:1904058)	3	1	.52	+	1.91	4.07E-01
proline catabolic process to glutamate (GO:0010133)	3	1	.52	+	1.91	4.07E-01
plus-end-directed organelle transport along microtubule (GO:0072386)	3	1	.52	+	1.91	4.07E-01
plus-end-directed vesicle transport along microtubule (GO:0072383)	3	1	.52	+	1.91	4.07E-01
nuclear envelope reassembly (GO:0031468)	3	1	.52	+	1.91	4.07E-01
pyridine nucleotide metabolic process (GO:0019362)	3	1	.52	+	1.91	4.07E-01
detection of UV (GO:0009589)	6	2	1.05	+	1.91	2.81E-01
specification of segmental identity, thorax (GO:0007384)	3	1	.52	+	1.91	4.07E-01
negative regulation of voltage-gated calcium channel activity (GO:1901386)	3	1	.52	+	1.91	4.07E-01
hexose biosynthetic process (GO:0019319)	6	2	1.05	+	1.91	2.81E-01
behavioral response to pain (GO:0048266)	3	1	.52	+	1.91	4.07E-01
response to pain (GO:0048265)	3	1	.52	+	1.91	4.07E-01
cell chemotaxis (GO:0060326)	6	2	1.05	+	1.91	2.81E-01
oocyte nucleus migration involved in oocyte dorsal/ventral axis specification (GO:0007312)	6	2	1.05	+	1.91	2.81E-01
cellular response to environmental stimulus (GO:0104004)	63	21	10.99	+	1.91	4.39E-03
cellular response to abiotic stimulus (GO:0071214)	63	21	10.99	+	1.91	4.39E-03
cellular iron ion homeostasis (GO:0006879)	9	3	1.57	+	1.91	2.09E-01
central nervous system formation (GO:0021556)	9	3	1.57	+	1.91	2.09E-01
tRNA transcription by RNA polymerase III (GO:0042797)	9	3	1.57	+	1.91	2.09E-01
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	42	14	7.32	+	1.91	1.77E-02
tRNA transcription (GO:0009304)	9	3	1.57	+	1.91	2.09E-01
organism emergence from protective structure (GO:0071684)	15	5	2.62	+	1.91	1.25E-01
snoRNA processing (GO:0043144)	9	3	1.57	+	1.91	2.09E-01
metallo-sulfur cluster assembly (GO:0031163)	9	3	1.57	+	1.91	2.09E-01
regulation of polysaccharide metabolic process (GO:0032881)	9	3	1.57	+	1.91	2.09E-01
negative regulation of stress-activated MAPK cascade (GO:0032873)	21	7	3.66	+	1.91	7.81E-02
cholesterol homeostasis (GO:0042632)	9	3	1.57	+	1.91	2.09E-01
cell-cell junction maintenance (GO:0045217)	9	3	1.57	+	1.91	2.09E-01
cellular response to hypoxia (GO:0071456)	21	7	3.66	+	1.91	7.81E-02
secondary alcohol metabolic process (GO:1902652)	18	6	3.14	+	1.91	9.82E-02
iron-sulfur cluster assembly (GO:0016226)	9	3	1.57	+	1.91	2.09E-01
regulation of circadian sleep/wake cycle, sleep (GO:0045187)	33	11	5.75	+	1.91	3.29E-02
cell-cell signaling involved in cell fate commitment (GO:0045168)	9	3	1.57	+	1.91	2.09E-01
regulation of heart rate (GO:0002027)	15	5	2.62	+	1.91	1.25E-01
regulation of extracellular matrix organization (GO:1903053)	9	3	1.57	+	1.91	2.09E-01
maturation of SSU-rRNA (GO:0030490)	18	6	3.14	+	1.91	9.82E-02
actin filament bundle organization (GO:0061572)	21	7	3.66	+	1.91	7.81E-02
protein palmitoylation (GO:0018345)	9	3	1.57	+	1.91	2.09E-01
regulation of glycogen metabolic process (GO:0070873)	9	3	1.57	+	1.91	2.09E-01
cell competition in a multicellular organism (GO:0035212)	18	6	3.14	+	1.91	9.82E-02
pupal development (GO:0035209)	15	5	2.62	+	1.91	1.25E-01
snoRNA metabolic process (GO:0016074)	9	3	1.57	+	1.91	2.09E-01
regulation of olfactory learning (GO:0090328)	9	3	1.57	+	1.91	2.09E-01
negative regulation of antimicrobial humoral response (GO:0008348)	18	6	3.14	+	1.91	9.82E-02
axonal transport of mitochondrion (GO:0019896)	9	3	1.57	+	1.91	2.09E-01
neuromuscular process (GO:0050905)	9	3	1.57	+	1.91	2.09E-01
amino acid transmembrane transport (GO:0003333)	18	6	3.14	+	1.91	9.82E-02
negative regulation of JNK cascade (GO:0046329)	21	7	3.66	+	1.91	7.81E-02
receptor internalization (GO:0031623)	9	3	1.57	+	1.91	2.09E-01
response to glucose (GO:0009749)	9	3	1.57	+	1.91	2.09E-01
RNA polymerase II preinitiation complex assembly (GO:0051123)	9	3	1.57	+	1.91	2.09E-01
entrainment of circadian clock (GO:0009649)	21	7	3.66	+	1.91	7.81E-02
trachea morphogenesis (GO:0060439)	9	3	1.57	+	1.91	2.09E-01
protein deneddylation (GO:0000338)	9	3	1.57	+	1.91	2.09E-01
response to anesthetic (GO:0072347)	9	3	1.57	+	1.91	2.09E-01
determination of left/right symmetry (GO:0007368)	9	3	1.57	+	1.91	2.09E-01
cGMP metabolic process (GO:0046068)	9	3	1.57	+	1.91	2.09E-01
ribosome biogenesis (GO:0042254)	109	36	19.01	+	1.89	2.86E-04
response to endoplasmic reticulum stress (GO:0034976)	49	16	8.54	+	1.87	1.41E-02
negative regulation of response to biotic stimulus (GO:0002832)	49	16	8.54	+	1.87	1.41E-02
establishment of protein localization to membrane (GO:0090150)	43	14	7.50	+	1.87	2.11E-02
glutathione metabolic process (GO:0006749)	40	13	6.98	+	1.86	2.59E-02
positive regulation of canonical Wnt signaling pathway (GO:0090263)	40	13	6.98	+	1.86	2.59E-02
sensory perception of mechanical stimulus (GO:0050954)	68	22	11.86	+	1.86	5.06E-03
detection of abiotic stimulus (GO:0009582)	68	22	11.86	+	1.86	5.06E-03
detection of external stimulus (GO:0009581)	68	22	11.86	+	1.86	5.06E-03
alcohol metabolic process (GO:0006066)	59	19	10.29	+	1.85	9.14E-03
protein targeting to membrane (GO:0006612)	28	9	4.88	+	1.84	6.02E-02
negative regulation of response to external stimulus (GO:0032102)	56	18	9.77	+	1.84	1.11E-02
monocarboxylic acid biosynthetic process (GO:0072330)	28	9	4.88	+	1.84	6.02E-02
purine ribonucleotide metabolic process (GO:0009150)	81	26	14.12	+	1.84	2.73E-03
positive regulation of hippo signaling (GO:0035332)	25	8	4.36	+	1.84	7.50E-02
salivary gland cell autophagic cell death (GO:0035071)	25	8	4.36	+	1.84	7.50E-02
negative regulation of defense response (GO:0031348)	47	15	8.20	+	1.83	2.04E-02
ecdysteroid metabolic process (GO:0045455)	22	7	3.84	+	1.82	9.39E-02
steroid biosynthetic process (GO:0006694)	22	7	3.84	+	1.82	9.39E-02
germ cell migration (GO:0008354)	44	14	7.67	+	1.82	2.50E-02
regulation of peptidoglycan recognition protein signaling pathway (GO:0061058)	22	7	3.84	+	1.82	9.39E-02
ecdysteroid biosynthetic process (GO:0045456)	19	6	3.31	+	1.81	1.18E-01
cellular response to lipid (GO:0071396)	19	6	3.31	+	1.81	1.18E-01
steroid hormone biosynthetic process (GO:0120178)	19	6	3.31	+	1.81	1.18E-01
copulation (GO:0007620)	19	6	3.31	+	1.81	1.18E-01
pigment metabolic process involved in developmental pigmentation (GO:0043324)	35	11	6.10	+	1.80	4.65E-02
eye pigment metabolic process (GO:0042441)	35	11	6.10	+	1.80	4.65E-02
pigment metabolic process involved in pigmentation (GO:0043474)	35	11	6.10	+	1.80	4.65E-02
endoplasmic reticulum unfolded protein response (GO:0030968)	16	5	2.79	+	1.79	1.51E-01
iron ion homeostasis (GO:0055072)	16	5	2.79	+	1.79	1.51E-01
asymmetric protein localization involved in cell fate determination (GO:0045167)	16	5	2.79	+	1.79	1.51E-01
aerobic respiration (GO:0009060)	32	10	5.58	+	1.79	5.75E-02
inositol phosphate metabolic process (GO:0043647)	16	5	2.79	+	1.79	1.51E-01
regulation of heart contraction (GO:0008016)	29	9	5.06	+	1.78	7.14E-02
regulation of blood circulation (GO:1903522)	29	9	5.06	+	1.78	7.14E-02
ribonucleotide metabolic process (GO:0009259)	87	27	15.17	+	1.78	3.58E-03
ribose phosphate metabolic process (GO:0019693)	87	27	15.17	+	1.78	3.58E-03
circadian rhythm (GO:0007623)	87	27	15.17	+	1.78	3.58E-03
compound eye photoreceptor development (GO:0042051)	71	22	12.38	+	1.78	8.12E-03
purine nucleotide metabolic process (GO:0006163)	84	26	14.65	+	1.78	4.34E-03
eye pigmentation (GO:0048069)	39	12	6.80	+	1.76	4.43E-02
xenobiotic metabolic process (GO:0006805)	13	4	2.27	+	1.76	1.94E-01
response to xenobiotic stimulus (GO:0009410)	13	4	2.27	+	1.76	1.94E-01
ecdysone biosynthetic process (GO:0006697)	13	4	2.27	+	1.76	1.94E-01
peroxisomal membrane transport (GO:0015919)	13	4	2.27	+	1.76	1.94E-01
nonassociative learning (GO:0046958)	13	4	2.27	+	1.76	1.94E-01
cellular response to xenobiotic stimulus (GO:0071466)	13	4	2.27	+	1.76	1.94E-01
secondary alcohol biosynthetic process (GO:1902653)	13	4	2.27	+	1.76	1.94E-01
regulation of mitotic sister chromatid segregation (GO:0033047)	13	4	2.27	+	1.76	1.94E-01
negative regulation of cell growth (GO:0030308)	13	4	2.27	+	1.76	1.94E-01
regulation of defense response to fungus (GO:1900150)	13	4	2.27	+	1.76	1.94E-01
induction of programmed cell death by hormones (GO:0035081)	13	4	2.27	+	1.76	1.94E-01
induction of programmed cell death by ecdysone (GO:0035078)	13	4	2.27	+	1.76	1.94E-01
ecdysone-mediated induction of salivary gland cell autophagic cell death (GO:0035072)	13	4	2.27	+	1.76	1.94E-01
steroid metabolic process (GO:0008202)	26	8	4.53	+	1.76	8.89E-02
Toll signaling pathway (GO:0008063)	13	4	2.27	+	1.76	1.94E-01
induction of programmed cell death (GO:0012502)	13	4	2.27	+	1.76	1.94E-01
peroxisomal transport (GO:0043574)	13	4	2.27	+	1.76	1.94E-01
maturation of 5.8S rRNA (GO:0000460)	13	4	2.27	+	1.76	1.94E-01
rhythmic process (GO:0048511)	88	27	15.35	+	1.76	4.15E-03
multicellular organismal homeostasis (GO:0048871)	62	19	10.81	+	1.76	1.46E-02
negative regulation of MAPK cascade (GO:0043409)	36	11	6.28	+	1.75	5.46E-02
transcription initiation from RNA polymerase II promoter (GO:0006367)	46	14	8.02	+	1.75	3.42E-02
mitochondrion localization (GO:0051646)	23	7	4.01	+	1.75	1.11E-01
negative regulation of organ growth (GO:0046621)	23	7	4.01	+	1.75	1.11E-01
regulation of multi-organism process (GO:0043900)	23	7	4.01	+	1.75	1.11E-01
eye photoreceptor cell development (GO:0042462)	73	22	12.73	+	1.73	1.09E-02
amino acid transport (GO:0006865)	20	6	3.49	+	1.72	1.40E-01
regulation of nurse cell apoptotic process (GO:0045477)	10	3	1.74	+	1.72	2.54E-01
circadian sleep/wake cycle (GO:0042745)	10	3	1.74	+	1.72	2.54E-01
ceramide metabolic process (GO:0006672)	10	3	1.74	+	1.72	2.54E-01
cell cycle comprising mitosis without cytokinesis (GO:0033301)	20	6	3.49	+	1.72	1.40E-01
sterol homeostasis (GO:0055092)	10	3	1.74	+	1.72	2.54E-01
negative regulation of histone modification (GO:0031057)	10	3	1.74	+	1.72	2.54E-01
Golgi to plasma membrane protein transport (GO:0043001)	10	3	1.74	+	1.72	2.54E-01
regulation of metal ion transport (GO:0010959)	30	9	5.23	+	1.72	8.37E-02
regulation of oxidative phosphorylation (GO:0002082)	10	3	1.74	+	1.72	2.54E-01
basal protein localization (GO:0045175)	10	3	1.74	+	1.72	2.54E-01
tRNA modification (GO:0006400)	10	3	1.74	+	1.72	2.54E-01
phospholipid dephosphorylation (GO:0046839)	10	3	1.74	+	1.72	2.54E-01
sterol metabolic process (GO:0016125)	20	6	3.49	+	1.72	1.40E-01
transcription preinitiation complex assembly (GO:0070897)	10	3	1.74	+	1.72	2.54E-01
oocyte nucleus localization involved in oocyte dorsal/ventral axis specification (GO:0051663)	10	3	1.74	+	1.72	2.54E-01
protein hydroxylation (GO:0018126)	10	3	1.74	+	1.72	2.54E-01
regulation of epithelial cell migration, open tracheal system (GO:2000274)	10	3	1.74	+	1.72	2.54E-01
unidimensional cell growth (GO:0009826)	20	6	3.49	+	1.72	1.40E-01
response to hexose (GO:0009746)	10	3	1.74	+	1.72	2.54E-01
negative regulation of protein serine/threonine kinase activity (GO:0071901)	10	3	1.74	+	1.72	2.54E-01
negative regulation of DNA-binding transcription factor activity (GO:0043433)	10	3	1.74	+	1.72	2.54E-01
cAMP metabolic process (GO:0046058)	10	3	1.74	+	1.72	2.54E-01
glucose homeostasis (GO:0042593)	37	11	6.45	+	1.70	6.36E-02
tissue homeostasis (GO:0001894)	54	16	9.42	+	1.70	3.07E-02
phosphatidylinositol phosphorylation (GO:0046854)	27	8	4.71	+	1.70	1.04E-01
response to light stimulus (GO:0009416)	125	37	21.80	+	1.70	1.65E-03
positive regulation of Wnt signaling pathway (GO:0030177)	44	13	7.67	+	1.69	4.87E-02
negative regulation of imaginal disc growth (GO:0045571)	17	5	2.96	+	1.69	1.79E-01
eye pigment biosynthetic process (GO:0006726)	34	10	5.93	+	1.69	7.85E-02
apical protein localization (GO:0045176)	17	5	2.96	+	1.69	1.79E-01
glycogen metabolic process (GO:0005977)	17	5	2.96	+	1.69	1.79E-01
syncytial blastoderm mitotic cell cycle (GO:0035186)	17	5	2.96	+	1.69	1.79E-01
energy reserve metabolic process (GO:0006112)	17	5	2.96	+	1.69	1.79E-01
cellular glucan metabolic process (GO:0006073)	17	5	2.96	+	1.69	1.79E-01
negative regulation of neural precursor cell proliferation (GO:2000178)	17	5	2.96	+	1.69	1.79E-01
adherens junction assembly (GO:0034333)	17	5	2.96	+	1.69	1.79E-01
negative regulation of neurogenesis (GO:0050768)	34	10	5.93	+	1.69	7.85E-02
glucan metabolic process (GO:0044042)	17	5	2.96	+	1.69	1.79E-01
negative regulation of neuroblast proliferation (GO:0007406)	17	5	2.96	+	1.69	1.79E-01
response to decreased oxygen levels (GO:0036293)	51	15	8.89	+	1.69	3.74E-02
developmental pigmentation (GO:0048066)	58	17	10.11	+	1.68	2.89E-02
regulation of circadian sleep/wake cycle (GO:0042749)	41	12	7.15	+	1.68	5.97E-02
hormone metabolic process (GO:0042445)	41	12	7.15	+	1.68	5.97E-02
regulation of ion transport (GO:0043269)	48	14	8.37	+	1.67	4.58E-02
endoplasmic reticulum organization (GO:0007029)	24	7	4.19	+	1.67	1.30E-01
protein transmembrane import into intracellular organelle (GO:0044743)	24	7	4.19	+	1.67	1.30E-01
hormone biosynthetic process (GO:0042446)	24	7	4.19	+	1.67	1.30E-01
carboxylic acid transmembrane transport (GO:1905039)	24	7	4.19	+	1.67	1.30E-01
ketone biosynthetic process (GO:0042181)	24	7	4.19	+	1.67	1.30E-01
organic acid transmembrane transport (GO:1903825)	24	7	4.19	+	1.67	1.30E-01
alpha-amino acid catabolic process (GO:1901606)	24	7	4.19	+	1.67	1.30E-01
positive regulation of translation (GO:0045727)	24	7	4.19	+	1.67	1.30E-01
purine-containing compound metabolic process (GO:0072521)	93	27	16.22	+	1.66	8.28E-03
lipid biosynthetic process (GO:0008610)	100	29	17.44	+	1.66	6.48E-03
organelle membrane fusion (GO:0090174)	45	13	7.85	+	1.66	5.60E-02
nucleotide metabolic process (GO:0009117)	101	29	17.61	+	1.65	7.36E-03
ncRNA processing (GO:0034470)	105	30	18.31	+	1.64	6.93E-03
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	7	2	1.22	+	1.64	3.45E-01
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	7	2	1.22	+	1.64	3.45E-01
intra-Golgi vesicle-mediated transport (GO:0006891)	21	6	3.66	+	1.64	1.64E-01
histone lysine demethylation (GO:0070076)	7	2	1.22	+	1.64	3.45E-01
histone demethylation (GO:0016577)	7	2	1.22	+	1.64	3.45E-01
heme biosynthetic process (GO:0006783)	7	2	1.22	+	1.64	3.45E-01
porphyrin-containing compound biosynthetic process (GO:0006779)	7	2	1.22	+	1.64	3.45E-01
protein autoprocessing (GO:0016540)	7	2	1.22	+	1.64	3.45E-01
neuron cell-cell adhesion (GO:0007158)	7	2	1.22	+	1.64	3.45E-01
mitochondrial respiratory chain complex I assembly (GO:0032981)	7	2	1.22	+	1.64	3.45E-01
cleavage furrow ingression (GO:0036090)	7	2	1.22	+	1.64	3.45E-01
regulation of cytokinetic process (GO:0032954)	7	2	1.22	+	1.64	3.45E-01
mitotic centrosome separation (GO:0007100)	7	2	1.22	+	1.64	3.45E-01
rhabdomere membrane biogenesis (GO:0045313)	7	2	1.22	+	1.64	3.45E-01
regulation of microtubule polymerization (GO:0031113)	7	2	1.22	+	1.64	3.45E-01
positive regulation of microtubule polymerization or depolymerization (GO:0031112)	7	2	1.22	+	1.64	3.45E-01
spindle assembly involved in male meiosis (GO:0007053)	7	2	1.22	+	1.64	3.45E-01
regulation of purine nucleotide metabolic process (GO:1900542)	7	2	1.22	+	1.64	3.45E-01
protein localization to chromosome, centromeric region (GO:0071459)	7	2	1.22	+	1.64	3.45E-01
negative regulation of protein kinase B signaling (GO:0051898)	7	2	1.22	+	1.64	3.45E-01
protein demethylation (GO:0006482)	7	2	1.22	+	1.64	3.45E-01
protein K11-linked ubiquitination (GO:0070979)	7	2	1.22	+	1.64	3.45E-01
positive regulation of RNA splicing (GO:0033120)	7	2	1.22	+	1.64	3.45E-01
filopodium assembly (GO:0046847)	7	2	1.22	+	1.64	3.45E-01
behavioral response to nutrient (GO:0051780)	7	2	1.22	+	1.64	3.45E-01
cellular response to sucrose stimulus (GO:0071329)	7	2	1.22	+	1.64	3.45E-01
cellular response to disaccharide stimulus (GO:0071324)	7	2	1.22	+	1.64	3.45E-01
transcription by RNA polymerase I (GO:0006360)	14	4	2.44	+	1.64	2.30E-01
respiratory chain complex IV assembly (GO:0008535)	7	2	1.22	+	1.64	3.45E-01
regulation of transcription by RNA polymerase I (GO:0006356)	7	2	1.22	+	1.64	3.45E-01
DNA-templated transcription, termination (GO:0006353)	7	2	1.22	+	1.64	3.45E-01
wing disc pattern formation (GO:0035222)	70	20	12.21	+	1.64	2.41E-02
tetrapyrrole biosynthetic process (GO:0033014)	7	2	1.22	+	1.64	3.45E-01
lumen formation, open tracheal system (GO:0035149)	28	8	4.88	+	1.64	1.21E-01
negative regulation of compound eye retinal cell programmed cell death (GO:0046673)	7	2	1.22	+	1.64	3.45E-01
negative regulation of retinal cell programmed cell death (GO:0046671)	7	2	1.22	+	1.64	3.45E-01
vesicle fusion to plasma membrane (GO:0099500)	7	2	1.22	+	1.64	3.45E-01
antennal morphogenesis (GO:0048800)	14	4	2.44	+	1.64	2.30E-01
regulation of cellular carbohydrate metabolic process (GO:0010675)	14	4	2.44	+	1.64	2.30E-01
regulation of nucleotide metabolic process (GO:0006140)	7	2	1.22	+	1.64	3.45E-01
positive regulation of Rho protein signal transduction (GO:0035025)	7	2	1.22	+	1.64	3.45E-01
retrograde transport, endosome to Golgi (GO:0042147)	21	6	3.66	+	1.64	1.64E-01
protein localization to kinetochore (GO:0034501)	7	2	1.22	+	1.64	3.45E-01
negative regulation of humoral immune response (GO:0002921)	21	6	3.66	+	1.64	1.64E-01
protein dealkylation (GO:0008214)	7	2	1.22	+	1.64	3.45E-01
regulation of mitochondrial fission (GO:0090140)	7	2	1.22	+	1.64	3.45E-01
positive regulation of neuron projection regeneration (GO:0070572)	7	2	1.22	+	1.64	3.45E-01
positive regulation of axon regeneration (GO:0048680)	7	2	1.22	+	1.64	3.45E-01
U4 snRNA 3'-end processing (GO:0034475)	7	2	1.22	+	1.64	3.45E-01
regulation of nucleobase-containing compound transport (GO:0032239)	7	2	1.22	+	1.64	3.45E-01
intercellular transport (GO:0010496)	7	2	1.22	+	1.64	3.45E-01
response to oxygen levels (GO:0070482)	56	16	9.77	+	1.64	4.03E-02
central nervous system neuron differentiation (GO:0021953)	7	2	1.22	+	1.64	3.45E-01
adherens junction organization (GO:0034332)	28	8	4.88	+	1.64	1.21E-01
histone monoubiquitination (GO:0010390)	7	2	1.22	+	1.64	3.45E-01
negative regulation of antimicrobial peptide production (GO:0002785)	14	4	2.44	+	1.64	2.30E-01
immune response-regulating signaling pathway (GO:0002764)	7	2	1.22	+	1.64	3.45E-01
membrane fusion (GO:0061025)	49	14	8.54	+	1.64	5.24E-02
tRNA processing (GO:0008033)	14	4	2.44	+	1.64	2.30E-01
positive regulation of heart contraction (GO:0045823)	7	2	1.22	+	1.64	3.45E-01
negative regulation of production of molecular mediator of immune response (GO:0002701)	14	4	2.44	+	1.64	2.30E-01
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	7	2	1.22	+	1.64	3.45E-01
chitin-based cuticle sclerotization (GO:0007593)	7	2	1.22	+	1.64	3.45E-01
response to nutrient (GO:0007584)	14	4	2.44	+	1.64	2.30E-01
ciliary basal body organization (GO:0032053)	7	2	1.22	+	1.64	3.45E-01
negative regulation of immune effector process (GO:0002698)	14	4	2.44	+	1.64	2.30E-01
NADH dehydrogenase complex assembly (GO:0010257)	7	2	1.22	+	1.64	3.45E-01
axonemal dynein complex assembly (GO:0070286)	7	2	1.22	+	1.64	3.45E-01
alcohol biosynthetic process (GO:0046165)	35	10	6.10	+	1.64	9.06E-02
methylguanosine-cap decapping (GO:0110156)	7	2	1.22	+	1.64	3.45E-01
positive regulation of binding (GO:0051099)	7	2	1.22	+	1.64	3.45E-01
response to X-ray (GO:0010165)	7	2	1.22	+	1.64	3.45E-01
microtubule sliding (GO:0051012)	7	2	1.22	+	1.64	3.45E-01
mitochondrial cytochrome c oxidase assembly (GO:0033617)	7	2	1.22	+	1.64	3.45E-01
positive regulation of blood circulation (GO:1903524)	7	2	1.22	+	1.64	3.45E-01
response to hypoxia (GO:0001666)	46	13	8.02	+	1.62	6.41E-02
photoreceptor cell development (GO:0042461)	92	26	16.04	+	1.62	1.29E-02
cellular carbohydrate metabolic process (GO:0044262)	46	13	8.02	+	1.62	6.41E-02
protein targeting (GO:0006605)	78	22	13.60	+	1.62	2.12E-02
nucleoside phosphate metabolic process (GO:0006753)	103	29	17.96	+	1.61	9.43E-03
lipid phosphorylation (GO:0046834)	32	9	5.58	+	1.61	1.12E-01
establishment or maintenance of apical/basal cell polarity (GO:0035088)	32	9	5.58	+	1.61	1.12E-01
establishment or maintenance of bipolar cell polarity (GO:0061245)	32	9	5.58	+	1.61	1.12E-01
mitochondrial transmembrane transport (GO:1990542)	32	9	5.58	+	1.61	1.12E-01
cellular amino acid catabolic process (GO:0009063)	25	7	4.36	+	1.61	1.51E-01
pigment biosynthetic process (GO:0046148)	50	14	8.72	+	1.61	5.98E-02
regulation of generation of precursor metabolites and energy (GO:0043467)	25	7	4.36	+	1.61	1.51E-01
hexose metabolic process (GO:0019318)	25	7	4.36	+	1.61	1.51E-01
vesicle fusion (GO:0006906)	43	12	7.50	+	1.60	7.84E-02
amide biosynthetic process (GO:0043604)	201	56	35.05	+	1.60	5.35E-04
oxidation-reduction process (GO:0055114)	298	83	51.96	+	1.60	2.67E-05
Notch signaling pathway (GO:0007219)	18	5	3.14	+	1.59	2.08E-01
ribosomal large subunit assembly (GO:0000027)	18	5	3.14	+	1.59	2.08E-01
aggressive behavior (GO:0002118)	18	5	3.14	+	1.59	2.08E-01
cyclic nucleotide metabolic process (GO:0009187)	18	5	3.14	+	1.59	2.08E-01
glutamine family amino acid metabolic process (GO:0009064)	18	5	3.14	+	1.59	2.08E-01
apposition of dorsal and ventral imaginal disc-derived wing surfaces (GO:0007475)	18	5	3.14	+	1.59	2.08E-01
muscle contraction (GO:0006936)	18	5	3.14	+	1.59	2.08E-01
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	29	8	5.06	+	1.58	1.39E-01
negative regulation of Notch signaling pathway (GO:0045746)	29	8	5.06	+	1.58	1.39E-01
peptidyl-serine modification (GO:0018209)	40	11	6.98	+	1.58	9.60E-02
cellular modified amino acid metabolic process (GO:0006575)	51	14	8.89	+	1.57	6.77E-02
negative regulation of immune response (GO:0050777)	51	14	8.89	+	1.57	6.77E-02
regulation of glial cell proliferation (GO:0060251)	11	3	1.92	+	1.56	3.01E-01
regulation of adult chitin-containing cuticle pigmentation (GO:0048082)	11	3	1.92	+	1.56	3.01E-01
endomitotic cell cycle (GO:0007113)	11	3	1.92	+	1.56	3.01E-01
phosphatidylinositol-mediated signaling (GO:0048015)	11	3	1.92	+	1.56	3.01E-01
response to molecule of bacterial origin (GO:0002237)	11	3	1.92	+	1.56	3.01E-01
glycophagy (GO:0061723)	11	3	1.92	+	1.56	3.01E-01
regulation of glucose metabolic process (GO:0010906)	11	3	1.92	+	1.56	3.01E-01
polysaccharide metabolic process (GO:0005976)	22	6	3.84	+	1.56	1.90E-01
positive regulation of nucleocytoplasmic transport (GO:0046824)	11	3	1.92	+	1.56	3.01E-01
cellular response to steroid hormone stimulus (GO:0071383)	11	3	1.92	+	1.56	3.01E-01
cellular response to reactive oxygen species (GO:0034614)	11	3	1.92	+	1.56	3.01E-01
cellular polysaccharide metabolic process (GO:0044264)	22	6	3.84	+	1.56	1.90E-01
response to steroid hormone (GO:0048545)	11	3	1.92	+	1.56	3.01E-01
regulation of antifungal peptide production (GO:0002788)	11	3	1.92	+	1.56	3.01E-01
mesoderm migration involved in gastrulation (GO:0007509)	11	3	1.92	+	1.56	3.01E-01
response to monosaccharide (GO:0034284)	11	3	1.92	+	1.56	3.01E-01
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	11	3	1.92	+	1.56	3.01E-01
regulation of MAP kinase activity (GO:0043405)	22	6	3.84	+	1.56	1.90E-01
steroid hormone mediated signaling pathway (GO:0043401)	11	3	1.92	+	1.56	3.01E-01
membrane protein proteolysis (GO:0033619)	11	3	1.92	+	1.56	3.01E-01
ribosome assembly (GO:0042255)	33	9	5.75	+	1.56	1.28E-01
synaptic growth at neuromuscular junction (GO:0051124)	33	9	5.75	+	1.56	1.28E-01
pigmentation (GO:0043473)	66	18	11.51	+	1.56	4.51E-02
glycerolipid metabolic process (GO:0046486)	77	21	13.43	+	1.56	3.25E-02
cellular response to oxidative stress (GO:0034599)	26	7	4.53	+	1.54	1.73E-01
calcium ion transmembrane transport (GO:0070588)	26	7	4.53	+	1.54	1.73E-01
intestinal stem cell homeostasis (GO:0036335)	26	7	4.53	+	1.54	1.73E-01
apical junction assembly (GO:0043297)	41	11	7.15	+	1.54	1.09E-01
regulation of system process (GO:0044057)	56	15	9.77	+	1.54	7.08E-02
cellular amide metabolic process (GO:0043603)	277	74	48.30	+	1.53	2.50E-04
organophosphate metabolic process (GO:0019637)	191	51	33.31	+	1.53	2.22E-03
receptor metabolic process (GO:0043112)	15	4	2.62	+	1.53	2.67E-01
intracellular receptor signaling pathway (GO:0030522)	15	4	2.62	+	1.53	2.67E-01
sterol biosynthetic process (GO:0016126)	15	4	2.62	+	1.53	2.67E-01
negative regulation of phosphorylation (GO:0042326)	60	16	10.46	+	1.53	6.57E-02
male sex differentiation (GO:0046661)	30	8	5.23	+	1.53	1.58E-01
cellular response to unfolded protein (GO:0034620)	30	8	5.23	+	1.53	1.58E-01
cellular ketone metabolic process (GO:0042180)	30	8	5.23	+	1.53	1.58E-01
ecdysone metabolic process (GO:0008205)	15	4	2.62	+	1.53	2.67E-01
negative regulation of ERK1 and ERK2 cascade (GO:0070373)	15	4	2.62	+	1.53	2.67E-01
ventral furrow formation (GO:0007370)	15	4	2.62	+	1.53	2.67E-01
translation (GO:0006412)	184	49	32.09	+	1.53	2.82E-03
peptide biosynthetic process (GO:0043043)	188	50	32.78	+	1.53	2.63E-03
monocarboxylic acid metabolic process (GO:0032787)	79	21	13.78	+	1.52	4.07E-02
phosphatidylinositol metabolic process (GO:0046488)	49	13	8.54	+	1.52	9.27E-02
cell-cell junction assembly (GO:0007043)	53	14	9.24	+	1.51	8.58E-02
mitochondrion organization (GO:0007005)	106	28	18.48	+	1.51	2.22E-02
ATP synthesis coupled proton transport (GO:0015986)	19	5	3.31	+	1.51	2.40E-01
energy coupled proton transport, down electrochemical gradient (GO:0015985)	19	5	3.31	+	1.51	2.40E-01
Golgi organization (GO:0007030)	57	15	9.94	+	1.51	7.93E-02
localization within membrane (GO:0051668)	19	5	3.31	+	1.51	2.40E-01
negative regulation of cell development (GO:0010721)	38	10	6.63	+	1.51	1.33E-01
peptidyl-serine phosphorylation (GO:0018105)	38	10	6.63	+	1.51	1.33E-01
regulation of carbohydrate metabolic process (GO:0006109)	19	5	3.31	+	1.51	2.40E-01
small molecule catabolic process (GO:0044282)	76	20	13.25	+	1.51	4.88E-02
regulation of nervous system process (GO:0031644)	19	5	3.31	+	1.51	2.40E-01
trachea development (GO:0060438)	19	5	3.31	+	1.51	2.40E-01
peptide metabolic process (GO:0006518)	251	66	43.77	+	1.51	7.96E-04
regulation of membrane potential (GO:0042391)	65	17	11.33	+	1.50	6.81E-02
response to radiation (GO:0009314)	157	41	27.38	+	1.50	8.09E-03
male genitalia development (GO:0030539)	23	6	4.01	+	1.50	2.16E-01
epithelial structure maintenance (GO:0010669)	23	6	4.01	+	1.50	2.16E-01
response to alkaloid (GO:0043279)	27	7	4.71	+	1.49	1.96E-01
DNA-templated transcription, initiation (GO:0006352)	54	14	9.42	+	1.49	9.58E-02
organelle fusion (GO:0048284)	54	14	9.42	+	1.49	9.58E-02
organic acid metabolic process (GO:0006082)	162	42	28.25	+	1.49	8.33E-03
negative regulation of protein phosphorylation (GO:0001933)	58	15	10.11	+	1.48	8.85E-02
protein transmembrane transport (GO:0071806)	31	8	5.41	+	1.48	1.79E-01
intracellular protein transmembrane transport (GO:0065002)	31	8	5.41	+	1.48	1.79E-01
regulation of stem cell differentiation (GO:2000736)	31	8	5.41	+	1.48	1.79E-01
response to unfolded protein (GO:0006986)	31	8	5.41	+	1.48	1.79E-01
phospholipid metabolic process (GO:0006644)	74	19	12.90	+	1.47	6.49E-02
transcription by RNA polymerase II (GO:0006366)	78	20	13.60	+	1.47	6.01E-02
organic hydroxy compound biosynthetic process (GO:1901617)	47	12	8.20	+	1.46	1.26E-01
synaptic vesicle exocytosis (GO:0016079)	51	13	8.89	+	1.46	1.16E-01
epidermis development (GO:0008544)	59	15	10.29	+	1.46	9.83E-02
cell junction assembly (GO:0034329)	103	26	17.96	+	1.45	4.23E-02
GTP metabolic process (GO:0046039)	4	1	.70	+	1.43	5.02E-01
xenobiotic transport (GO:0042908)	4	1	.70	+	1.43	5.02E-01
stress granule assembly (GO:0034063)	8	2	1.40	+	1.43	4.07E-01
regulation of female receptivity, post-mating (GO:0046008)	12	3	2.09	+	1.43	3.48E-01
eye pigment precursor transport (GO:0006856)	4	1	.70	+	1.43	5.02E-01
iron ion transport (GO:0006826)	12	3	2.09	+	1.43	3.48E-01
polysaccharide catabolic process (GO:0000272)	12	3	2.09	+	1.43	3.48E-01
compartment boundary maintenance (GO:0060289)	4	1	.70	+	1.43	5.02E-01
neuron-neuron synaptic transmission (GO:0007270)	4	1	.70	+	1.43	5.02E-01
cytokine-mediated signaling pathway (GO:0019221)	16	4	2.79	+	1.43	3.06E-01
regulation of cell maturation (GO:1903429)	16	4	2.79	+	1.43	3.06E-01
male germ-line cyst encapsulation (GO:0048140)	8	2	1.40	+	1.43	4.07E-01
regulation of catecholamine secretion (GO:0050433)	8	2	1.40	+	1.43	4.07E-01
pheromone biosynthetic process (GO:0042811)	4	1	.70	+	1.43	5.02E-01
pheromone metabolic process (GO:0042810)	4	1	.70	+	1.43	5.02E-01
negative regulation of actin filament depolymerization (GO:0030835)	8	2	1.40	+	1.43	4.07E-01
positive regulation of nucleotide biosynthetic process (GO:0030810)	4	1	.70	+	1.43	5.02E-01
NADP metabolic process (GO:0006739)	8	2	1.40	+	1.43	4.07E-01
cuticle hydrocarbon biosynthetic process (GO:0006723)	4	1	.70	+	1.43	5.02E-01
membrane protein intracellular domain proteolysis (GO:0031293)	4	1	.70	+	1.43	5.02E-01
juvenile hormone mediated signaling pathway (GO:0035626)	4	1	.70	+	1.43	5.02E-01
nonribosomal peptide biosynthetic process (GO:0019184)	4	1	.70	+	1.43	5.02E-01
cell cycle switching (GO:0060184)	4	1	.70	+	1.43	5.02E-01
anterior/posterior lineage restriction, imaginal disc (GO:0048099)	4	1	.70	+	1.43	5.02E-01
regulation of developmental pigmentation (GO:0048070)	24	6	4.19	+	1.43	2.44E-01
protein localization to microtubule organizing center (GO:1905508)	4	1	.70	+	1.43	5.02E-01
long-chain fatty acid biosynthetic process (GO:0042759)	4	1	.70	+	1.43	5.02E-01
negative regulation of protein maturation (GO:1903318)	4	1	.70	+	1.43	5.02E-01
positive regulation of mRNA splicing, via spliceosome (GO:0048026)	4	1	.70	+	1.43	5.02E-01
inositol lipid-mediated signaling (GO:0048017)	12	3	2.09	+	1.43	3.48E-01
dosage compensation complex assembly (GO:0042714)	4	1	.70	+	1.43	5.02E-01
positive regulation of activin receptor signaling pathway (GO:0032927)	4	1	.70	+	1.43	5.02E-01
regulation of activin receptor signaling pathway (GO:0032925)	4	1	.70	+	1.43	5.02E-01
ovarian follicle cell stalk formation (GO:0030713)	12	3	2.09	+	1.43	3.48E-01
glycerol ether metabolic process (GO:0006662)	4	1	.70	+	1.43	5.02E-01
fatty acid metabolic process (GO:0006631)	48	12	8.37	+	1.43	1.40E-01
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	12	3	2.09	+	1.43	3.48E-01
cotranslational protein targeting to membrane (GO:0006613)	12	3	2.09	+	1.43	3.48E-01
peptide catabolic process (GO:0043171)	4	1	.70	+	1.43	5.02E-01
ribosomal large subunit export from nucleus (GO:0000055)	4	1	.70	+	1.43	5.02E-01
ribosomal subunit export from nucleus (GO:0000054)	8	2	1.40	+	1.43	4.07E-01
secretory granule organization (GO:0033363)	8	2	1.40	+	1.43	4.07E-01
amino acid salvage (GO:0043102)	4	1	.70	+	1.43	5.02E-01
purine-containing compound salvage (GO:0043101)	4	1	.70	+	1.43	5.02E-01
mitotic spindle assembly checkpoint (GO:0007094)	12	3	2.09	+	1.43	3.48E-01
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	8	2	1.40	+	1.43	4.07E-01
glucan catabolic process (GO:0009251)	12	3	2.09	+	1.43	3.48E-01
regulation of cardioblast cell fate specification (GO:0042686)	4	1	.70	+	1.43	5.02E-01
glycolipid biosynthetic process (GO:0009247)	16	4	2.79	+	1.43	3.06E-01
spindle assembly involved in female meiosis I (GO:0007057)	4	1	.70	+	1.43	5.02E-01
regulation of polysaccharide biosynthetic process (GO:0032885)	4	1	.70	+	1.43	5.02E-01
positive regulation of DNA endoreduplication (GO:0032877)	4	1	.70	+	1.43	5.02E-01
negative regulation of oxidative stress-induced cell death (GO:1903202)	4	1	.70	+	1.43	5.02E-01
cellular response to transforming growth factor beta stimulus (GO:0071560)	8	2	1.40	+	1.43	4.07E-01
response to transforming growth factor beta (GO:0071559)	8	2	1.40	+	1.43	4.07E-01
negative regulation of mitotic sister chromatid separation (GO:2000816)	12	3	2.09	+	1.43	3.48E-01
negative regulation of chromosome segregation (GO:0051985)	12	3	2.09	+	1.43	3.48E-01
protein localization to centrosome (GO:0071539)	4	1	.70	+	1.43	5.02E-01
nucleobase-containing small molecule metabolic process (GO:0055086)	128	32	22.32	+	1.43	2.98E-02
regulation of amine transport (GO:0051952)	8	2	1.40	+	1.43	4.07E-01
methionine metabolic process (GO:0006555)	4	1	.70	+	1.43	5.02E-01
glutamine metabolic process (GO:0006541)	4	1	.70	+	1.43	5.02E-01
positive regulation of purine nucleotide metabolic process (GO:1900544)	4	1	.70	+	1.43	5.02E-01
glutamate biosynthetic process (GO:0006537)	4	1	.70	+	1.43	5.02E-01
positive regulation of calcium ion transport (GO:0051928)	4	1	.70	+	1.43	5.02E-01
arginine metabolic process (GO:0006525)	4	1	.70	+	1.43	5.02E-01
glycoprotein catabolic process (GO:0006516)	4	1	.70	+	1.43	5.02E-01
membrane protein ectodomain proteolysis (GO:0006509)	8	2	1.40	+	1.43	4.07E-01
GPI anchor biosynthetic process (GO:0006506)	8	2	1.40	+	1.43	4.07E-01
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270)	4	1	.70	+	1.43	5.02E-01
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	4	1	.70	+	1.43	5.02E-01
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	4	1	.70	+	1.43	5.02E-01
negative regulation of cation channel activity (GO:2001258)	4	1	.70	+	1.43	5.02E-01
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	4	1	.70	+	1.43	5.02E-01
tumor necrosis factor-mediated signaling pathway (GO:0033209)	12	3	2.09	+	1.43	3.48E-01
nucleoside biosynthetic process (GO:0009163)	12	3	2.09	+	1.43	3.48E-01
regulation of autophagy of mitochondrion (GO:1903146)	8	2	1.40	+	1.43	4.07E-01
regulation of imaginal disc-derived wing size (GO:0044719)	12	3	2.09	+	1.43	3.48E-01
positive regulation of stem cell differentiation (GO:2000738)	4	1	.70	+	1.43	5.02E-01
protein lipidation (GO:0006497)	24	6	4.19	+	1.43	2.44E-01
O-glycan processing (GO:0016266)	4	1	.70	+	1.43	5.02E-01
regulation of glucan biosynthetic process (GO:0010962)	4	1	.70	+	1.43	5.02E-01
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428)	8	2	1.40	+	1.43	4.07E-01
negative regulation of protein processing (GO:0010955)	4	1	.70	+	1.43	5.02E-01
histone H3-K9 modification (GO:0061647)	8	2	1.40	+	1.43	4.07E-01
N-terminal protein amino acid acetylation (GO:0006474)	4	1	.70	+	1.43	5.02E-01
protein ADP-ribosylation (GO:0006471)	4	1	.70	+	1.43	5.02E-01
calcium ion import into cytosol (GO:1902656)	4	1	.70	+	1.43	5.02E-01
C-terminal protein amino acid modification (GO:0018410)	4	1	.70	+	1.43	5.02E-01
apoptotic mitochondrial changes (GO:0008637)	4	1	.70	+	1.43	5.02E-01
regulation of dopamine secretion (GO:0014059)	8	2	1.40	+	1.43	4.07E-01
tRNA wobble uridine modification (GO:0002098)	4	1	.70	+	1.43	5.02E-01
tRNA wobble base modification (GO:0002097)	4	1	.70	+	1.43	5.02E-01
regulation of neuron maturation (GO:0014041)	16	4	2.79	+	1.43	3.06E-01
synaptic target attraction (GO:0016200)	4	1	.70	+	1.43	5.02E-01
regulation of gliogenesis (GO:0014013)	12	3	2.09	+	1.43	3.48E-01
demethylation (GO:0070988)	8	2	1.40	+	1.43	4.07E-01
nucleotide-sugar transmembrane transport (GO:0015780)	4	1	.70	+	1.43	5.02E-01
imaginal disc-derived wing hair site selection (GO:0035320)	4	1	.70	+	1.43	5.02E-01
regulation of glycogen catabolic process (GO:0005981)	4	1	.70	+	1.43	5.02E-01
glycogen catabolic process (GO:0005980)	12	3	2.09	+	1.43	3.48E-01
regulation of glycogen biosynthetic process (GO:0005979)	4	1	.70	+	1.43	5.02E-01
negative regulation of hormone secretion (GO:0046888)	4	1	.70	+	1.43	5.02E-01
succinate transport (GO:0015744)	4	1	.70	+	1.43	5.02E-01
methionine biosynthetic process (GO:0009086)	4	1	.70	+	1.43	5.02E-01
ribonucleoside biosynthetic process (GO:0042455)	12	3	2.09	+	1.43	3.48E-01
purine nucleoside biosynthetic process (GO:0042451)	12	3	2.09	+	1.43	3.48E-01
cellular response to ecdysone (GO:0071390)	16	4	2.79	+	1.43	3.06E-01
regulation of neuron remodeling (GO:1904799)	16	4	2.79	+	1.43	3.06E-01
cellular response to tumor necrosis factor (GO:0071356)	12	3	2.09	+	1.43	3.48E-01
medium-chain fatty acid metabolic process (GO:0051791)	4	1	.70	+	1.43	5.02E-01
cellular response to cytokine stimulus (GO:0071345)	16	4	2.79	+	1.43	3.06E-01
positive regulation of purine nucleotide biosynthetic process (GO:1900373)	4	1	.70	+	1.43	5.02E-01
terpenoid biosynthetic process (GO:0016114)	4	1	.70	+	1.43	5.02E-01
germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)	4	1	.70	+	1.43	5.02E-01
cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)	4	1	.70	+	1.43	5.02E-01
anterior head segmentation (GO:0035288)	8	2	1.40	+	1.43	4.07E-01
ring gland development (GO:0035271)	4	1	.70	+	1.43	5.02E-01
endocrine system development (GO:0035270)	4	1	.70	+	1.43	5.02E-01
negative regulation of mitotic sister chromatid segregation (GO:0033048)	12	3	2.09	+	1.43	3.48E-01
negative regulation of sister chromatid segregation (GO:0033046)	12	3	2.09	+	1.43	3.48E-01
labial disc development (GO:0035217)	4	1	.70	+	1.43	5.02E-01
negative regulation of response to DNA damage stimulus (GO:2001021)	4	1	.70	+	1.43	5.02E-01
iron ion transmembrane transport (GO:0034755)	4	1	.70	+	1.43	5.02E-01
negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)	4	1	.70	+	1.43	5.02E-01
positive regulation of protein import into nucleus (GO:0042307)	4	1	.70	+	1.43	5.02E-01
L-methionine salvage (GO:0071267)	4	1	.70	+	1.43	5.02E-01
L-methionine biosynthetic process (GO:0071265)	4	1	.70	+	1.43	5.02E-01
negative regulation of phosphoprotein phosphatase activity (GO:0032515)	4	1	.70	+	1.43	5.02E-01
actin filament capping (GO:0051693)	8	2	1.40	+	1.43	4.07E-01
detection of temperature stimulus (GO:0016048)	4	1	.70	+	1.43	5.02E-01
peptidyl-arginine methylation (GO:0018216)	8	2	1.40	+	1.43	4.07E-01
mitochondrial RNA metabolic process (GO:0000959)	8	2	1.40	+	1.43	4.07E-01
UTP biosynthetic process (GO:0006228)	4	1	.70	+	1.43	5.02E-01
pyrimidine nucleobase catabolic process (GO:0006208)	4	1	.70	+	1.43	5.02E-01
terminal cell fate specification, open tracheal system (GO:0035154)	4	1	.70	+	1.43	5.02E-01
sperm competition (GO:0046692)	12	3	2.09	+	1.43	3.48E-01
sterol regulatory element binding protein cleavage (GO:0035103)	4	1	.70	+	1.43	5.02E-01
tetrahydrofolate metabolic process (GO:0046653)	4	1	.70	+	1.43	5.02E-01
negative regulation of insulin receptor signaling pathway (GO:0046627)	24	6	4.19	+	1.43	2.44E-01
regulation of Rab protein signal transduction (GO:0032483)	8	2	1.40	+	1.43	4.07E-01
peptidyl-arginine modification (GO:0018195)	8	2	1.40	+	1.43	4.07E-01
mitotic spindle checkpoint (GO:0071174)	12	3	2.09	+	1.43	3.48E-01
positive regulation of protein import (GO:1904591)	4	1	.70	+	1.43	5.02E-01
spindle assembly checkpoint (GO:0071173)	12	3	2.09	+	1.43	3.48E-01
response to tumor necrosis factor (GO:0034612)	12	3	2.09	+	1.43	3.48E-01
regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)	4	1	.70	+	1.43	5.02E-01
Wnt protein secretion (GO:0061355)	8	2	1.40	+	1.43	4.07E-01
GTP biosynthetic process (GO:0006183)	4	1	.70	+	1.43	5.02E-01
establishment of proximal/distal cell polarity (GO:0022606)	4	1	.70	+	1.43	5.02E-01
positive regulation of mitochondrial fusion (GO:0010636)	4	1	.70	+	1.43	5.02E-01
regulation of mitochondrial fusion (GO:0010635)	8	2	1.40	+	1.43	4.07E-01
negative regulation of peptide hormone secretion (GO:0090278)	4	1	.70	+	1.43	5.02E-01
positive regulation of lipophagy (GO:1904504)	4	1	.70	+	1.43	5.02E-01
response to nicotine (GO:0035094)	4	1	.70	+	1.43	5.02E-01
protein localization involved in establishment of planar polarity (GO:0090251)	4	1	.70	+	1.43	5.02E-01
salivary gland histolysis (GO:0035070)	32	8	5.58	+	1.43	2.00E-01
regulation of execution phase of apoptosis (GO:1900117)	4	1	.70	+	1.43	5.02E-01
regulation of Rac protein signal transduction (GO:0035020)	4	1	.70	+	1.43	5.02E-01
negative regulation of Ras protein signal transduction (GO:0046580)	4	1	.70	+	1.43	5.02E-01
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836)	4	1	.70	+	1.43	5.02E-01
lipoprotein biosynthetic process (GO:0042158)	24	6	4.19	+	1.43	2.44E-01
cellular response to glucose starvation (GO:0042149)	4	1	.70	+	1.43	5.02E-01
sulfate transport (GO:0008272)	4	1	.70	+	1.43	5.02E-01
pentose-phosphate shunt (GO:0006098)	4	1	.70	+	1.43	5.02E-01
regulation of ceramide biosynthetic process (GO:2000303)	4	1	.70	+	1.43	5.02E-01
negative regulation of phosphorus metabolic process (GO:0010563)	68	17	11.86	+	1.43	9.25E-02
negative regulation of cellular response to insulin stimulus (GO:1900077)	24	6	4.19	+	1.43	2.44E-01
maintenance of protein location in nucleus (GO:0051457)	4	1	.70	+	1.43	5.02E-01
establishment of epithelial cell planar polarity (GO:0090163)	4	1	.70	+	1.43	5.02E-01
cuticle chitin metabolic process (GO:0006034)	4	1	.70	+	1.43	5.02E-01
non-recombinational repair (GO:0000726)	8	2	1.40	+	1.43	4.07E-01
dendrite self-avoidance (GO:0070593)	16	4	2.79	+	1.43	3.06E-01
mitochondrion morphogenesis (GO:0070584)	8	2	1.40	+	1.43	4.07E-01
regulation of neuron projection regeneration (GO:0070570)	8	2	1.40	+	1.43	4.07E-01
positive regulation of axon extension involved in regeneration (GO:0048691)	4	1	.70	+	1.43	5.02E-01
regulation of axon extension involved in regeneration (GO:0048690)	4	1	.70	+	1.43	5.02E-01
positive regulation of sprouting of injured axon (GO:0048687)	4	1	.70	+	1.43	5.02E-01
regulation of sprouting of injured axon (GO:0048686)	4	1	.70	+	1.43	5.02E-01
regulation of axon regeneration (GO:0048679)	8	2	1.40	+	1.43	4.07E-01
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	4	1	.70	+	1.43	5.02E-01
detection of temperature stimulus involved in sensory perception of pain (GO:0050965)	4	1	.70	+	1.43	5.02E-01
detection of temperature stimulus involved in sensory perception (GO:0050961)	4	1	.70	+	1.43	5.02E-01
hydrocarbon biosynthetic process (GO:0120251)	4	1	.70	+	1.43	5.02E-01
calcium ion import (GO:0070509)	8	2	1.40	+	1.43	4.07E-01
sensory perception of temperature stimulus (GO:0050951)	4	1	.70	+	1.43	5.02E-01
membrane lipid biosynthetic process (GO:0046467)	32	8	5.58	+	1.43	2.00E-01
embryonic anterior midgut (ectodermal) morphogenesis (GO:0048615)	4	1	.70	+	1.43	5.02E-01
embryonic ectodermal digestive tract morphogenesis (GO:0048613)	4	1	.70	+	1.43	5.02E-01
embryonic ectodermal digestive tract development (GO:0048611)	4	1	.70	+	1.43	5.02E-01
cellular polysaccharide catabolic process (GO:0044247)	12	3	2.09	+	1.43	3.48E-01
regulation of photoreceptor cell axon guidance (GO:2000289)	4	1	.70	+	1.43	5.02E-01
negative regulation of reproductive process (GO:2000242)	12	3	2.09	+	1.43	3.48E-01
positive regulation of nucleotide metabolic process (GO:0045981)	4	1	.70	+	1.43	5.02E-01
negative regulation of DNA replication (GO:0008156)	12	3	2.09	+	1.43	3.48E-01
response to lipid (GO:0033993)	48	12	8.37	+	1.43	1.40E-01
positive regulation of cell-cell adhesion (GO:0022409)	12	3	2.09	+	1.43	3.48E-01
positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	16	4	2.79	+	1.43	3.06E-01
negative regulation of phosphate metabolic process (GO:0045936)	68	17	11.86	+	1.43	9.25E-02
P-body assembly (GO:0033962)	8	2	1.40	+	1.43	4.07E-01
regulation of ribosome biogenesis (GO:0090069)	4	1	.70	+	1.43	5.02E-01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	4	1	.70	+	1.43	5.02E-01
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	12	3	2.09	+	1.43	3.48E-01
ectodermal digestive tract morphogenesis (GO:0048567)	8	2	1.40	+	1.43	4.07E-01
glycosyl compound biosynthetic process (GO:1901659)	12	3	2.09	+	1.43	3.48E-01
cellular response to ketone (GO:1901655)	16	4	2.79	+	1.43	3.06E-01
anterior head development (GO:0097065)	8	2	1.40	+	1.43	4.07E-01
mechanosensory behavior (GO:0007638)	12	3	2.09	+	1.43	3.48E-01
regulation of calcium-mediated signaling (GO:0050848)	8	2	1.40	+	1.43	4.07E-01
monosaccharide catabolic process (GO:0046365)	4	1	.70	+	1.43	5.02E-01
monosaccharide biosynthetic process (GO:0046364)	8	2	1.40	+	1.43	4.07E-01
imaginal disc-derived wing expansion (GO:0048526)	8	2	1.40	+	1.43	4.07E-01
lateral inhibition (GO:0046331)	8	2	1.40	+	1.43	4.07E-01
negative regulation of histone H3-K27 methylation (GO:0061086)	4	1	.70	+	1.43	5.02E-01
protein sumoylation (GO:0016925)	8	2	1.40	+	1.43	4.07E-01
establishment of meiotic spindle localization (GO:0051295)	4	1	.70	+	1.43	5.02E-01
cell dedifferentiation (GO:0043697)	8	2	1.40	+	1.43	4.07E-01
dedifferentiation (GO:0043696)	8	2	1.40	+	1.43	4.07E-01
male germline stem cell symmetric division (GO:0098730)	4	1	.70	+	1.43	5.02E-01
peptidoglycan recognition protein signaling pathway (GO:0061057)	16	4	2.79	+	1.43	3.06E-01
germline stem cell symmetric division (GO:0098729)	4	1	.70	+	1.43	5.02E-01
symmetric stem cell division (GO:0098724)	4	1	.70	+	1.43	5.02E-01
ocellus development (GO:0008056)	4	1	.70	+	1.43	5.02E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	12	3	2.09	+	1.43	3.48E-01
protein tetramerization (GO:0051262)	4	1	.70	+	1.43	5.02E-01
calcium ion import across plasma membrane (GO:0098703)	4	1	.70	+	1.43	5.02E-01
negative regulation of meiotic nuclear division (GO:0045835)	4	1	.70	+	1.43	5.02E-01
membrane invagination (GO:0010324)	24	6	4.19	+	1.43	2.44E-01
cellular response to nutrient (GO:0031670)	4	1	.70	+	1.43	5.02E-01
response to sucrose (GO:0009744)	16	4	2.79	+	1.43	3.06E-01
replication fork protection (GO:0048478)	4	1	.70	+	1.43	5.02E-01
response to paraquat (GO:1901562)	4	1	.70	+	1.43	5.02E-01
L-methionine salvage from methylthioadenosine (GO:0019509)	4	1	.70	+	1.43	5.02E-01
primary sex determination, germ-line (GO:0007542)	4	1	.70	+	1.43	5.02E-01
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	4	1	.70	+	1.43	5.02E-01
outflow tract morphogenesis (GO:0003151)	4	1	.70	+	1.43	5.02E-01
gonadal mesoderm development (GO:0007506)	8	2	1.40	+	1.43	4.07E-01
negative regulation of protein secretion (GO:0050709)	4	1	.70	+	1.43	5.02E-01
regulation of cardiac cell fate specification (GO:2000043)	4	1	.70	+	1.43	5.02E-01
positive regulation of TOR signaling (GO:0032008)	24	6	4.19	+	1.43	2.44E-01
regulation of adenylate cyclase activity (GO:0045761)	4	1	.70	+	1.43	5.02E-01
glucose 6-phosphate metabolic process (GO:0051156)	8	2	1.40	+	1.43	4.07E-01
ribosome localization (GO:0033750)	8	2	1.40	+	1.43	4.07E-01
spindle checkpoint (GO:0031577)	12	3	2.09	+	1.43	3.48E-01
positive regulation of mRNA processing (GO:0050685)	4	1	.70	+	1.43	5.02E-01
negative regulation of chromosome separation (GO:1905819)	12	3	2.09	+	1.43	3.48E-01
imaginal disc growth (GO:0007446)	12	3	2.09	+	1.43	3.48E-01
anterior midgut (ectodermal) morphogenesis (GO:0007441)	4	1	.70	+	1.43	5.02E-01
response to mechanical stimulus (GO:0009612)	32	8	5.58	+	1.43	2.00E-01
ectodermal digestive tract development (GO:0007439)	8	2	1.40	+	1.43	4.07E-01
RNA decapping (GO:0110154)	8	2	1.40	+	1.43	4.07E-01
plasma membrane invagination (GO:0099024)	24	6	4.19	+	1.43	2.44E-01
mitochondrion distribution (GO:0048311)	12	3	2.09	+	1.43	3.48E-01
purine ribonucleoside biosynthetic process (GO:0046129)	12	3	2.09	+	1.43	3.48E-01
negative regulation of compound eye photoreceptor cell differentiation (GO:0110118)	8	2	1.40	+	1.43	4.07E-01
nuclear envelope organization (GO:0006998)	12	3	2.09	+	1.43	3.48E-01
cellular response to sterol (GO:0036315)	16	4	2.79	+	1.43	3.06E-01
ER-nucleus signaling pathway (GO:0006984)	8	2	1.40	+	1.43	4.07E-01
ether metabolic process (GO:0018904)	4	1	.70	+	1.43	5.02E-01
striated muscle contraction (GO:0006941)	4	1	.70	+	1.43	5.02E-01
substrate-dependent cell migration (GO:0006929)	4	1	.70	+	1.43	5.02E-01
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	8	2	1.40	+	1.43	4.07E-01
dorsal closure, elongation of leading edge cells (GO:0007394)	8	2	1.40	+	1.43	4.07E-01
innervation (GO:0060384)	4	1	.70	+	1.43	5.02E-01
regulation of calcium ion-dependent exocytosis (GO:0017158)	8	2	1.40	+	1.43	4.07E-01
regulation of voltage-gated calcium channel activity (GO:1901385)	4	1	.70	+	1.43	5.02E-01
germ-band extension (GO:0007377)	8	2	1.40	+	1.43	4.07E-01
posterior midgut invagination (GO:0007374)	4	1	.70	+	1.43	5.02E-01
hexose catabolic process (GO:0019320)	4	1	.70	+	1.43	5.02E-01
mucopolysaccharide metabolic process (GO:1903510)	4	1	.70	+	1.43	5.02E-01
UTP metabolic process (GO:0046051)	4	1	.70	+	1.43	5.02E-01
pole plasm protein localization (GO:0007318)	12	3	2.09	+	1.43	3.48E-01
glycerophospholipid metabolic process (GO:0006650)	60	15	10.46	+	1.43	1.09E-01
plasma membrane organization (GO:0007009)	20	5	3.49	+	1.43	2.72E-01
phospholipid biosynthetic process (GO:0008654)	28	7	4.88	+	1.43	2.20E-01
imaginal disc-derived wing margin morphogenesis (GO:0008587)	52	13	9.07	+	1.43	1.28E-01
regulated exocytosis (GO:0045055)	56	14	9.77	+	1.43	1.18E-01
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	36	9	6.28	+	1.43	1.82E-01
liquid clearance, open tracheal system (GO:0035002)	20	5	3.49	+	1.43	2.72E-01
regulation of canonical Wnt signaling pathway (GO:0060828)	76	19	13.25	+	1.43	7.90E-02
regulation of proteasomal protein catabolic process (GO:0061136)	40	10	6.98	+	1.43	1.66E-01
mesodermal cell migration (GO:0008078)	20	5	3.49	+	1.43	2.72E-01
cellular response to topologically incorrect protein (GO:0035967)	36	9	6.28	+	1.43	1.82E-01
oxoacid metabolic process (GO:0043436)	160	40	27.90	+	1.43	1.67E-02
negative regulation of protein modification process (GO:0031400)	76	19	13.25	+	1.43	7.90E-02
regulation of circadian rhythm (GO:0042752)	81	20	14.12	+	1.42	8.03E-02
carboxylic acid metabolic process (GO:0019752)	154	38	26.85	+	1.42	2.30E-02
ncRNA metabolic process (GO:0034660)	126	31	21.97	+	1.41	3.83E-02
synapse assembly (GO:0007416)	57	14	9.94	+	1.41	1.30E-01
membrane organization (GO:0061024)	167	41	29.12	+	1.41	2.02E-02
regulation of cellular protein catabolic process (GO:1903362)	49	12	8.54	+	1.40	1.54E-01
imaginal disc-derived wing hair organization (GO:0035317)	45	11	7.85	+	1.40	1.68E-01
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)	45	11	7.85	+	1.40	1.68E-01
regulation of Toll signaling pathway (GO:0008592)	45	11	7.85	+	1.40	1.68E-01
signal release (GO:0023061)	86	21	15.00	+	1.40	8.13E-02
cellular lipid metabolic process (GO:0044255)	172	42	29.99	+	1.40	2.04E-02
regulation of response to external stimulus (GO:0032101)	197	48	34.35	+	1.40	1.44E-02
negative regulation of cellular catabolic process (GO:0031330)	37	9	6.45	+	1.39	2.02E-01
response to topologically incorrect protein (GO:0035966)	37	9	6.45	+	1.39	2.02E-01
negative regulation of transport (GO:0051051)	37	9	6.45	+	1.39	2.02E-01
RNA modification (GO:0009451)	33	8	5.75	+	1.39	2.23E-01
cell-cell junction organization (GO:0045216)	66	16	11.51	+	1.39	1.21E-01
lipid modification (GO:0030258)	62	15	10.81	+	1.39	1.31E-01
cellular response to chemical stress (GO:0062197)	29	7	5.06	+	1.38	2.46E-01
regulation of sister chromatid segregation (GO:0033045)	29	7	5.06	+	1.38	2.46E-01
organic acid biosynthetic process (GO:0016053)	58	14	10.11	+	1.38	1.43E-01
carboxylic acid biosynthetic process (GO:0046394)	58	14	10.11	+	1.38	1.43E-01
dephosphorylation (GO:0016311)	83	20	14.47	+	1.38	9.60E-02
regulation of tube architecture, open tracheal system (GO:0035152)	83	20	14.47	+	1.38	9.60E-02
regulation of behavior (GO:0050795)	83	20	14.47	+	1.38	9.60E-02
organophosphate biosynthetic process (GO:0090407)	108	26	18.83	+	1.38	6.58E-02
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	25	6	4.36	+	1.38	2.73E-01
purine ribonucleoside triphosphate metabolic process (GO:0009205)	25	6	4.36	+	1.38	2.73E-01
mesoderm formation (GO:0001707)	25	6	4.36	+	1.38	2.73E-01
purine nucleoside triphosphate biosynthetic process (GO:0009145)	25	6	4.36	+	1.38	2.73E-01
proton transmembrane transport (GO:1902600)	50	12	8.72	+	1.38	1.70E-01
regulation of mitochondrion organization (GO:0010821)	25	6	4.36	+	1.38	2.73E-01
positive regulation of multicellular organism growth (GO:0040018)	25	6	4.36	+	1.38	2.73E-01
calcium-mediated signaling (GO:0019722)	25	6	4.36	+	1.38	2.73E-01
histone exchange (GO:0043486)	25	6	4.36	+	1.38	2.73E-01
carbohydrate homeostasis (GO:0033500)	46	11	8.02	+	1.37	1.85E-01
non-sensory hair organization (GO:0035316)	46	11	8.02	+	1.37	1.85E-01
hair cell differentiation (GO:0035315)	46	11	8.02	+	1.37	1.85E-01
protein localization to membrane (GO:0072657)	92	22	16.04	+	1.37	8.94E-02
organonitrogen compound biosynthetic process (GO:1901566)	431	103	75.16	+	1.37	8.65E-04
phosphorylation (GO:0016310)	314	75	54.76	+	1.37	4.31E-03
regulation of vesicle-mediated transport (GO:0060627)	109	26	19.01	+	1.37	7.15E-02
exocytosis (GO:0006887)	84	20	14.65	+	1.37	1.04E-01
ATP biosynthetic process (GO:0006754)	21	5	3.66	+	1.37	3.05E-01
'de novo' protein folding (GO:0006458)	21	5	3.66	+	1.37	3.05E-01
eye-antennal disc development (GO:0035214)	63	15	10.99	+	1.37	1.44E-01
synaptic vesicle docking (GO:0016081)	21	5	3.66	+	1.37	3.05E-01
postsynapse organization (GO:0099173)	21	5	3.66	+	1.37	3.05E-01
ribonucleoprotein complex biogenesis (GO:0022613)	156	37	27.20	+	1.36	4.03E-02
neurotransmitter secretion (GO:0007269)	76	18	13.25	+	1.36	1.23E-01
regulation of BMP signaling pathway (GO:0030510)	38	9	6.63	+	1.36	2.23E-01
signal release from synapse (GO:0099643)	76	18	13.25	+	1.36	1.23E-01
regulation of TOR signaling (GO:0032006)	38	9	6.63	+	1.36	2.23E-01
eye-antennal disc morphogenesis (GO:0007455)	38	9	6.63	+	1.36	2.23E-01
phosphate-containing compound metabolic process (GO:0006796)	511	121	89.11	+	1.36	4.29E-04
small molecule biosynthetic process (GO:0044283)	131	31	22.84	+	1.36	5.77E-02
small molecule metabolic process (GO:0044281)	351	83	61.21	+	1.36	3.56E-03
anatomical structure regression (GO:0060033)	55	13	9.59	+	1.36	1.70E-01
purine ribonucleotide biosynthetic process (GO:0009152)	55	13	9.59	+	1.36	1.70E-01
response to fungus (GO:0009620)	55	13	9.59	+	1.36	1.70E-01
negative regulation of cell communication (GO:0010648)	301	71	52.49	+	1.35	7.12E-03
glycolipid metabolic process (GO:0006664)	17	4	2.96	+	1.35	3.45E-01
positive regulation of BMP signaling pathway (GO:0030513)	17	4	2.96	+	1.35	3.45E-01
muscle attachment (GO:0016203)	34	8	5.93	+	1.35	2.46E-01
negative regulation of nuclear division (GO:0051784)	17	4	2.96	+	1.35	3.45E-01
regulation of protein catabolic process (GO:0042176)	68	16	11.86	+	1.35	1.44E-01
regulation of Wnt signaling pathway (GO:0030111)	85	20	14.82	+	1.35	1.13E-01
negative regulation of protein polymerization (GO:0032272)	17	4	2.96	+	1.35	3.45E-01
reactive oxygen species metabolic process (GO:0072593)	17	4	2.96	+	1.35	3.45E-01
skeletal muscle organ development (GO:0060538)	34	8	5.93	+	1.35	2.46E-01
liposaccharide metabolic process (GO:1903509)	17	4	2.96	+	1.35	3.45E-01
negative regulation of signaling (GO:0023057)	302	71	52.66	+	1.35	7.65E-03
response to oxidative stress (GO:0006979)	107	25	18.66	+	1.34	9.03E-02
protein import (GO:0017038)	60	14	10.46	+	1.34	1.70E-01
monosaccharide metabolic process (GO:0005996)	30	7	5.23	+	1.34	2.72E-01
larval chitin-based cuticle development (GO:0008363)	30	7	5.23	+	1.34	2.72E-01
positive regulation of Ras protein signal transduction (GO:0046579)	30	7	5.23	+	1.34	2.72E-01
response to carbohydrate (GO:0009743)	30	7	5.23	+	1.34	2.72E-01
positive regulation of small GTPase mediated signal transduction (GO:0051057)	30	7	5.23	+	1.34	2.72E-01
phosphorus metabolic process (GO:0006793)	519	121	90.50	+	1.34	7.58E-04
neuron maturation (GO:0042551)	43	10	7.50	+	1.33	2.23E-01
defense response to fungus (GO:0050832)	43	10	7.50	+	1.33	2.23E-01
imaginal disc pattern formation (GO:0007447)	99	23	17.26	+	1.33	1.05E-01
instar larval development (GO:0002168)	69	16	12.03	+	1.33	1.57E-01
lipid metabolic process (GO:0006629)	216	50	37.67	+	1.33	2.86E-02
negative regulation of apoptotic process (GO:0043066)	78	18	13.60	+	1.32	1.44E-01
ATP-dependent chromatin remodeling (GO:0043044)	39	9	6.80	+	1.32	2.45E-01
negative regulation of catabolic process (GO:0009895)	39	9	6.80	+	1.32	2.45E-01
negative regulation of response to stimulus (GO:0048585)	325	75	56.67	+	1.32	9.41E-03
establishment of protein localization to plasma membrane (GO:0061951)	13	3	2.27	+	1.32	3.95E-01
inter-male aggressive behavior (GO:0002121)	13	3	2.27	+	1.32	3.95E-01
purine nucleoside triphosphate metabolic process (GO:0009144)	26	6	4.53	+	1.32	3.03E-01
multi-multicellular organism process (GO:0044706)	13	3	2.27	+	1.32	3.95E-01
regulation of apoptotic process involved in development (GO:1904748)	13	3	2.27	+	1.32	3.95E-01
peptidyl-threonine phosphorylation (GO:0018107)	13	3	2.27	+	1.32	3.95E-01
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	13	3	2.27	+	1.32	3.95E-01
protein localization to chromosome (GO:0034502)	13	3	2.27	+	1.32	3.95E-01
regulation of cytosolic calcium ion concentration (GO:0051480)	26	6	4.53	+	1.32	3.03E-01
nuclear RNA surveillance (GO:0071027)	13	3	2.27	+	1.32	3.95E-01
aerobic electron transport chain (GO:0019646)	13	3	2.27	+	1.32	3.95E-01
negative regulation of mitotic nuclear division (GO:0045839)	13	3	2.27	+	1.32	3.95E-01
negative regulation of TOR signaling (GO:0032007)	13	3	2.27	+	1.32	3.95E-01
antennal development (GO:0007469)	26	6	4.53	+	1.32	3.03E-01
axon target recognition (GO:0007412)	13	3	2.27	+	1.32	3.95E-01
negative regulation of secretion (GO:0051048)	13	3	2.27	+	1.32	3.95E-01
response to reactive oxygen species (GO:0000302)	26	6	4.53	+	1.32	3.03E-01
insemination (GO:0007320)	13	3	2.27	+	1.32	3.95E-01
ribonucleotide biosynthetic process (GO:0009260)	61	14	10.64	+	1.32	1.85E-01
protein folding (GO:0006457)	61	14	10.64	+	1.32	1.85E-01
ribose phosphate biosynthetic process (GO:0046390)	61	14	10.64	+	1.32	1.85E-01
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	61	14	10.64	+	1.32	1.85E-01
epidermal cell differentiation (GO:0009913)	48	11	8.37	+	1.31	2.22E-01
protein stabilization (GO:0050821)	35	8	6.10	+	1.31	2.70E-01
regulation of defense response (GO:0031347)	127	29	22.15	+	1.31	9.00E-02
regulation of hippo signaling (GO:0035330)	57	13	9.94	+	1.31	2.02E-01
purine nucleotide biosynthetic process (GO:0006164)	57	13	9.94	+	1.31	2.02E-01
negative regulation of signal transduction (GO:0009968)	281	64	49.00	+	1.31	1.99E-02
negative regulation of protein-containing complex assembly (GO:0031333)	22	5	3.84	+	1.30	3.39E-01
negative regulation of BMP signaling pathway (GO:0030514)	22	5	3.84	+	1.30	3.39E-01
dendrite guidance (GO:0070983)	22	5	3.84	+	1.30	3.39E-01
sphingolipid biosynthetic process (GO:0030148)	22	5	3.84	+	1.30	3.39E-01
secretion (GO:0046903)	163	37	28.42	+	1.30	6.66E-02
regulation of response to biotic stimulus (GO:0002831)	141	32	24.59	+	1.30	8.31E-02
secretion by cell (GO:0032940)	150	34	26.16	+	1.30	7.71E-02
RNA biosynthetic process (GO:0032774)	106	24	18.48	+	1.30	1.22E-01
positive regulation of cellular amide metabolic process (GO:0034250)	53	12	9.24	+	1.30	2.20E-01
regulation of chromosome segregation (GO:0051983)	31	7	5.41	+	1.29	2.99E-01
cuticle development involved in chitin-based cuticle molting cycle (GO:0042337)	31	7	5.41	+	1.29	2.99E-01
homeostasis of number of cells (GO:0048872)	31	7	5.41	+	1.29	2.99E-01
purine-containing compound biosynthetic process (GO:0072522)	62	14	10.81	+	1.29	2.01E-01
nucleoside phosphate biosynthetic process (GO:1901293)	71	16	12.38	+	1.29	1.83E-01
nucleotide biosynthetic process (GO:0009165)	71	16	12.38	+	1.29	1.83E-01
programmed cell death involved in cell development (GO:0010623)	80	18	13.95	+	1.29	1.68E-01
positive regulation of endocytosis (GO:0045807)	40	9	6.98	+	1.29	2.67E-01
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	40	9	6.98	+	1.29	2.67E-01
regulation of immune response (GO:0050776)	138	31	24.06	+	1.29	9.56E-02
regulation of defense response to bacterium (GO:1900424)	49	11	8.54	+	1.29	2.41E-01
locomotory behavior (GO:0007626)	165	37	28.77	+	1.29	7.60E-02
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	67	15	11.68	+	1.28	1.99E-01
cellular nitrogen compound biosynthetic process (GO:0044271)	463	103	80.74	+	1.28	7.23E-03
regulation of intracellular protein transport (GO:0033157)	27	6	4.71	+	1.27	3.33E-01
regulation of response to wounding (GO:1903034)	27	6	4.71	+	1.27	3.33E-01
regulation of Notch signaling pathway (GO:0008593)	54	12	9.42	+	1.27	2.38E-01
autophagosome organization (GO:1905037)	27	6	4.71	+	1.27	3.33E-01
regulation of organ growth (GO:0046620)	63	14	10.99	+	1.27	2.16E-01
lipoprotein metabolic process (GO:0042157)	27	6	4.71	+	1.27	3.33E-01
regulation of binding (GO:0051098)	27	6	4.71	+	1.27	3.33E-01
single fertilization (GO:0007338)	27	6	4.71	+	1.27	3.33E-01
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	9	2	1.57	+	1.27	4.65E-01
adrenergic receptor signaling pathway (GO:0071875)	9	2	1.57	+	1.27	4.65E-01
regulation of imaginal disc growth (GO:0045570)	45	10	7.85	+	1.27	2.64E-01
energy taxis (GO:0009453)	18	4	3.14	+	1.27	3.84E-01
receptor signaling pathway via JAK-STAT (GO:0007259)	9	2	1.57	+	1.27	4.65E-01
regulation of actin filament depolymerization (GO:0030834)	9	2	1.57	+	1.27	4.65E-01
nucleosome mobilization (GO:0042766)	9	2	1.57	+	1.27	4.65E-01
amine biosynthetic process (GO:0009309)	9	2	1.57	+	1.27	4.65E-01
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	9	2	1.57	+	1.27	4.65E-01
pyrimidine ribonucleotide biosynthetic process (GO:0009220)	9	2	1.57	+	1.27	4.65E-01
pyrimidine ribonucleotide metabolic process (GO:0009218)	9	2	1.57	+	1.27	4.65E-01
peroxisome organization (GO:0007031)	18	4	3.14	+	1.27	3.84E-01
GPI anchor metabolic process (GO:0006505)	9	2	1.57	+	1.27	4.65E-01
receptor signaling pathway via STAT (GO:0097696)	9	2	1.57	+	1.27	4.65E-01
metaphase/anaphase transition of cell cycle (GO:0044784)	9	2	1.57	+	1.27	4.65E-01
negative regulation of protein kinase activity (GO:0006469)	18	4	3.14	+	1.27	3.84E-01
regulation of cellular response to oxidative stress (GO:1900407)	9	2	1.57	+	1.27	4.65E-01
regulation of protein dephosphorylation (GO:0035304)	9	2	1.57	+	1.27	4.65E-01
positive regulation of lipid biosynthetic process (GO:0046889)	9	2	1.57	+	1.27	4.65E-01
aromatic amino acid family catabolic process (GO:0009074)	9	2	1.57	+	1.27	4.65E-01
cellular biogenic amine biosynthetic process (GO:0042401)	9	2	1.57	+	1.27	4.65E-01
protein targeting to ER (GO:0045047)	18	4	3.14	+	1.27	3.84E-01
sperm mitochondrion organization (GO:0030382)	9	2	1.57	+	1.27	4.65E-01
phototaxis (GO:0042331)	18	4	3.14	+	1.27	3.84E-01
regulation of protein import into nucleus (GO:0042306)	9	2	1.57	+	1.27	4.65E-01
L-alpha-amino acid transmembrane transport (GO:1902475)	9	2	1.57	+	1.27	4.65E-01
cellular response to acid chemical (GO:0071229)	9	2	1.57	+	1.27	4.65E-01
pyrimidine nucleobase metabolic process (GO:0006206)	9	2	1.57	+	1.27	4.65E-01
imaginal disc-derived male genitalia morphogenesis (GO:0048803)	18	4	3.14	+	1.27	3.84E-01
regulation of protein import (GO:1904589)	9	2	1.57	+	1.27	4.65E-01
somatic stem cell population maintenance (GO:0035019)	18	4	3.14	+	1.27	3.84E-01
regulation of melanization defense response (GO:0035007)	9	2	1.57	+	1.27	4.65E-01
negative regulation of neuromuscular synaptic transmission (GO:1900074)	9	2	1.57	+	1.27	4.65E-01
aminoglycan biosynthetic process (GO:0006023)	9	2	1.57	+	1.27	4.65E-01
cellular carbohydrate catabolic process (GO:0044275)	18	4	3.14	+	1.27	3.84E-01
microtubule anchoring (GO:0034453)	9	2	1.57	+	1.27	4.65E-01
substrate adhesion-dependent cell spreading (GO:0034446)	9	2	1.57	+	1.27	4.65E-01
cell junction maintenance (GO:0034331)	18	4	3.14	+	1.27	3.84E-01
negative regulation of TORC1 signaling (GO:1904262)	9	2	1.57	+	1.27	4.65E-01
engulfment of apoptotic cell (GO:0043652)	9	2	1.57	+	1.27	4.65E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599)	18	4	3.14	+	1.27	3.84E-01
cellular protein complex disassembly (GO:0043624)	18	4	3.14	+	1.27	3.84E-01
muscle organ development (GO:0007517)	72	16	12.56	+	1.27	1.97E-01
response to disaccharide (GO:0034285)	18	4	3.14	+	1.27	3.84E-01
positive regulation of DNA replication (GO:0045740)	9	2	1.57	+	1.27	4.65E-01
regulation of defense response to virus (GO:0050688)	18	4	3.14	+	1.27	3.84E-01
ventral midline development (GO:0007418)	9	2	1.57	+	1.27	4.65E-01
heart morphogenesis (GO:0003007)	36	8	6.28	+	1.27	2.95E-01
positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0006964)	9	2	1.57	+	1.27	4.65E-01
sulfur compound transport (GO:0072348)	9	2	1.57	+	1.27	4.65E-01
compartment pattern specification (GO:0007386)	9	2	1.57	+	1.27	4.65E-01
response to cytokine (GO:0034097)	18	4	3.14	+	1.27	3.84E-01
nucleic acid-templated transcription (GO:0097659)	104	23	18.14	+	1.27	1.51E-01
transcription, DNA-templated (GO:0006351)	104	23	18.14	+	1.27	1.51E-01
negative regulation of programmed cell death (GO:0043069)	86	19	15.00	+	1.27	1.79E-01
chemical homeostasis (GO:0048878)	204	45	35.57	+	1.26	6.77E-02
endomembrane system organization (GO:0010256)	127	28	22.15	+	1.26	1.27E-01
establishment of protein localization to organelle (GO:0072594)	109	24	19.01	+	1.26	1.49E-01
behavioral response to ethanol (GO:0048149)	50	11	8.72	+	1.26	2.61E-01
neuron remodeling (GO:0016322)	41	9	7.15	+	1.26	2.90E-01
negative regulation of proteolysis (GO:0045861)	41	9	7.15	+	1.26	2.90E-01
export from cell (GO:0140352)	155	34	27.03	+	1.26	1.06E-01
response to ethanol (GO:0045471)	64	14	11.16	+	1.25	2.33E-01
regulation of mRNA splicing, via spliceosome (GO:0048024)	64	14	11.16	+	1.25	2.33E-01
formation of primary germ layer (GO:0001704)	32	7	5.58	+	1.25	3.26E-01
negative regulation of intracellular signal transduction (GO:1902532)	96	21	16.74	+	1.25	1.75E-01
positive regulation of proteasomal protein catabolic process (GO:1901800)	32	7	5.58	+	1.25	3.26E-01
negative regulation of cell population proliferation (GO:0008285)	64	14	11.16	+	1.25	2.33E-01
regulation of protein polymerization (GO:0032271)	64	14	11.16	+	1.25	2.33E-01
regulation of antimicrobial humoral response (GO:0002759)	64	14	11.16	+	1.25	2.33E-01
cellular biosynthetic process (GO:0044249)	733	160	127.82	+	1.25	1.80E-03
regulation of cellular response to growth factor stimulus (GO:0090287)	55	12	9.59	+	1.25	2.57E-01
intracellular protein transport (GO:0006886)	266	58	46.38	+	1.25	5.11E-02
nuclear transport (GO:0051169)	78	17	13.60	+	1.25	2.09E-01
regulation of RNA splicing (GO:0043484)	78	17	13.60	+	1.25	2.09E-01
nucleocytoplasmic transport (GO:0006913)	78	17	13.60	+	1.25	2.09E-01
response to abiotic stimulus (GO:0009628)	349	76	60.86	+	1.25	2.95E-02
gene expression (GO:0010467)	630	137	109.86	+	1.25	4.45E-03
regulation of GTPase activity (GO:0043087)	69	15	12.03	+	1.25	2.30E-01
positive regulation of protein-containing complex assembly (GO:0031334)	46	10	8.02	+	1.25	2.86E-01
positive regulation of circadian rhythm (GO:0042753)	23	5	4.01	+	1.25	3.73E-01
regulation of microtubule polymerization or depolymerization (GO:0031110)	23	5	4.01	+	1.25	3.73E-01
negative regulation of stem cell proliferation (GO:2000647)	23	5	4.01	+	1.25	3.73E-01
gravitaxis (GO:0042332)	23	5	4.01	+	1.25	3.73E-01
axoneme assembly (GO:0035082)	23	5	4.01	+	1.25	3.73E-01
regulation of protein depolymerization (GO:1901879)	23	5	4.01	+	1.25	3.73E-01
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	23	5	4.01	+	1.25	3.73E-01
regulation of female receptivity (GO:0045924)	23	5	4.01	+	1.25	3.73E-01
respiratory system development (GO:0060541)	230	50	40.11	+	1.25	6.87E-02
response to gravity (GO:0009629)	23	5	4.01	+	1.25	3.73E-01
positive regulation of protein serine/threonine kinase activity (GO:0071902)	23	5	4.01	+	1.25	3.73E-01
regulation of DNA-binding transcription factor activity (GO:0051090)	23	5	4.01	+	1.25	3.73E-01
biosynthetic process (GO:0009058)	756	164	131.83	+	1.24	2.02E-03
nitrogen compound transport (GO:0071705)	406	88	70.80	+	1.24	2.24E-02
carbohydrate derivative metabolic process (GO:1901135)	240	52	41.85	+	1.24	6.75E-02
open tracheal system development (GO:0007424)	222	48	38.71	+	1.24	7.83E-02
vesicle docking (GO:0048278)	37	8	6.45	+	1.24	3.20E-01
organic substance biosynthetic process (GO:1901576)	746	161	130.09	+	1.24	2.73E-03
protein processing (GO:0016485)	51	11	8.89	+	1.24	2.81E-01
cellular amino acid metabolic process (GO:0006520)	65	14	11.33	+	1.24	2.50E-01
multicellular organism aging (GO:0010259)	149	32	25.98	+	1.23	1.37E-01
homeostatic process (GO:0042592)	378	81	65.92	+	1.23	3.46E-02
regulation of TORC1 signaling (GO:1903432)	28	6	4.88	+	1.23	3.63E-01
positive regulation of actin filament polymerization (GO:0030838)	28	6	4.88	+	1.23	3.63E-01
selective autophagy (GO:0061912)	14	3	2.44	+	1.23	4.41E-01
female germ-line stem cell population maintenance (GO:0036099)	28	6	4.88	+	1.23	3.63E-01
regulation of regulated secretory pathway (GO:1903305)	14	3	2.44	+	1.23	4.41E-01
oocyte localization involved in germarium-derived egg chamber formation (GO:0030720)	14	3	2.44	+	1.23	4.41E-01
phosphatidylinositol biosynthetic process (GO:0006661)	14	3	2.44	+	1.23	4.41E-01
negative regulation of cell cycle G1/S phase transition (GO:1902807)	14	3	2.44	+	1.23	4.41E-01
regulation of microtubule depolymerization (GO:0031114)	14	3	2.44	+	1.23	4.41E-01
ribonucleoside triphosphate biosynthetic process (GO:0009201)	28	6	4.88	+	1.23	3.63E-01
mRNA cis splicing, via spliceosome (GO:0045292)	14	3	2.44	+	1.23	4.41E-01
ribonucleoside triphosphate metabolic process (GO:0009199)	28	6	4.88	+	1.23	3.63E-01
nucleoside triphosphate biosynthetic process (GO:0009142)	28	6	4.88	+	1.23	3.63E-01
pteridine-containing compound metabolic process (GO:0042558)	14	3	2.44	+	1.23	4.41E-01
regulation of neuroblast proliferation (GO:1902692)	42	9	7.32	+	1.23	3.14E-01
regulation of mitotic sister chromatid separation (GO:0010965)	28	6	4.88	+	1.23	3.63E-01
regulation of small molecule metabolic process (GO:0062012)	28	6	4.88	+	1.23	3.63E-01
cellular response to carbohydrate stimulus (GO:0071322)	14	3	2.44	+	1.23	4.41E-01
transcription elongation from RNA polymerase II promoter (GO:0006368)	14	3	2.44	+	1.23	4.41E-01
DNA-templated transcription, elongation (GO:0006354)	14	3	2.44	+	1.23	4.41E-01
trunk segmentation (GO:0035290)	14	3	2.44	+	1.23	4.41E-01
organ growth (GO:0035265)	14	3	2.44	+	1.23	4.41E-01
peptidyl-threonine modification (GO:0018210)	14	3	2.44	+	1.23	4.41E-01
peptidyl-proline modification (GO:0018208)	14	3	2.44	+	1.23	4.41E-01
organelle localization by membrane tethering (GO:0140056)	42	9	7.32	+	1.23	3.14E-01
lipid storage (GO:0019915)	14	3	2.44	+	1.23	4.41E-01
synaptic vesicle cycle (GO:0099504)	98	21	17.09	+	1.23	1.99E-01
chitin-based embryonic cuticle biosynthetic process (GO:0008362)	14	3	2.44	+	1.23	4.41E-01
RNA surveillance (GO:0071025)	14	3	2.44	+	1.23	4.41E-01
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	28	6	4.88	+	1.23	3.63E-01
positive regulation of heterochromatin organization (GO:0120263)	14	3	2.44	+	1.23	4.41E-01
lipid oxidation (GO:0034440)	14	3	2.44	+	1.23	4.41E-01
membrane docking (GO:0022406)	42	9	7.32	+	1.23	3.14E-01
regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002813)	14	3	2.44	+	1.23	4.41E-01
chemosensory behavior (GO:0007635)	70	15	12.21	+	1.23	2.46E-01
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	14	3	2.44	+	1.23	4.41E-01
negative regulation of innate immune response (GO:0045824)	28	6	4.88	+	1.23	3.63E-01
membrane biogenesis (GO:0044091)	14	3	2.44	+	1.23	4.41E-01
regulation of immune effector process (GO:0002697)	70	15	12.21	+	1.23	2.46E-01
regulation of chromosome separation (GO:1905818)	28	6	4.88	+	1.23	3.63E-01
mesoderm morphogenesis (GO:0048332)	28	6	4.88	+	1.23	3.63E-01
vesicle-mediated transport in synapse (GO:0099003)	98	21	17.09	+	1.23	1.99E-01
body morphogenesis (GO:0010171)	14	3	2.44	+	1.23	4.41E-01
medium-term memory (GO:0072375)	14	3	2.44	+	1.23	4.41E-01
positive regulation of heterochromatin assembly (GO:0031453)	14	3	2.44	+	1.23	4.41E-01
regulation of ATP metabolic process (GO:1903578)	14	3	2.44	+	1.23	4.41E-01
establishment of protein localization (GO:0045184)	342	73	59.64	+	1.22	4.63E-02
protein dephosphorylation (GO:0006470)	61	13	10.64	+	1.22	2.72E-01
olfactory behavior (GO:0042048)	61	13	10.64	+	1.22	2.72E-01
aging (GO:0007568)	155	33	27.03	+	1.22	1.44E-01
anion transport (GO:0006820)	94	20	16.39	+	1.22	2.15E-01
transmembrane transport (GO:0055085)	329	70	57.37	+	1.22	5.29E-02
organic acid catabolic process (GO:0016054)	47	10	8.20	+	1.22	3.08E-01
carboxylic acid catabolic process (GO:0046395)	47	10	8.20	+	1.22	3.08E-01
protein transport (GO:0015031)	329	70	57.37	+	1.22	5.29E-02
wing disc development (GO:0035220)	348	74	60.68	+	1.22	4.81E-02
macromolecule biosynthetic process (GO:0009059)	471	100	82.13	+	1.22	2.53E-02
receptor-mediated endocytosis (GO:0006898)	33	7	5.75	+	1.22	3.54E-01
regulation of protein-containing complex assembly (GO:0043254)	99	21	17.26	+	1.22	2.11E-01
regulation of neurotransmitter levels (GO:0001505)	99	21	17.26	+	1.22	2.11E-01
negative regulation of cellular response to growth factor stimulus (GO:0090288)	33	7	5.75	+	1.22	3.54E-01
positive regulation of protein polymerization (GO:0032273)	33	7	5.75	+	1.22	3.54E-01
cell death (GO:0008219)	137	29	23.89	+	1.21	1.69E-01
peptide transport (GO:0015833)	331	70	57.72	+	1.21	5.84E-02
cellular response to chemical stimulus (GO:0070887)	294	62	51.27	+	1.21	7.43E-02
amide transport (GO:0042886)	332	70	57.89	+	1.21	6.13E-02
endocytosis (GO:0006897)	114	24	19.88	+	1.21	2.02E-01
negative regulation of cell projection organization (GO:0031345)	19	4	3.31	+	1.21	4.23E-01
regulation of actin filament polymerization (GO:0030833)	57	12	9.94	+	1.21	2.96E-01
basement membrane organization (GO:0071711)	19	4	3.31	+	1.21	4.23E-01
male anatomical structure morphogenesis (GO:0090598)	19	4	3.31	+	1.21	4.23E-01
carbohydrate metabolic process (GO:0005975)	133	28	23.19	+	1.21	1.81E-01
chitin-based larval cuticle pattern formation (GO:0035293)	19	4	3.31	+	1.21	4.23E-01
tube formation (GO:0035148)	38	8	6.63	+	1.21	3.46E-01
post-embryonic genitalia morphogenesis (GO:0035126)	19	4	3.31	+	1.21	4.23E-01
male genitalia morphogenesis (GO:0048808)	19	4	3.31	+	1.21	4.23E-01
imaginal disc-derived genitalia morphogenesis (GO:0048805)	19	4	3.31	+	1.21	4.23E-01
positive regulation of TORC1 signaling (GO:1904263)	19	4	3.31	+	1.21	4.23E-01
dicarboxylic acid metabolic process (GO:0043648)	19	4	3.31	+	1.21	4.23E-01
negative regulation of cell size (GO:0045792)	19	4	3.31	+	1.21	4.23E-01
chaperone cofactor-dependent protein refolding (GO:0051085)	19	4	3.31	+	1.21	4.23E-01
'de novo' posttranslational protein folding (GO:0051084)	19	4	3.31	+	1.21	4.23E-01
negative regulation of kinase activity (GO:0033673)	19	4	3.31	+	1.21	4.23E-01
segment polarity determination (GO:0007367)	38	8	6.63	+	1.21	3.46E-01
response to oxygen-containing compound (GO:1901700)	262	55	45.69	+	1.20	9.37E-02
glycoprotein metabolic process (GO:0009100)	62	13	10.81	+	1.20	2.90E-01
protein maturation (GO:0051604)	62	13	10.81	+	1.20	2.90E-01
mating behavior (GO:0007617)	105	22	18.31	+	1.20	2.21E-01
lipid catabolic process (GO:0016042)	43	9	7.50	+	1.20	3.38E-01
reproductive behavior (GO:0019098)	110	23	19.18	+	1.20	2.17E-01
response to alcohol (GO:0097305)	110	23	19.18	+	1.20	2.17E-01
regulation of humoral immune response (GO:0002920)	67	14	11.68	+	1.20	2.85E-01
organic substance transport (GO:0071702)	460	96	80.21	+	1.20	4.04E-02
ion homeostasis (GO:0050801)	115	24	20.05	+	1.20	2.14E-01
RNA processing (GO:0006396)	283	59	49.35	+	1.20	9.34E-02
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	24	5	4.19	+	1.19	4.07E-01
protein localization to cell periphery (GO:1990778)	48	10	8.37	+	1.19	3.30E-01
regulation of mitotic metaphase/anaphase transition (GO:0030071)	24	5	4.19	+	1.19	4.07E-01
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	48	10	8.37	+	1.19	3.30E-01
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	24	5	4.19	+	1.19	4.07E-01
positive regulation of transport (GO:0051050)	120	25	20.93	+	1.19	2.11E-01
negative regulation of nervous system development (GO:0051961)	77	16	13.43	+	1.19	2.74E-01
negative regulation of cellular protein metabolic process (GO:0032269)	164	34	28.60	+	1.19	1.75E-01
negative regulation of protein metabolic process (GO:0051248)	164	34	28.60	+	1.19	1.75E-01
response to wounding (GO:0009611)	82	17	14.30	+	1.19	2.69E-01
mitotic cell cycle, embryonic (GO:0045448)	29	6	5.06	+	1.19	3.94E-01
regulation of endocytosis (GO:0030100)	58	12	10.11	+	1.19	3.16E-01
cellular lipid catabolic process (GO:0044242)	29	6	5.06	+	1.19	3.94E-01
positive regulation of behavior (GO:0048520)	29	6	5.06	+	1.19	3.94E-01
fertilization (GO:0009566)	29	6	5.06	+	1.19	3.94E-01
vesicle organization (GO:0016050)	92	19	16.04	+	1.18	2.60E-01
gastrulation involving germ band extension (GO:0010004)	34	7	5.93	+	1.18	3.82E-01
gastrulation with mouth forming first (GO:0001703)	34	7	5.93	+	1.18	3.82E-01
transition metal ion homeostasis (GO:0055076)	34	7	5.93	+	1.18	3.82E-01
cuticle pattern formation (GO:0035017)	34	7	5.93	+	1.18	3.82E-01
tight junction organization (GO:0120193)	34	7	5.93	+	1.18	3.82E-01
tight junction assembly (GO:0120192)	34	7	5.93	+	1.18	3.82E-01
cation homeostasis (GO:0055080)	107	22	18.66	+	1.18	2.47E-01
determination of adult lifespan (GO:0008340)	146	30	25.46	+	1.18	2.05E-01
negative regulation of Wnt signaling pathway (GO:0030178)	39	8	6.80	+	1.18	3.72E-01
regulation of cellular response to insulin stimulus (GO:1900076)	39	8	6.80	+	1.18	3.72E-01
organic hydroxy compound metabolic process (GO:1901615)	117	24	20.40	+	1.18	2.38E-01
regulation of response to stress (GO:0080134)	239	49	41.68	+	1.18	1.41E-01
protein-containing complex disassembly (GO:0032984)	44	9	7.67	+	1.17	3.62E-01
cytosolic transport (GO:0016482)	44	9	7.67	+	1.17	3.62E-01
sleep (GO:0030431)	44	9	7.67	+	1.17	3.62E-01
gland morphogenesis (GO:0022612)	88	18	15.35	+	1.17	2.80E-01
salivary gland morphogenesis (GO:0007435)	88	18	15.35	+	1.17	2.80E-01
dorsal/ventral pattern formation (GO:0009953)	132	27	23.02	+	1.17	2.27E-01
neurotransmitter transport (GO:0006836)	93	19	16.22	+	1.17	2.75E-01
regulation of transport (GO:0051049)	240	49	41.85	+	1.17	1.47E-01
cellular macromolecule biosynthetic process (GO:0034645)	456	93	79.52	+	1.17	6.73E-02
protein polyubiquitination (GO:0000209)	54	11	9.42	+	1.17	3.44E-01
neuromuscular synaptic transmission (GO:0007274)	54	11	9.42	+	1.17	3.44E-01
morphogenesis of a branching structure (GO:0001763)	54	11	9.42	+	1.17	3.44E-01
branching morphogenesis of an epithelial tube (GO:0048754)	54	11	9.42	+	1.17	3.44E-01
morphogenesis of a branching epithelium (GO:0061138)	54	11	9.42	+	1.17	3.44E-01
regulation of protein stability (GO:0031647)	54	11	9.42	+	1.17	3.44E-01
branching involved in open tracheal system development (GO:0060446)	54	11	9.42	+	1.17	3.44E-01
mating (GO:0007618)	113	23	19.70	+	1.17	2.55E-01
intracellular transport (GO:0046907)	462	94	80.56	+	1.17	6.90E-02
regulation of antimicrobial peptide production (GO:0002784)	59	12	10.29	+	1.17	3.36E-01
regulation of production of molecular mediator of immune response (GO:0002700)	59	12	10.29	+	1.17	3.36E-01
programmed cell death (GO:0012501)	133	27	23.19	+	1.16	2.38E-01
negative regulation of immune system process (GO:0002683)	69	14	12.03	+	1.16	3.21E-01
instar larval or pupal development (GO:0002165)	498	101	86.84	+	1.16	6.51E-02
response to hormone (GO:0009725)	74	15	12.90	+	1.16	3.14E-01
post-embryonic animal morphogenesis (GO:0009886)	425	86	74.11	+	1.16	8.69E-02
Golgi vesicle transport (GO:0048193)	104	21	18.14	+	1.16	2.79E-01
ion transmembrane transport (GO:0034220)	218	44	38.01	+	1.16	1.81E-01
protein localization (GO:0008104)	517	104	90.15	+	1.15	7.27E-02
vesicle-mediated transport (GO:0016192)	374	75	65.22	+	1.15	1.19E-01
RNA metabolic process (GO:0016070)	439	88	76.55	+	1.15	9.85E-02
neuron cellular homeostasis (GO:0070050)	25	5	4.36	+	1.15	4.41E-01
anatomical structure homeostasis (GO:0060249)	145	29	25.28	+	1.15	2.53E-01
autophagosome assembly (GO:0000045)	25	5	4.36	+	1.15	4.41E-01
organelle disassembly (GO:1903008)	25	5	4.36	+	1.15	4.41E-01
cellular response to alcohol (GO:0097306)	25	5	4.36	+	1.15	4.41E-01
negative regulation of cell death (GO:0060548)	105	21	18.31	+	1.15	2.93E-01
muscle system process (GO:0003012)	25	5	4.36	+	1.15	4.41E-01
organelle transport along microtubule (GO:0072384)	25	5	4.36	+	1.15	4.41E-01
regulation of exocytosis (GO:0017157)	25	5	4.36	+	1.15	4.41E-01
regulation of receptor-mediated endocytosis (GO:0048259)	25	5	4.36	+	1.15	4.41E-01
plasma membrane to endosome transport (GO:0048227)	5	1	.87	+	1.15	5.82E-01
female germline ring canal formation (GO:0007301)	10	2	1.74	+	1.15	5.20E-01
CTP metabolic process (GO:0046036)	5	1	.87	+	1.15	5.82E-01
protein localization to Golgi apparatus (GO:0034067)	5	1	.87	+	1.15	5.82E-01
negative regulation of protein ubiquitination (GO:0031397)	5	1	.87	+	1.15	5.82E-01
multicellular organismal response to stress (GO:0033555)	5	1	.87	+	1.15	5.82E-01
positive regulation of glial cell proliferation (GO:0060252)	5	1	.87	+	1.15	5.82E-01
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	5	1	.87	+	1.15	5.82E-01
germarium-derived cystoblast division (GO:0048142)	10	2	1.74	+	1.15	5.20E-01
positive regulation of neuron death (GO:1901216)	10	2	1.74	+	1.15	5.20E-01
negative regulation of actin filament polymerization (GO:0030837)	15	3	2.62	+	1.15	4.86E-01
regulation of actin filament length (GO:0030832)	60	12	10.46	+	1.15	3.57E-01
histone ubiquitination (GO:0016574)	10	2	1.74	+	1.15	5.20E-01
negative regulation of entry into reproductive diapause (GO:0061964)	5	1	.87	+	1.15	5.82E-01
protein import into peroxisome matrix (GO:0016558)	10	2	1.74	+	1.15	5.20E-01
ubiquinone biosynthetic process (GO:0006744)	5	1	.87	+	1.15	5.82E-01
ubiquinone metabolic process (GO:0006743)	5	1	.87	+	1.15	5.82E-01
NADPH regeneration (GO:0006740)	5	1	.87	+	1.15	5.82E-01
R7 cell development (GO:0045467)	15	3	2.62	+	1.15	4.86E-01
R8 cell fate specification (GO:0045464)	20	4	3.49	+	1.15	4.61E-01
regulation of carbohydrate biosynthetic process (GO:0043255)	5	1	.87	+	1.15	5.82E-01
regulation of adherens junction organization (GO:1903391)	5	1	.87	+	1.15	5.82E-01
female mating behavior (GO:0060180)	30	6	5.23	+	1.15	4.25E-01
antennal joint development (GO:0048098)	5	1	.87	+	1.15	5.82E-01
negative regulation of circadian rhythm (GO:0042754)	5	1	.87	+	1.15	5.82E-01
embryonic epithelial tube formation (GO:0001838)	5	1	.87	+	1.15	5.82E-01
hydrogen peroxide metabolic process (GO:0042743)	10	2	1.74	+	1.15	5.20E-01
inositol phosphate biosynthetic process (GO:0032958)	5	1	.87	+	1.15	5.82E-01
clathrin-dependent endocytosis involved in vitellogenesis (GO:0061883)	5	1	.87	+	1.15	5.82E-01
membrane lipid metabolic process (GO:0006643)	40	8	6.98	+	1.15	3.98E-01
SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	5	1	.87	+	1.15	5.82E-01
anaphase-promoting complex-dependent catabolic process (GO:0031145)	15	3	2.62	+	1.15	4.86E-01
coenzyme A biosynthetic process (GO:0015937)	5	1	.87	+	1.15	5.82E-01
positive regulation of microtubule polymerization (GO:0031116)	5	1	.87	+	1.15	5.82E-01
regulation of postsynaptic membrane potential (GO:0060078)	5	1	.87	+	1.15	5.82E-01
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	5	1	.87	+	1.15	5.82E-01
guanosine-containing compound biosynthetic process (GO:1901070)	5	1	.87	+	1.15	5.82E-01
heart contraction (GO:0060047)	5	1	.87	+	1.15	5.82E-01
optic lobe placode development (GO:0001748)	5	1	.87	+	1.15	5.82E-01
regulation of oxidative stress-induced cell death (GO:1903201)	5	1	.87	+	1.15	5.82E-01
autophagy of nucleus (GO:0044804)	10	2	1.74	+	1.15	5.20E-01
regulation of calcium ion transmembrane transporter activity (GO:1901019)	5	1	.87	+	1.15	5.82E-01
antifungal innate immune response (GO:0061760)	5	1	.87	+	1.15	5.82E-01
negative regulation of establishment of protein localization (GO:1904950)	10	2	1.74	+	1.15	5.20E-01
response to hyperoxia (GO:0055093)	5	1	.87	+	1.15	5.82E-01
regulation of synaptic transmission, glutamatergic (GO:0051966)	5	1	.87	+	1.15	5.82E-01
calcium ion homeostasis (GO:0055074)	40	8	6.98	+	1.15	3.98E-01
mitochondrion disassembly (GO:0061726)	20	4	3.49	+	1.15	4.61E-01
cellular metabolic compound salvage (GO:0043094)	10	2	1.74	+	1.15	5.20E-01
phosphate ion transmembrane transport (GO:0035435)	5	1	.87	+	1.15	5.82E-01
positive regulation of cation channel activity (GO:2001259)	10	2	1.74	+	1.15	5.20E-01
protein localization to synapse (GO:0035418)	10	2	1.74	+	1.15	5.20E-01
chromatin remodeling at centromere (GO:0031055)	5	1	.87	+	1.15	5.82E-01
aminergic neurotransmitter loading into synaptic vesicle (GO:0015842)	5	1	.87	+	1.15	5.82E-01
amine transport (GO:0015837)	5	1	.87	+	1.15	5.82E-01
negative phototaxis (GO:0046957)	5	1	.87	+	1.15	5.82E-01
regulation of calcium ion transmembrane transport (GO:1903169)	5	1	.87	+	1.15	5.82E-01
nucleoside triphosphate metabolic process (GO:0009141)	30	6	5.23	+	1.15	4.25E-01
histone arginine methylation (GO:0034969)	5	1	.87	+	1.15	5.82E-01
ribonucleoside metabolic process (GO:0009119)	15	3	2.62	+	1.15	4.86E-01
cellular response to X-ray (GO:0071481)	5	1	.87	+	1.15	5.82E-01
regulation of cardioblast differentiation (GO:0051890)	5	1	.87	+	1.15	5.82E-01
intracellular steroid hormone receptor signaling pathway (GO:0030518)	10	2	1.74	+	1.15	5.20E-01
protein autoubiquitination (GO:0051865)	10	2	1.74	+	1.15	5.20E-01
maintenance of epithelial cell apical/basal polarity (GO:0045199)	5	1	.87	+	1.15	5.82E-01
peptidyl-tyrosine dephosphorylation (GO:0035335)	10	2	1.74	+	1.15	5.20E-01
organic anion transport (GO:0015711)	65	13	11.33	+	1.15	3.48E-01
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)	35	7	6.10	+	1.15	4.10E-01
regulation of protein export from nucleus (GO:0046825)	5	1	.87	+	1.15	5.82E-01
regulation of cardiocyte differentiation (GO:1905207)	5	1	.87	+	1.15	5.82E-01
pigment metabolic process (GO:0042440)	95	19	16.57	+	1.15	3.05E-01
RNA methylation (GO:0001510)	15	3	2.62	+	1.15	4.86E-01
cellular response to glucose stimulus (GO:0071333)	5	1	.87	+	1.15	5.82E-01
transcription by RNA polymerase III (GO:0006383)	15	3	2.62	+	1.15	4.86E-01
regulation of transcription by RNA polymerase III (GO:0006359)	5	1	.87	+	1.15	5.82E-01
negative regulation of mitochondrion organization (GO:0010823)	5	1	.87	+	1.15	5.82E-01
head segmentation (GO:0035287)	20	4	3.49	+	1.15	4.61E-01
brain segmentation (GO:0035284)	5	1	.87	+	1.15	5.82E-01
central nervous system segmentation (GO:0035283)	5	1	.87	+	1.15	5.82E-01
protein localization to nuclear envelope (GO:0090435)	5	1	.87	+	1.15	5.82E-01
regulation of protein exit from endoplasmic reticulum (GO:0070861)	5	1	.87	+	1.15	5.82E-01
early endosome to late endosome transport (GO:0045022)	5	1	.87	+	1.15	5.82E-01
synaptic transmission, glutamatergic (GO:0035249)	10	2	1.74	+	1.15	5.20E-01
peptidyl-arginine N-methylation (GO:0035246)	5	1	.87	+	1.15	5.82E-01
monovalent inorganic cation transport (GO:0015672)	130	26	22.67	+	1.15	2.67E-01
negative regulation of ion transmembrane transport (GO:0034766)	5	1	.87	+	1.15	5.82E-01
negative regulation of transmembrane transport (GO:0034763)	5	1	.87	+	1.15	5.82E-01
negative energy taxis (GO:0052129)	5	1	.87	+	1.15	5.82E-01
positive regulation of DNA biosynthetic process (GO:2000573)	5	1	.87	+	1.15	5.82E-01
endosome transport via multivesicular body sorting pathway (GO:0032509)	20	4	3.49	+	1.15	4.61E-01
regulation of protein kinase A signaling (GO:0010738)	5	1	.87	+	1.15	5.82E-01
CTP biosynthetic process (GO:0006241)	5	1	.87	+	1.15	5.82E-01
branch fusion, open tracheal system (GO:0035147)	20	4	3.49	+	1.15	4.61E-01
tube fusion (GO:0035146)	20	4	3.49	+	1.15	4.61E-01
inorganic ion import across plasma membrane (GO:0099587)	20	4	3.49	+	1.15	4.61E-01
response to organophosphorus (GO:0046683)	5	1	.87	+	1.15	5.82E-01
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	5	1	.87	+	1.15	5.82E-01
purine nucleoside metabolic process (GO:0042278)	15	3	2.62	+	1.15	4.86E-01
response to peptidoglycan (GO:0032494)	5	1	.87	+	1.15	5.82E-01
fatty acid elongation, polyunsaturated fatty acid (GO:0034626)	5	1	.87	+	1.15	5.82E-01
fatty acid elongation, monounsaturated fatty acid (GO:0034625)	5	1	.87	+	1.15	5.82E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	30	6	5.23	+	1.15	4.25E-01
embryonic cleavage (GO:0040016)	5	1	.87	+	1.15	5.82E-01
negative regulation of ion transmembrane transporter activity (GO:0032413)	5	1	.87	+	1.15	5.82E-01
negative regulation of transporter activity (GO:0032410)	5	1	.87	+	1.15	5.82E-01
cGMP biosynthetic process (GO:0006182)	5	1	.87	+	1.15	5.82E-01
larval locomotory behavior (GO:0008345)	35	7	6.10	+	1.15	4.10E-01
adenosine catabolic process (GO:0006154)	5	1	.87	+	1.15	5.82E-01
regulation of cAMP-mediated signaling (GO:0043949)	5	1	.87	+	1.15	5.82E-01
regulation of lipophagy (GO:1904502)	5	1	.87	+	1.15	5.82E-01
hemocyte migration (GO:0035099)	20	4	3.49	+	1.15	4.61E-01
regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	5	1	.87	+	1.15	5.82E-01
acetaldehyde metabolic process (GO:0006117)	5	1	.87	+	1.15	5.82E-01
ecdysone receptor-mediated signaling pathway (GO:0035076)	10	2	1.74	+	1.15	5.20E-01
protein modification by small protein removal (GO:0070646)	45	9	7.85	+	1.15	3.86E-01
positive regulation of melanization defense response (GO:0035008)	5	1	.87	+	1.15	5.82E-01
mitochondrial respirasome assembly (GO:0097250)	5	1	.87	+	1.15	5.82E-01
protein localization to cytoskeleton (GO:0044380)	5	1	.87	+	1.15	5.82E-01
vesicle-mediated transport between endosomal compartments (GO:0098927)	5	1	.87	+	1.15	5.82E-01
nuclear mRNA surveillance (GO:0071028)	10	2	1.74	+	1.15	5.20E-01
peptidyl-lysine trimethylation (GO:0018023)	5	1	.87	+	1.15	5.82E-01
regulation of intracellular pH (GO:0051453)	20	4	3.49	+	1.15	4.61E-01
intracellular pH reduction (GO:0051452)	15	3	2.62	+	1.15	4.86E-01
UDP-N-acetylglucosamine metabolic process (GO:0006047)	5	1	.87	+	1.15	5.82E-01
DNA catabolic process, exonucleolytic (GO:0000738)	5	1	.87	+	1.15	5.82E-01
DNA double-strand break processing (GO:0000729)	5	1	.87	+	1.15	5.82E-01
meiotic DNA double-strand break processing (GO:0000706)	5	1	.87	+	1.15	5.82E-01
positive regulation of response to cytokine stimulus (GO:0060760)	5	1	.87	+	1.15	5.82E-01
response to axon injury (GO:0048678)	10	2	1.74	+	1.15	5.20E-01
hydrocarbon metabolic process (GO:0120252)	5	1	.87	+	1.15	5.82E-01
microtubule anchoring at centrosome (GO:0034454)	5	1	.87	+	1.15	5.82E-01
actin filament depolymerization (GO:0030042)	5	1	.87	+	1.15	5.82E-01
circadian sleep/wake cycle process (GO:0022410)	5	1	.87	+	1.15	5.82E-01
regulation of oxidoreductase activity (GO:0051341)	5	1	.87	+	1.15	5.82E-01
protein localization to microtubule cytoskeleton (GO:0072698)	5	1	.87	+	1.15	5.82E-01
protein localization to cell cortex (GO:0072697)	5	1	.87	+	1.15	5.82E-01
negative regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002814)	5	1	.87	+	1.15	5.82E-01
positive regulation of organelle assembly (GO:1902117)	5	1	.87	+	1.15	5.82E-01
positive regulation of antifungal peptide production (GO:0002804)	10	2	1.74	+	1.15	5.20E-01
protein localization to plasma membrane (GO:0072659)	40	8	6.98	+	1.15	3.98E-01
positive regulation of oxidative phosphorylation (GO:1903862)	5	1	.87	+	1.15	5.82E-01
determination of bilateral symmetry (GO:0009855)	15	3	2.62	+	1.15	4.86E-01
presynaptic membrane organization (GO:0097090)	10	2	1.74	+	1.15	5.20E-01
quinone biosynthetic process (GO:1901663)	5	1	.87	+	1.15	5.82E-01
quinone metabolic process (GO:1901661)	5	1	.87	+	1.15	5.82E-01
embryonic digestive tract morphogenesis (GO:0048557)	5	1	.87	+	1.15	5.82E-01
positive regulation of calcium-mediated signaling (GO:0050850)	5	1	.87	+	1.15	5.82E-01
amino sugar biosynthetic process (GO:0046349)	5	1	.87	+	1.15	5.82E-01
circadian sleep/wake cycle, sleep (GO:0050802)	5	1	.87	+	1.15	5.82E-01
regulation of histone H3-K27 methylation (GO:0061085)	5	1	.87	+	1.15	5.82E-01
potassium ion import across plasma membrane (GO:1990573)	10	2	1.74	+	1.15	5.20E-01
negative regulation of sevenless signaling pathway (GO:0045873)	5	1	.87	+	1.15	5.82E-01
regulation of actin polymerization or depolymerization (GO:0008064)	60	12	10.46	+	1.15	3.57E-01
pH reduction (GO:0045851)	15	3	2.62	+	1.15	4.86E-01
positive regulation of nurse cell apoptotic process (GO:0045850)	5	1	.87	+	1.15	5.82E-01
mitochondrial fusion (GO:0008053)	5	1	.87	+	1.15	5.82E-01
regulation of phosphoprotein phosphatase activity (GO:0043666)	5	1	.87	+	1.15	5.82E-01
dicarboxylic acid biosynthetic process (GO:0043650)	5	1	.87	+	1.15	5.82E-01
blood circulation (GO:0008015)	5	1	.87	+	1.15	5.82E-01
negative regulation of protein transport (GO:0051224)	10	2	1.74	+	1.15	5.20E-01
specification of symmetry (GO:0009799)	15	3	2.62	+	1.15	4.86E-01
body fluid secretion (GO:0007589)	5	1	.87	+	1.15	5.82E-01
morphogenesis of an epithelial fold (GO:0060571)	10	2	1.74	+	1.15	5.20E-01
pyridine-containing compound biosynthetic process (GO:0072525)	5	1	.87	+	1.15	5.82E-01
synaptic vesicle membrane organization (GO:0048499)	5	1	.87	+	1.15	5.82E-01
negative regulation of axonogenesis (GO:0050771)	5	1	.87	+	1.15	5.82E-01
negative regulation of molecular function (GO:0044092)	90	18	15.69	+	1.15	3.11E-01
larval heart development (GO:0007508)	5	1	.87	+	1.15	5.82E-01
positive regulation of chromatin assembly or disassembly (GO:0045799)	15	3	2.62	+	1.15	4.86E-01
inorganic cation import across plasma membrane (GO:0098659)	20	4	3.49	+	1.15	4.61E-01
positive regulation of Toll signaling pathway (GO:0045752)	30	6	5.23	+	1.15	4.25E-01
nuclear export (GO:0051168)	55	11	9.59	+	1.15	3.66E-01
cleavage involved in rRNA processing (GO:0000469)	10	2	1.74	+	1.15	5.20E-01
regulation of translation in response to stress (GO:0043555)	5	1	.87	+	1.15	5.82E-01
autophagy of mitochondrion (GO:0000422)	20	4	3.49	+	1.15	4.61E-01
mesenchyme development (GO:0060485)	10	2	1.74	+	1.15	5.20E-01
phenol-containing compound biosynthetic process (GO:0046189)	10	2	1.74	+	1.15	5.20E-01
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	5	1	.87	+	1.15	5.82E-01
multivesicular body sorting pathway (GO:0071985)	20	4	3.49	+	1.15	4.61E-01
purine ribonucleoside metabolic process (GO:0046128)	15	3	2.62	+	1.15	4.86E-01
inosine biosynthetic process (GO:0046103)	5	1	.87	+	1.15	5.82E-01
inosine metabolic process (GO:0046102)	5	1	.87	+	1.15	5.82E-01
nucleus organization (GO:0006997)	65	13	11.33	+	1.15	3.48E-01
negative regulation of cation transmembrane transport (GO:1904063)	5	1	.87	+	1.15	5.82E-01
regulation of locomotor rhythm (GO:1904059)	10	2	1.74	+	1.15	5.20E-01
regulation of cellular carbohydrate catabolic process (GO:0043471)	5	1	.87	+	1.15	5.82E-01
phagocytosis, engulfment (GO:0006911)	15	3	2.62	+	1.15	4.86E-01
negative regulation of small GTPase mediated signal transduction (GO:0051058)	5	1	.87	+	1.15	5.82E-01
fatty acid elongation, unsaturated fatty acid (GO:0019368)	5	1	.87	+	1.15	5.82E-01
fatty acid elongation, saturated fatty acid (GO:0019367)	5	1	.87	+	1.15	5.82E-01
initiation of dorsal closure (GO:0007392)	10	2	1.74	+	1.15	5.20E-01
amnioserosa formation (GO:0007378)	5	1	.87	+	1.15	5.82E-01
periodic partitioning (GO:0007365)	45	9	7.85	+	1.15	3.86E-01
adenosine metabolic process (GO:0046085)	5	1	.87	+	1.15	5.82E-01
head morphogenesis (GO:0060323)	5	1	.87	+	1.15	5.82E-01
regulation of biological quality (GO:0065008)	1062	212	185.19	+	1.14	1.76E-02
instar larval or pupal morphogenesis (GO:0048707)	412	82	71.84	+	1.14	1.20E-01
negative regulation of developmental process (GO:0051093)	186	37	32.43	+	1.14	2.30E-01
regulation of signal transduction (GO:0009966)	619	123	107.94	+	1.14	7.12E-02
organic cyclic compound biosynthetic process (GO:1901362)	307	61	53.53	+	1.14	1.64E-01
defense response to bacterium (GO:0042742)	146	29	25.46	+	1.14	2.64E-01
inorganic ion homeostasis (GO:0098771)	106	21	18.48	+	1.14	3.08E-01
imaginal disc development (GO:0007444)	505	100	88.06	+	1.14	1.03E-01
metal ion homeostasis (GO:0055065)	86	17	15.00	+	1.13	3.35E-01
negative regulation of developmental growth (GO:0048640)	81	16	14.12	+	1.13	3.42E-01
cuticle development (GO:0042335)	152	30	26.51	+	1.13	2.71E-01
metamorphosis (GO:0007552)	431	85	75.16	+	1.13	1.32E-01
courtship behavior (GO:0007619)	71	14	12.38	+	1.13	3.59E-01
transport (GO:0006810)	1055	208	183.97	+	1.13	2.91E-02
inorganic ion transmembrane transport (GO:0098660)	178	35	31.04	+	1.13	2.58E-01
organonitrogen compound metabolic process (GO:1901564)	1419	279	247.44	+	1.13	1.25E-02
wound healing (GO:0042060)	56	11	9.77	+	1.13	3.87E-01
establishment of protein localization to extracellular region (GO:0035592)	51	10	8.89	+	1.12	3.98E-01
macroautophagy (GO:0016236)	51	10	8.89	+	1.12	3.98E-01
divalent inorganic cation homeostasis (GO:0072507)	51	10	8.89	+	1.12	3.98E-01
negative regulation of multicellular organismal process (GO:0051241)	143	28	24.94	+	1.12	2.94E-01
morphogenesis of follicular epithelium (GO:0016333)	46	9	8.02	+	1.12	4.10E-01
negative regulation of growth (GO:0045926)	92	18	16.04	+	1.12	3.44E-01
regulation of protein serine/threonine kinase activity (GO:0071900)	46	9	8.02	+	1.12	4.10E-01
establishment or maintenance of cell polarity (GO:0007163)	179	35	31.21	+	1.12	2.69E-01
wing disc morphogenesis (GO:0007472)	266	52	46.38	+	1.12	2.18E-01
imaginal disc-derived wing morphogenesis (GO:0007476)	256	50	44.64	+	1.12	2.25E-01
process utilizing autophagic mechanism (GO:0061919)	82	16	14.30	+	1.12	3.60E-01
regulation of insulin receptor signaling pathway (GO:0046626)	41	8	7.15	+	1.12	4.24E-01
autophagy (GO:0006914)	82	16	14.30	+	1.12	3.60E-01
cellular metabolic process (GO:0044237)	2210	431	385.38	+	1.12	1.91E-03
neuromuscular junction development (GO:0007528)	77	15	13.43	+	1.12	3.69E-01
asymmetric neuroblast division (GO:0055059)	36	7	6.28	+	1.12	4.38E-01
gastrulation (GO:0007369)	72	14	12.56	+	1.12	3.78E-01
cellular nitrogen compound metabolic process (GO:0034641)	1041	202	181.53	+	1.11	5.26E-02
regulation of immune system process (GO:0002682)	191	37	33.31	+	1.11	2.81E-01
establishment of localization (GO:0051234)	1105	214	192.69	+	1.11	4.95E-02
regulation of translation (GO:0006417)	93	18	16.22	+	1.11	3.60E-01
septate junction assembly (GO:0019991)	31	6	5.41	+	1.11	4.55E-01
response to organic substance (GO:0010033)	389	75	67.83	+	1.11	2.00E-01
negative regulation of cell differentiation (GO:0045596)	83	16	14.47	+	1.11	3.78E-01
regulation of neurogenesis (GO:0050767)	109	21	19.01	+	1.10	3.53E-01
behavior (GO:0007610)	447	86	77.95	+	1.10	1.86E-01
RNA transport (GO:0050658)	78	15	13.60	+	1.10	3.87E-01
nucleic acid transport (GO:0050657)	78	15	13.60	+	1.10	3.87E-01
response to UV (GO:0009411)	26	5	4.53	+	1.10	4.75E-01
dorsal appendage formation (GO:0046843)	52	10	9.07	+	1.10	4.22E-01
cellular component maintenance (GO:0043954)	26	5	4.53	+	1.10	4.75E-01
regulation of intracellular transport (GO:0032386)	52	10	9.07	+	1.10	4.22E-01
import across plasma membrane (GO:0098739)	26	5	4.53	+	1.10	4.75E-01
metabolic process (GO:0008152)	2487	478	433.68	+	1.10	2.88E-03
regulation of cell communication (GO:0010646)	724	139	126.25	+	1.10	1.23E-01
regulation of signaling (GO:0023051)	724	139	126.25	+	1.10	1.23E-01
positive regulation of intracellular signal transduction (GO:1902533)	146	28	25.46	+	1.10	3.31E-01
regulation of innate immune response (GO:0045088)	73	14	12.73	+	1.10	3.97E-01
regulation of mRNA processing (GO:0050684)	73	14	12.73	+	1.10	3.97E-01
response to external stimulus (GO:0009605)	772	148	134.62	+	1.10	1.18E-01
adult behavior (GO:0030534)	141	27	24.59	+	1.10	3.38E-01
regulation of cellular component biogenesis (GO:0044087)	282	54	49.17	+	1.10	2.59E-01
cytoplasmic translation (GO:0002181)	94	18	16.39	+	1.10	3.77E-01
negative regulation of smoothened signaling pathway (GO:0045879)	47	9	8.20	+	1.10	4.35E-01
aromatic compound biosynthetic process (GO:0019438)	277	53	48.30	+	1.10	2.64E-01
regulation of hormone levels (GO:0010817)	68	13	11.86	+	1.10	4.08E-01
regulation of multicellular organismal process (GO:0051239)	504	96	87.89	+	1.09	1.97E-01
regulation of pH (GO:0006885)	21	4	3.66	+	1.09	4.98E-01
cell redox homeostasis (GO:0045454)	21	4	3.66	+	1.09	4.98E-01
germarium-derived female germ-line cyst formation (GO:0030727)	21	4	3.66	+	1.09	4.98E-01
regulation of cellular pH (GO:0030641)	21	4	3.66	+	1.09	4.98E-01
dsRNA transport (GO:0033227)	21	4	3.66	+	1.09	4.98E-01
positive regulation of response to wounding (GO:1903036)	21	4	3.66	+	1.09	4.98E-01
tRNA metabolic process (GO:0006399)	21	4	3.66	+	1.09	4.98E-01
spindle assembly involved in meiosis (GO:0090306)	21	4	3.66	+	1.09	4.98E-01
genitalia morphogenesis (GO:0035112)	21	4	3.66	+	1.09	4.98E-01
regulation of multicellular organism growth (GO:0040014)	42	8	7.32	+	1.09	4.50E-01
response to ecdysone (GO:0035075)	42	8	7.32	+	1.09	4.50E-01
axonal transport (GO:0098930)	21	4	3.66	+	1.09	4.98E-01
glycerophospholipid biosynthetic process (GO:0046474)	21	4	3.66	+	1.09	4.98E-01
negative regulation of transferase activity (GO:0051348)	21	4	3.66	+	1.09	4.98E-01
synaptic vesicle recycling (GO:0036465)	42	8	7.32	+	1.09	4.50E-01
R8 cell fate commitment (GO:0007460)	21	4	3.66	+	1.09	4.98E-01
response to bacterium (GO:0009617)	168	32	29.30	+	1.09	3.31E-01
response to sterol (GO:0036314)	42	8	7.32	+	1.09	4.50E-01
positive regulation of receptor-mediated endocytosis (GO:0048260)	21	4	3.66	+	1.09	4.98E-01
establishment of localization in cell (GO:0051649)	589	112	102.71	+	1.09	1.80E-01
heterocycle biosynthetic process (GO:0018130)	279	53	48.65	+	1.09	2.81E-01
post-embryonic development (GO:0009791)	558	106	97.30	+	1.09	1.90E-01
regulation of response to stimulus (GO:0048583)	774	147	134.97	+	1.09	1.44E-01
regulation of intracellular signal transduction (GO:1902531)	274	52	47.78	+	1.09	2.85E-01
tube morphogenesis (GO:0035239)	464	88	80.91	+	1.09	2.21E-01
cellular protein localization (GO:0034613)	385	73	67.14	+	1.09	2.46E-01
protein localization to organelle (GO:0033365)	153	29	26.68	+	1.09	3.51E-01
response to organic cyclic compound (GO:0014070)	95	18	16.57	+	1.09	3.94E-01
epithelial tube morphogenesis (GO:0060562)	428	81	74.63	+	1.09	2.38E-01
exocrine system development (GO:0035272)	111	21	19.36	+	1.08	3.83E-01
salivary gland development (GO:0007431)	111	21	19.36	+	1.08	3.83E-01
cellular calcium ion homeostasis (GO:0006874)	37	7	6.45	+	1.08	4.66E-01
carboxylic acid transport (GO:0046942)	37	7	6.45	+	1.08	4.66E-01
presynaptic endocytosis (GO:0140238)	37	7	6.45	+	1.08	4.66E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090)	37	7	6.45	+	1.08	4.66E-01
synaptic vesicle endocytosis (GO:0048488)	37	7	6.45	+	1.08	4.66E-01
regulation of mRNA metabolic process (GO:1903311)	90	17	15.69	+	1.08	4.03E-01
nucleobase-containing compound transport (GO:0015931)	90	17	15.69	+	1.08	4.03E-01
regulation of cellular protein localization (GO:1903827)	53	10	9.24	+	1.08	4.45E-01
alpha-amino acid metabolic process (GO:1901605)	53	10	9.24	+	1.08	4.45E-01
positive regulation of protein catabolic process (GO:0045732)	53	10	9.24	+	1.08	4.45E-01
regulation of cellular localization (GO:0060341)	106	20	18.48	+	1.08	3.92E-01
macromolecule localization (GO:0033036)	626	118	109.16	+	1.08	1.98E-01
regulation of supramolecular fiber organization (GO:1902903)	101	19	17.61	+	1.08	4.01E-01
post-embryonic animal organ morphogenesis (GO:0048563)	367	69	64.00	+	1.08	2.76E-01
imaginal disc morphogenesis (GO:0007560)	367	69	64.00	+	1.08	2.76E-01
protein metabolic process (GO:0019538)	1112	209	193.91	+	1.08	1.23E-01
potassium ion transport (GO:0006813)	32	6	5.58	+	1.08	4.85E-01
germ-line stem-cell niche homeostasis (GO:0060250)	16	3	2.79	+	1.08	5.28E-01
JNK cascade (GO:0007254)	16	3	2.79	+	1.08	5.28E-01
germ-line cyst encapsulation (GO:0048138)	16	3	2.79	+	1.08	5.28E-01
apoptotic cell clearance (GO:0043277)	16	3	2.79	+	1.08	5.28E-01
regulation of cation channel activity (GO:2001257)	16	3	2.79	+	1.08	5.28E-01
regulation of nuclear division (GO:0051783)	48	9	8.37	+	1.08	4.59E-01
mRNA polyadenylation (GO:0006378)	16	3	2.79	+	1.08	5.28E-01
prepupal development (GO:0035210)	16	3	2.79	+	1.08	5.28E-01
regulation of tube size, open tracheal system (GO:0035151)	48	9	8.37	+	1.08	4.59E-01
genitalia development (GO:0048806)	32	6	5.58	+	1.08	4.85E-01
proteoglycan biosynthetic process (GO:0030166)	16	3	2.79	+	1.08	5.28E-01
proteoglycan metabolic process (GO:0006029)	16	3	2.79	+	1.08	5.28E-01
cell migration involved in gastrulation (GO:0042074)	16	3	2.79	+	1.08	5.28E-01
DNA endoreduplication (GO:0042023)	16	3	2.79	+	1.08	5.28E-01
regulation of smoothened signaling pathway (GO:0008589)	80	15	13.95	+	1.08	4.24E-01
chromatin remodeling (GO:0006338)	80	15	13.95	+	1.08	4.24E-01
regulation of proteolysis (GO:0030162)	112	21	19.53	+	1.08	3.99E-01
establishment of RNA localization (GO:0051236)	80	15	13.95	+	1.08	4.24E-01
ion transport (GO:0006811)	315	59	54.93	+	1.07	3.05E-01
carbohydrate derivative biosynthetic process (GO:1901137)	139	26	24.24	+	1.07	3.86E-01
peptidyl-amino acid modification (GO:0018193)	220	41	38.36	+	1.07	3.54E-01
nucleobase-containing compound biosynthetic process (GO:0034654)	231	43	40.28	+	1.07	3.53E-01
tube development (GO:0035295)	634	118	110.56	+	1.07	2.40E-01
regulation of mitotic nuclear division (GO:0007088)	43	8	7.50	+	1.07	4.75E-01
cellular response to peptide hormone stimulus (GO:0071375)	43	8	7.50	+	1.07	4.75E-01
negative regulation of mitotic cell cycle phase transition (GO:1901991)	43	8	7.50	+	1.07	4.75E-01
negative regulation of cell cycle phase transition (GO:1901988)	43	8	7.50	+	1.07	4.75E-01
cellular response to peptide (GO:1901653)	43	8	7.50	+	1.07	4.75E-01
cell-cell signaling by wnt (GO:0198738)	43	8	7.50	+	1.07	4.75E-01
photoreceptor cell differentiation (GO:0046530)	183	34	31.91	+	1.07	3.78E-01
regulation of growth (GO:0040008)	280	52	48.83	+	1.07	3.41E-01
cellular component biogenesis (GO:0044085)	803	149	140.03	+	1.06	2.19E-01
localization (GO:0051179)	1466	272	255.64	+	1.06	1.26E-01
MAPK cascade (GO:0000165)	27	5	4.71	+	1.06	5.07E-01
embryonic hemopoiesis (GO:0035162)	27	5	4.71	+	1.06	5.07E-01
regulation of intracellular mRNA localization (GO:1904580)	27	5	4.71	+	1.06	5.07E-01
larval midgut histolysis (GO:0035069)	27	5	4.71	+	1.06	5.07E-01
centrosome duplication (GO:0051298)	27	5	4.71	+	1.06	5.07E-01
compound eye photoreceptor cell differentiation (GO:0001751)	162	30	28.25	+	1.06	3.95E-01
organic substance metabolic process (GO:0071704)	2269	420	395.67	+	1.06	6.35E-02
primary metabolic process (GO:0044238)	2080	385	362.71	+	1.06	7.77E-02
cellular protein metabolic process (GO:0044267)	995	184	173.51	+	1.06	2.02E-01
response to organonitrogen compound (GO:0010243)	119	22	20.75	+	1.06	4.21E-01
cellular response to organic substance (GO:0071310)	211	39	36.79	+	1.06	3.78E-01
mRNA metabolic process (GO:0016071)	222	41	38.71	+	1.06	3.76E-01
tissue morphogenesis (GO:0048729)	547	101	95.39	+	1.06	2.88E-01
neuroblast division (GO:0055057)	38	7	6.63	+	1.06	4.94E-01
organic acid transport (GO:0015849)	38	7	6.63	+	1.06	4.94E-01
cellular process (GO:0009987)	4426	815	771.80	+	1.06	8.17E-04
nitrogen compound metabolic process (GO:0006807)	1965	361	342.65	+	1.05	1.19E-01
establishment of cell polarity (GO:0030010)	49	9	8.54	+	1.05	4.83E-01
regulation of cellular response to stress (GO:0080135)	98	18	17.09	+	1.05	4.45E-01
cell junction organization (GO:0034330)	218	40	38.01	+	1.05	3.94E-01
cellular homeostasis (GO:0019725)	169	31	29.47	+	1.05	4.13E-01
chitin-based cuticle development (GO:0040003)	120	22	20.93	+	1.05	4.36E-01
cellular response to oxygen-containing compound (GO:1901701)	120	22	20.93	+	1.05	4.36E-01
negative regulation of mitotic cell cycle (GO:0045930)	60	11	10.46	+	1.05	4.75E-01
animal organ morphogenesis (GO:0009887)	666	122	116.14	+	1.05	2.95E-01
cellular response to hormone stimulus (GO:0032870)	71	13	12.38	+	1.05	4.68E-01
regulation of actin filament organization (GO:0110053)	71	13	12.38	+	1.05	4.68E-01
spermatid development (GO:0007286)	82	15	14.30	+	1.05	4.61E-01
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261)	11	2	1.92	+	1.04	5.72E-01
female germ-line cyst formation (GO:0048135)	22	4	3.84	+	1.04	5.34E-01
positive regulation of supramolecular fiber organization (GO:1902905)	44	8	7.67	+	1.04	5.01E-01
protein localization to extracellular region (GO:0071692)	55	10	9.59	+	1.04	4.90E-01
ovarian fusome organization (GO:0030723)	11	2	1.92	+	1.04	5.72E-01
positive regulation of defense response to virus by host (GO:0002230)	11	2	1.92	+	1.04	5.72E-01
centriole replication (GO:0007099)	22	4	3.84	+	1.04	5.34E-01
phospholipid transport (GO:0015914)	11	2	1.92	+	1.04	5.72E-01
sperm motility (GO:0097722)	22	4	3.84	+	1.04	5.34E-01
lysosomal transport (GO:0007041)	22	4	3.84	+	1.04	5.34E-01
vacuolar acidification (GO:0007035)	11	2	1.92	+	1.04	5.72E-01
zinc ion homeostasis (GO:0055069)	11	2	1.92	+	1.04	5.72E-01
L-amino acid transport (GO:0015807)	11	2	1.92	+	1.04	5.72E-01
establishment or maintenance of neuroblast polarity (GO:0045196)	11	2	1.92	+	1.04	5.72E-01
protein localization to endoplasmic reticulum (GO:0070972)	22	4	3.84	+	1.04	5.34E-01
dopamine metabolic process (GO:0042417)	11	2	1.92	+	1.04	5.72E-01
nucleosome assembly (GO:0006334)	22	4	3.84	+	1.04	5.34E-01
negative regulation of cell migration (GO:0030336)	11	2	1.92	+	1.04	5.72E-01
flagellated sperm motility (GO:0030317)	22	4	3.84	+	1.04	5.34E-01
regulation of tube diameter, open tracheal system (GO:0035158)	11	2	1.92	+	1.04	5.72E-01
exocytic process (GO:0140029)	44	8	7.67	+	1.04	5.01E-01
cellular response to UV (GO:0034644)	11	2	1.92	+	1.04	5.72E-01
regulation of establishment of planar polarity (GO:0090175)	22	4	3.84	+	1.04	5.34E-01
organophosphate catabolic process (GO:0046434)	22	4	3.84	+	1.04	5.34E-01
photoreceptor cell fate specification (GO:0043704)	22	4	3.84	+	1.04	5.34E-01
response to ketone (GO:1901654)	44	8	7.67	+	1.04	5.01E-01
response to peptide (GO:1901652)	44	8	7.67	+	1.04	5.01E-01
positive regulation of cellular protein localization (GO:1903829)	22	4	3.84	+	1.04	5.34E-01
visual behavior (GO:0007632)	22	4	3.84	+	1.04	5.34E-01
negative regulation of cell motility (GO:2000146)	11	2	1.92	+	1.04	5.72E-01
positive regulation of DNA-templated transcription, initiation (GO:2000144)	11	2	1.92	+	1.04	5.72E-01
negative regulation of cellular component movement (GO:0051271)	11	2	1.92	+	1.04	5.72E-01
response to nutrient levels (GO:0031667)	143	26	24.94	+	1.04	4.42E-01
genital disc morphogenesis (GO:0007483)	22	4	3.84	+	1.04	5.34E-01
regulation of defense response to virus by host (GO:0050691)	11	2	1.92	+	1.04	5.72E-01
regulation of mRNA stability (GO:0043488)	11	2	1.92	+	1.04	5.72E-01
positive regulation of DNA metabolic process (GO:0051054)	11	2	1.92	+	1.04	5.72E-01
response to peptide hormone (GO:0043434)	44	8	7.67	+	1.04	5.01E-01
calcium-ion regulated exocytosis (GO:0017156)	11	2	1.92	+	1.04	5.72E-01
male mating behavior (GO:0060179)	66	12	11.51	+	1.04	4.82E-01
regulation of actin cytoskeleton organization (GO:0032956)	99	18	17.26	+	1.04	4.62E-01
transition metal ion transport (GO:0000041)	33	6	5.75	+	1.04	5.14E-01
cellular chemical homeostasis (GO:0055082)	99	18	17.26	+	1.04	4.62E-01
RNA catabolic process (GO:0006401)	66	12	11.51	+	1.04	4.82E-01
negative regulation of hippo signaling (GO:0035331)	33	6	5.75	+	1.04	5.14E-01
cilium movement (GO:0003341)	33	6	5.75	+	1.04	5.14E-01
axo-dendritic transport (GO:0008088)	33	6	5.75	+	1.04	5.14E-01
positive regulation of cellular component biogenesis (GO:0044089)	132	24	23.02	+	1.04	4.46E-01
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	33	6	5.75	+	1.04	5.14E-01
positive regulation of signal transduction (GO:0009967)	336	61	58.59	+	1.04	3.92E-01
cell-cell signaling (GO:0007267)	270	49	47.08	+	1.04	4.08E-01
morphogenesis of an epithelium (GO:0002009)	530	96	92.42	+	1.04	3.64E-01
regulation of developmental growth (GO:0048638)	221	40	38.54	+	1.04	4.28E-01
sensory perception of smell (GO:0007608)	94	17	16.39	+	1.04	4.73E-01
cell communication (GO:0007154)	1001	181	174.55	+	1.04	3.08E-01
eye photoreceptor cell differentiation (GO:0001754)	166	30	28.95	+	1.04	4.47E-01
tissue development (GO:0009888)	892	161	155.55	+	1.04	3.30E-01
regulation of cellular amide metabolic process (GO:0034248)	133	24	23.19	+	1.03	4.61E-01
negative regulation of organelle organization (GO:0010639)	61	11	10.64	+	1.03	4.97E-01
epithelium development (GO:0060429)	827	149	144.21	+	1.03	3.47E-01
organic substance catabolic process (GO:1901575)	461	83	80.39	+	1.03	3.97E-01
nuclear-transcribed mRNA catabolic process (GO:0000956)	50	9	8.72	+	1.03	5.07E-01
positive regulation of GTPase activity (GO:0043547)	50	9	8.72	+	1.03	5.07E-01
response to chemical (GO:0042221)	867	156	151.19	+	1.03	3.49E-01
cation transport (GO:0006812)	228	41	39.76	+	1.03	4.43E-01
positive regulation of cellular protein catabolic process (GO:1903364)	39	7	6.80	+	1.03	5.21E-01
positive regulation of immune response (GO:0050778)	78	14	13.60	+	1.03	4.93E-01
phagocytosis (GO:0006909)	39	7	6.80	+	1.03	5.21E-01
animal organ development (GO:0048513)	1048	188	182.75	+	1.03	3.46E-01
response to extracellular stimulus (GO:0009991)	145	26	25.28	+	1.03	4.70E-01
imaginal disc-derived appendage morphogenesis (GO:0035114)	307	55	53.53	+	1.03	4.38E-01
imaginal disc-derived appendage development (GO:0048737)	313	56	54.58	+	1.03	4.41E-01
response to nitrogen compound (GO:1901698)	123	22	21.45	+	1.03	4.82E-01
cellular response to stimulus (GO:0051716)	1119	200	195.13	+	1.02	3.61E-01
potassium ion transmembrane transport (GO:0071805)	28	5	4.88	+	1.02	5.39E-01
regulation of protein-containing complex disassembly (GO:0043244)	28	5	4.88	+	1.02	5.39E-01
sphingolipid metabolic process (GO:0006665)	28	5	4.88	+	1.02	5.39E-01
establishment or maintenance of polarity of follicular epithelium (GO:0016334)	28	5	4.88	+	1.02	5.39E-01
monovalent inorganic cation homeostasis (GO:0055067)	28	5	4.88	+	1.02	5.39E-01
cellular amino acid biosynthetic process (GO:0008652)	28	5	4.88	+	1.02	5.39E-01
negative regulation of cell cycle process (GO:0010948)	56	10	9.77	+	1.02	5.13E-01
mRNA catabolic process (GO:0006402)	56	10	9.77	+	1.02	5.13E-01
divalent metal ion transport (GO:0070838)	56	10	9.77	+	1.02	5.13E-01
divalent inorganic cation transport (GO:0072511)	56	10	9.77	+	1.02	5.13E-01
cellular macromolecule localization (GO:0070727)	437	78	76.20	+	1.02	4.32E-01
response to external biotic stimulus (GO:0043207)	297	53	51.79	+	1.02	4.51E-01
response to other organism (GO:0051707)	297	53	51.79	+	1.02	4.51E-01
response to biotic stimulus (GO:0009607)	297	53	51.79	+	1.02	4.51E-01
regulation of actin filament-based process (GO:0032970)	101	18	17.61	+	1.02	4.95E-01
appendage morphogenesis (GO:0035107)	309	55	53.88	+	1.02	4.57E-01
inorganic cation transmembrane transport (GO:0098662)	163	29	28.42	+	1.02	4.82E-01
post-embryonic appendage morphogenesis (GO:0035120)	298	53	51.96	+	1.02	4.61E-01
signal transduction (GO:0007165)	765	136	133.40	+	1.02	4.18E-01
positive regulation of antimicrobial peptide production (GO:0002225)	45	8	7.85	+	1.02	5.26E-01
regulation of microtubule-based process (GO:0032886)	45	8	7.85	+	1.02	5.26E-01
RNA export from nucleus (GO:0006405)	45	8	7.85	+	1.02	5.26E-01
positive regulation of humoral immune response (GO:0002922)	45	8	7.85	+	1.02	5.26E-01
spermatid differentiation (GO:0048515)	90	16	15.69	+	1.02	5.03E-01
positive regulation of antimicrobial humoral response (GO:0002760)	45	8	7.85	+	1.02	5.26E-01
positive regulation of production of molecular mediator of immune response (GO:0002702)	45	8	7.85	+	1.02	5.26E-01
cellular divalent inorganic cation homeostasis (GO:0072503)	45	8	7.85	+	1.02	5.26E-01
positive regulation of immune effector process (GO:0002699)	45	8	7.85	+	1.02	5.26E-01
heterocycle metabolic process (GO:0046483)	816	145	142.29	+	1.02	4.17E-01
regulation of hydrolase activity (GO:0051336)	152	27	26.51	+	1.02	4.88E-01
regulation of molecular function (GO:0065009)	338	60	58.94	+	1.02	4.62E-01
appendage development (GO:0048736)	316	56	55.10	+	1.02	4.70E-01
cation transmembrane transport (GO:0098655)	175	31	30.52	+	1.02	4.90E-01
signaling (GO:0023052)	977	173	170.37	+	1.02	4.25E-01
macromolecule metabolic process (GO:0043170)	1746	309	304.47	+	1.01	3.90E-01
defense response to other organism (GO:0098542)	260	46	45.34	+	1.01	4.81E-01
catabolic process (GO:0009056)	537	95	93.64	+	1.01	4.57E-01
mRNA processing (GO:0006397)	164	29	28.60	+	1.01	4.95E-01
synaptic signaling (GO:0099536)	198	35	34.53	+	1.01	4.91E-01
regulation of protein metabolic process (GO:0051246)	447	79	77.95	+	1.01	4.67E-01
interspecies interaction between organisms (GO:0044419)	300	53	52.31	+	1.01	4.81E-01
positive regulation of cytosolic calcium ion concentration (GO:0007204)	17	3	2.96	+	1.01	5.69E-01
positive regulation of ion transport (GO:0043270)	17	3	2.96	+	1.01	5.69E-01
regulation of protein kinase B signaling (GO:0051896)	17	3	2.96	+	1.01	5.69E-01
cellular response to organic cyclic compound (GO:0071407)	34	6	5.93	+	1.01	5.43E-01
aromatic amino acid family metabolic process (GO:0009072)	17	3	2.96	+	1.01	5.69E-01
Wnt signaling pathway (GO:0016055)	34	6	5.93	+	1.01	5.43E-01
nucleus localization (GO:0051647)	34	6	5.93	+	1.01	5.43E-01
regulation of heterochromatin organization (GO:0120261)	17	3	2.96	+	1.01	5.69E-01
hemopoiesis (GO:0030097)	68	12	11.86	+	1.01	5.23E-01
feeding behavior (GO:0007631)	34	6	5.93	+	1.01	5.43E-01
regulation of wound healing (GO:0061041)	17	3	2.96	+	1.01	5.69E-01
RNA polyadenylation (GO:0043631)	17	3	2.96	+	1.01	5.69E-01
regulation of DNA binding (GO:0051101)	17	3	2.96	+	1.01	5.69E-01
vesicle docking involved in exocytosis (GO:0006904)	34	6	5.93	+	1.01	5.43E-01
regulation of heterochromatin assembly (GO:0031445)	17	3	2.96	+	1.01	5.69E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	51	9	8.89	+	1.01	5.31E-01
regulation of stem cell proliferation (GO:0072091)	51	9	8.89	+	1.01	5.31E-01
regulation of epithelial cell migration (GO:0010632)	51	9	8.89	+	1.01	5.31E-01
regulation of neural precursor cell proliferation (GO:2000177)	51	9	8.89	+	1.01	5.31E-01
cell maturation (GO:0048469)	153	27	26.68	+	1.01	5.02E-01
system development (GO:0048731)	1464	258	255.29	+	1.01	4.34E-01
organic cyclic compound metabolic process (GO:1901360)	891	157	155.37	+	1.01	4.57E-01
defense response (GO:0006952)	267	47	46.56	+	1.01	4.94E-01
anatomical structure morphogenesis (GO:0009653)	1279	225	223.03	+	1.01	4.53E-01
germ-line stem cell population maintenance (GO:0030718)	74	13	12.90	+	1.01	5.27E-01
plasma membrane bounded cell projection assembly (GO:0120031)	74	13	12.90	+	1.01	5.27E-01
developmental maturation (GO:0021700)	171	30	29.82	+	1.01	5.12E-01
biological_process (GO:0008150)	5587	980	974.26	+	1.01	2.28E-01
cell-cell adhesion (GO:0098609)	97	17	16.91	+	1.01	5.25E-01
anatomical structure development (GO:0048856)	2170	380	378.40	+	1.00	4.71E-01
regulation of cellular component organization (GO:0051128)	634	111	110.56	+	1.00	4.97E-01
calcium ion transport (GO:0006816)	40	7	6.98	+	1.00	5.47E-01
nucleobase-containing compound metabolic process (GO:0006139)	760	133	132.53	+	1.00	4.96E-01
post-embryonic animal organ development (GO:0048569)	423	74	73.76	+	1.00	5.06E-01
regulation of catalytic activity (GO:0050790)	275	48	47.95	+	1.00	5.18E-01
positive regulation of immune system process (GO:0002684)	86	15	15.00	+	1.00	5.35E-01
actin filament organization (GO:0007015)	109	19	19.01	-	1.00	5.60E-01
biological regulation (GO:0065007)	3146	548	548.60	-	1.00	4.97E-01
multicellular organism development (GO:0007275)	1913	333	333.59	-	1.00	4.99E-01
response to stimulus (GO:0050896)	1908	332	332.72	-	1.00	4.96E-01
gland development (GO:0048732)	161	28	28.08	-	1.00	5.44E-01
cilium movement involved in cell motility (GO:0060294)	23	4	4.01	-	1.00	6.27E-01
germarium-derived egg chamber formation (GO:0007293)	92	16	16.04	-	1.00	5.62E-01
mRNA 3'-end processing (GO:0031124)	23	4	4.01	-	1.00	6.27E-01
establishment of imaginal disc-derived wing hair orientation (GO:0001737)	23	4	4.01	-	1.00	6.27E-01
vacuolar transport (GO:0007034)	46	8	8.02	-	1.00	5.90E-01
cellular transition metal ion homeostasis (GO:0046916)	23	4	4.01	-	1.00	6.27E-01
spiracle morphogenesis, open tracheal system (GO:0035277)	23	4	4.01	-	1.00	6.27E-01
positive regulation of cytoskeleton organization (GO:0051495)	46	8	8.02	-	1.00	5.90E-01
regulation of cysteine-type endopeptidase activity (GO:2000116)	23	4	4.01	-	1.00	6.27E-01
centriole assembly (GO:0098534)	23	4	4.01	-	1.00	6.27E-01
cellular macromolecule metabolic process (GO:0044260)	1369	238	238.72	-	1.00	4.96E-01
cellular localization (GO:0051641)	737	128	128.52	-	1.00	5.04E-01
regulation of cellular catabolic process (GO:0031329)	167	29	29.12	-	1.00	5.40E-01
organic cyclic compound catabolic process (GO:1901361)	121	21	21.10	-	1.00	5.49E-01
response to stress (GO:0006950)	847	147	147.70	-	1.00	4.97E-01
regulation of cell population proliferation (GO:0042127)	196	34	34.18	-	.99	5.33E-01
regulation of localization (GO:0032879)	421	73	73.41	-	.99	5.11E-01
anatomical structure maturation (GO:0071695)	156	27	27.20	-	.99	5.35E-01
regulation of tube size (GO:0035150)	52	9	9.07	-	.99	5.78E-01
developmental process (GO:0032502)	2263	391	394.62	-	.99	4.22E-01
regulation of synaptic growth at neuromuscular junction (GO:0008582)	110	19	19.18	-	.99	5.44E-01
regulation of reproductive process (GO:2000241)	110	19	19.18	-	.99	5.44E-01
regulation of programmed cell death (GO:0043067)	168	29	29.30	-	.99	5.27E-01
lipid homeostasis (GO:0055088)	58	10	10.11	-	.99	5.69E-01
regulation of DNA replication (GO:0006275)	29	5	5.06	-	.99	6.06E-01
regulation of neuromuscular junction development (GO:1904396)	116	20	20.23	-	.99	5.39E-01
chaperone-mediated protein folding (GO:0061077)	29	5	5.06	-	.99	6.06E-01
cellular cation homeostasis (GO:0030003)	87	15	15.17	-	.99	5.50E-01
positive regulation of cellular component organization (GO:0051130)	267	46	46.56	-	.99	5.06E-01
positive regulation of cell communication (GO:0010647)	366	63	63.82	-	.99	4.91E-01
positive regulation of signaling (GO:0023056)	366	63	63.82	-	.99	4.91E-01
proteolysis (GO:0006508)	343	59	59.81	-	.99	4.91E-01
regulation of Ras protein signal transduction (GO:0046578)	64	11	11.16	-	.99	5.60E-01
growth (GO:0040007)	163	28	28.42	-	.99	5.18E-01
developmental growth (GO:0048589)	163	28	28.42	-	.99	5.18E-01
neuron development (GO:0048666)	495	85	86.32	-	.98	4.70E-01
negative regulation of cellular process (GO:0048523)	1009	173	175.95	-	.98	4.23E-01
regulation of cell development (GO:0060284)	140	24	24.41	-	.98	5.20E-01
cellular response to organonitrogen compound (GO:0071417)	70	12	12.21	-	.98	5.52E-01
molting cycle (GO:0042303)	70	12	12.21	-	.98	5.52E-01
molting cycle, chitin-based cuticle (GO:0007591)	70	12	12.21	-	.98	5.52E-01
epithelial cell migration, open tracheal system (GO:0007427)	35	6	6.10	-	.98	5.90E-01
cellular aromatic compound metabolic process (GO:0006725)	859	147	149.79	-	.98	4.24E-01
cell morphogenesis (GO:0000902)	450	77	78.47	-	.98	4.61E-01
regulation of synapse organization (GO:0050807)	152	26	26.51	-	.98	5.12E-01
cellular response to nutrient levels (GO:0031669)	76	13	13.25	-	.98	5.45E-01
chemical synaptic transmission (GO:0007268)	193	33	33.66	-	.98	5.00E-01
anterograde trans-synaptic signaling (GO:0098916)	193	33	33.66	-	.98	5.00E-01
macromolecule modification (GO:0043412)	696	119	121.37	-	.98	4.33E-01
regulation of synapse assembly (GO:0051963)	117	20	20.40	-	.98	5.23E-01
positive regulation of response to stimulus (GO:0048584)	410	70	71.50	-	.98	4.58E-01
vacuole organization (GO:0007033)	41	7	7.15	-	.98	5.76E-01
response to starvation (GO:0042594)	129	22	22.49	-	.98	5.14E-01
regulation of anatomical structure size (GO:0090066)	217	37	37.84	-	.98	4.88E-01
cellular ion homeostasis (GO:0006873)	88	15	15.35	-	.98	5.32E-01
regulation of chromosome organization (GO:0033044)	88	15	15.35	-	.98	5.32E-01
cell projection assembly (GO:0030031)	88	15	15.35	-	.98	5.32E-01
positive regulation of response to external stimulus (GO:0032103)	88	15	15.35	-	.98	5.32E-01
protein secretion (GO:0009306)	47	8	8.20	-	.98	5.65E-01
stem cell population maintenance (GO:0019827)	94	16	16.39	-	.98	5.27E-01
maintenance of cell number (GO:0098727)	94	16	16.39	-	.98	5.27E-01
regulation of apoptotic process (GO:0042981)	141	24	24.59	-	.98	5.06E-01
regulation of cellular protein metabolic process (GO:0032268)	423	72	73.76	-	.98	4.46E-01
negative regulation of cellular component organization (GO:0051129)	147	25	25.63	-	.98	5.02E-01
negative regulation of biological process (GO:0048519)	1147	195	200.01	-	.97	3.64E-01
regulation of cell death (GO:0010941)	200	34	34.88	-	.97	4.85E-01
metal ion transport (GO:0030001)	153	26	26.68	-	.97	4.98E-01
organelle assembly (GO:0070925)	265	45	46.21	-	.97	4.66E-01
nucleosome organization (GO:0034728)	53	9	9.24	-	.97	5.55E-01
anatomical structure formation involved in morphogenesis (GO:0048646)	454	77	79.17	-	.97	4.29E-01
male courtship behavior (GO:0008049)	59	10	10.29	-	.97	5.47E-01
regulation of establishment of protein localization (GO:0070201)	59	10	10.29	-	.97	5.47E-01
regulation of catabolic process (GO:0009894)	189	32	32.96	-	.97	4.79E-01
trans-synaptic signaling (GO:0099537)	195	33	34.00	-	.97	4.76E-01
regulation of biological process (GO:0050789)	2857	483	498.20	-	.97	1.79E-01
multicellular organismal process (GO:0032501)	2680	453	467.34	-	.97	1.93E-01
cellular response to starvation (GO:0009267)	71	12	12.38	-	.97	5.32E-01
regulation of organelle organization (GO:0033043)	296	50	51.62	-	.97	4.45E-01
protein modification process (GO:0036211)	664	112	115.79	-	.97	3.77E-01
epithelial cell differentiation (GO:0030855)	332	56	57.89	-	.97	4.33E-01
morphogenesis of a polarized epithelium (GO:0001738)	83	14	14.47	-	.97	5.20E-01
cellular protein modification process (GO:0006464)	664	112	115.79	-	.97	3.77E-01
positive regulation of biological process (GO:0048518)	1324	223	230.88	-	.97	2.92E-01
positive regulation of cellular process (GO:0048522)	1224	206	213.44	-	.97	2.99E-01
microtubule-based movement (GO:0007018)	113	19	19.70	-	.96	4.96E-01
cellular component organization or biogenesis (GO:0071840)	2013	338	351.03	-	.96	2.05E-01
taxis (GO:0042330)	304	51	53.01	-	.96	4.24E-01
regulation of cellular process (GO:0050794)	2684	449	468.03	-	.96	1.23E-01
cellular component assembly (GO:0022607)	718	120	125.20	-	.96	3.30E-01
cellular catabolic process (GO:0044248)	473	79	82.48	-	.96	3.71E-01
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	6	1	1.05	-	.96	7.19E-01
positive regulation of DNA binding (GO:0043388)	6	1	1.05	-	.96	7.19E-01
phosphate ion transport (GO:0006817)	6	1	1.05	-	.96	7.19E-01
superoxide metabolic process (GO:0006801)	6	1	1.05	-	.96	7.19E-01
regulation of vesicle fusion (GO:0031338)	6	1	1.05	-	.96	7.19E-01
sperm axoneme assembly (GO:0007288)	12	2	2.09	-	.96	6.52E-01
regulation of short-term neuronal synaptic plasticity (GO:0048172)	6	1	1.05	-	.96	7.19E-01
carbohydrate derivative transport (GO:1901264)	12	2	2.09	-	.96	6.52E-01
regulation of cell-matrix adhesion (GO:0001952)	6	1	1.05	-	.96	7.19E-01
regulation of neuronal synaptic plasticity (GO:0048168)	12	2	2.09	-	.96	6.52E-01
mRNA modification (GO:0016556)	6	1	1.05	-	.96	7.19E-01
folic acid-containing compound metabolic process (GO:0006760)	6	1	1.05	-	.96	7.19E-01
exosomal secretion (GO:1990182)	6	1	1.05	-	.96	7.19E-01
sodium-independent organic anion transport (GO:0043252)	6	1	1.05	-	.96	7.19E-01
positive regulation of protein-containing complex disassembly (GO:0043243)	6	1	1.05	-	.96	7.19E-01
transforming growth factor beta receptor signaling pathway (GO:0007179)	6	1	1.05	-	.96	7.19E-01
very long-chain fatty acid biosynthetic process (GO:0042761)	6	1	1.05	-	.96	7.19E-01
regulation of protein maturation (GO:1903317)	6	1	1.05	-	.96	7.19E-01
muscle thin filament assembly (GO:0071689)	6	1	1.05	-	.96	7.19E-01
fucosylation (GO:0036065)	6	1	1.05	-	.96	7.19E-01
ovulation (GO:0030728)	6	1	1.05	-	.96	7.19E-01
fatty acid beta-oxidation (GO:0006635)	12	2	2.09	-	.96	6.52E-01
protein targeting to lysosome (GO:0006622)	6	1	1.05	-	.96	7.19E-01
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620)	6	1	1.05	-	.96	7.19E-01
G1/S transition of mitotic cell cycle (GO:0000082)	12	2	2.09	-	.96	6.52E-01
equator specification (GO:0045317)	6	1	1.05	-	.96	7.19E-01
rRNA methylation (GO:0031167)	6	1	1.05	-	.96	7.19E-01
regulation of protein localization to membrane (GO:1905475)	12	2	2.09	-	.96	6.52E-01
coenzyme A metabolic process (GO:0015936)	6	1	1.05	-	.96	7.19E-01
RNA 3'-end processing (GO:0031123)	54	9	9.42	-	.96	5.32E-01
negative regulation of microtubule polymerization or depolymerization (GO:0031111)	12	2	2.09	-	.96	6.52E-01
positive regulation of crystal cell differentiation (GO:0042691)	6	1	1.05	-	.96	7.19E-01
extracellular exosome biogenesis (GO:0097734)	6	1	1.05	-	.96	7.19E-01
cell cycle G1/S phase transition (GO:0044843)	12	2	2.09	-	.96	6.52E-01
regulation of DNA endoreduplication (GO:0032875)	6	1	1.05	-	.96	7.19E-01
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	6	1	1.05	-	.96	7.19E-01
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	6	1	1.05	-	.96	7.19E-01
reflex (GO:0060004)	6	1	1.05	-	.96	7.19E-01
distributive segregation (GO:0032837)	6	1	1.05	-	.96	7.19E-01
proline metabolic process (GO:0006560)	6	1	1.05	-	.96	7.19E-01
sodium ion homeostasis (GO:0055078)	6	1	1.05	-	.96	7.19E-01
L-phenylalanine catabolic process (GO:0006559)	6	1	1.05	-	.96	7.19E-01
L-phenylalanine metabolic process (GO:0006558)	6	1	1.05	-	.96	7.19E-01
protein monoubiquitination (GO:0006513)	12	2	2.09	-	.96	6.52E-01
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	6	1	1.05	-	.96	7.19E-01
regulation of double-strand break repair (GO:2000779)	6	1	1.05	-	.96	7.19E-01
nuclear body organization (GO:0030575)	6	1	1.05	-	.96	7.19E-01
larval behavior (GO:0030537)	48	8	8.37	-	.96	5.41E-01
positive regulation of neuron projection development (GO:0010976)	12	2	2.09	-	.96	6.52E-01
signal peptide processing (GO:0006465)	6	1	1.05	-	.96	7.19E-01
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	6	1	1.05	-	.96	7.19E-01
negative regulation of phosphatase activity (GO:0010923)	6	1	1.05	-	.96	7.19E-01
positive regulation of gliogenesis (GO:0014015)	6	1	1.05	-	.96	7.19E-01
bulk synaptic vesicle endocytosis (GO:0150008)	6	1	1.05	-	.96	7.19E-01
regulation of dephosphorylation (GO:0035303)	12	2	2.09	-	.96	6.52E-01
calcium ion transmembrane import into cytosol (GO:0097553)	6	1	1.05	-	.96	7.19E-01
positive regulation of protein localization to plasma membrane (GO:1903078)	6	1	1.05	-	.96	7.19E-01
female gonad development (GO:0008585)	12	2	2.09	-	.96	6.52E-01
response to misfolded protein (GO:0051788)	6	1	1.05	-	.96	7.19E-01
mitochondrial transcription (GO:0006390)	6	1	1.05	-	.96	7.19E-01
cellular response to hexose stimulus (GO:0071331)	6	1	1.05	-	.96	7.19E-01
positive regulation of mitochondrion organization (GO:0010822)	12	2	2.09	-	.96	6.52E-01
posterior head segmentation (GO:0035289)	12	2	2.09	-	.96	6.52E-01
extracellular vesicle biogenesis (GO:0140112)	6	1	1.05	-	.96	7.19E-01
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	6	1	1.05	-	.96	7.19E-01
regulation of phosphorylation (GO:0042325)	216	36	37.67	-	.96	4.33E-01
cellular response to cadmium ion (GO:0071276)	6	1	1.05	-	.96	7.19E-01
cellular response to arsenic-containing substance (GO:0071243)	6	1	1.05	-	.96	7.19E-01
rRNA catabolic process (GO:0016075)	12	2	2.09	-	.96	6.52E-01
cellular response to misfolded protein (GO:0071218)	6	1	1.05	-	.96	7.19E-01
response to amino acid starvation (GO:1990928)	12	2	2.09	-	.96	6.52E-01
phagosome maturation (GO:0090382)	6	1	1.05	-	.96	7.19E-01
peptidyl-glutamic acid modification (GO:0018200)	6	1	1.05	-	.96	7.19E-01
pyrimidine nucleotide biosynthetic process (GO:0006221)	12	2	2.09	-	.96	6.52E-01
pyrimidine nucleotide metabolic process (GO:0006220)	12	2	2.09	-	.96	6.52E-01
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	6	1	1.05	-	.96	7.19E-01
negative regulation of intracellular protein transport (GO:0090317)	6	1	1.05	-	.96	7.19E-01
amnioserosa maintenance (GO:0046665)	6	1	1.05	-	.96	7.19E-01
synaptic vesicle endosomal processing (GO:0099532)	12	2	2.09	-	.96	6.52E-01
heart formation (GO:0060914)	6	1	1.05	-	.96	7.19E-01
plasma membrane tubulation (GO:0097320)	6	1	1.05	-	.96	7.19E-01
amino acid import across plasma membrane (GO:0089718)	6	1	1.05	-	.96	7.19E-01
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	6	1	1.05	-	.96	7.19E-01
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	12	2	2.09	-	.96	6.52E-01
negative regulation of multicellular organism growth (GO:0040015)	12	2	2.09	-	.96	6.52E-01
positive regulation of ion transmembrane transporter activity (GO:0032414)	12	2	2.09	-	.96	6.52E-01
positive regulation of transporter activity (GO:0032411)	12	2	2.09	-	.96	6.52E-01
histone H4-K16 acetylation (GO:0043984)	6	1	1.05	-	.96	7.19E-01
cell adhesion involved in heart morphogenesis (GO:0061343)	12	2	2.09	-	.96	6.52E-01
heparan sulfate proteoglycan metabolic process (GO:0030201)	12	2	2.09	-	.96	6.52E-01
regulation of cell morphogenesis (GO:0022604)	78	13	13.60	-	.96	5.07E-01
adult feeding behavior (GO:0008343)	12	2	2.09	-	.96	6.52E-01
AMP biosynthetic process (GO:0006167)	6	1	1.05	-	.96	7.19E-01
endosome to lysosome transport (GO:0008333)	12	2	2.09	-	.96	6.52E-01
larval midgut cell programmed cell death (GO:0035096)	24	4	4.19	-	.96	5.93E-01
pupation (GO:0035074)	6	1	1.05	-	.96	7.19E-01
fertilization, exchange of chromosomal proteins (GO:0035042)	6	1	1.05	-	.96	7.19E-01
regulation of protein processing (GO:0070613)	6	1	1.05	-	.96	7.19E-01
development of primary female sexual characteristics (GO:0046545)	12	2	2.09	-	.96	6.52E-01
negative regulation of photoreceptor cell differentiation (GO:0046533)	12	2	2.09	-	.96	6.52E-01
regulation of synaptic vesicle exocytosis (GO:2000300)	6	1	1.05	-	.96	7.19E-01
positive regulation of meiotic cell cycle (GO:0051446)	6	1	1.05	-	.96	7.19E-01
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	6	1	1.05	-	.96	7.19E-01
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	6	1	1.05	-	.96	7.19E-01
glycosaminoglycan biosynthetic process (GO:0006024)	6	1	1.05	-	.96	7.19E-01
positive regulation of mitochondrial fission (GO:0090141)	6	1	1.05	-	.96	7.19E-01
apoptotic signaling pathway (GO:0097190)	24	4	4.19	-	.96	5.93E-01
postsynaptic membrane assembly (GO:0097104)	6	1	1.05	-	.96	7.19E-01
regulation of DNA biosynthetic process (GO:2000278)	6	1	1.05	-	.96	7.19E-01
negative regulation of antibacterial peptide biosynthetic process (GO:0002809)	6	1	1.05	-	.96	7.19E-01
negative regulation of antimicrobial peptide biosynthetic process (GO:0002806)	6	1	1.05	-	.96	7.19E-01
embryonic digestive tract development (GO:0048566)	6	1	1.05	-	.96	7.19E-01
proboscis extension reflex (GO:0007637)	6	1	1.05	-	.96	7.19E-01
jump response (GO:0007630)	6	1	1.05	-	.96	7.19E-01
diacylglycerol metabolic process (GO:0046339)	6	1	1.05	-	.96	7.19E-01
peptide secretion (GO:0002790)	48	8	8.37	-	.96	5.41E-01
negative regulation of antibacterial peptide production (GO:0002787)	6	1	1.05	-	.96	7.19E-01
post-translational protein modification (GO:0043687)	6	1	1.05	-	.96	7.19E-01
cellular response to extracellular stimulus (GO:0031668)	78	13	13.60	-	.96	5.07E-01
digestion (GO:0007586)	12	2	2.09	-	.96	6.52E-01
pyrimidine-containing compound catabolic process (GO:0072529)	6	1	1.05	-	.96	7.19E-01
positive regulation of dendrite morphogenesis (GO:0050775)	12	2	2.09	-	.96	6.52E-01
triglyceride homeostasis (GO:0070328)	24	4	4.19	-	.96	5.93E-01
regulation of vacuole organization (GO:0044088)	6	1	1.05	-	.96	7.19E-01
regulation of ARF protein signal transduction (GO:0032012)	6	1	1.05	-	.96	7.19E-01
cellular response to nitrogen levels (GO:0043562)	6	1	1.05	-	.96	7.19E-01
histoblast morphogenesis (GO:0007488)	12	2	2.09	-	.96	6.52E-01
imaginal disc-derived male genitalia development (GO:0007485)	24	4	4.19	-	.96	5.93E-01
notum development (GO:0007477)	6	1	1.05	-	.96	7.19E-01
heparan sulfate proteoglycan biosynthetic process (GO:0015012)	12	2	2.09	-	.96	6.52E-01
calcium ion transport into cytosol (GO:0060402)	6	1	1.05	-	.96	7.19E-01
germ-line sex determination (GO:0018992)	6	1	1.05	-	.96	7.19E-01
nucleobase catabolic process (GO:0046113)	6	1	1.05	-	.96	7.19E-01
cellular response to nitrogen starvation (GO:0006995)	6	1	1.05	-	.96	7.19E-01
positive regulation of DNA-binding transcription factor activity (GO:0051091)	12	2	2.09	-	.96	6.52E-01
negative regulation of neuron differentiation (GO:0045665)	12	2	2.09	-	.96	6.52E-01
microtubule anchoring at microtubule organizing center (GO:0072393)	6	1	1.05	-	.96	7.19E-01
vesicle fusion with Golgi apparatus (GO:0048280)	6	1	1.05	-	.96	7.19E-01
periodic partitioning by pair rule gene (GO:0007366)	6	1	1.05	-	.96	7.19E-01
negative regulation of secretion by cell (GO:1903531)	12	2	2.09	-	.96	6.52E-01
regulation of syncytial blastoderm mitotic cell cycle (GO:0007348)	6	1	1.05	-	.96	7.19E-01
response to increased oxygen levels (GO:0036296)	6	1	1.05	-	.96	7.19E-01
maternal specification of dorsal/ventral axis, oocyte, soma encoded (GO:0007313)	6	1	1.05	-	.96	7.19E-01
response to temperature stimulus (GO:0009266)	114	19	19.88	-	.96	4.80E-01
morphogenesis of embryonic epithelium (GO:0016331)	114	19	19.88	-	.96	4.80E-01
regulation of cytoskeleton organization (GO:0051493)	138	23	24.06	-	.96	4.67E-01
embryonic morphogenesis (GO:0048598)	210	35	36.62	-	.96	4.35E-01
sensory perception (GO:0007600)	276	46	48.13	-	.96	4.13E-01
post-Golgi vesicle-mediated transport (GO:0006892)	30	5	5.23	-	.96	5.75E-01
microtubule cytoskeleton organization (GO:0000226)	264	44	46.04	-	.96	4.17E-01
negative regulation of protein-containing complex disassembly (GO:0043242)	18	3	3.14	-	.96	6.16E-01
G protein-coupled receptor signaling pathway (GO:0007186)	168	28	29.30	-	.96	4.52E-01
protein export from nucleus (GO:0006611)	42	7	7.32	-	.96	5.50E-01
cellular response to insulin stimulus (GO:0032869)	42	7	7.32	-	.96	5.50E-01
sensory organ precursor cell fate determination (GO:0016360)	18	3	3.14	-	.96	6.16E-01
negative regulation of chromosome organization (GO:2001251)	18	3	3.14	-	.96	6.16E-01
organophosphate ester transport (GO:0015748)	18	3	3.14	-	.96	6.16E-01
fatty acid catabolic process (GO:0009062)	18	3	3.14	-	.96	6.16E-01
regulation of chromatin assembly (GO:0010847)	18	3	3.14	-	.96	6.16E-01
regulation of cell cycle (GO:0051726)	246	41	42.90	-	.96	4.23E-01
heterochromatin organization (GO:0070828)	36	6	6.28	-	.96	5.62E-01
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	36	6	6.28	-	.96	5.62E-01
positive regulation of cell growth (GO:0030307)	42	7	7.32	-	.96	5.50E-01
autophagosome maturation (GO:0097352)	18	3	3.14	-	.96	6.16E-01
negative regulation of protein depolymerization (GO:1901880)	18	3	3.14	-	.96	6.16E-01
positive regulation of intracellular transport (GO:0032388)	18	3	3.14	-	.96	6.16E-01
regulation of meiotic cell cycle (GO:0051445)	18	3	3.14	-	.96	6.16E-01
chitin metabolic process (GO:0006030)	36	6	6.28	-	.96	5.62E-01
negative regulation of cell fate commitment (GO:0010454)	18	3	3.14	-	.96	6.16E-01
learning (GO:0007612)	60	10	10.46	-	.96	5.25E-01
centrosome separation (GO:0051299)	18	3	3.14	-	.96	6.16E-01
cell fate determination involved in pattern specification (GO:0060582)	18	3	3.14	-	.96	6.16E-01
pyrimidine-containing compound metabolic process (GO:0072527)	18	3	3.14	-	.96	6.16E-01
positive regulation of cell adhesion (GO:0045785)	18	3	3.14	-	.96	6.16E-01
import into nucleus (GO:0051170)	36	6	6.28	-	.96	5.62E-01
vesicle budding from membrane (GO:0006900)	18	3	3.14	-	.96	6.16E-01
positive regulation of secretion by cell (GO:1903532)	30	5	5.23	-	.96	5.75E-01
organelle organization (GO:0006996)	1278	212	222.86	-	.95	2.17E-01
positive regulation of multicellular organismal process (GO:0051240)	187	31	32.61	-	.95	4.32E-01
protein modification by small protein conjugation or removal (GO:0070647)	175	29	30.52	-	.95	4.37E-01
regulation of cellular component size (GO:0032535)	157	26	27.38	-	.95	4.44E-01
generation of neurons (GO:0048699)	719	119	125.38	-	.95	2.90E-01
microtubule-based process (GO:0007017)	333	55	58.07	-	.95	3.71E-01
cellular response to external stimulus (GO:0071496)	85	14	14.82	-	.94	4.83E-01
endosomal transport (GO:0016197)	85	14	14.82	-	.94	4.83E-01
negative regulation of cell cycle (GO:0045786)	85	14	14.82	-	.94	4.83E-01
cellular response to stress (GO:0033554)	401	66	69.93	-	.94	3.41E-01
reproductive system development (GO:0061458)	79	13	13.78	-	.94	4.88E-01
reproductive structure development (GO:0048608)	79	13	13.78	-	.94	4.88E-01
positive regulation of response to biotic stimulus (GO:0002833)	79	13	13.78	-	.94	4.88E-01
cellular response to nitrogen compound (GO:1901699)	73	12	12.73	-	.94	4.93E-01
cellular metal ion homeostasis (GO:0006875)	67	11	11.68	-	.94	4.98E-01
regulation of cell growth (GO:0001558)	67	11	11.68	-	.94	4.98E-01
protein phosphorylation (GO:0006468)	195	32	34.00	-	.94	4.06E-01
organelle localization (GO:0051640)	195	32	34.00	-	.94	4.06E-01
mRNA splicing, via spliceosome (GO:0000398)	128	21	22.32	-	.94	4.43E-01
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	128	21	22.32	-	.94	4.43E-01
regulation of protein phosphorylation (GO:0001932)	183	30	31.91	-	.94	4.10E-01
cell part morphogenesis (GO:0032990)	366	60	63.82	-	.94	3.39E-01
dendrite development (GO:0016358)	122	20	21.27	-	.94	4.46E-01
regulation of cell junction assembly (GO:1901888)	122	20	21.27	-	.94	4.46E-01
regulation of phosphate metabolic process (GO:0019220)	232	38	40.46	-	.94	3.85E-01
dendrite morphogenesis (GO:0048813)	116	19	20.23	-	.94	4.49E-01
regulation of phosphorus metabolic process (GO:0051174)	232	38	40.46	-	.94	3.85E-01
transport along microtubule (GO:0010970)	55	9	9.59	-	.94	5.10E-01
heterocycle catabolic process (GO:0046700)	110	18	19.18	-	.94	4.52E-01
plasma membrane bounded cell projection organization (GO:0120036)	489	80	85.27	-	.94	2.99E-01
maintenance of location (GO:0051235)	49	8	8.54	-	.94	5.17E-01
response to insulin (GO:0032868)	43	7	7.50	-	.93	5.25E-01
myofibril assembly (GO:0030239)	43	7	7.50	-	.93	5.25E-01
neuron differentiation (GO:0030182)	627	102	109.34	-	.93	2.47E-01
embryonic development via the syncytial blastoderm (GO:0001700)	160	26	27.90	-	.93	4.05E-01
mesoderm development (GO:0007498)	80	13	13.95	-	.93	4.69E-01
positive regulation of growth (GO:0045927)	117	19	20.40	-	.93	4.34E-01
cell projection organization (GO:0030030)	499	81	87.02	-	.93	2.71E-01
peptidyl-lysine modification (GO:0018205)	111	18	19.36	-	.93	4.36E-01
establishment of tissue polarity (GO:0007164)	74	12	12.90	-	.93	4.73E-01
establishment of planar polarity (GO:0001736)	74	12	12.90	-	.93	4.73E-01
regulation of ERK1 and ERK2 cascade (GO:0070372)	37	6	6.45	-	.93	5.34E-01
oocyte dorsal/ventral axis specification (GO:0007310)	37	6	6.45	-	.93	5.34E-01
system process (GO:0003008)	501	81	87.36	-	.93	2.59E-01
cell projection morphogenesis (GO:0048858)	359	58	62.60	-	.93	3.01E-01
plasma membrane bounded cell projection morphogenesis (GO:0120039)	359	58	62.60	-	.93	3.01E-01
RNA splicing, via transesterification reactions (GO:0000375)	130	21	22.67	-	.93	4.14E-01
synapse organization (GO:0050808)	161	26	28.08	-	.93	3.92E-01
negative regulation of supramolecular fiber organization (GO:1902904)	31	5	5.41	-	.92	5.45E-01
microtubule bundle formation (GO:0001578)	31	5	5.41	-	.92	5.45E-01
signal transduction by protein phosphorylation (GO:0023014)	31	5	5.41	-	.92	5.45E-01
humoral immune response (GO:0006959)	31	5	5.41	-	.92	5.45E-01
positive regulation of secretion (GO:0051047)	31	5	5.41	-	.92	5.45E-01
regulation of synapse structure or activity (GO:0050803)	180	29	31.39	-	.92	3.76E-01
neurogenesis (GO:0022008)	758	122	132.18	-	.92	1.84E-01
cytoskeleton organization (GO:0007010)	460	74	80.21	-	.92	2.56E-01
regulation of protein transport (GO:0051223)	56	9	9.77	-	.92	4.87E-01
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	56	9	9.77	-	.92	4.87E-01
microtubule-based transport (GO:0099111)	56	9	9.77	-	.92	4.87E-01
response to endogenous stimulus (GO:0009719)	137	22	23.89	-	.92	3.99E-01
cell development (GO:0048468)	1128	181	196.70	-	.92	1.13E-01
regulation of MAPK cascade (GO:0043408)	106	17	18.48	-	.92	4.23E-01
cellular component organization (GO:0016043)	1943	311	338.82	-	.92	3.41E-02
cilium-dependent cell motility (GO:0060285)	25	4	4.36	-	.92	5.59E-01
cell cycle checkpoint (GO:0000075)	50	8	8.72	-	.92	4.93E-01
acylglycerol homeostasis (GO:0055090)	25	4	4.36	-	.92	5.59E-01
development of primary sexual characteristics (GO:0045137)	50	8	8.72	-	.92	4.93E-01
cilium or flagellum-dependent cell motility (GO:0001539)	25	4	4.36	-	.92	5.59E-01
heterochromatin organization involved in chromatin silencing (GO:0070868)	25	4	4.36	-	.92	5.59E-01
regulation of ion transmembrane transport (GO:0034765)	25	4	4.36	-	.92	5.59E-01
regulation of transmembrane transport (GO:0034762)	25	4	4.36	-	.92	5.59E-01
gonad development (GO:0008406)	50	8	8.72	-	.92	4.93E-01
terminal branching, open tracheal system (GO:0007430)	25	4	4.36	-	.92	5.59E-01
regulation of pole plasm oskar mRNA localization (GO:0007317)	25	4	4.36	-	.92	5.59E-01
eggshell chorion assembly (GO:0007306)	75	12	13.08	-	.92	4.54E-01
external encapsulating structure organization (GO:0045229)	75	12	13.08	-	.92	4.54E-01
head development (GO:0060322)	125	20	21.80	-	.92	4.02E-01
cellular developmental process (GO:0048869)	1388	222	242.04	-	.92	7.43E-02
regulation of developmental process (GO:0050793)	594	95	103.58	-	.92	2.02E-01
cell morphogenesis involved in differentiation (GO:0000904)	394	63	68.71	-	.92	2.61E-01
embryo development ending in birth or egg hatching (GO:0009792)	169	27	29.47	-	.92	3.66E-01
neuron projection morphogenesis (GO:0048812)	357	57	62.25	-	.92	2.71E-01
cell differentiation (GO:0030154)	1378	220	240.29	-	.92	7.12E-02
regulation of nervous system development (GO:0051960)	188	30	32.78	-	.92	3.51E-01
cell growth (GO:0016049)	69	11	12.03	-	.91	4.57E-01
cellular protein-containing complex assembly (GO:0034622)	245	39	42.72	-	.91	3.14E-01
cellular macromolecule catabolic process (GO:0044265)	289	46	50.40	-	.91	2.92E-01
amino sugar metabolic process (GO:0006040)	44	7	7.67	-	.91	4.99E-01
positive regulation of smoothened signaling pathway (GO:0045880)	44	7	7.67	-	.91	4.99E-01
RNA splicing (GO:0008380)	132	21	23.02	-	.91	3.86E-01
cellular nitrogen compound catabolic process (GO:0044270)	107	17	18.66	-	.91	4.07E-01
nucleic acid metabolic process (GO:0090304)	630	100	109.86	-	.91	1.73E-01
positive regulation of programmed cell death (GO:0043068)	63	10	10.99	-	.91	4.61E-01
regulation of mitotic cell cycle phase transition (GO:1901990)	82	13	14.30	-	.91	4.32E-01
cellular component disassembly (GO:0022411)	82	13	14.30	-	.91	4.32E-01
protein-containing complex subunit organization (GO:0043933)	341	54	59.46	-	.91	2.57E-01
compound eye morphogenesis (GO:0001745)	259	41	45.16	-	.91	2.94E-01
regulation of actomyosin structure organization (GO:0110020)	19	3	3.31	-	.91	5.77E-01
Golgi to plasma membrane transport (GO:0006893)	19	3	3.31	-	.91	5.77E-01
establishment of mitotic spindle orientation (GO:0000132)	19	3	3.31	-	.91	5.77E-01
cell migration (GO:0016477)	247	39	43.07	-	.91	2.95E-01
regulation of transmembrane transporter activity (GO:0022898)	19	3	3.31	-	.91	5.77E-01
regulation of ion transmembrane transporter activity (GO:0032412)	19	3	3.31	-	.91	5.77E-01
regulation of transporter activity (GO:0032409)	19	3	3.31	-	.91	5.77E-01
histone H4 acetylation (GO:0043967)	19	3	3.31	-	.91	5.77E-01
compound eye development (GO:0048749)	323	51	56.32	-	.91	2.58E-01
cellular aldehyde metabolic process (GO:0006081)	19	3	3.31	-	.91	5.77E-01
ncRNA transcription (GO:0098781)	19	3	3.31	-	.91	5.77E-01
regulation of mRNA catabolic process (GO:0061013)	19	3	3.31	-	.91	5.77E-01
proximal/distal pattern formation, imaginal disc (GO:0007449)	19	3	3.31	-	.91	5.77E-01
neuron projection development (GO:0031175)	380	60	66.26	-	.91	2.35E-01
nervous system development (GO:0007399)	906	143	157.99	-	.91	1.04E-01
nervous system process (GO:0050877)	439	69	76.55	-	.90	2.02E-01
localization of cell (GO:0051674)	280	44	48.83	-	.90	2.67E-01
regulation of small GTPase mediated signal transduction (GO:0051056)	70	11	12.21	-	.90	4.37E-01
cellular component morphogenesis (GO:0032989)	471	74	82.13	-	.90	1.91E-01
cell motility (GO:0048870)	274	43	47.78	-	.90	2.67E-01
modification-dependent protein catabolic process (GO:0019941)	198	31	34.53	-	.90	3.07E-01
locomotion (GO:0040011)	543	85	94.69	-	.90	1.61E-01
immune system process (GO:0002376)	262	41	45.69	-	.90	2.68E-01
cellular component assembly involved in morphogenesis (GO:0010927)	128	20	22.32	-	.90	3.59E-01
insulin receptor signaling pathway (GO:0008286)	32	5	5.58	-	.90	5.15E-01
negative regulation of cytoskeleton organization (GO:0051494)	32	5	5.58	-	.90	5.15E-01
supramolecular fiber organization (GO:0097435)	173	27	30.17	-	.90	3.19E-01
regulation of cell migration (GO:0030334)	77	12	13.43	-	.89	4.16E-01
protein acylation (GO:0043543)	77	12	13.43	-	.89	4.16E-01
regulation of cell projection organization (GO:0031344)	122	19	21.27	-	.89	3.60E-01
protein catabolic process (GO:0030163)	212	33	36.97	-	.89	2.86E-01
lipid localization (GO:0010876)	45	7	7.85	-	.89	4.74E-01
larval development (GO:0002164)	148	23	25.81	-	.89	3.32E-01
regulation of cell shape (GO:0008360)	58	9	10.11	-	.89	4.43E-01
macromolecule methylation (GO:0043414)	58	9	10.11	-	.89	4.43E-01
regulation of protein kinase activity (GO:0045859)	71	11	12.38	-	.89	4.18E-01
hematopoietic or lymphoid organ development (GO:0048534)	84	13	14.65	-	.89	3.96E-01
immune system development (GO:0002520)	84	13	14.65	-	.89	3.96E-01
Unclassified (UNCLASSIFIED)	291	45	50.74	-	.89	2.28E-01
positive regulation of developmental growth (GO:0048639)	97	15	16.91	-	.89	3.78E-01
proteolysis involved in cellular protein catabolic process (GO:0051603)	207	32	36.10	-	.89	2.77E-01
cell morphogenesis involved in neuron differentiation (GO:0048667)	356	55	62.08	-	.89	1.96E-01
macromolecule catabolic process (GO:0009057)	324	50	56.50	-	.88	2.08E-01
multi-organism reproductive process (GO:0044703)	890	137	155.20	-	.88	5.97E-02
sexual reproduction (GO:0019953)	890	137	155.20	-	.88	5.97E-02
positive regulation of border follicle cell migration (GO:1903688)	39	6	6.80	-	.88	4.79E-01
response to inorganic substance (GO:0010035)	65	10	11.33	-	.88	4.20E-01
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	130	20	22.67	-	.88	3.32E-01
positive regulation of cell maturation (GO:1903431)	13	2	2.27	-	.88	6.05E-01
postsynaptic membrane organization (GO:0001941)	13	2	2.27	-	.88	6.05E-01
regulation of response to oxidative stress (GO:1902882)	13	2	2.27	-	.88	6.05E-01
protein targeting to vacuole (GO:0006623)	13	2	2.27	-	.88	6.05E-01
non-canonical Wnt signaling pathway (GO:0035567)	13	2	2.27	-	.88	6.05E-01
late endosome to vacuole transport (GO:0045324)	13	2	2.27	-	.88	6.05E-01
ribosomal small subunit assembly (GO:0000028)	13	2	2.27	-	.88	6.05E-01
spindle assembly involved in female meiosis (GO:0007056)	13	2	2.27	-	.88	6.05E-01
lysosome organization (GO:0007040)	13	2	2.27	-	.88	6.05E-01
catecholamine metabolic process (GO:0006584)	13	2	2.27	-	.88	6.05E-01
stress-activated protein kinase signaling cascade (GO:0031098)	26	4	4.53	-	.88	5.25E-01
cyclic nucleotide biosynthetic process (GO:0009190)	13	2	2.27	-	.88	6.05E-01
nucleobase metabolic process (GO:0009112)	13	2	2.27	-	.88	6.05E-01
positive regulation of neuron maturation (GO:0014042)	13	2	2.27	-	.88	6.05E-01
positive regulation of neuron remodeling (GO:1904801)	13	2	2.27	-	.88	6.05E-01
synaptic vesicle priming (GO:0016082)	13	2	2.27	-	.88	6.05E-01
cellular response to metal ion (GO:0071248)	13	2	2.27	-	.88	6.05E-01
positive regulation of organ growth (GO:0046622)	26	4	4.53	-	.88	5.25E-01
negative regulation of locomotion (GO:0040013)	13	2	2.27	-	.88	6.05E-01
regulation of cell size (GO:0008361)	91	14	15.87	-	.88	3.78E-01
aminoglycan metabolic process (GO:0006022)	52	8	9.07	-	.88	4.46E-01
negative regulation of cell fate specification (GO:0009996)	13	2	2.27	-	.88	6.05E-01
proximal/distal pattern formation (GO:0009954)	26	4	4.53	-	.88	5.25E-01
cellular protein catabolic process (GO:0044257)	208	32	36.27	-	.88	2.67E-01
protein transport along microtubule (GO:0098840)	13	2	2.27	-	.88	6.05E-01
cellular monovalent inorganic cation homeostasis (GO:0030004)	26	4	4.53	-	.88	5.25E-01
regulation of transferase activity (GO:0051338)	104	16	18.14	-	.88	3.62E-01
modulation of chemical synaptic transmission (GO:0050804)	117	18	20.40	-	.88	3.46E-01
lytic vacuole organization (GO:0080171)	13	2	2.27	-	.88	6.05E-01
regulation of trans-synaptic signaling (GO:0099177)	117	18	20.40	-	.88	3.46E-01
muscle tissue development (GO:0060537)	13	2	2.27	-	.88	6.05E-01
catechol-containing compound metabolic process (GO:0009712)	13	2	2.27	-	.88	6.05E-01
primary sex determination (GO:0007538)	13	2	2.27	-	.88	6.05E-01
microtubule-based protein transport (GO:0099118)	13	2	2.27	-	.88	6.05E-01
regulation of animal organ morphogenesis (GO:2000027)	26	4	4.53	-	.88	5.25E-01
haltere development (GO:0007482)	13	2	2.27	-	.88	6.05E-01
imaginal disc-derived wing vein specification (GO:0007474)	52	8	9.07	-	.88	4.46E-01
sensory organ development (GO:0007423)	416	64	72.54	-	.88	1.64E-01
positive regulation of cation transmembrane transport (GO:1904064)	13	2	2.27	-	.88	6.05E-01
regulation of RNA stability (GO:0043487)	13	2	2.27	-	.88	6.05E-01
regulation of secondary metabolic process (GO:0043455)	13	2	2.27	-	.88	6.05E-01
fatty acid oxidation (GO:0019395)	13	2	2.27	-	.88	6.05E-01
multi-organism process (GO:0051704)	891	137	155.37	-	.88	5.80E-02
sensory organ morphogenesis (GO:0090596)	267	41	46.56	-	.88	2.27E-01
eye morphogenesis (GO:0048592)	267	41	46.56	-	.88	2.27E-01
posttranscriptional regulation of gene expression (GO:0010608)	137	21	23.89	-	.88	3.19E-01
positive regulation of cellular biosynthetic process (GO:0031328)	418	64	72.89	-	.88	1.54E-01
positive regulation of biosynthetic process (GO:0009891)	418	64	72.89	-	.88	1.54E-01
regulation of cell cycle phase transition (GO:1901987)	85	13	14.82	-	.88	3.79E-01
positive regulation of hydrolase activity (GO:0051345)	85	13	14.82	-	.88	3.79E-01
second-messenger-mediated signaling (GO:0019932)	72	11	12.56	-	.88	3.99E-01
developmental growth involved in morphogenesis (GO:0060560)	72	11	12.56	-	.88	3.99E-01
regulation of mitotic cell cycle (GO:0007346)	144	22	25.11	-	.88	3.07E-01
multicellular organismal reproductive process (GO:0048609)	884	135	154.15	-	.88	4.97E-02
regulation of nitrogen compound metabolic process (GO:0051171)	1336	204	232.97	-	.88	1.59E-02
protein modification by small protein conjugation (GO:0032446)	131	20	22.84	-	.88	3.19E-01
positive regulation of cell projection organization (GO:0031346)	59	9	10.29	-	.87	4.22E-01
methylation (GO:0032259)	59	9	10.29	-	.87	4.22E-01
negative regulation of nitrogen compound metabolic process (GO:0051172)	466	71	81.26	-	.87	1.28E-01
muscle structure development (GO:0061061)	184	28	32.09	-	.87	2.65E-01
response to toxic substance (GO:0009636)	46	7	8.02	-	.87	4.49E-01
detection of stimulus (GO:0051606)	171	26	29.82	-	.87	2.75E-01
regulation of cell motility (GO:2000145)	79	12	13.78	-	.87	3.80E-01
aromatic compound catabolic process (GO:0019439)	112	17	19.53	-	.87	3.32E-01
regulation of primary metabolic process (GO:0080090)	1351	205	235.59	-	.87	1.18E-02
regionalization (GO:0003002)	422	64	73.59	-	.87	1.35E-01
protein deubiquitination (GO:0016579)	33	5	5.75	-	.87	4.86E-01
protein-containing complex assembly (GO:0065003)	264	40	46.04	-	.87	2.04E-01
cytoskeleton-dependent intracellular transport (GO:0030705)	66	10	11.51	-	.87	4.00E-01
immune effector process (GO:0002252)	66	10	11.51	-	.87	4.00E-01
negative regulation of catalytic activity (GO:0043086)	66	10	11.51	-	.87	4.00E-01
proteasomal protein catabolic process (GO:0010498)	132	20	23.02	-	.87	3.06E-01
import into cell (GO:0098657)	33	5	5.75	-	.87	4.86E-01
response to virus (GO:0009615)	33	5	5.75	-	.87	4.86E-01
multicellular organism reproduction (GO:0032504)	945	143	164.79	-	.87	3.33E-02
regulation of cell cycle process (GO:0010564)	152	23	26.51	-	.87	2.84E-01
modification-dependent macromolecule catabolic process (GO:0043632)	205	31	35.75	-	.87	2.39E-01
organonitrogen compound catabolic process (GO:1901565)	291	44	50.74	-	.87	1.85E-01
oocyte axis specification (GO:0007309)	106	16	18.48	-	.87	3.32E-01
positive regulation of catalytic activity (GO:0043085)	159	24	27.73	-	.87	2.73E-01
regulation of JNK cascade (GO:0046328)	53	8	9.24	-	.87	4.23E-01
positive regulation of nitrogen compound metabolic process (GO:0051173)	603	91	105.15	-	.87	7.78E-02
eye development (GO:0001654)	338	51	58.94	-	.87	1.59E-01
visual system development (GO:0150063)	338	51	58.94	-	.87	1.59E-01
sensory system development (GO:0048880)	338	51	58.94	-	.87	1.59E-01
actin cytoskeleton organization (GO:0030036)	219	33	38.19	-	.86	2.23E-01
protein-DNA complex subunit organization (GO:0071824)	93	14	16.22	-	.86	3.46E-01
asymmetric cell division (GO:0008356)	93	14	16.22	-	.86	3.46E-01
cellular response to endogenous stimulus (GO:0071495)	133	20	23.19	-	.86	2.94E-01
cell adhesion (GO:0007155)	153	23	26.68	-	.86	2.73E-01
immune response (GO:0006955)	153	23	26.68	-	.86	2.73E-01
negative regulation of macromolecule metabolic process (GO:0010605)	559	84	97.48	-	.86	8.13E-02
positive regulation of macromolecule biosynthetic process (GO:0010557)	386	58	67.31	-	.86	1.32E-01
positive regulation of protein metabolic process (GO:0051247)	233	35	40.63	-	.86	2.08E-01
regulation of macromolecule metabolic process (GO:0060255)	1439	216	250.93	-	.86	5.60E-03
reproductive process (GO:0022414)	1000	150	174.38	-	.86	2.20E-02
sodium ion transport (GO:0006814)	60	9	10.46	-	.86	4.01E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	20	3	3.49	-	.86	5.39E-01
mitotic cell cycle checkpoint (GO:0007093)	40	6	6.98	-	.86	4.53E-01
canonical Wnt signaling pathway (GO:0060070)	20	3	3.49	-	.86	5.39E-01
positive regulation of DNA-templated transcription, elongation (GO:0032786)	20	3	3.49	-	.86	5.39E-01
regulation of lipid biosynthetic process (GO:0046890)	20	3	3.49	-	.86	5.39E-01
positive regulation of epithelial cell migration (GO:0010634)	40	6	6.98	-	.86	4.53E-01
stress-activated MAPK cascade (GO:0051403)	20	3	3.49	-	.86	5.39E-01
intrinsic apoptotic signaling pathway (GO:0097193)	20	3	3.49	-	.86	5.39E-01
apical constriction (GO:0003383)	20	3	3.49	-	.86	5.39E-01
positive regulation of protein kinase activity (GO:0045860)	40	6	6.98	-	.86	4.53E-01
regulation of secretion (GO:0051046)	80	12	13.95	-	.86	3.62E-01
positive regulation of molecular function (GO:0044093)	187	28	32.61	-	.86	2.36E-01
positive regulation of organelle organization (GO:0010638)	127	19	22.15	-	.86	2.93E-01
regulation of nucleobase-containing compound metabolic process (GO:0019219)	950	142	165.66	-	.86	2.30E-02
movement of cell or subcellular component (GO:0006928)	569	85	99.22	-	.86	7.12E-02
mushroom body development (GO:0016319)	67	10	11.68	-	.86	3.80E-01
reproduction (GO:0000003)	1059	158	184.67	-	.86	1.54E-02
pattern specification process (GO:0007389)	456	68	79.52	-	.86	9.71E-02
regulation of cellular metabolic process (GO:0031323)	1437	214	250.58	-	.85	3.89E-03
ubiquitin-dependent protein catabolic process (GO:0006511)	195	29	34.00	-	.85	2.19E-01
positive regulation of cell death (GO:0010942)	74	11	12.90	-	.85	3.62E-01
regulation of protein modification process (GO:0031399)	249	37	43.42	-	.85	1.80E-01
regulation of metabolic process (GO:0019222)	1562	232	272.38	-	.85	2.11E-03
cellular process involved in reproduction in multicellular organism (GO:0022412)	741	110	129.21	-	.85	3.69E-02
biological adhesion (GO:0022610)	155	23	27.03	-	.85	2.51E-01
R8 cell differentiation (GO:0045465)	27	4	4.71	-	.85	4.93E-01
nuclear migration (GO:0007097)	27	4	4.71	-	.85	4.93E-01
snRNA metabolic process (GO:0016073)	27	4	4.71	-	.85	4.93E-01
defense response to virus (GO:0051607)	27	4	4.71	-	.85	4.93E-01
epithelial cell morphogenesis (GO:0003382)	27	4	4.71	-	.85	4.93E-01
regulation of cell-cell adhesion (GO:0022407)	27	4	4.71	-	.85	4.93E-01
hormone-mediated signaling pathway (GO:0009755)	27	4	4.71	-	.85	4.93E-01
imaginal disc-derived genitalia development (GO:0007484)	27	4	4.71	-	.85	4.93E-01
regulation of peptide transport (GO:0090087)	61	9	10.64	-	.85	3.80E-01
positive regulation of proteolysis (GO:0045862)	61	9	10.64	-	.85	3.80E-01
regulation of multicellular organismal development (GO:2000026)	244	36	42.55	-	.85	1.72E-01
embryo development (GO:0009790)	461	68	80.39	-	.85	8.11E-02
cell surface receptor signaling pathway (GO:0007166)	278	41	48.48	-	.85	1.52E-01
negative regulation of cellular metabolic process (GO:0031324)	509	75	88.76	-	.84	6.78E-02
protein import into nucleus (GO:0006606)	34	5	5.93	-	.84	4.57E-01
columnar/cuboidal epithelial cell differentiation (GO:0002065)	272	40	47.43	-	.84	1.51E-01
regulation of lipid storage (GO:0010883)	34	5	5.93	-	.84	4.57E-01
chaeta morphogenesis (GO:0008407)	34	5	5.93	-	.84	4.57E-01
regulation of tube length, open tracheal system (GO:0035159)	34	5	5.93	-	.84	4.57E-01
regulation of RNA metabolic process (GO:0051252)	918	135	160.08	-	.84	1.57E-02
oocyte construction (GO:0007308)	109	16	19.01	-	.84	2.89E-01
regulation of cell differentiation (GO:0045595)	246	36	42.90	-	.84	1.59E-01
germ cell development (GO:0007281)	615	90	107.24	-	.84	4.12E-02
glucosamine-containing compound metabolic process (GO:1901071)	41	6	7.15	-	.84	4.27E-01
regulation of axonogenesis (GO:0050770)	41	6	7.15	-	.84	4.27E-01
regulation of border follicle cell migration (GO:1903684)	41	6	7.15	-	.84	4.27E-01
stem cell division (GO:0017145)	82	12	14.30	-	.84	3.28E-01
actin filament-based process (GO:0030029)	233	34	40.63	-	.84	1.63E-01
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	377	55	65.74	-	.84	9.34E-02
chorion-containing eggshell formation (GO:0007304)	96	14	16.74	-	.84	3.00E-01
regulation of protein localization (GO:0032880)	96	14	16.74	-	.84	3.00E-01
positive regulation of chromosome organization (GO:2001252)	48	7	8.37	-	.84	4.02E-01
nucleobase-containing compound catabolic process (GO:0034655)	96	14	16.74	-	.84	3.00E-01
pole plasm assembly (GO:0007315)	48	7	8.37	-	.84	4.02E-01
regulation of macromolecule biosynthetic process (GO:0010556)	947	138	165.14	-	.84	1.05E-02
chromatin organization (GO:0006325)	268	39	46.73	-	.83	1.38E-01
cilium assembly (GO:0060271)	55	8	9.59	-	.83	3.80E-01
regulation of stress-activated MAPK cascade (GO:0032872)	55	8	9.59	-	.83	3.80E-01
cytoplasm organization (GO:0007028)	55	8	9.59	-	.83	3.80E-01
muscle cell development (GO:0055001)	55	8	9.59	-	.83	3.80E-01
positive regulation of cell cycle (GO:0045787)	55	8	9.59	-	.83	3.80E-01
centrosome cycle (GO:0007098)	62	9	10.81	-	.83	3.60E-01
gamete generation (GO:0007276)	787	114	137.24	-	.83	1.67E-02
regulation of cellular biosynthetic process (GO:0031326)	988	143	172.29	-	.83	7.09E-03
regulation of biosynthetic process (GO:0009889)	990	143	172.64	-	.83	6.55E-03
regulation of cellular macromolecule biosynthetic process (GO:2000112)	942	136	164.27	-	.83	7.92E-03
regulation of gene expression (GO:0010468)	1103	159	192.34	-	.83	3.67E-03
regulation of plasma membrane bounded cell projection organization (GO:0120035)	118	17	20.58	-	.83	2.53E-01
positive regulation of macromolecule metabolic process (GO:0010604)	632	91	110.21	-	.83	2.72E-02
positive regulation of gene expression (GO:0010628)	417	60	72.72	-	.83	6.56E-02
epithelial cell development (GO:0002064)	285	41	49.70	-	.82	1.14E-01
negative regulation of metabolic process (GO:0009892)	598	86	104.28	-	.82	3.06E-02
regulation of RNA biosynthetic process (GO:2001141)	835	120	145.61	-	.82	1.09E-02
regulation of transcription, DNA-templated (GO:0006355)	835	120	145.61	-	.82	1.09E-02
regulation of nucleic acid-templated transcription (GO:1903506)	835	120	145.61	-	.82	1.09E-02
positive regulation of metabolic process (GO:0009893)	710	102	123.81	-	.82	1.86E-02
positive regulation of developmental process (GO:0051094)	216	31	37.67	-	.82	1.52E-01
positive regulation of cellular metabolic process (GO:0031325)	662	95	115.44	-	.82	2.22E-02
chemotaxis (GO:0006935)	251	36	43.77	-	.82	1.29E-01
response to metal ion (GO:0010038)	42	6	7.32	-	.82	4.02E-01
N-terminal protein amino acid modification (GO:0031365)	7	1	1.22	-	.82	6.55E-01
vitellogenesis (GO:0007296)	7	1	1.22	-	.82	6.55E-01
sensory perception of pain (GO:0019233)	7	1	1.22	-	.82	6.55E-01
regulation of synaptic plasticity (GO:0048167)	35	5	6.10	-	.82	4.29E-01
smoothened signaling pathway (GO:0007224)	14	2	2.44	-	.82	5.59E-01
Notch receptor processing (GO:0007220)	14	2	2.44	-	.82	5.59E-01
male germ-line stem cell asymmetric division (GO:0048133)	7	1	1.22	-	.82	6.55E-01
histone phosphorylation (GO:0016572)	7	1	1.22	-	.82	6.55E-01
regulation of entry into reproductive diapause (GO:0061963)	7	1	1.22	-	.82	6.55E-01
protein ubiquitination (GO:0016567)	119	17	20.75	-	.82	2.41E-01
membrane assembly (GO:0071709)	7	1	1.22	-	.82	6.55E-01
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	14	2	2.44	-	.82	5.59E-01
protein-DNA complex assembly (GO:0065004)	56	8	9.77	-	.82	3.59E-01
male courtship behavior, veined wing generated song production (GO:0045433)	14	2	2.44	-	.82	5.59E-01
chromatin-mediated maintenance of transcription (GO:0048096)	7	1	1.22	-	.82	6.55E-01
regulation of compound eye pigmentation (GO:0048076)	7	1	1.22	-	.82	6.55E-01
regulation of eye pigmentation (GO:0048073)	7	1	1.22	-	.82	6.55E-01
negative gravitaxis (GO:0048060)	7	1	1.22	-	.82	6.55E-01
female meiosis I (GO:0007144)	7	1	1.22	-	.82	6.55E-01
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	7	1	1.22	-	.82	6.55E-01
positive regulation of mRNA metabolic process (GO:1903313)	14	2	2.44	-	.82	5.59E-01
germline ring canal formation (GO:0030725)	14	2	2.44	-	.82	5.59E-01
glycosphingolipid biosynthetic process (GO:0006688)	7	1	1.22	-	.82	6.55E-01
glycosphingolipid metabolic process (GO:0006687)	7	1	1.22	-	.82	6.55E-01
eggshell formation (GO:0030703)	98	14	17.09	-	.82	2.72E-01
pattern recognition receptor signaling pathway (GO:0002221)	7	1	1.22	-	.82	6.55E-01
positive regulation of protein localization to membrane (GO:1905477)	7	1	1.22	-	.82	6.55E-01
regulation of exit from mitosis (GO:0007096)	7	1	1.22	-	.82	6.55E-01
muscle cell fate specification (GO:0042694)	7	1	1.22	-	.82	6.55E-01
mitotic chromosome condensation (GO:0007076)	21	3	3.66	-	.82	5.02E-01
guanosine-containing compound metabolic process (GO:1901068)	7	1	1.22	-	.82	6.55E-01
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	7	1	1.22	-	.82	6.55E-01
regulation of potassium ion transmembrane transporter activity (GO:1901016)	7	1	1.22	-	.82	6.55E-01
endoderm formation (GO:0001706)	7	1	1.22	-	.82	6.55E-01
potassium ion homeostasis (GO:0055075)	7	1	1.22	-	.82	6.55E-01
ommatidial rotation (GO:0016318)	28	4	4.88	-	.82	4.61E-01
amino acid import (GO:0043090)	7	1	1.22	-	.82	6.55E-01
cilium organization (GO:0044782)	63	9	10.99	-	.82	3.41E-01
nucleoside catabolic process (GO:0009164)	7	1	1.22	-	.82	6.55E-01
behavioral response to starvation (GO:0042595)	7	1	1.22	-	.82	6.55E-01
detection of stimulus involved in sensory perception of pain (GO:0062149)	7	1	1.22	-	.82	6.55E-01
cellular glucose homeostasis (GO:0001678)	7	1	1.22	-	.82	6.55E-01
regulation of chromatin assembly or disassembly (GO:0001672)	21	3	3.66	-	.82	5.02E-01
pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	7	1	1.22	-	.82	6.55E-01
negative regulation of DNA-templated transcription, elongation (GO:0032785)	7	1	1.22	-	.82	6.55E-01
glycoprotein biosynthetic process (GO:0009101)	49	7	8.54	-	.82	3.79E-01
paracrine signaling (GO:0038001)	7	1	1.22	-	.82	6.55E-01
ribonucleoprotein complex export from nucleus (GO:0071426)	35	5	6.10	-	.82	4.29E-01
regulation of phosphatase activity (GO:0010921)	7	1	1.22	-	.82	6.55E-01
determination of muscle attachment site (GO:0016204)	7	1	1.22	-	.82	6.55E-01
glandular epithelial cell differentiation (GO:0002067)	7	1	1.22	-	.82	6.55E-01
RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	7	1	1.22	-	.82	6.55E-01
negative regulation of protein dephosphorylation (GO:0035308)	7	1	1.22	-	.82	6.55E-01
negative regulation of chromatin organization (GO:1905268)	21	3	3.66	-	.82	5.02E-01
serine family amino acid biosynthetic process (GO:0009070)	7	1	1.22	-	.82	6.55E-01
regulation of protein localization to plasma membrane (GO:1903076)	7	1	1.22	-	.82	6.55E-01
aspartate family amino acid biosynthetic process (GO:0009067)	7	1	1.22	-	.82	6.55E-01
phosphatidylinositol dephosphorylation (GO:0046856)	7	1	1.22	-	.82	6.55E-01
negative regulation of nucleocytoplasmic transport (GO:0046823)	7	1	1.22	-	.82	6.55E-01
regulation of nucleocytoplasmic transport (GO:0046822)	28	4	4.88	-	.82	4.61E-01
ribonucleoside catabolic process (GO:0042454)	7	1	1.22	-	.82	6.55E-01
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	7	1	1.22	-	.82	6.55E-01
cellular response to monosaccharide stimulus (GO:0071326)	7	1	1.22	-	.82	6.55E-01
innate immune response (GO:0045087)	98	14	17.09	-	.82	2.72E-01
specification of segmental identity, trunk (GO:0035292)	7	1	1.22	-	.82	6.55E-01
gonad morphogenesis (GO:0035262)	7	1	1.22	-	.82	6.55E-01
actin nucleation (GO:0045010)	14	2	2.44	-	.82	5.59E-01
genital disc anterior/posterior pattern formation (GO:0035224)	7	1	1.22	-	.82	6.55E-01
genital disc pattern formation (GO:0035221)	7	1	1.22	-	.82	6.55E-01
haltere disc development (GO:0035216)	14	2	2.44	-	.82	5.59E-01
positive regulation of ion transmembrane transport (GO:0034767)	14	2	2.44	-	.82	5.59E-01
positive regulation of transmembrane transport (GO:0034764)	14	2	2.44	-	.82	5.59E-01
cellular response to calcium ion (GO:0071277)	7	1	1.22	-	.82	6.55E-01
microvillus organization (GO:0032528)	7	1	1.22	-	.82	6.55E-01
cellular response to mechanical stimulus (GO:0071260)	7	1	1.22	-	.82	6.55E-01
cytokinetic process (GO:0032506)	35	5	6.10	-	.82	4.29E-01
positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	14	2	2.44	-	.82	5.59E-01
cellular response to amino acid stimulus (GO:0071230)	7	1	1.22	-	.82	6.55E-01
carbohydrate biosynthetic process (GO:0016051)	21	3	3.66	-	.82	5.02E-01
DNA topological change (GO:0006265)	7	1	1.22	-	.82	6.55E-01
positive regulation of cell development (GO:0010720)	77	11	13.43	-	.82	3.10E-01
protein localization to cell junction (GO:1902414)	14	2	2.44	-	.82	5.59E-01
positive regulation of wound healing (GO:0090303)	14	2	2.44	-	.82	5.59E-01
cGMP-mediated signaling (GO:0019934)	7	1	1.22	-	.82	6.55E-01
sperm storage (GO:0046693)	7	1	1.22	-	.82	6.55E-01
response to arsenic-containing substance (GO:0046685)	7	1	1.22	-	.82	6.55E-01
ncRNA catabolic process (GO:0034661)	14	2	2.44	-	.82	5.59E-01
nucleobase-containing small molecule catabolic process (GO:0034656)	7	1	1.22	-	.82	6.55E-01
cellular protein-containing complex localization (GO:0034629)	7	1	1.22	-	.82	6.55E-01
ribonucleoprotein complex localization (GO:0071166)	35	5	6.10	-	.82	4.29E-01
regulation of meiotic nuclear division (GO:0040020)	7	1	1.22	-	.82	6.55E-01
positive regulation of Wnt protein secretion (GO:0061357)	7	1	1.22	-	.82	6.55E-01
regulation of Wnt protein secretion (GO:0061356)	7	1	1.22	-	.82	6.55E-01
neural precursor cell proliferation (GO:0061351)	49	7	8.54	-	.82	3.79E-01
regulation of protein localization to nucleus (GO:1900180)	14	2	2.44	-	.82	5.59E-01
purine nucleoside catabolic process (GO:0006152)	7	1	1.22	-	.82	6.55E-01
pupariation (GO:0035073)	14	2	2.44	-	.82	5.59E-01
pyrimidine nucleobase biosynthetic process (GO:0019856)	7	1	1.22	-	.82	6.55E-01
dorsal trunk growth, open tracheal system (GO:0035001)	7	1	1.22	-	.82	6.55E-01
imaginal disc fusion, thorax closure (GO:0046529)	21	3	3.66	-	.82	5.02E-01
imaginal disc fusion (GO:0046528)	21	3	3.66	-	.82	5.02E-01
nephrocyte filtration (GO:0097206)	7	1	1.22	-	.82	6.55E-01
renal filtration (GO:0097205)	7	1	1.22	-	.82	6.55E-01
regulation of lipid transport (GO:0032368)	7	1	1.22	-	.82	6.55E-01
regulation of ubiquitin-protein transferase activity (GO:0051438)	7	1	1.22	-	.82	6.55E-01
mannose metabolic process (GO:0006013)	7	1	1.22	-	.82	6.55E-01
regulation of microtubule cytoskeleton organization (GO:0070507)	35	5	6.10	-	.82	4.29E-01
regulation of viral life cycle (GO:1903900)	7	1	1.22	-	.82	6.55E-01
receptor localization to synapse (GO:0097120)	7	1	1.22	-	.82	6.55E-01
presynaptic membrane assembly (GO:0097105)	7	1	1.22	-	.82	6.55E-01
protein-DNA complex remodeling (GO:0001120)	7	1	1.22	-	.82	6.55E-01
transcription open complex formation at RNA polymerase II promoter (GO:0001113)	7	1	1.22	-	.82	6.55E-01
DNA-templated transcription open complex formation (GO:0001112)	7	1	1.22	-	.82	6.55E-01
promoter clearance from RNA polymerase II promoter (GO:0001111)	7	1	1.22	-	.82	6.55E-01
positive regulation of feeding behavior (GO:2000253)	7	1	1.22	-	.82	6.55E-01
promoter clearance during DNA-templated transcription (GO:0001109)	7	1	1.22	-	.82	6.55E-01
skeletal myofibril assembly (GO:0014866)	7	1	1.22	-	.82	6.55E-01
actin filament polymerization (GO:0030041)	7	1	1.22	-	.82	6.55E-01
positive regulation of protein localization to cell periphery (GO:1904377)	7	1	1.22	-	.82	6.55E-01
negative regulation of hydrolase activity (GO:0051346)	42	6	7.32	-	.82	4.02E-01
regulation of organelle assembly (GO:1902115)	21	3	3.66	-	.82	5.02E-01
positive regulation of voltage-gated potassium channel activity (GO:1903818)	7	1	1.22	-	.82	6.55E-01
negative regulation of behavior (GO:0048521)	14	2	2.44	-	.82	5.59E-01
lipid droplet organization (GO:0034389)	7	1	1.22	-	.82	6.55E-01
protein-containing complex remodeling (GO:0034367)	7	1	1.22	-	.82	6.55E-01
negative regulation of peptide secretion (GO:0002792)	7	1	1.22	-	.82	6.55E-01
retrograde axonal transport (GO:0008090)	7	1	1.22	-	.82	6.55E-01
positive regulation of DNA-dependent DNA replication (GO:2000105)	7	1	1.22	-	.82	6.55E-01
negative regulation of DNA-dependent DNA replication (GO:2000104)	7	1	1.22	-	.82	6.55E-01
asymmetric stem cell division (GO:0098722)	56	8	9.77	-	.82	3.59E-01
sensory organ boundary specification (GO:0008052)	21	3	3.66	-	.82	5.02E-01
neurotransmitter loading into synaptic vesicle (GO:0098700)	7	1	1.22	-	.82	6.55E-01
maintenance of protein localization in organelle (GO:0072595)	7	1	1.22	-	.82	6.55E-01
ncRNA 3'-end processing (GO:0043628)	28	4	4.88	-	.82	4.61E-01
regulation of insulin secretion (GO:0050796)	7	1	1.22	-	.82	6.55E-01
pyridine-containing compound metabolic process (GO:0072524)	7	1	1.22	-	.82	6.55E-01
peptidyl-proline hydroxylation (GO:0019511)	7	1	1.22	-	.82	6.55E-01
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	28	4	4.88	-	.82	4.61E-01
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	42	6	7.32	-	.82	4.02E-01
visceral muscle development (GO:0007522)	14	2	2.44	-	.82	5.59E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	21	3	3.66	-	.82	5.02E-01
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	7	1	1.22	-	.82	6.55E-01
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	7	1	1.22	-	.82	6.55E-01
exonucleolytic trimming involved in rRNA processing (GO:0000459)	7	1	1.22	-	.82	6.55E-01
regulation of neuron apoptotic process (GO:0043523)	21	3	3.66	-	.82	5.02E-01
regulation of myosin II filament organization (GO:0043519)	7	1	1.22	-	.82	6.55E-01
regulation of JUN kinase activity (GO:0043506)	7	1	1.22	-	.82	6.55E-01
regulation of cell projection assembly (GO:0060491)	42	6	7.32	-	.82	4.02E-01
endoderm development (GO:0007492)	7	1	1.22	-	.82	6.55E-01
negative regulation of mRNA processing (GO:0050686)	7	1	1.22	-	.82	6.55E-01
postsynapse assembly (GO:0099068)	7	1	1.22	-	.82	6.55E-01
primary branching, open tracheal system (GO:0007428)	7	1	1.22	-	.82	6.55E-01
cytosolic calcium ion transport (GO:0060401)	7	1	1.22	-	.82	6.55E-01
oviposition (GO:0018991)	7	1	1.22	-	.82	6.55E-01
neuroblast proliferation (GO:0007405)	49	7	8.54	-	.82	3.79E-01
purine ribonucleoside catabolic process (GO:0046130)	7	1	1.22	-	.82	6.55E-01
cellular response to virus (GO:0098586)	7	1	1.22	-	.82	6.55E-01
negative regulation of R7 cell differentiation (GO:0045677)	7	1	1.22	-	.82	6.55E-01
regulation of cation transmembrane transport (GO:1904062)	21	3	3.66	-	.82	5.02E-01
enteroendocrine cell differentiation (GO:0035883)	7	1	1.22	-	.82	6.55E-01
regulation of carbohydrate catabolic process (GO:0043470)	7	1	1.22	-	.82	6.55E-01
regulation of ATPase activity (GO:0043462)	7	1	1.22	-	.82	6.55E-01
positive regulation of hemocyte differentiation (GO:0045612)	7	1	1.22	-	.82	6.55E-01
mRNA transport (GO:0051028)	35	5	6.10	-	.82	4.29E-01
barbed-end actin filament capping (GO:0051016)	7	1	1.22	-	.82	6.55E-01
positive regulation of MAP kinase activity (GO:0043406)	14	2	2.44	-	.82	5.59E-01
SMAD protein signal transduction (GO:0060395)	14	2	2.44	-	.82	5.59E-01
positive regulation of ATP metabolic process (GO:1903580)	7	1	1.22	-	.82	6.55E-01
regulation of secretion by cell (GO:1903530)	77	11	13.43	-	.82	3.10E-01
positive regulation of RNA metabolic process (GO:0051254)	365	52	63.65	-	.82	7.13E-02
positive regulation of cellular protein metabolic process (GO:0032270)	219	31	38.19	-	.81	1.33E-01
regulation of anatomical structure morphogenesis (GO:0022603)	156	22	27.20	-	.81	1.81E-01
positive regulation of RNA biosynthetic process (GO:1902680)	348	49	60.68	-	.81	6.60E-02
positive regulation of transcription, DNA-templated (GO:0045893)	348	49	60.68	-	.81	6.60E-02
positive regulation of nucleic acid-templated transcription (GO:1903508)	348	49	60.68	-	.81	6.60E-02
axonogenesis (GO:0007409)	277	39	48.30	-	.81	9.42E-02
neuron projection guidance (GO:0097485)	242	34	42.20	-	.81	1.11E-01
developmental process involved in reproduction (GO:0003006)	762	107	132.88	-	.81	7.81E-03
cell division (GO:0051301)	221	31	38.54	-	.80	1.22E-01
negative regulation of transcription by RNA polymerase II (GO:0000122)	157	22	27.38	-	.80	1.73E-01
imaginal disc-derived wing vein morphogenesis (GO:0008586)	43	6	7.50	-	.80	3.78E-01
negative regulation of neuromuscular junction development (GO:1904397)	43	6	7.50	-	.80	3.78E-01
negative regulation of synaptic growth at neuromuscular junction (GO:0045886)	43	6	7.50	-	.80	3.78E-01
ovarian follicle cell development (GO:0030707)	258	36	44.99	-	.80	9.47E-02
axon development (GO:0061564)	287	40	50.05	-	.80	7.98E-02
ameboidal-type cell migration (GO:0001667)	151	21	26.33	-	.80	1.71E-01
columnar/cuboidal epithelial cell development (GO:0002066)	259	36	45.16	-	.80	9.04E-02
regulation of histone modification (GO:0031056)	36	5	6.28	-	.80	4.02E-01
larval lymph gland hemopoiesis (GO:0035167)	36	5	6.28	-	.80	4.02E-01
post-embryonic hemopoiesis (GO:0035166)	36	5	6.28	-	.80	4.02E-01
oocyte differentiation (GO:0009994)	144	20	25.11	-	.80	1.77E-01
tissue migration (GO:0090130)	144	20	25.11	-	.80	1.77E-01
oogenesis (GO:0048477)	519	72	90.50	-	.80	2.11E-02
oocyte anterior/posterior axis specification (GO:0007314)	65	9	11.33	-	.79	3.04E-01
oocyte development (GO:0048599)	123	17	21.45	-	.79	1.97E-01
mitotic cytokinesis (GO:0000281)	58	8	10.11	-	.79	3.19E-01
germ-line cyst formation (GO:0048134)	29	4	5.06	-	.79	4.30E-01
negative regulation of ERBB signaling pathway (GO:1901185)	29	4	5.06	-	.79	4.30E-01
cellular response to heat (GO:0034605)	29	4	5.06	-	.79	4.30E-01
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	29	4	5.06	-	.79	4.30E-01
positive regulation of reproductive process (GO:2000243)	58	8	10.11	-	.79	3.19E-01
positive regulation of Notch signaling pathway (GO:0045747)	29	4	5.06	-	.79	4.30E-01
cognition (GO:0050890)	145	20	25.28	-	.79	1.68E-01
learning or memory (GO:0007611)	145	20	25.28	-	.79	1.68E-01
regulation of locomotion (GO:0040012)	109	15	19.01	-	.79	2.12E-01
positive regulation of catabolic process (GO:0009896)	109	15	19.01	-	.79	2.12E-01
female gamete generation (GO:0007292)	567	78	98.87	-	.79	1.34E-02
hindgut development (GO:0061525)	51	7	8.89	-	.79	3.36E-01
establishment of ommatidial planar polarity (GO:0042067)	51	7	8.89	-	.79	3.36E-01
regulation of cellular component movement (GO:0051270)	102	14	17.79	-	.79	2.20E-01
hindgut morphogenesis (GO:0007442)	51	7	8.89	-	.79	3.36E-01
apoptotic process (GO:0006915)	73	10	12.73	-	.79	2.74E-01
sex differentiation (GO:0007548)	95	13	16.57	-	.78	2.29E-01
regulation of cell cycle G1/S phase transition (GO:1902806)	22	3	3.84	-	.78	4.66E-01
negative regulation of synapse assembly (GO:0051964)	44	6	7.67	-	.78	3.54E-01
regulation of histone methylation (GO:0031060)	22	3	3.84	-	.78	4.66E-01
nucleoside metabolic process (GO:0009116)	22	3	3.84	-	.78	4.66E-01
regulation of axon extension (GO:0030516)	22	3	3.84	-	.78	4.66E-01
protein methylation (GO:0006479)	44	6	7.67	-	.78	3.54E-01
positive regulation of neuroblast proliferation (GO:0002052)	22	3	3.84	-	.78	4.66E-01
regulation of extent of cell growth (GO:0061387)	22	3	3.84	-	.78	4.66E-01
regulation of Rho protein signal transduction (GO:0035023)	22	3	3.84	-	.78	4.66E-01
protein alkylation (GO:0008213)	44	6	7.67	-	.78	3.54E-01
vesicle-mediated transport to the plasma membrane (GO:0098876)	22	3	3.84	-	.78	4.66E-01
nucleobase-containing small molecule biosynthetic process (GO:0034404)	22	3	3.84	-	.78	4.66E-01
actin-mediated cell contraction (GO:0070252)	22	3	3.84	-	.78	4.66E-01
negative regulation of synapse organization (GO:1905809)	44	6	7.67	-	.78	3.54E-01
monocarboxylic acid catabolic process (GO:0072329)	22	3	3.84	-	.78	4.66E-01
positive regulation of defense response (GO:0031349)	66	9	11.51	-	.78	2.87E-01
histone acetylation (GO:0016573)	66	9	11.51	-	.78	2.87E-01
internal protein amino acid acetylation (GO:0006475)	66	9	11.51	-	.78	2.87E-01
peptidyl-lysine acetylation (GO:0018394)	66	9	11.51	-	.78	2.87E-01
internal peptidyl-lysine acetylation (GO:0018393)	66	9	11.51	-	.78	2.87E-01
brain development (GO:0007420)	103	14	17.96	-	.78	2.08E-01
RNA localization (GO:0006403)	140	19	24.41	-	.78	1.57E-01
muscle cell differentiation (GO:0042692)	96	13	16.74	-	.78	2.16E-01
intracellular signal transduction (GO:0035556)	288	39	50.22	-	.78	5.63E-02
head involution (GO:0008258)	37	5	6.45	-	.77	3.75E-01
positive regulation of synaptic growth at neuromuscular junction (GO:0045887)	37	5	6.45	-	.77	3.75E-01
cellularization (GO:0007349)	89	12	15.52	-	.77	2.25E-01
protein acetylation (GO:0006473)	67	9	11.68	-	.77	2.70E-01
maternal determination of anterior/posterior axis, embryo (GO:0008358)	67	9	11.68	-	.77	2.70E-01
regulation of transcription by RNA polymerase II (GO:0006357)	614	82	107.07	-	.77	4.81E-03
positive regulation of cell population proliferation (GO:0008284)	75	10	13.08	-	.76	2.43E-01
male courtship behavior, veined wing vibration (GO:0016545)	15	2	2.62	-	.76	5.14E-01
fusome organization (GO:0045478)	15	2	2.62	-	.76	5.14E-01
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	15	2	2.62	-	.76	5.14E-01
oocyte microtubule cytoskeleton organization (GO:0016325)	30	4	5.23	-	.76	4.00E-01
intercellular bridge organization (GO:0043063)	15	2	2.62	-	.76	5.14E-01
response to purine-containing compound (GO:0014074)	15	2	2.62	-	.76	5.14E-01
regulation of tube diameter (GO:0035296)	15	2	2.62	-	.76	5.14E-01
cellular response to inorganic substance (GO:0071241)	15	2	2.62	-	.76	5.14E-01
regulation of cytokinesis (GO:0032465)	15	2	2.62	-	.76	5.14E-01
epithelial cell migration (GO:0010631)	135	18	23.54	-	.76	1.45E-01
negative regulation of cell junction assembly (GO:1901889)	45	6	7.85	-	.76	3.32E-01
neuron fate specification (GO:0048665)	30	4	5.23	-	.76	4.00E-01
actin polymerization or depolymerization (GO:0008154)	15	2	2.62	-	.76	5.14E-01
regulation of antibacterial peptide biosynthetic process (GO:0002808)	30	4	5.23	-	.76	4.00E-01
regulation of antibacterial peptide production (GO:0002786)	30	4	5.23	-	.76	4.00E-01
pyrimidine-containing compound biosynthetic process (GO:0072528)	15	2	2.62	-	.76	5.14E-01
positive regulation of neurogenesis (GO:0050769)	60	8	10.46	-	.76	2.82E-01
positive regulation of axon extension (GO:0045773)	15	2	2.62	-	.76	5.14E-01
regulation of cyclin-dependent protein kinase activity (GO:1904029)	15	2	2.62	-	.76	5.14E-01
chromatin assembly (GO:0031497)	30	4	5.23	-	.76	4.00E-01
positive regulation of nervous system development (GO:0051962)	98	13	17.09	-	.76	1.93E-01
striated muscle cell differentiation (GO:0051146)	83	11	14.47	-	.76	2.20E-01
axon guidance (GO:0007411)	234	31	40.80	-	.76	6.41E-02
microtubule organizing center organization (GO:0031023)	68	9	11.86	-	.76	2.54E-01
epithelium migration (GO:0090132)	136	18	23.72	-	.76	1.37E-01
regulation of autophagy (GO:0010506)	91	12	15.87	-	.76	2.00E-01
regulation of kinase activity (GO:0043549)	91	12	15.87	-	.76	2.00E-01
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	38	5	6.63	-	.75	3.50E-01
positive regulation of innate immune response (GO:0045089)	38	5	6.63	-	.75	3.50E-01
renal tubule morphogenesis (GO:0061333)	38	5	6.63	-	.75	3.50E-01
encapsulation of foreign target (GO:0035010)	38	5	6.63	-	.75	3.50E-01
regulation of embryonic development (GO:0045995)	38	5	6.63	-	.75	3.50E-01
Malpighian tubule morphogenesis (GO:0007443)	38	5	6.63	-	.75	3.50E-01
establishment of organelle localization (GO:0051656)	137	18	23.89	-	.75	1.30E-01
digestive system development (GO:0055123)	99	13	17.26	-	.75	1.82E-01
digestive tract development (GO:0048565)	99	13	17.26	-	.75	1.82E-01
dorsal closure (GO:0007391)	99	13	17.26	-	.75	1.82E-01
regulation of protein ubiquitination (GO:0031396)	23	3	4.01	-	.75	4.31E-01
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)	23	3	4.01	-	.75	4.31E-01
cytoplasmic microtubule organization (GO:0031122)	23	3	4.01	-	.75	4.31E-01
regulation of neurotransmitter secretion (GO:0046928)	23	3	4.01	-	.75	4.31E-01
maintenance of location in cell (GO:0051651)	23	3	4.01	-	.75	4.31E-01
cytokinesis (GO:0000910)	92	12	16.04	-	.75	1.88E-01
female sex differentiation (GO:0046660)	23	3	4.01	-	.75	4.31E-01
regulation of neurotransmitter transport (GO:0051588)	23	3	4.01	-	.75	4.31E-01
associative learning (GO:0008306)	46	6	8.02	-	.75	3.10E-01
regulation of terminal button organization (GO:2000331)	23	3	4.01	-	.75	4.31E-01
positive regulation of neural precursor cell proliferation (GO:2000179)	23	3	4.01	-	.75	4.31E-01
regulation of DNA-templated transcription, initiation (GO:2000142)	23	3	4.01	-	.75	4.31E-01
regulation of hemocyte differentiation (GO:0045610)	23	3	4.01	-	.75	4.31E-01
striated muscle cell development (GO:0055002)	54	7	9.42	-	.74	2.76E-01
regulation of neuron projection development (GO:0010975)	85	11	14.82	-	.74	1.95E-01
blastoderm segmentation (GO:0007350)	170	22	29.64	-	.74	8.71E-02
negative regulation of gene expression (GO:0010629)	426	55	74.29	-	.74	9.54E-03
germarium-derived oocyte differentiation (GO:0030706)	31	4	5.41	-	.74	3.72E-01
sarcomere organization (GO:0045214)	31	4	5.41	-	.74	3.72E-01
spindle localization (GO:0051653)	31	4	5.41	-	.74	3.72E-01
regulation of dendrite morphogenesis (GO:0048814)	31	4	5.41	-	.74	3.72E-01
establishment of spindle localization (GO:0051293)	31	4	5.41	-	.74	3.72E-01
cell fate commitment involved in pattern specification (GO:0060581)	31	4	5.41	-	.74	3.72E-01
protein-containing complex localization (GO:0031503)	62	8	10.81	-	.74	2.48E-01
negative regulation of RNA metabolic process (GO:0051253)	296	38	51.62	-	.74	2.65E-02
regulation of ERBB signaling pathway (GO:1901184)	39	5	6.80	-	.74	3.26E-01
protein autophosphorylation (GO:0046777)	39	5	6.80	-	.74	3.26E-01
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	39	5	6.80	-	.74	3.26E-01
positive regulation of neuromuscular junction development (GO:1904398)	39	5	6.80	-	.74	3.26E-01
regulation of DNA metabolic process (GO:0051052)	39	5	6.80	-	.74	3.26E-01
mitotic cell cycle (GO:0000278)	351	45	61.21	-	.74	1.60E-02
negative regulation of translation (GO:0017148)	47	6	8.20	-	.73	2.89E-01
negative regulation of cellular amide metabolic process (GO:0034249)	55	7	9.59	-	.73	2.58E-01
spermatogenesis (GO:0007283)	197	25	34.35	-	.73	5.71E-02
response to heat (GO:0009408)	71	9	12.38	-	.73	2.09E-01
positive regulation of cellular catabolic process (GO:0031331)	95	12	16.57	-	.72	1.56E-01
male gamete generation (GO:0048232)	238	30	41.50	-	.72	3.58E-02
cellular zinc ion homeostasis (GO:0006882)	8	1	1.40	-	.72	5.93E-01
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	8	1	1.40	-	.72	5.93E-01
polysaccharide biosynthetic process (GO:0000271)	8	1	1.40	-	.72	5.93E-01
peptidoglycan metabolic process (GO:0000270)	8	1	1.40	-	.72	5.93E-01
mitochondrial fission (GO:0000266)	8	1	1.40	-	.72	5.93E-01
regulation of synaptic vesicle recycling (GO:1903421)	8	1	1.40	-	.72	5.93E-01
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	8	1	1.40	-	.72	5.93E-01
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	8	1	1.40	-	.72	5.93E-01
female germ-line cyst encapsulation (GO:0048139)	8	1	1.40	-	.72	5.93E-01
positive regulation of potassium ion transport (GO:0043268)	8	1	1.40	-	.72	5.93E-01
regulation of potassium ion transport (GO:0043266)	8	1	1.40	-	.72	5.93E-01
negative regulation of female receptivity, post-mating (GO:0045434)	8	1	1.40	-	.72	5.93E-01
proteasome assembly (GO:0043248)	8	1	1.40	-	.72	5.93E-01
mitochondrial ATP synthesis coupled proton transport (GO:0042776)	8	1	1.40	-	.72	5.93E-01
regulation of syncytium formation by plasma membrane fusion (GO:0060142)	8	1	1.40	-	.72	5.93E-01
male courtship behavior, veined wing extension (GO:0048065)	16	2	2.79	-	.72	4.72E-01
R3/R4 cell differentiation (GO:0048056)	16	2	2.79	-	.72	4.72E-01
hydrogen peroxide catabolic process (GO:0042744)	8	1	1.40	-	.72	5.93E-01
amine metabolic process (GO:0009308)	16	2	2.79	-	.72	4.72E-01
central complex development (GO:0048036)	8	1	1.40	-	.72	5.93E-01
activin receptor signaling pathway (GO:0032924)	8	1	1.40	-	.72	5.93E-01
germarium-derived female germ-line cyst encapsulation (GO:0030708)	8	1	1.40	-	.72	5.93E-01
DNA replication checkpoint (GO:0000076)	16	2	2.79	-	.72	4.72E-01
regulation of SNARE complex assembly (GO:0035542)	8	1	1.40	-	.72	5.93E-01
rRNA 3'-end processing (GO:0031125)	8	1	1.40	-	.72	5.93E-01
peptidoglycan catabolic process (GO:0009253)	8	1	1.40	-	.72	5.93E-01
Bolwig's organ morphogenesis (GO:0001746)	8	1	1.40	-	.72	5.93E-01
cellular biogenic amine metabolic process (GO:0006576)	16	2	2.79	-	.72	4.72E-01
regulation of cell cycle G2/M phase transition (GO:1902749)	32	4	5.58	-	.72	3.45E-01
female meiosis chromosome segregation (GO:0016321)	16	2	2.79	-	.72	4.72E-01
Bolwig's organ development (GO:0055034)	8	1	1.40	-	.72	5.93E-01
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	8	1	1.40	-	.72	5.93E-01
negative regulation of apoptotic signaling pathway (GO:2001234)	8	1	1.40	-	.72	5.93E-01
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	8	1	1.40	-	.72	5.93E-01
mitotic cell cycle phase transition (GO:0044772)	32	4	5.58	-	.72	3.45E-01
purine nucleoside monophosphate biosynthetic process (GO:0009127)	8	1	1.40	-	.72	5.93E-01
cellular response to ionizing radiation (GO:0071479)	16	2	2.79	-	.72	4.72E-01
female genitalia development (GO:0030540)	8	1	1.40	-	.72	5.93E-01
negative regulation of neuron projection development (GO:0010977)	8	1	1.40	-	.72	5.93E-01
protein N-linked glycosylation (GO:0006487)	16	2	2.79	-	.72	4.72E-01
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	8	1	1.40	-	.72	5.93E-01
attachment of spindle microtubules to kinetochore (GO:0008608)	8	1	1.40	-	.72	5.93E-01
cell-cell fusion (GO:0140253)	32	4	5.58	-	.72	3.45E-01
RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	8	1	1.40	-	.72	5.93E-01
RNA phosphodiester bond hydrolysis (GO:0090501)	24	3	4.19	-	.72	3.98E-01
morphogenesis of an epithelial sheet (GO:0002011)	8	1	1.40	-	.72	5.93E-01
lamellipodium organization (GO:0097581)	8	1	1.40	-	.72	5.93E-01
glutamine family amino acid biosynthetic process (GO:0009084)	8	1	1.40	-	.72	5.93E-01
serine family amino acid metabolic process (GO:0009069)	8	1	1.40	-	.72	5.93E-01
aspartate family amino acid metabolic process (GO:0009066)	8	1	1.40	-	.72	5.93E-01
ubiquitin-dependent ERAD pathway (GO:0030433)	16	2	2.79	-	.72	4.72E-01
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	8	1	1.40	-	.72	5.93E-01
positive regulation of apoptotic process involved in development (GO:1904747)	8	1	1.40	-	.72	5.93E-01
DNA replication-independent nucleosome assembly (GO:0006336)	8	1	1.40	-	.72	5.93E-01
microtubule polymerization (GO:0046785)	16	2	2.79	-	.72	4.72E-01
protein localization to lysosome (GO:0061462)	8	1	1.40	-	.72	5.93E-01
regulation of cell morphogenesis involved in differentiation (GO:0010769)	16	2	2.79	-	.72	4.72E-01
nucleotide-excision repair (GO:0006289)	24	3	4.19	-	.72	3.98E-01
mitotic cytokinetic process (GO:1902410)	8	1	1.40	-	.72	5.93E-01
negative regulation of gene silencing by RNA (GO:0060967)	8	1	1.40	-	.72	5.93E-01
positive regulation of insulin receptor signaling pathway (GO:0046628)	16	2	2.79	-	.72	4.72E-01
response to calcium ion (GO:0051592)	8	1	1.40	-	.72	5.93E-01
positive regulation of protein localization to nucleus (GO:1900182)	8	1	1.40	-	.72	5.93E-01
glycosaminoglycan metabolic process (GO:0030203)	16	2	2.79	-	.72	4.72E-01
regulation of symbiotic process (GO:0043903)	8	1	1.40	-	.72	5.93E-01
positive regulation of photoreceptor cell differentiation (GO:0046534)	8	1	1.40	-	.72	5.93E-01
isoprenoid biosynthetic process (GO:0008299)	8	1	1.40	-	.72	5.93E-01
regulation of stress fiber assembly (GO:0051492)	8	1	1.40	-	.72	5.93E-01
myotube differentiation (GO:0014902)	32	4	5.58	-	.72	3.45E-01
positive regulation of cellular response to insulin stimulus (GO:1900078)	16	2	2.79	-	.72	4.72E-01
regulation of neuromuscular synaptic transmission (GO:1900073)	24	3	4.19	-	.72	3.98E-01
syncytium formation by plasma membrane fusion (GO:0000768)	32	4	5.58	-	.72	3.45E-01
regulation of myoblast fusion (GO:1901739)	8	1	1.40	-	.72	5.93E-01
regulation of transcriptional start site selection at RNA polymerase II promoter (GO:0001178)	8	1	1.40	-	.72	5.93E-01
sensory perception of bitter taste (GO:0050913)	8	1	1.40	-	.72	5.93E-01
lamellipodium assembly (GO:0030032)	8	1	1.40	-	.72	5.93E-01
positive regulation of antibacterial peptide production (GO:0002803)	24	3	4.19	-	.72	3.98E-01
embryonic organ morphogenesis (GO:0048562)	8	1	1.40	-	.72	5.93E-01
glycosyl compound metabolic process (GO:1901657)	24	3	4.19	-	.72	3.98E-01
negative regulation of cellular protein localization (GO:1903828)	8	1	1.40	-	.72	5.93E-01
digestive tract morphogenesis (GO:0048546)	64	8	11.16	-	.72	2.17E-01
alpha-amino acid biosynthetic process (GO:1901607)	24	3	4.19	-	.72	3.98E-01
cellular amine metabolic process (GO:0044106)	16	2	2.79	-	.72	4.72E-01
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899)	8	1	1.40	-	.72	5.93E-01
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	32	4	5.58	-	.72	3.45E-01
establishment of spindle orientation (GO:0051294)	24	3	4.19	-	.72	3.98E-01
positive regulation of lipid metabolic process (GO:0045834)	16	2	2.79	-	.72	4.72E-01
regulation of viral process (GO:0050792)	8	1	1.40	-	.72	5.93E-01
regulation of presynapse organization (GO:0099174)	24	3	4.19	-	.72	3.98E-01
myoblast fusion (GO:0007520)	32	4	5.58	-	.72	3.45E-01
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	8	1	1.40	-	.72	5.93E-01
negative regulation of salivary gland boundary specification (GO:0045705)	8	1	1.40	-	.72	5.93E-01
regulation of salivary gland boundary specification (GO:0045704)	8	1	1.40	-	.72	5.93E-01
progression of morphogenetic furrow involved in compound eye morphogenesis (GO:0007458)	8	1	1.40	-	.72	5.93E-01
presynapse assembly (GO:0099054)	8	1	1.40	-	.72	5.93E-01
defasciculation of motor neuron axon (GO:0007415)	8	1	1.40	-	.72	5.93E-01
somatic sex determination (GO:0018993)	16	2	2.79	-	.72	4.72E-01
positive regulation of antibacterial peptide biosynthetic process (GO:0006963)	24	3	4.19	-	.72	3.98E-01
syncytium formation (GO:0006949)	32	4	5.58	-	.72	3.45E-01
cellular polysaccharide biosynthetic process (GO:0033692)	8	1	1.40	-	.72	5.93E-01
nerve development (GO:0021675)	8	1	1.40	-	.72	5.93E-01
positive regulation of potassium ion transmembrane transport (GO:1901381)	8	1	1.40	-	.72	5.93E-01
regulation of potassium ion transmembrane transport (GO:1901379)	8	1	1.40	-	.72	5.93E-01
regulation of neuron death (GO:1901214)	40	5	6.98	-	.72	3.03E-01
cell fate specification (GO:0001708)	80	10	13.95	-	.72	1.77E-01
embryonic pattern specification (GO:0009880)	184	23	32.09	-	.72	5.64E-02
positive regulation of cell differentiation (GO:0045597)	105	13	18.31	-	.71	1.25E-01
negative regulation of RNA biosynthetic process (GO:1902679)	283	35	49.35	-	.71	1.79E-02
negative regulation of transcription, DNA-templated (GO:0045892)	283	35	49.35	-	.71	1.79E-02
negative regulation of nucleic acid-templated transcription (GO:1903507)	283	35	49.35	-	.71	1.79E-02
defense response to Gram-negative bacterium (GO:0050829)	81	10	14.12	-	.71	1.66E-01
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	308	38	53.71	-	.71	1.33E-02
chaeta development (GO:0022416)	73	9	12.73	-	.71	1.83E-01
negative regulation of macromolecule biosynthetic process (GO:0010558)	334	41	58.24	-	.70	9.28E-03
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	334	41	58.24	-	.70	9.28E-03
mitotic cell cycle process (GO:1903047)	245	30	42.72	-	.70	2.36E-02
genital disc development (GO:0035215)	49	6	8.54	-	.70	2.50E-01
positive regulation of phosphorus metabolic process (GO:0010562)	131	16	22.84	-	.70	8.45E-02
positive regulation of phosphate metabolic process (GO:0045937)	131	16	22.84	-	.70	8.45E-02
positive regulation of synapse assembly (GO:0051965)	41	5	7.15	-	.70	2.81E-01
protein localization to nucleus (GO:0034504)	41	5	7.15	-	.70	2.81E-01
memory (GO:0007613)	107	13	18.66	-	.70	1.10E-01
male meiosis cytokinesis (GO:0007112)	33	4	5.75	-	.70	3.19E-01
chromatin assembly or disassembly (GO:0006333)	33	4	5.75	-	.70	3.19E-01
peptidyl-lysine methylation (GO:0018022)	33	4	5.75	-	.70	3.19E-01
positive regulation of transferase activity (GO:0051347)	66	8	11.51	-	.70	1.88E-01
regulation of antimicrobial peptide biosynthetic process (GO:0002805)	33	4	5.75	-	.70	3.19E-01
segment specification (GO:0007379)	33	4	5.75	-	.70	3.19E-01
negative regulation of cellular biosynthetic process (GO:0031327)	347	42	60.51	-	.69	6.32E-03
negative regulation of biosynthetic process (GO:0009890)	347	42	60.51	-	.69	6.32E-03
cytoskeleton-dependent cytokinesis (GO:0061640)	91	11	15.87	-	.69	1.32E-01
regulation of chromatin organization (GO:1902275)	91	11	15.87	-	.69	1.32E-01
stem cell proliferation (GO:0072089)	58	7	10.11	-	.69	2.09E-01
Malpighian tubule development (GO:0072002)	58	7	10.11	-	.69	2.09E-01
positive regulation of locomotion (GO:0040017)	58	7	10.11	-	.69	2.09E-01
renal tubule development (GO:0061326)	58	7	10.11	-	.69	2.09E-01
positive regulation of kinase activity (GO:0033674)	58	7	10.11	-	.69	2.09E-01
pole plasm oskar mRNA localization (GO:0045451)	25	3	4.36	-	.69	3.66E-01
positive regulation of stem cell proliferation (GO:2000648)	25	3	4.36	-	.69	3.66E-01
axon choice point recognition (GO:0016198)	25	3	4.36	-	.69	3.66E-01
establishment of mitotic spindle localization (GO:0040001)	25	3	4.36	-	.69	3.66E-01
positive regulation of filopodium assembly (GO:0051491)	25	3	4.36	-	.69	3.66E-01
antimicrobial humoral response (GO:0019730)	25	3	4.36	-	.69	3.66E-01
short-term memory (GO:0007614)	25	3	4.36	-	.69	3.66E-01
central nervous system development (GO:0007417)	251	30	43.77	-	.69	1.62E-02
positive regulation of cell junction assembly (GO:1901890)	42	5	7.32	-	.68	2.60E-01
positive regulation of transcription by RNA polymerase II (GO:0045944)	269	32	46.91	-	.68	1.22E-02
extracellular structure organization (GO:0043062)	59	7	10.29	-	.68	1.94E-01
actomyosin structure organization (GO:0031032)	76	9	13.25	-	.68	1.48E-01
DNA packaging (GO:0006323)	76	9	13.25	-	.68	1.48E-01
heart development (GO:0007507)	93	11	16.22	-	.68	1.15E-01
circulatory system development (GO:0072359)	93	11	16.22	-	.68	1.15E-01
cell cycle process (GO:0022402)	441	52	76.90	-	.68	1.19E-03
cell cycle (GO:0007049)	526	62	91.72	-	.68	3.89E-04
lipid transport (GO:0006869)	34	4	5.93	-	.67	2.94E-01
cystoblast division (GO:0007282)	17	2	2.96	-	.67	4.31E-01
oocyte fate determination (GO:0030716)	34	4	5.93	-	.67	2.94E-01
negative regulation of cell cycle G2/M phase transition (GO:1902750)	17	2	2.96	-	.67	4.31E-01
regulation of lamellipodium organization (GO:1902743)	17	2	2.96	-	.67	4.31E-01
cell cycle phase transition (GO:0044770)	34	4	5.93	-	.67	2.94E-01
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	17	2	2.96	-	.67	4.31E-01
positive regulation of macroautophagy (GO:0016239)	17	2	2.96	-	.67	4.31E-01
thermosensory behavior (GO:0040040)	17	2	2.96	-	.67	4.31E-01
peptidyl-tyrosine phosphorylation (GO:0018108)	17	2	2.96	-	.67	4.31E-01
regulation of lamellipodium assembly (GO:0010591)	17	2	2.96	-	.67	4.31E-01
regulation of filopodium assembly (GO:0051489)	34	4	5.93	-	.67	2.94E-01
dorsal/ventral axis specification (GO:0009950)	68	8	11.86	-	.67	1.63E-01
protein refolding (GO:0042026)	17	2	2.96	-	.67	4.31E-01
neuron recognition (GO:0008038)	102	12	17.79	-	.67	9.78E-02
positive regulation of gene expression, epigenetic (GO:0045815)	17	2	2.96	-	.67	4.31E-01
spindle assembly (GO:0051225)	51	6	8.89	-	.67	2.15E-01
tracheal outgrowth, open tracheal system (GO:0007426)	17	2	2.96	-	.67	4.31E-01
histone modification (GO:0016570)	145	17	25.28	-	.67	5.22E-02
covalent chromatin modification (GO:0016569)	145	17	25.28	-	.67	5.22E-02
sperm individualization (GO:0007291)	43	5	7.50	-	.67	2.41E-01
meiotic cytokinesis (GO:0033206)	43	5	7.50	-	.67	2.41E-01
regulation of cell adhesion (GO:0030155)	43	5	7.50	-	.67	2.41E-01
axis specification (GO:0009798)	164	19	28.60	-	.66	3.62E-02
positive regulation of protein phosphorylation (GO:0001934)	104	12	18.14	-	.66	8.49E-02
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	26	3	4.53	-	.66	3.36E-01
mRNA export from nucleus (GO:0006406)	26	3	4.53	-	.66	3.36E-01
secondary metabolite biosynthetic process (GO:0044550)	26	3	4.53	-	.66	3.36E-01
positive regulation of cell migration (GO:0030335)	52	6	9.07	-	.66	1.99E-01
protein polymerization (GO:0051258)	26	3	4.53	-	.66	3.36E-01
regulation of lipid localization (GO:1905952)	26	3	4.53	-	.66	3.36E-01
actin cytoskeleton reorganization (GO:0031532)	26	3	4.53	-	.66	3.36E-01
ovarian follicle cell migration (GO:0007297)	105	12	18.31	-	.66	7.90E-02
segmentation (GO:0035282)	210	24	36.62	-	.66	1.62E-02
olfactory learning (GO:0008355)	35	4	6.10	-	.66	2.71E-01
cell recognition (GO:0008037)	105	12	18.31	-	.66	7.90E-02
ribonucleoprotein complex assembly (GO:0022618)	79	9	13.78	-	.65	1.19E-01
establishment or maintenance of cytoskeleton polarity (GO:0030952)	44	5	7.67	-	.65	2.22E-01
regulation of gene expression, epigenetic (GO:0040029)	88	10	15.35	-	.65	1.01E-01
extracellular matrix organization (GO:0030198)	44	5	7.67	-	.65	2.22E-01
embryonic hindgut morphogenesis (GO:0048619)	44	5	7.67	-	.65	2.22E-01
female meiotic nuclear division (GO:0007143)	53	6	9.24	-	.65	1.84E-01
positive regulation of phosphorylation (GO:0042327)	124	14	21.62	-	.65	5.39E-02
small GTPase mediated signal transduction (GO:0007264)	80	9	13.95	-	.65	1.10E-01
germarium-derived oocyte fate determination (GO:0007294)	27	3	4.71	-	.64	3.08E-01
Ras protein signal transduction (GO:0007265)	63	7	10.99	-	.64	1.43E-01
regulation of endopeptidase activity (GO:0052548)	54	6	9.42	-	.64	1.70E-01
regulation of embryonic cell shape (GO:0016476)	27	3	4.71	-	.64	3.08E-01
regulation of DNA-templated transcription, elongation (GO:0032784)	27	3	4.71	-	.64	3.08E-01
RNA interference (GO:0016246)	27	3	4.71	-	.64	3.08E-01
Rab protein signal transduction (GO:0032482)	27	3	4.71	-	.64	3.08E-01
molting cycle process (GO:0022404)	27	3	4.71	-	.64	3.08E-01
positive regulation of antimicrobial peptide biosynthetic process (GO:0002807)	27	3	4.71	-	.64	3.08E-01
lymph gland development (GO:0048542)	54	6	9.42	-	.64	1.70E-01
positive regulation of cell motility (GO:2000147)	54	6	9.42	-	.64	1.70E-01
sex determination (GO:0007530)	27	3	4.71	-	.64	3.08E-01
photoreceptor cell axon guidance (GO:0072499)	27	3	4.71	-	.64	3.08E-01
AMP metabolic process (GO:0046033)	9	1	1.57	-	.64	5.35E-01
regulation of feeding behavior (GO:0060259)	18	2	3.14	-	.64	3.92E-01
Rho protein signal transduction (GO:0007266)	18	2	3.14	-	.64	3.92E-01
delamination (GO:0060232)	9	1	1.57	-	.64	5.35E-01
response to water (GO:0009415)	9	1	1.57	-	.64	5.35E-01
response to cold (GO:0009409)	9	1	1.57	-	.64	5.35E-01
ommochrome biosynthetic process (GO:0006727)	18	2	3.14	-	.64	3.92E-01
epithelial tube formation (GO:0072175)	9	1	1.57	-	.64	5.35E-01
response to amino acid (GO:0043200)	9	1	1.57	-	.64	5.35E-01
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	18	2	3.14	-	.64	3.92E-01
non-motile cilium assembly (GO:1905515)	18	2	3.14	-	.64	3.92E-01
mating behavior, sex discrimination (GO:0048047)	9	1	1.57	-	.64	5.35E-01
negative regulation of mRNA metabolic process (GO:1903312)	9	1	1.57	-	.64	5.35E-01
very long-chain fatty acid metabolic process (GO:0000038)	9	1	1.57	-	.64	5.35E-01
cell activation (GO:0001775)	9	1	1.57	-	.64	5.35E-01
tyrosine metabolic process (GO:0006570)	9	1	1.57	-	.64	5.35E-01
positive regulation of protein kinase B signaling (GO:0051897)	9	1	1.57	-	.64	5.35E-01
regulation of translational initiation (GO:0006446)	9	1	1.57	-	.64	5.35E-01
translational elongation (GO:0006414)	9	1	1.57	-	.64	5.35E-01
translational initiation (GO:0006413)	9	1	1.57	-	.64	5.35E-01
negative regulation of dephosphorylation (GO:0035305)	9	1	1.57	-	.64	5.35E-01
cellular response to ethanol (GO:0071361)	9	1	1.57	-	.64	5.35E-01
regulation of cell-substrate adhesion (GO:0010810)	9	1	1.57	-	.64	5.35E-01
postreplication repair (GO:0006301)	9	1	1.57	-	.64	5.35E-01
sensory organ precursor cell division (GO:0045035)	9	1	1.57	-	.64	5.35E-01
ocellus pigmentation (GO:0033060)	18	2	3.14	-	.64	3.92E-01
DNA replication-independent nucleosome organization (GO:0034724)	9	1	1.57	-	.64	5.35E-01
peptidyl-tyrosine modification (GO:0018212)	18	2	3.14	-	.64	3.92E-01
epithelial cell type specification, open tracheal system (GO:0035153)	9	1	1.57	-	.64	5.35E-01
positive regulation of mitotic sister chromatid separation (GO:1901970)	9	1	1.57	-	.64	5.35E-01
maintenance of synapse structure (GO:0099558)	9	1	1.57	-	.64	5.35E-01
response to cadmium ion (GO:0046686)	9	1	1.57	-	.64	5.35E-01
regulation of compound eye retinal cell programmed cell death (GO:0046669)	18	2	3.14	-	.64	3.92E-01
regulation of retinal cell programmed cell death (GO:0046668)	18	2	3.14	-	.64	3.92E-01
histone mRNA metabolic process (GO:0008334)	9	1	1.57	-	.64	5.35E-01
polytene chromosome puffing (GO:0035079)	9	1	1.57	-	.64	5.35E-01
maintenance of presynaptic active zone structure (GO:0048790)	9	1	1.57	-	.64	5.35E-01
centromere complex assembly (GO:0034508)	9	1	1.57	-	.64	5.35E-01
glycosaminoglycan catabolic process (GO:0006027)	9	1	1.57	-	.64	5.35E-01
detection of mechanical stimulus involved in sensory perception (GO:0050974)	9	1	1.57	-	.64	5.35E-01
neuron fate determination (GO:0048664)	9	1	1.57	-	.64	5.35E-01
apical constriction involved in gastrulation (GO:0003384)	9	1	1.57	-	.64	5.35E-01
epithelial cell morphogenesis involved in gastrulation (GO:0003381)	9	1	1.57	-	.64	5.35E-01
neuronal stem cell population maintenance (GO:0097150)	9	1	1.57	-	.64	5.35E-01
detection of stimulus involved in sensory perception (GO:0050906)	90	10	15.69	-	.64	8.68E-02
negative regulation of feeding behavior (GO:2000252)	9	1	1.57	-	.64	5.35E-01
response to acid chemical (GO:0001101)	18	2	3.14	-	.64	3.92E-01
regulation of protein localization to cell periphery (GO:1904375)	9	1	1.57	-	.64	5.35E-01
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	9	1	1.57	-	.64	5.35E-01
glycosyl compound catabolic process (GO:1901658)	9	1	1.57	-	.64	5.35E-01
ERAD pathway (GO:0036503)	18	2	3.14	-	.64	3.92E-01
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898)	9	1	1.57	-	.64	5.35E-01
ocellus pigment biosynthetic process (GO:0008055)	18	2	3.14	-	.64	3.92E-01
striated muscle tissue development (GO:0014706)	9	1	1.57	-	.64	5.35E-01
positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	9	1	1.57	-	.64	5.35E-01
motor neuron axon guidance (GO:0008045)	72	8	12.56	-	.64	1.20E-01
clathrin-dependent endocytosis (GO:0072583)	18	2	3.14	-	.64	3.92E-01
primary sex determination, soma (GO:0007539)	9	1	1.57	-	.64	5.35E-01
negative regulation of neuron apoptotic process (GO:0043524)	18	2	3.14	-	.64	3.92E-01
positive regulation of chromosome separation (GO:1905820)	9	1	1.57	-	.64	5.35E-01
foregut morphogenesis (GO:0007440)	9	1	1.57	-	.64	5.35E-01
ocellus pigment metabolic process (GO:0046158)	18	2	3.14	-	.64	3.92E-01
ommochrome metabolic process (GO:0046152)	18	2	3.14	-	.64	3.92E-01
chromosome organization (GO:0051276)	443	49	77.25	-	.63	2.50E-04
cell population proliferation (GO:0008283)	109	12	19.01	-	.63	5.87E-02
border follicle cell migration (GO:0007298)	91	10	15.87	-	.63	8.04E-02
ribonucleoprotein complex subunit organization (GO:0071826)	82	9	14.30	-	.63	9.44E-02
photoreceptor cell fate commitment (GO:0046552)	73	8	12.73	-	.63	1.11E-01
positive regulation of chromatin organization (GO:1905269)	46	5	8.02	-	.62	1.88E-01
intracellular mRNA localization involved in pattern specification process (GO:0060810)	46	5	8.02	-	.62	1.88E-01
meiotic spindle organization (GO:0000212)	37	4	6.45	-	.62	2.28E-01
regulation of lipid metabolic process (GO:0019216)	37	4	6.45	-	.62	2.28E-01
protein glycosylation (GO:0006486)	37	4	6.45	-	.62	2.28E-01
macromolecule glycosylation (GO:0043413)	37	4	6.45	-	.62	2.28E-01
nuclear division (GO:0000280)	223	24	38.89	-	.62	6.36E-03
organelle fission (GO:0048285)	233	25	40.63	-	.62	5.11E-03
regulation of protein modification by small protein conjugation or removal (GO:1903320)	28	3	4.88	-	.61	2.81E-01
maintenance of protein location (GO:0045185)	28	3	4.88	-	.61	2.81E-01
muscle cell cellular homeostasis (GO:0046716)	28	3	4.88	-	.61	2.81E-01
regulation of protein secretion (GO:0050708)	28	3	4.88	-	.61	2.81E-01
positive regulation of protein modification process (GO:0031401)	140	15	24.41	-	.61	2.74E-02
adult locomotory behavior (GO:0008344)	75	8	13.08	-	.61	9.48E-02
R7 cell differentiation (GO:0045466)	47	5	8.20	-	.61	1.73E-01
anterior/posterior axis specification, embryo (GO:0008595)	94	10	16.39	-	.61	6.35E-02
chromosome condensation (GO:0030261)	47	5	8.20	-	.61	1.73E-01
tripartite regional subdivision (GO:0007351)	94	10	16.39	-	.61	6.35E-02
eye photoreceptor cell fate commitment (GO:0042706)	66	7	11.51	-	.61	1.12E-01
renal system development (GO:0072001)	66	7	11.51	-	.61	1.12E-01
compound eye photoreceptor fate commitment (GO:0001752)	66	7	11.51	-	.61	1.12E-01
urogenital system development (GO:0001655)	66	7	11.51	-	.61	1.12E-01
eggshell chorion gene amplification (GO:0007307)	19	2	3.31	-	.60	3.56E-01
positive regulation of imaginal disc growth (GO:0045572)	19	2	3.31	-	.60	3.56E-01
glycosylation (GO:0070085)	38	4	6.63	-	.60	2.09E-01
pole cell formation (GO:0007279)	19	2	3.31	-	.60	3.56E-01
chromatin silencing (GO:0006342)	57	6	9.94	-	.60	1.33E-01
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	19	2	3.31	-	.60	3.56E-01
post-transcriptional gene silencing by RNA (GO:0035194)	38	4	6.63	-	.60	2.09E-01
regulation of DNA-dependent DNA replication (GO:0090329)	19	2	3.31	-	.60	3.56E-01
negative regulation of gene silencing (GO:0060969)	19	2	3.31	-	.60	3.56E-01
regulation of gene silencing by RNA (GO:0060966)	19	2	3.31	-	.60	3.56E-01
oocyte microtubule cytoskeleton polarization (GO:0008103)	19	2	3.31	-	.60	3.56E-01
metaphase plate congression (GO:0051310)	19	2	3.31	-	.60	3.56E-01
establishment of protein localization to vacuole (GO:0072666)	19	2	3.31	-	.60	3.56E-01
protein localization to vacuole (GO:0072665)	19	2	3.31	-	.60	3.56E-01
embryonic organ development (GO:0048568)	57	6	9.94	-	.60	1.33E-01
defense response to Gram-positive bacterium (GO:0050830)	38	4	6.63	-	.60	2.09E-01
negative regulation of gene expression, epigenetic (GO:0045814)	57	6	9.94	-	.60	1.33E-01
presynapse organization (GO:0099172)	19	2	3.31	-	.60	3.56E-01
positive regulation of axonogenesis (GO:0050772)	19	2	3.31	-	.60	3.56E-01
leg disc morphogenesis (GO:0007478)	76	8	13.25	-	.60	8.73E-02
germ-band shortening (GO:0007390)	19	2	3.31	-	.60	3.56E-01
cell fate commitment (GO:0045165)	276	29	48.13	-	.60	1.69E-03
chromatin organization involved in regulation of transcription (GO:0034401)	67	7	11.68	-	.60	1.03E-01
anterior/posterior pattern specification (GO:0009952)	154	16	26.85	-	.60	1.60E-02
pole cell development (GO:0007277)	29	3	5.06	-	.59	2.56E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	29	3	5.06	-	.59	2.56E-01
regulation of peptidase activity (GO:0052547)	58	6	10.11	-	.59	1.22E-01
meiosis I (GO:0007127)	58	6	10.11	-	.59	1.22E-01
cell cycle DNA replication (GO:0044786)	29	3	5.06	-	.59	2.56E-01
neuron fate commitment (GO:0048663)	87	9	15.17	-	.59	6.31E-02
leg disc development (GO:0035218)	97	10	16.91	-	.59	4.98E-02
embryonic axis specification (GO:0000578)	97	10	16.91	-	.59	4.98E-02
long-term memory (GO:0007616)	68	7	11.86	-	.59	9.46E-02
positive regulation of cellular component movement (GO:0051272)	68	7	11.86	-	.59	9.46E-02
histone methylation (GO:0016571)	39	4	6.80	-	.59	1.91E-01
synaptic target recognition (GO:0008039)	39	4	6.80	-	.59	1.91E-01
positive regulation of cell size (GO:0045793)	39	4	6.80	-	.59	1.91E-01
mitotic nuclear division (GO:0140014)	88	9	15.35	-	.59	5.81E-02
cortical cytoskeleton organization (GO:0030865)	59	6	10.29	-	.58	1.12E-01
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	69	7	12.03	-	.58	8.68E-02
DNA conformation change (GO:0071103)	99	10	17.26	-	.58	4.21E-02
cell fate determination (GO:0001709)	119	12	20.75	-	.58	2.65E-02
cortical actin cytoskeleton organization (GO:0030866)	50	5	8.72	-	.57	1.33E-01
developmental cell growth (GO:0048588)	50	5	8.72	-	.57	1.33E-01
response to insecticide (GO:0017085)	20	2	3.49	-	.57	3.23E-01
response to pheromone (GO:0019236)	20	2	3.49	-	.57	3.23E-01
synaptic transmission, cholinergic (GO:0007271)	10	1	1.74	-	.57	4.80E-01
negative regulation of neuron death (GO:1901215)	30	3	5.23	-	.57	2.33E-01
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	10	1	1.74	-	.57	4.80E-01
sex comb development (GO:0045498)	10	1	1.74	-	.57	4.80E-01
male meiosis I (GO:0007141)	10	1	1.74	-	.57	4.80E-01
mitotic DNA replication checkpoint (GO:0033314)	10	1	1.74	-	.57	4.80E-01
regulation of crystal cell differentiation (GO:0042689)	10	1	1.74	-	.57	4.80E-01
nucleotide-sugar metabolic process (GO:0009225)	10	1	1.74	-	.57	4.80E-01
negative regulation of microtubule depolymerization (GO:0007026)	10	1	1.74	-	.57	4.80E-01
purine ribonucleoside monophosphate metabolic process (GO:0009167)	10	1	1.74	-	.57	4.80E-01
ribonucleoside monophosphate biosynthetic process (GO:0009156)	10	1	1.74	-	.57	4.80E-01
purine nucleoside monophosphate metabolic process (GO:0009126)	10	1	1.74	-	.57	4.80E-01
pseudocleavage involved in syncytial blastoderm formation (GO:0030589)	10	1	1.74	-	.57	4.80E-01
pseudocleavage (GO:0030588)	10	1	1.74	-	.57	4.80E-01
positive regulation of receptor signaling pathway via STAT (GO:1904894)	10	1	1.74	-	.57	4.80E-01
regulation of axon guidance (GO:1902667)	20	2	3.49	-	.57	3.23E-01
negative regulation of endopeptidase activity (GO:0010951)	30	3	5.23	-	.57	2.33E-01
positive regulation of defense response to bacterium (GO:1900426)	30	3	5.23	-	.57	2.33E-01
negative regulation of lipid storage (GO:0010888)	10	1	1.74	-	.57	4.80E-01
double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	10	1	1.74	-	.57	4.80E-01
tracheal pit formation in open tracheal system (GO:0035202)	10	1	1.74	-	.57	4.80E-01
regulation of response to DNA damage stimulus (GO:2001020)	20	2	3.49	-	.57	3.23E-01
digestive system process (GO:0022600)	10	1	1.74	-	.57	4.80E-01
response to odorant (GO:1990834)	10	1	1.74	-	.57	4.80E-01
negative regulation of chromatin silencing (GO:0031936)	10	1	1.74	-	.57	4.80E-01
negative regulation of intracellular transport (GO:0032387)	10	1	1.74	-	.57	4.80E-01
regulation of cellular ketone metabolic process (GO:0010565)	10	1	1.74	-	.57	4.80E-01
antibacterial humoral response (GO:0019731)	20	2	3.49	-	.57	3.23E-01
intraciliary transport (GO:0042073)	10	1	1.74	-	.57	4.80E-01
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	10	1	1.74	-	.57	4.80E-01
negative regulation of peptidase activity (GO:0010466)	30	3	5.23	-	.57	2.33E-01
regulation of cell fate commitment (GO:0010453)	30	3	5.23	-	.57	2.33E-01
negative regulation of female receptivity (GO:0007621)	10	1	1.74	-	.57	4.80E-01
positive regulation of mRNA catabolic process (GO:0061014)	10	1	1.74	-	.57	4.80E-01
detoxification of zinc ion (GO:0010312)	10	1	1.74	-	.57	4.80E-01
negative regulation of lipid localization (GO:1905953)	10	1	1.74	-	.57	4.80E-01
regulation of stem cell division (GO:2000035)	10	1	1.74	-	.57	4.80E-01
response to ionizing radiation (GO:0010212)	30	3	5.23	-	.57	2.33E-01
cellular response to amino acid starvation (GO:0034198)	10	1	1.74	-	.57	4.80E-01
nucleobase biosynthetic process (GO:0046112)	10	1	1.74	-	.57	4.80E-01
nuclear pore organization (GO:0006999)	10	1	1.74	-	.57	4.80E-01
regulation of muscle contraction (GO:0006937)	10	1	1.74	-	.57	4.80E-01
stress response to zinc ion (GO:1990359)	10	1	1.74	-	.57	4.80E-01
gene silencing (GO:0016458)	112	11	19.53	-	.56	2.59E-02
sodium ion transmembrane transport (GO:0035725)	51	5	8.89	-	.56	1.21E-01
meiotic nuclear division (GO:0140013)	153	15	26.68	-	.56	9.57E-03
formation of anatomical boundary (GO:0048859)	41	4	7.15	-	.56	1.59E-01
animal organ formation (GO:0048645)	41	4	7.15	-	.56	1.59E-01
sensory perception of chemical stimulus (GO:0007606)	195	19	34.00	-	.56	3.32E-03
imaginal disc-derived leg morphogenesis (GO:0007480)	72	7	12.56	-	.56	6.67E-02
anterior/posterior axis specification (GO:0009948)	103	10	17.96	-	.56	2.99E-02
reciprocal homologous recombination (GO:0140527)	31	3	5.41	-	.55	2.12E-01
reciprocal meiotic recombination (GO:0007131)	31	3	5.41	-	.55	2.12E-01
chromosome segregation (GO:0007059)	146	14	25.46	-	.55	9.26E-03
chromatin organization involved in negative regulation of transcription (GO:0097549)	63	6	10.99	-	.55	7.81E-02
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	21	2	3.66	-	.55	2.91E-01
positive regulation of apoptotic process (GO:0043065)	42	4	7.32	-	.55	1.44E-01
DNA amplification (GO:0006277)	21	2	3.66	-	.55	2.91E-01
snRNA 3'-end processing (GO:0034472)	21	2	3.66	-	.55	2.91E-01
dosage compensation (GO:0007549)	21	2	3.66	-	.55	2.91E-01
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)	21	2	3.66	-	.55	2.91E-01
cell-substrate adhesion (GO:0031589)	21	2	3.66	-	.55	2.91E-01
male meiotic nuclear division (GO:0007140)	74	7	12.90	-	.54	5.57E-02
DNA replication (GO:0006260)	74	7	12.90	-	.54	5.57E-02
ovarian nurse cell to oocyte transport (GO:0007300)	32	3	5.58	-	.54	1.92E-01
pole plasm mRNA localization (GO:0019094)	32	3	5.58	-	.54	1.92E-01
histone lysine methylation (GO:0034968)	32	3	5.58	-	.54	1.92E-01
positive regulation of protein transport (GO:0051222)	32	3	5.58	-	.54	1.92E-01
midgut development (GO:0007494)	32	3	5.58	-	.54	1.92E-01
formation of animal organ boundary (GO:0010160)	32	3	5.58	-	.54	1.92E-01
homologous recombination (GO:0035825)	32	3	5.58	-	.54	1.92E-01
regulation of neuron differentiation (GO:0045664)	75	7	13.08	-	.54	5.08E-02
posttranscriptional gene silencing (GO:0016441)	43	4	7.50	-	.53	1.31E-01
intracellular mRNA localization involved in anterior/posterior axis specification (GO:0060811)	43	4	7.50	-	.53	1.31E-01
positive regulation of autophagy (GO:0010508)	43	4	7.50	-	.53	1.31E-01
spindle organization (GO:0007051)	97	9	16.91	-	.53	2.64E-02
endosomal vesicle fusion (GO:0034058)	11	1	1.92	-	.52	4.28E-01
response to zinc ion (GO:0010043)	11	1	1.92	-	.52	4.28E-01
bicoid mRNA localization (GO:0045450)	11	1	1.92	-	.52	4.28E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	110	10	19.18	-	.52	1.59E-02
peptide hormone processing (GO:0016486)	11	1	1.92	-	.52	4.28E-01
regulation of compound eye photoreceptor development (GO:0045314)	11	1	1.92	-	.52	4.28E-01
signaling receptor ligand precursor processing (GO:0140448)	11	1	1.92	-	.52	4.28E-01
receptor clustering (GO:0043113)	11	1	1.92	-	.52	4.28E-01
microtubule polymerization or depolymerization (GO:0031109)	22	2	3.84	-	.52	2.63E-01
vesicle transport along microtubule (GO:0047496)	11	1	1.92	-	.52	4.28E-01
peptidyl-tyrosine autophosphorylation (GO:0038083)	11	1	1.92	-	.52	4.28E-01
cellular response to gamma radiation (GO:0071480)	11	1	1.92	-	.52	4.28E-01
positive regulation of lipid storage (GO:0010884)	11	1	1.92	-	.52	4.28E-01
positive regulation of nuclear division (GO:0051785)	11	1	1.92	-	.52	4.28E-01
mismatch repair (GO:0006298)	11	1	1.92	-	.52	4.28E-01
regulation of DNA repair (GO:0006282)	11	1	1.92	-	.52	4.28E-01
DNA unwinding involved in DNA replication (GO:0006268)	11	1	1.92	-	.52	4.28E-01
positive regulation of intracellular protein transport (GO:0090316)	11	1	1.92	-	.52	4.28E-01
cellular carbohydrate biosynthetic process (GO:0034637)	11	1	1.92	-	.52	4.28E-01
regulation of development, heterochronic (GO:0040034)	11	1	1.92	-	.52	4.28E-01
female sex determination (GO:0030237)	11	1	1.92	-	.52	4.28E-01
axon ensheathment (GO:0008366)	11	1	1.92	-	.52	4.28E-01
establishment or maintenance of monopolar cell polarity (GO:0061339)	11	1	1.92	-	.52	4.28E-01
regulation of peptide hormone secretion (GO:0090276)	11	1	1.92	-	.52	4.28E-01
regulation of muscle system process (GO:0090257)	11	1	1.92	-	.52	4.28E-01
negative regulation of autophagy (GO:0010507)	22	2	3.84	-	.52	2.63E-01
regulation of actin filament bundle assembly (GO:0032231)	11	1	1.92	-	.52	4.28E-01
establishment of monopolar cell polarity (GO:0061162)	11	1	1.92	-	.52	4.28E-01
negative regulation of cell-cell adhesion (GO:0022408)	11	1	1.92	-	.52	4.28E-01
establishment of chromosome localization (GO:0051303)	22	2	3.84	-	.52	2.63E-01
anesthesia-resistant memory (GO:0007615)	11	1	1.92	-	.52	4.28E-01
poly(A)+ mRNA export from nucleus (GO:0016973)	11	1	1.92	-	.52	4.28E-01
Arp2/3 complex-mediated actin nucleation (GO:0034314)	11	1	1.92	-	.52	4.28E-01
anterograde axonal transport (GO:0008089)	11	1	1.92	-	.52	4.28E-01
positive regulation of mitotic nuclear division (GO:0045840)	11	1	1.92	-	.52	4.28E-01
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	22	2	3.84	-	.52	2.63E-01
synaptic vesicle recycling via endosome (GO:0036466)	11	1	1.92	-	.52	4.28E-01
response to salt stress (GO:0009651)	11	1	1.92	-	.52	4.28E-01
specification of segmental identity, head (GO:0007380)	11	1	1.92	-	.52	4.28E-01
enzyme linked receptor protein signaling pathway (GO:0007167)	132	12	23.02	-	.52	8.47E-03
positive regulation of establishment of protein localization (GO:1904951)	33	3	5.75	-	.52	1.74E-01
regulation of peptide secretion (GO:0002791)	33	3	5.75	-	.52	1.74E-01
DNA integrity checkpoint (GO:0031570)	33	3	5.75	-	.52	1.74E-01
positive regulation of MAPK cascade (GO:0043410)	66	6	11.51	-	.52	5.90E-02
mitotic sister chromatid segregation (GO:0000070)	78	7	13.60	-	.51	3.84E-02
DNA-dependent DNA replication (GO:0006261)	67	6	11.68	-	.51	5.36E-02
neuropeptide signaling pathway (GO:0007218)	56	5	9.77	-	.51	7.55E-02
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	45	4	7.85	-	.51	1.08E-01
cyclic-nucleotide-mediated signaling (GO:0019935)	45	4	7.85	-	.51	1.08E-01
regulation of dendrite development (GO:0050773)	45	4	7.85	-	.51	1.08E-01
regulation of hemocyte proliferation (GO:0035206)	34	3	5.93	-	.51	1.57E-01
actin filament-based movement (GO:0030048)	34	3	5.93	-	.51	1.57E-01
positive regulation of cell cycle process (GO:0090068)	34	3	5.93	-	.51	1.57E-01
ventral cord development (GO:0007419)	68	6	11.86	-	.51	4.87E-02
pole plasm RNA localization (GO:0007316)	34	3	5.93	-	.51	1.57E-01
gene silencing by RNA (GO:0031047)	46	4	8.02	-	.50	9.75E-02
positive regulation of endopeptidase activity (GO:0010950)	23	2	4.01	-	.50	2.36E-01
axon midline choice point recognition (GO:0016199)	23	2	4.01	-	.50	2.36E-01
snRNA processing (GO:0016180)	23	2	4.01	-	.50	2.36E-01
regulation of chromatin silencing (GO:0031935)	35	3	6.10	-	.49	1.41E-01
regulation of cell division (GO:0051302)	35	3	6.10	-	.49	1.41E-01
meiotic cell cycle process (GO:1903046)	191	16	33.31	-	.48	5.92E-04
zinc ion transport (GO:0006829)	12	1	2.09	-	.48	3.81E-01
ensheathment of neurons (GO:0007272)	12	1	2.09	-	.48	3.81E-01
cyclic purine nucleotide metabolic process (GO:0052652)	12	1	2.09	-	.48	3.81E-01
retinal ganglion cell axon guidance (GO:0031290)	12	1	2.09	-	.48	3.81E-01
compound eye pigmentation (GO:0048072)	12	1	2.09	-	.48	3.81E-01
zinc ion transmembrane transport (GO:0071577)	12	1	2.09	-	.48	3.81E-01
response to caffeine (GO:0031000)	12	1	2.09	-	.48	3.81E-01
nucleoside monophosphate biosynthetic process (GO:0009124)	12	1	2.09	-	.48	3.81E-01
regulation of eye photoreceptor cell development (GO:0042478)	12	1	2.09	-	.48	3.81E-01
positive regulation of small molecule metabolic process (GO:0062013)	12	1	2.09	-	.48	3.81E-01
stress response to metal ion (GO:0097501)	12	1	2.09	-	.48	3.81E-01
chromosome localization (GO:0050000)	24	2	4.19	-	.48	2.12E-01
mitotic spindle assembly (GO:0090307)	12	1	2.09	-	.48	3.81E-01
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	48	4	8.37	-	.48	7.95E-02
regulation of reactive oxygen species metabolic process (GO:2000377)	12	1	2.09	-	.48	3.81E-01
sensory perception of touch (GO:0050975)	12	1	2.09	-	.48	3.81E-01
R7 cell fate commitment (GO:0007465)	24	2	4.19	-	.48	2.12E-01
R3/R4 cell fate commitment (GO:0007464)	12	1	2.09	-	.48	3.81E-01
axonal defasciculation (GO:0007414)	12	1	2.09	-	.48	3.81E-01
cAMP-mediated signaling (GO:0019933)	36	3	6.28	-	.48	1.27E-01
regulation of gene silencing (GO:0060968)	60	5	10.46	-	.48	5.06E-02
cellular response to DNA damage stimulus (GO:0006974)	168	14	29.30	-	.48	1.20E-03
DNA recombination (GO:0006310)	73	6	12.73	-	.47	2.96E-02
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	49	4	8.54	-	.47	7.16E-02
meiotic cell cycle (GO:0051321)	199	16	34.70	-	.46	2.67E-04
mitotic spindle organization (GO:0007052)	50	4	8.72	-	.46	6.44E-02
regulation of cell fate specification (GO:0042659)	25	2	4.36	-	.46	1.89E-01
positive regulation of peptidase activity (GO:0010952)	25	2	4.36	-	.46	1.89E-01
regulation of chemotaxis (GO:0050920)	25	2	4.36	-	.46	1.89E-01
anterior/posterior pattern specification, imaginal disc (GO:0007448)	25	2	4.36	-	.46	1.89E-01
regulation of compound eye photoreceptor cell differentiation (GO:0110116)	25	2	4.36	-	.46	1.89E-01
meiosis I cell cycle process (GO:0061982)	101	8	17.61	-	.45	8.43E-03
germ-line stem cell division (GO:0042078)	38	3	6.63	-	.45	1.03E-01
gliogenesis (GO:0042063)	76	6	13.25	-	.45	2.17E-02
sister chromatid segregation (GO:0000819)	89	7	15.52	-	.45	1.28E-02
recombinational repair (GO:0000725)	51	4	8.89	-	.45	5.79E-02
double-strand break repair via homologous recombination (GO:0000724)	51	4	8.89	-	.45	5.79E-02
nuclear chromosome segregation (GO:0098813)	128	10	22.32	-	.45	2.72E-03
carbohydrate derivative catabolic process (GO:1901136)	39	3	6.80	-	.44	9.20E-02
positive regulation of protein ubiquitination (GO:0031398)	13	1	2.27	-	.44	3.38E-01
regulation of sevenless signaling pathway (GO:0045501)	13	1	2.27	-	.44	3.38E-01
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	13	1	2.27	-	.44	3.38E-01
male germ-line stem cell population maintenance (GO:0036098)	13	1	2.27	-	.44	3.38E-01
muscle cell fate commitment (GO:0042693)	13	1	2.27	-	.44	3.38E-01
regulation of synaptic activity (GO:0060025)	13	1	2.27	-	.44	3.38E-01
mesodermal cell fate commitment (GO:0001710)	13	1	2.27	-	.44	3.38E-01
imaginal disc-derived leg joint morphogenesis (GO:0016348)	13	1	2.27	-	.44	3.38E-01
positive regulation of histone methylation (GO:0031062)	13	1	2.27	-	.44	3.38E-01
regulation of apoptotic signaling pathway (GO:2001233)	13	1	2.27	-	.44	3.38E-01
ribonucleoside monophosphate metabolic process (GO:0009161)	13	1	2.27	-	.44	3.38E-01
regulation of receptor signaling pathway via STAT (GO:1904892)	26	2	4.53	-	.44	1.69E-01
protein O-linked glycosylation (GO:0006493)	13	1	2.27	-	.44	3.38E-01
positive regulation of axon guidance (GO:1902669)	13	1	2.27	-	.44	3.38E-01
regulation of macroautophagy (GO:0016241)	26	2	4.53	-	.44	1.69E-01
homologous chromosome segregation (GO:0045143)	13	1	2.27	-	.44	3.38E-01
dosage compensation by hyperactivation of X chromosome (GO:0009047)	13	1	2.27	-	.44	3.38E-01
cellular pigmentation (GO:0033059)	13	1	2.27	-	.44	3.38E-01
DNA-dependent DNA replication maintenance of fidelity (GO:0045005)	13	1	2.27	-	.44	3.38E-01
positive regulation of chromatin silencing (GO:0031937)	13	1	2.27	-	.44	3.38E-01
presynaptic active zone organization (GO:1990709)	13	1	2.27	-	.44	3.38E-01
double-strand break repair via break-induced replication (GO:0000727)	13	1	2.27	-	.44	3.38E-01
detection of mechanical stimulus (GO:0050982)	13	1	2.27	-	.44	3.38E-01
regulation of muscle organ development (GO:0048634)	13	1	2.27	-	.44	3.38E-01
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	26	2	4.53	-	.44	1.69E-01
detoxification (GO:0098754)	26	2	4.53	-	.44	1.69E-01
protein depolymerization (GO:0051261)	13	1	2.27	-	.44	3.38E-01
response to gamma radiation (GO:0010332)	13	1	2.27	-	.44	3.38E-01
terminal button organization (GO:0072553)	13	1	2.27	-	.44	3.38E-01
mesodermal cell differentiation (GO:0048333)	13	1	2.27	-	.44	3.38E-01
response to osmotic stress (GO:0006970)	13	1	2.27	-	.44	3.38E-01
regulation of mRNA 3'-end processing (GO:0031440)	13	1	2.27	-	.44	3.38E-01
intracellular mRNA localization (GO:0008298)	66	5	11.51	-	.43	2.70E-02
DNA metabolic process (GO:0006259)	212	16	36.97	-	.43	6.97E-05
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	27	2	4.71	-	.42	1.51E-01
DNA damage checkpoint (GO:0000077)	27	2	4.71	-	.42	1.51E-01
telomere maintenance (GO:0000723)	27	2	4.71	-	.42	1.51E-01
telomere organization (GO:0032200)	27	2	4.71	-	.42	1.51E-01
cellular response to growth factor stimulus (GO:0071363)	41	3	7.15	-	.42	7.36E-02
DNA repair (GO:0006281)	139	10	24.24	-	.41	8.45E-04
regulation of oskar mRNA translation (GO:0046011)	14	1	2.44	-	.41	2.99E-01
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	14	1	2.44	-	.41	2.99E-01
histone deacetylation (GO:0016575)	14	1	2.44	-	.41	2.99E-01
negative regulation of cell adhesion (GO:0007162)	14	1	2.44	-	.41	2.99E-01
microtubule organizing center localization (GO:0061842)	14	1	2.44	-	.41	2.99E-01
larval feeding behavior (GO:0030536)	14	1	2.44	-	.41	2.99E-01
protein deacetylation (GO:0006476)	14	1	2.44	-	.41	2.99E-01
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	14	1	2.44	-	.41	2.99E-01
response to growth factor (GO:0070848)	42	3	7.32	-	.41	6.57E-02
centrosome localization (GO:0051642)	14	1	2.44	-	.41	2.99E-01
piRNA metabolic process (GO:0034587)	14	1	2.44	-	.41	2.99E-01
axon extension (GO:0048675)	28	2	4.88	-	.41	1.34E-01
regulation of mitotic cell cycle, embryonic (GO:0009794)	14	1	2.44	-	.41	2.99E-01
purine-containing compound catabolic process (GO:0072523)	14	1	2.44	-	.41	2.99E-01
adult somatic muscle development (GO:0007527)	14	1	2.44	-	.41	2.99E-01
phenol-containing compound metabolic process (GO:0018958)	56	4	9.77	-	.41	3.34E-02
ectoderm development (GO:0007398)	14	1	2.44	-	.41	2.99E-01
somatic muscle development (GO:0007525)	71	5	12.38	-	.40	1.55E-02
regulation of photoreceptor cell differentiation (GO:0046532)	43	3	7.50	-	.40	5.86E-02
neuron projection extension (GO:1990138)	29	2	5.06	-	.40	1.19E-01
melanotic encapsulation of foreign target (GO:0035011)	29	2	5.06	-	.40	1.19E-01
positive regulation of mitotic cell cycle (GO:0045931)	29	2	5.06	-	.40	1.19E-01
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	44	3	7.67	-	.39	5.22E-02
double-strand break repair (GO:0006302)	74	5	12.90	-	.39	1.11E-02
secondary metabolic process (GO:0019748)	74	5	12.90	-	.39	1.11E-02
cytoplasmic transport, nurse cell to oocyte (GO:0007303)	15	1	2.62	-	.38	2.64E-01
cellular response to BMP stimulus (GO:0071773)	15	1	2.62	-	.38	2.64E-01
karyosome formation (GO:0061988)	30	2	5.23	-	.38	1.06E-01
cell-matrix adhesion (GO:0007160)	15	1	2.62	-	.38	2.64E-01
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	15	1	2.62	-	.38	2.64E-01
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968)	15	1	2.62	-	.38	2.64E-01
oocyte karyosome formation (GO:0030717)	30	2	5.23	-	.38	1.06E-01
mitotic metaphase plate congression (GO:0007080)	15	1	2.62	-	.38	2.64E-01
endosome organization (GO:0007032)	15	1	2.62	-	.38	2.64E-01
mitotic G2/M transition checkpoint (GO:0044818)	15	1	2.62	-	.38	2.64E-01
nucleoside monophosphate metabolic process (GO:0009123)	15	1	2.62	-	.38	2.64E-01
BMP signaling pathway (GO:0030509)	15	1	2.62	-	.38	2.64E-01
regulation of hormone secretion (GO:0046883)	15	1	2.62	-	.38	2.64E-01
adult walking behavior (GO:0007628)	15	1	2.62	-	.38	2.64E-01
protein complex oligomerization (GO:0051259)	15	1	2.62	-	.38	2.64E-01
positive regulation of lipid localization (GO:1905954)	15	1	2.62	-	.38	2.64E-01
sevenless signaling pathway (GO:0045500)	16	1	2.79	-	.36	2.32E-01
response to BMP (GO:0071772)	16	1	2.79	-	.36	2.32E-01
protein deacylation (GO:0035601)	16	1	2.79	-	.36	2.32E-01
walking behavior (GO:0090659)	16	1	2.79	-	.36	2.32E-01
negative regulation of receptor signaling pathway via STAT (GO:1904893)	16	1	2.79	-	.36	2.32E-01
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	16	1	2.79	-	.36	2.32E-01
DNA catabolic process (GO:0006308)	16	1	2.79	-	.36	2.32E-01
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)	16	1	2.79	-	.36	2.32E-01
leg disc proximal/distal pattern formation (GO:0007479)	16	1	2.79	-	.36	2.32E-01
heart process (GO:0003015)	16	1	2.79	-	.36	2.32E-01
circulatory system process (GO:0003013)	16	1	2.79	-	.36	2.32E-01
negative regulation of hemocyte differentiation (GO:0045611)	16	1	2.79	-	.36	2.32E-01
glial cell migration (GO:0008347)	33	2	5.75	-	.35	7.33E-02
larval somatic muscle development (GO:0007526)	33	2	5.75	-	.35	7.33E-02
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	17	1	2.96	-	.34	2.04E-01
maintenance of protein location in cell (GO:0032507)	17	1	2.96	-	.34	2.04E-01
establishment of vesicle localization (GO:0051650)	51	3	8.89	-	.34	2.25E-02
gene silencing by miRNA (GO:0035195)	17	1	2.96	-	.34	2.04E-01
negative chemotaxis (GO:0050919)	17	1	2.96	-	.34	2.04E-01
macromolecule deacylation (GO:0098732)	17	1	2.96	-	.34	2.04E-01
positive regulation of neuron differentiation (GO:0045666)	17	1	2.96	-	.34	2.04E-01
DNA biosynthetic process (GO:0071897)	34	2	5.93	-	.34	6.47E-02
detection of chemical stimulus involved in sensory perception (GO:0050907)	70	4	12.21	-	.33	6.35E-03
vesicle localization (GO:0051648)	54	3	9.42	-	.32	1.54E-02
wing disc anterior/posterior pattern formation (GO:0048100)	18	1	3.14	-	.32	1.79E-01
DNA duplex unwinding (GO:0032508)	18	1	3.14	-	.32	1.79E-01
histone H3-K4 methylation (GO:0051568)	18	1	3.14	-	.32	1.79E-01
cell fate commitment involved in formation of primary germ layer (GO:0060795)	18	1	3.14	-	.32	1.79E-01
positive regulation of protein secretion (GO:0050714)	18	1	3.14	-	.32	1.79E-01
activation of GTPase activity (GO:0090630)	19	1	3.31	-	.30	1.57E-01
positive regulation of histone modification (GO:0031058)	19	1	3.31	-	.30	1.57E-01
DNA geometric change (GO:0032392)	19	1	3.31	-	.30	1.57E-01
germline stem cell asymmetric division (GO:0098728)	19	1	3.31	-	.30	1.57E-01
leg disc pattern formation (GO:0035223)	20	1	3.49	-	.29	1.37E-01
positive regulation of mitotic cell cycle phase transition (GO:1901992)	20	1	3.49	-	.29	1.37E-01
stem cell development (GO:0048864)	20	1	3.49	-	.29	1.37E-01
aminoglycan catabolic process (GO:0006026)	20	1	3.49	-	.29	1.37E-01
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	20	1	3.49	-	.29	1.37E-01
positive regulation of peptide secretion (GO:0002793)	20	1	3.49	-	.29	1.37E-01
melanization defense response (GO:0035006)	41	2	7.15	-	.28	2.61E-02
detection of chemical stimulus (GO:0009593)	105	5	18.31	-	.27	2.35E-04
response to fibroblast growth factor (GO:0071774)	21	1	3.66	-	.27	1.19E-01
fibroblast growth factor receptor signaling pathway (GO:0008543)	21	1	3.66	-	.27	1.19E-01
positive regulation of cell cycle phase transition (GO:1901989)	21	1	3.66	-	.27	1.19E-01
vesicle cytoskeletal trafficking (GO:0099518)	21	1	3.66	-	.27	1.19E-01
endocytic recycling (GO:0032456)	21	1	3.66	-	.27	1.19E-01
cellular response to fibroblast growth factor stimulus (GO:0044344)	21	1	3.66	-	.27	1.19E-01
neuron projection fasciculation (GO:0106030)	21	1	3.66	-	.27	1.19E-01
synaptic vesicle transport (GO:0048489)	21	1	3.66	-	.27	1.19E-01
axonal fasciculation (GO:0007413)	21	1	3.66	-	.27	1.19E-01
cell adhesion mediated by integrin (GO:0033627)	21	1	3.66	-	.27	1.19E-01
zygotic determination of anterior/posterior axis, embryo (GO:0007354)	21	1	3.66	-	.27	1.19E-01
melanin metabolic process (GO:0006582)	45	2	7.85	-	.25	1.52E-02
neuroblast fate commitment (GO:0014017)	23	1	4.01	-	.25	9.04E-02
synaptic vesicle localization (GO:0097479)	23	1	4.01	-	.25	9.04E-02
imaginal disc-derived leg segmentation (GO:0036011)	24	1	4.19	-	.24	7.85E-02
mitotic DNA integrity checkpoint (GO:0044774)	24	1	4.19	-	.24	7.85E-02
appendage segmentation (GO:0035285)	24	1	4.19	-	.24	7.85E-02
activation of protein kinase activity (GO:0032147)	24	1	4.19	-	.24	7.85E-02
regulation of R7 cell differentiation (GO:0045676)	24	1	4.19	-	.24	7.85E-02
epidermal growth factor receptor signaling pathway (GO:0007173)	25	1	4.36	-	.23	6.81E-02
ERBB signaling pathway (GO:0038127)	25	1	4.36	-	.23	6.81E-02
chromosome organization involved in meiotic cell cycle (GO:0070192)	50	2	8.72	-	.23	7.63E-03
peripheral nervous system development (GO:0007422)	51	2	8.89	-	.22	6.63E-03
hemocyte differentiation (GO:0042386)	27	1	4.71	-	.21	5.11E-02
histone H3 acetylation (GO:0043966)	27	1	4.71	-	.21	5.11E-02
positive regulation of JNK cascade (GO:0046330)	27	1	4.71	-	.21	5.11E-02
positive regulation of stress-activated MAPK cascade (GO:0032874)	29	1	5.06	-	.20	3.82E-02
meiotic chromosome segregation (GO:0045132)	58	2	10.11	-	.20	2.44E-03
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	29	1	5.06	-	.20	3.82E-02
stem cell fate commitment (GO:0048865)	31	1	5.41	-	.18	2.85E-02
stem cell differentiation (GO:0048863)	62	2	10.81	-	.18	1.36E-03
neuroblast differentiation (GO:0014016)	38	1	6.63	-	.15	9.95E-03
sensory perception of taste (GO:0050909)	59	1	10.29	-	.10	3.68E-04
UMP metabolic process (GO:0046049)	1	0	.17	-	 < 0.01	8.40E-01
regulation of flagellated sperm motility (GO:1901317)	2	0	.35	-	 < 0.01	7.06E-01
TMP metabolic process (GO:0046044)	1	0	.17	-	 < 0.01	8.40E-01
IMP metabolic process (GO:0046040)	2	0	.35	-	 < 0.01	7.06E-01
vitelline membrane formation involved in chorion-containing eggshell formation (GO:0007305)	7	0	1.22	-	 < 0.01	2.95E-01
nurse cell nucleus anchoring (GO:0007302)	1	0	.17	-	 < 0.01	8.40E-01
RNA (guanine-N7)-methylation (GO:0036265)	1	0	.17	-	 < 0.01	8.40E-01
maintenance of mitotic sister chromatid cohesion (GO:0034088)	2	0	.35	-	 < 0.01	7.06E-01
establishment of mitotic sister chromatid cohesion (GO:0034087)	1	0	.17	-	 < 0.01	8.40E-01
RNA capping (GO:0036260)	2	0	.35	-	 < 0.01	7.06E-01
maintenance of sister chromatid cohesion (GO:0034086)	2	0	.35	-	 < 0.01	7.06E-01
establishment of sister chromatid cohesion (GO:0034085)	3	0	.52	-	 < 0.01	5.93E-01
alkanesulfonate transport (GO:0042918)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of Golgi vesicle fusion to target membrane (GO:0048215)	2	0	.35	-	 < 0.01	7.06E-01
regulation of G2/MI transition of meiotic cell cycle (GO:0110030)	2	0	.35	-	 < 0.01	7.06E-01
regulation of Golgi vesicle fusion to target membrane (GO:0048214)	2	0	.35	-	 < 0.01	7.06E-01
GMP metabolic process (GO:0046037)	1	0	.17	-	 < 0.01	8.40E-01
Golgi vesicle fusion to target membrane (GO:0048210)	2	0	.35	-	 < 0.01	7.06E-01
cellular response to catecholamine stimulus (GO:0071870)	13	0	2.27	-	 < 0.01	1.03E-01
multivesicular body assembly (GO:0036258)	2	0	.35	-	 < 0.01	7.06E-01
multivesicular body organization (GO:0036257)	3	0	.52	-	 < 0.01	5.93E-01
astral microtubule nucleation (GO:0030954)	2	0	.35	-	 < 0.01	7.06E-01
astral microtubule organization (GO:0030953)	4	0	.70	-	 < 0.01	4.98E-01
establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	3	0	.52	-	 < 0.01	5.93E-01
regulation of vesicle targeting, to, from or within Golgi (GO:0048209)	1	0	.17	-	 < 0.01	8.40E-01
COPII vesicle coating (GO:0048208)	1	0	.17	-	 < 0.01	8.40E-01
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	1	0	.17	-	 < 0.01	8.40E-01
COPI coating of Golgi vesicle (GO:0048205)	1	0	.17	-	 < 0.01	8.40E-01
response to catecholamine (GO:0071869)	13	0	2.27	-	 < 0.01	1.03E-01
cellular response to monoamine stimulus (GO:0071868)	13	0	2.27	-	 < 0.01	1.03E-01
response to monoamine (GO:0071867)	13	0	2.27	-	 < 0.01	1.03E-01
Golgi transport vesicle coating (GO:0048200)	1	0	.17	-	 < 0.01	8.40E-01
regulation of basement membrane organization (GO:0110011)	4	0	.70	-	 < 0.01	4.98E-01
basolateral protein secretion (GO:0110010)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of oskar mRNA translation (GO:0046012)	2	0	.35	-	 < 0.01	7.06E-01
mitotic cell cycle arrest (GO:0071850)	1	0	.17	-	 < 0.01	8.40E-01
actin filament debranching (GO:0071846)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of ecdysteroid secretion (GO:0046000)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to nuclear inner membrane (GO:0036228)	3	0	.52	-	 < 0.01	5.93E-01
Golgi to endosome transport (GO:0006895)	2	0	.35	-	 < 0.01	7.06E-01
mating pheromone secretion (GO:0071834)	1	0	.17	-	 < 0.01	8.40E-01
contractile ring contraction (GO:0036213)	10	0	1.74	-	 < 0.01	1.75E-01
contractile ring maintenance (GO:0036212)	2	0	.35	-	 < 0.01	7.06E-01
purine ribonucleoside bisphosphate catabolic process (GO:0034037)	1	0	.17	-	 < 0.01	8.40E-01
cellular sodium ion homeostasis (GO:0006883)	5	0	.87	-	 < 0.01	4.18E-01
purine nucleoside bisphosphate catabolic process (GO:0034034)	1	0	.17	-	 < 0.01	8.40E-01
ribonucleoside bisphosphate catabolic process (GO:0034031)	1	0	.17	-	 < 0.01	8.40E-01
cellular copper ion homeostasis (GO:0006878)	6	0	1.05	-	 < 0.01	3.51E-01
pyrimidine nucleotide transport (GO:0006864)	1	0	.17	-	 < 0.01	8.40E-01
nucleotide transport (GO:0006862)	5	0	.87	-	 < 0.01	4.18E-01
replication fork arrest involved in DNA replication termination (GO:0071807)	1	0	.17	-	 < 0.01	8.40E-01
oligopeptide transport (GO:0006857)	1	0	.17	-	 < 0.01	8.40E-01
mitochondrial pyruvate transmembrane transport (GO:0006850)	1	0	.17	-	 < 0.01	8.40E-01
specification of animal organ identity (GO:0010092)	4	0	.70	-	 < 0.01	4.98E-01
pyruvate transport (GO:0006848)	3	0	.52	-	 < 0.01	5.93E-01
acyl carnitine transport (GO:0006844)	1	0	.17	-	 < 0.01	8.40E-01
mitochondrial citrate transmembrane transport (GO:0006843)	1	0	.17	-	 < 0.01	8.40E-01
tricarboxylic acid transport (GO:0006842)	3	0	.52	-	 < 0.01	5.93E-01
polarity specification of proximal/distal axis (GO:0010085)	2	0	.35	-	 < 0.01	7.06E-01
serotonin transport (GO:0006837)	1	0	.17	-	 < 0.01	8.40E-01
Rac protein signal transduction (GO:0016601)	1	0	.17	-	 < 0.01	8.40E-01
copper ion transport (GO:0006825)	7	0	1.22	-	 < 0.01	2.95E-01
histone glutamine methylation (GO:1990258)	1	0	.17	-	 < 0.01	8.40E-01
subsynaptic reticulum organization (GO:1990255)	4	0	.70	-	 < 0.01	4.98E-01
cellular response to leucine starvation (GO:1990253)	1	0	.17	-	 < 0.01	8.40E-01
response to manganese ion (GO:0010042)	1	0	.17	-	 < 0.01	8.40E-01
response to carbon dioxide (GO:0010037)	3	0	.52	-	 < 0.01	5.93E-01
protein glycosylation in Golgi (GO:0033578)	1	0	.17	-	 < 0.01	8.40E-01
regulation of lysosomal lumen pH (GO:0035751)	1	0	.17	-	 < 0.01	8.40E-01
protein glycosylation in endoplasmic reticulum (GO:0033577)	1	0	.17	-	 < 0.01	8.40E-01
meiotic chromosome condensation (GO:0010032)	7	0	1.22	-	 < 0.01	2.95E-01
immune response-activating cell surface receptor signaling pathway (GO:0002429)	1	0	.17	-	 < 0.01	8.40E-01
spliceosomal complex assembly (GO:0000245)	9	0	1.57	-	 < 0.01	2.08E-01
spliceosomal tri-snRNP complex assembly (GO:0000244)	2	0	.35	-	 < 0.01	7.06E-01
cell proliferation involved in compound eye morphogenesis (GO:0035736)	2	0	.35	-	 < 0.01	7.06E-01
intraciliary transport involved in cilium assembly (GO:0035735)	1	0	.17	-	 < 0.01	8.40E-01
unsaturated fatty acid metabolic process (GO:0033559)	3	0	.52	-	 < 0.01	5.93E-01
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	5	0	.87	-	 < 0.01	4.18E-01
intraciliary retrograde transport (GO:0035721)	5	0	.87	-	 < 0.01	4.18E-01
cardioblast differentiation (GO:0010002)	15	0	2.62	-	 < 0.01	7.29E-02
glial cell differentiation (GO:0010001)	37	0	6.45	-	 < 0.01	1.55E-03
ubiquitin-dependent endocytosis (GO:0070086)	1	0	.17	-	 < 0.01	8.40E-01
histone H2A ubiquitination (GO:0033522)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of vesicle fusion (GO:0031340)	4	0	.70	-	 < 0.01	4.98E-01
glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)	1	0	.17	-	 < 0.01	8.40E-01
N-acetylneuraminate catabolic process (GO:0019262)	1	0	.17	-	 < 0.01	8.40E-01
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	1	0	.17	-	 < 0.01	8.40E-01
proton-transporting V-type ATPase complex assembly (GO:0070070)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of sarcomere organization (GO:0060298)	2	0	.35	-	 < 0.01	7.06E-01
regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cilium movement involved in cell motility (GO:0060295)	2	0	.35	-	 < 0.01	7.06E-01
long-term synaptic depression (GO:0060292)	1	0	.17	-	 < 0.01	8.40E-01
long-term synaptic potentiation (GO:0060291)	3	0	.52	-	 < 0.01	5.93E-01
cellular glucuronidation (GO:0052695)	1	0	.17	-	 < 0.01	8.40E-01
carnitine metabolic process, CoA-linked (GO:0019254)	1	0	.17	-	 < 0.01	8.40E-01
galactose homeostasis (GO:0033501)	1	0	.17	-	 < 0.01	8.40E-01
ovarian follicle cell-cell adhesion (GO:0007299)	6	0	1.05	-	 < 0.01	3.51E-01
formation of a compartment boundary (GO:0060288)	4	0	.70	-	 < 0.01	4.98E-01
growth of a germarium-derived egg chamber (GO:0007295)	10	0	1.74	-	 < 0.01	1.75E-01
spermatid nucleus elongation (GO:0007290)	4	0	.70	-	 < 0.01	4.98E-01
mitotic actomyosin contractile ring assembly (GO:1903475)	3	0	.52	-	 < 0.01	5.93E-01
citrulline biosynthetic process (GO:0019240)	1	0	.17	-	 < 0.01	8.40E-01
nucleoside phosphate catabolic process (GO:1901292)	10	0	1.74	-	 < 0.01	1.75E-01
positive regulation of ovulation (GO:0060279)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of double-strand break repair via single-strand annealing (GO:1901291)	1	0	.17	-	 < 0.01	8.40E-01
regulation of ovulation (GO:0060278)	2	0	.35	-	 < 0.01	7.06E-01
Nebenkern assembly (GO:0007287)	2	0	.35	-	 < 0.01	7.06E-01
primary spermatocyte growth (GO:0007285)	4	0	.70	-	 < 0.01	4.98E-01
spermatogonial cell division (GO:0007284)	4	0	.70	-	 < 0.01	4.98E-01
vesicle targeting, to, from or within Golgi (GO:0048199)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055)	1	0	.17	-	 < 0.01	8.40E-01
7-methylguanosine RNA capping (GO:0009452)	2	0	.35	-	 < 0.01	7.06E-01
centripetally migrating follicle cell migration (GO:0060269)	5	0	.87	-	 < 0.01	4.18E-01
pole cell fate determination (GO:0007278)	4	0	.70	-	 < 0.01	4.98E-01
gamma-aminobutyric acid catabolic process (GO:0009450)	1	0	.17	-	 < 0.01	8.40E-01
G protein-coupled adenosine receptor signaling pathway (GO:0001973)	1	0	.17	-	 < 0.01	8.40E-01
neuronal action potential (GO:0019228)	3	0	.52	-	 < 0.01	5.93E-01
regulation of protein localization to chromatin (GO:1905634)	4	0	.70	-	 < 0.01	4.98E-01
transmission of nerve impulse (GO:0019226)	10	0	1.74	-	 < 0.01	1.75E-01
protein localization to euchromatin (GO:1905632)	1	0	.17	-	 < 0.01	8.40E-01
arachidonic acid secretion (GO:0050482)	3	0	.52	-	 < 0.01	5.93E-01
putrescine biosynthetic process (GO:0009446)	2	0	.35	-	 < 0.01	7.06E-01
putrescine metabolic process (GO:0009445)	2	0	.35	-	 < 0.01	7.06E-01
pyridoxal 5'-phosphate salvage (GO:0009443)	1	0	.17	-	 < 0.01	8.40E-01
glycolate metabolic process (GO:0009441)	2	0	.35	-	 < 0.01	7.06E-01
startle response (GO:0001964)	4	0	.70	-	 < 0.01	4.98E-01
synaptic transmission, dopaminergic (GO:0001963)	2	0	.35	-	 < 0.01	7.06E-01
tyrosine phosphorylation of STAT protein (GO:0007260)	1	0	.17	-	 < 0.01	8.40E-01
regulation of steroid metabolic process (GO:0019218)	5	0	.87	-	 < 0.01	4.18E-01
carnitine metabolic process (GO:0009437)	2	0	.35	-	 < 0.01	7.06E-01
glyoxylate catabolic process (GO:0009436)	1	0	.17	-	 < 0.01	8.40E-01
JUN phosphorylation (GO:0007258)	1	0	.17	-	 < 0.01	8.40E-01
activation of JUN kinase activity (GO:0007257)	3	0	.52	-	 < 0.01	5.93E-01
activation of JNKK activity (GO:0007256)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of neurotransmitter secretion (GO:0001956)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of cell-matrix adhesion (GO:0001954)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of cell-matrix adhesion (GO:0001953)	1	0	.17	-	 < 0.01	8.40E-01
activation of NF-kappaB-inducing kinase activity (GO:0007250)	1	0	.17	-	 < 0.01	8.40E-01
regulation of long-term neuronal synaptic plasticity (GO:0048169)	1	0	.17	-	 < 0.01	8.40E-01
antisense RNA metabolic process (GO:0042868)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cell maturation (GO:1903430)	1	0	.17	-	 < 0.01	8.40E-01
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.35	-	 < 0.01	7.06E-01
I-kappaB kinase/NF-kappaB signaling (GO:0007249)	3	0	.52	-	 < 0.01	5.93E-01
regulation of mitotic spindle organization (GO:0060236)	5	0	.87	-	 < 0.01	4.18E-01
oenocyte delamination (GO:0060233)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of presynapse assembly (GO:1905607)	1	0	.17	-	 < 0.01	8.40E-01
regulation of presynapse assembly (GO:1905606)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	1	0	.17	-	 < 0.01	8.40E-01
regulation of reactive oxygen species biosynthetic process (GO:1903426)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of synaptic vesicle recycling (GO:1903423)	4	0	.70	-	 < 0.01	4.98E-01
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	1	0	.17	-	 < 0.01	8.40E-01
response to water deprivation (GO:0009414)	5	0	.87	-	 < 0.01	4.18E-01
toxin catabolic process (GO:0009407)	6	0	1.05	-	 < 0.01	3.51E-01
toxin metabolic process (GO:0009404)	7	0	1.22	-	 < 0.01	2.95E-01
positive regulation of hh target transcription factor activity (GO:0007228)	1	0	.17	-	 < 0.01	8.40E-01
signal transduction downstream of smoothened (GO:0007227)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of receptor recycling (GO:0001920)	2	0	.35	-	 < 0.01	7.06E-01
amyloid-beta metabolic process (GO:0050435)	3	0	.52	-	 < 0.01	5.93E-01
spermatocyte division (GO:0048137)	14	0	2.44	-	 < 0.01	8.68E-02
male germ-line cyst formation (GO:0048136)	1	0	.17	-	 < 0.01	8.40E-01
female germ-line stem cell asymmetric division (GO:0048132)	15	0	2.62	-	 < 0.01	7.29E-02
defense response to protozoan (GO:0042832)	2	0	.35	-	 < 0.01	7.06E-01
L-arginine transmembrane transport (GO:1903400)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of NIK/NF-kappaB signaling (GO:1901223)	1	0	.17	-	 < 0.01	8.40E-01
regulation of NIK/NF-kappaB signaling (GO:1901222)	1	0	.17	-	 < 0.01	8.40E-01
G protein-coupled glutamate receptor signaling pathway (GO:0007216)	3	0	.52	-	 < 0.01	5.93E-01
glutamate receptor signaling pathway (GO:0007215)	6	0	1.05	-	 < 0.01	3.51E-01
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213)	2	0	.35	-	 < 0.01	7.06E-01
dopamine receptor signaling pathway (GO:0007212)	7	0	1.22	-	 < 0.01	2.95E-01
serotonin receptor signaling pathway (GO:0007210)	5	0	.87	-	 < 0.01	4.18E-01
pyridoxal phosphate biosynthetic process (GO:0042823)	2	0	.35	-	 < 0.01	7.06E-01
pyridoxal phosphate metabolic process (GO:0042822)	2	0	.35	-	 < 0.01	7.06E-01
endoplasmic reticulum tubular network organization (GO:0071786)	2	0	.35	-	 < 0.01	7.06E-01
phospholipase C-activating serotonin receptor signaling pathway (GO:0007208)	2	0	.35	-	 < 0.01	7.06E-01
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205)	4	0	.70	-	 < 0.01	4.98E-01
regulation of polarized epithelial cell differentiation (GO:0030860)	2	0	.35	-	 < 0.01	7.06E-01
vitamin B6 biosynthetic process (GO:0042819)	2	0	.35	-	 < 0.01	7.06E-01
pyridoxal metabolic process (GO:0042817)	1	0	.17	-	 < 0.01	8.40E-01
vitamin B6 metabolic process (GO:0042816)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of extracellular matrix assembly (GO:1901203)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of extracellular matrix assembly (GO:1901202)	1	0	.17	-	 < 0.01	8.40E-01
regulation of extracellular matrix assembly (GO:1901201)	2	0	.35	-	 < 0.01	7.06E-01
polarized epithelial cell differentiation (GO:0030859)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of epithelial cell differentiation (GO:0030858)	1	0	.17	-	 < 0.01	8.40E-01
regulation of epithelial cell differentiation (GO:0030856)	3	0	.52	-	 < 0.01	5.93E-01
establishment of thoracic bristle planar orientation (GO:0048106)	1	0	.17	-	 < 0.01	8.40E-01
establishment of body hair planar orientation (GO:0048105)	1	0	.17	-	 < 0.01	8.40E-01
nuclear membrane organization (GO:0071763)	2	0	.35	-	 < 0.01	7.06E-01
meiosis II cell cycle process (GO:0061983)	25	0	4.36	-	 < 0.01	1.27E-02
positive regulation of actin filament depolymerization (GO:0030836)	1	0	.17	-	 < 0.01	8.40E-01
histone deubiquitination (GO:0016578)	9	0	1.57	-	 < 0.01	2.08E-01
histone dephosphorylation (GO:0016576)	1	0	.17	-	 < 0.01	8.40E-01
DNA strand elongation involved in mitotic DNA replication (GO:1902983)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of entry into reproductive diapause (GO:0061965)	2	0	.35	-	 < 0.01	7.06E-01
polyphosphate catabolic process (GO:0006798)	1	0	.17	-	 < 0.01	8.40E-01
polyphosphate metabolic process (GO:0006797)	1	0	.17	-	 < 0.01	8.40E-01
transcriptional activation by promoter-enhancer looping (GO:0071733)	2	0	.35	-	 < 0.01	7.06E-01
mitotic DNA replication preinitiation complex assembly (GO:1902977)	1	0	.17	-	 < 0.01	8.40E-01
response to nitric oxide (GO:0071731)	1	0	.17	-	 < 0.01	8.40E-01
mitotic DNA replication initiation (GO:1902975)	5	0	.87	-	 < 0.01	4.18E-01
midbody abscission (GO:0061952)	1	0	.17	-	 < 0.01	8.40E-01
protoporphyrinogen IX biosynthetic process (GO:0006782)	2	0	.35	-	 < 0.01	7.06E-01
mitotic DNA replication (GO:1902969)	11	0	1.92	-	 < 0.01	1.47E-01
peroxisome fission (GO:0016559)	4	0	.70	-	 < 0.01	4.98E-01
detoxification of arsenic-containing substance (GO:0071722)	1	0	.17	-	 < 0.01	8.40E-01
base conversion or substitution editing (GO:0016553)	5	0	.87	-	 < 0.01	4.18E-01
vitamin A metabolic process (GO:0006776)	1	0	.17	-	 < 0.01	8.40E-01
fat-soluble vitamin metabolic process (GO:0006775)	3	0	.52	-	 < 0.01	5.93E-01
icosanoid transport (GO:0071715)	3	0	.52	-	 < 0.01	5.93E-01
male courtship behavior, proboscis-mediated licking (GO:0016546)	1	0	.17	-	 < 0.01	8.40E-01
male courtship behavior, tapping to detect pheromone (GO:0016544)	2	0	.35	-	 < 0.01	7.06E-01
male courtship behavior, orientation prior to leg tapping and wing vibration (GO:0016543)	2	0	.35	-	 < 0.01	7.06E-01
water-soluble vitamin metabolic process (GO:0006767)	6	0	1.05	-	 < 0.01	3.51E-01
vitamin metabolic process (GO:0006766)	9	0	1.57	-	 < 0.01	2.08E-01
protein localization to early endosome (GO:1902946)	2	0	.35	-	 < 0.01	7.06E-01
cytoplasmic U snRNP body assembly (GO:1990194)	1	0	.17	-	 < 0.01	8.40E-01
glutathione catabolic process (GO:0006751)	1	0	.17	-	 < 0.01	8.40E-01
NADP biosynthetic process (GO:0006741)	1	0	.17	-	 < 0.01	8.40E-01
nurse cell apoptotic process (GO:0045476)	11	0	1.92	-	 < 0.01	1.47E-01
positive regulation of p38MAPK cascade (GO:1900745)	1	0	.17	-	 < 0.01	8.40E-01
stress response to cadmium ion (GO:1990170)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of protein polyubiquitination (GO:1902916)	1	0	.17	-	 < 0.01	8.40E-01
histone H2A phosphorylation (GO:1990164)	1	0	.17	-	 < 0.01	8.40E-01
R8 cell development (GO:0045463)	4	0	.70	-	 < 0.01	4.98E-01
activation of MAPK activity (GO:0000187)	7	0	1.22	-	 < 0.01	2.95E-01
activation of MAPKK activity (GO:0000186)	3	0	.52	-	 < 0.01	5.93E-01
activation of MAPKKK activity (GO:0000185)	4	0	.70	-	 < 0.01	4.98E-01
juvenile hormone biosynthetic process (GO:0006718)	1	0	.17	-	 < 0.01	8.40E-01
specification of axis polarity (GO:0065001)	8	0	1.40	-	 < 0.01	2.48E-01
tricarboxylic acid transmembrane transport (GO:0035674)	1	0	.17	-	 < 0.01	8.40E-01
galactose catabolic process via UDP-galactose (GO:0033499)	2	0	.35	-	 < 0.01	7.06E-01
oligopeptide transmembrane transport (GO:0035672)	1	0	.17	-	 < 0.01	8.40E-01
myoblast differentiation (GO:0045445)	5	0	.87	-	 < 0.01	4.18E-01
replication fork processing (GO:0031297)	4	0	.70	-	 < 0.01	4.98E-01
retrograde transport, endosome to plasma membrane (GO:1990126)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of nitric oxide biosynthetic process (GO:0045429)	1	0	.17	-	 < 0.01	8.40E-01
regulation of nitric oxide biosynthetic process (GO:0045428)	1	0	.17	-	 < 0.01	8.40E-01
Ran protein signal transduction (GO:0031291)	2	0	.35	-	 < 0.01	7.06E-01
telomere maintenance in response to DNA damage (GO:0043247)	3	0	.52	-	 < 0.01	5.93E-01
locomotory exploration behavior (GO:0035641)	1	0	.17	-	 < 0.01	8.40E-01
exploration behavior (GO:0035640)	1	0	.17	-	 < 0.01	8.40E-01
ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of cyclase activity (GO:0031280)	1	0	.17	-	 < 0.01	8.40E-01
multicellular organismal signaling (GO:0035637)	10	0	1.74	-	 < 0.01	1.75E-01
maintenance of blood-brain barrier (GO:0035633)	1	0	.17	-	 < 0.01	8.40E-01
protein linear deubiquitination (GO:1990108)	1	0	.17	-	 < 0.01	8.40E-01
ceramide transport (GO:0035627)	1	0	.17	-	 < 0.01	8.40E-01
ER to Golgi ceramide transport (GO:0035621)	1	0	.17	-	 < 0.01	8.40E-01
stress granule disassembly (GO:0035617)	1	0	.17	-	 < 0.01	8.40E-01
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616)	1	0	.17	-	 < 0.01	8.40E-01
regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117)	1	0	.17	-	 < 0.01	8.40E-01
response to leucine (GO:0043201)	2	0	.35	-	 < 0.01	7.06E-01
phospholipid catabolic process (GO:0009395)	2	0	.35	-	 < 0.01	7.06E-01
2'-deoxyribonucleotide metabolic process (GO:0009394)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of adherens junction organization (GO:1903392)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of homophilic cell adhesion (GO:1903387)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of homophilic cell adhesion (GO:1903386)	1	0	.17	-	 < 0.01	8.40E-01
regulation of homophilic cell adhesion (GO:1903385)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of protein desumoylation (GO:0060189)	1	0	.17	-	 < 0.01	8.40E-01
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198)	2	0	.35	-	 < 0.01	7.06E-01
regulation of protein desumoylation (GO:0060188)	1	0	.17	-	 < 0.01	8.40E-01
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197)	1	0	.17	-	 < 0.01	8.40E-01
auditory behavior (GO:0031223)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of adenylate cyclase activity (GO:0007194)	1	0	.17	-	 < 0.01	8.40E-01
adenylate cyclase-activating serotonin receptor signaling pathway (GO:0007192)	1	0	.17	-	 < 0.01	8.40E-01
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	4	0	.70	-	 < 0.01	4.98E-01
activation of adenylate cyclase activity (GO:0007190)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of protein localization to endoplasmic reticulum (GO:1905552)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein localization to endoplasmic reticulum (GO:1905550)	1	0	.17	-	 < 0.01	8.40E-01
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	2	0	.35	-	 < 0.01	7.06E-01
carbohydrate storage (GO:0052576)	1	0	.17	-	 < 0.01	8.40E-01
receptor recycling (GO:0001881)	3	0	.52	-	 < 0.01	5.93E-01
carbohydrate localization (GO:0052575)	1	0	.17	-	 < 0.01	8.40E-01
snRNA transcription by RNA polymerase III (GO:0042796)	4	0	.70	-	 < 0.01	4.98E-01
snRNA transcription by RNA polymerase II (GO:0042795)	6	0	1.05	-	 < 0.01	3.51E-01
male pigmentation (GO:0048094)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of male pigmentation (GO:0048092)	1	0	.17	-	 < 0.01	8.40E-01
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of ERBB signaling pathway (GO:1901186)	9	0	1.57	-	 < 0.01	2.08E-01
posttranslational protein targeting to membrane, translocation (GO:0031204)	5	0	.87	-	 < 0.01	4.18E-01
regulation of epidermal growth factor-activated receptor activity (GO:0007176)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	3	0	.52	-	 < 0.01	5.93E-01
signal complex assembly (GO:0007172)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905536)	3	0	.52	-	 < 0.01	5.93E-01
regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535)	3	0	.52	-	 < 0.01	5.93E-01
regulation of male pigmentation (GO:0048088)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of developmental pigmentation (GO:0048086)	3	0	.52	-	 < 0.01	5.93E-01
regulation of nucleus organization (GO:1903353)	1	0	.17	-	 < 0.01	8.40E-01
L-ornithine transmembrane transport (GO:1903352)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to dopamine (GO:1903351)	13	0	2.27	-	 < 0.01	1.03E-01
response to dopamine (GO:1903350)	13	0	2.27	-	 < 0.01	1.03E-01
regulation of dopamine receptor signaling pathway (GO:0060159)	1	0	.17	-	 < 0.01	8.40E-01
receptor guanylyl cyclase signaling pathway (GO:0007168)	2	0	.35	-	 < 0.01	7.06E-01
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of protein polyglycylation (GO:1903346)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein polyglycylation (GO:1903344)	1	0	.17	-	 < 0.01	8.40E-01
sex-specific pigmentation (GO:0048071)	3	0	.52	-	 < 0.01	5.93E-01
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	4	0	.70	-	 < 0.01	4.98E-01
signal transduction in response to DNA damage (GO:0042770)	5	0	.87	-	 < 0.01	4.18E-01
primary amino compound biosynthetic process (GO:1901162)	2	0	.35	-	 < 0.01	7.06E-01
primary amino compound metabolic process (GO:1901160)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of presynaptic active zone assembly (GO:1905519)	1	0	.17	-	 < 0.01	8.40E-01
regulation of presynaptic active zone assembly (GO:1905518)	1	0	.17	-	 < 0.01	8.40E-01
female somatic sex determination (GO:0019101)	5	0	.87	-	 < 0.01	4.18E-01
male germ-line sex determination (GO:0019100)	1	0	.17	-	 < 0.01	8.40E-01
very long-chain fatty acid catabolic process (GO:0042760)	3	0	.52	-	 < 0.01	5.93E-01
ribonucleoprotein complex disassembly (GO:0032988)	3	0	.52	-	 < 0.01	5.93E-01
protein-DNA complex disassembly (GO:0032986)	1	0	.17	-	 < 0.01	8.40E-01
female meiosis II (GO:0007147)	6	0	1.05	-	 < 0.01	3.51E-01
meiotic recombination nodule assembly (GO:0007146)	1	0	.17	-	 < 0.01	8.40E-01
phagolysosome assembly (GO:0001845)	4	0	.70	-	 < 0.01	4.98E-01
regulation of tRNA metabolic process (GO:1903326)	1	0	.17	-	 < 0.01	8.40E-01
R2/R5 cell differentiation (GO:0048054)	1	0	.17	-	 < 0.01	8.40E-01
R1/R6 development (GO:0048053)	1	0	.17	-	 < 0.01	8.40E-01
R1/R6 cell differentiation (GO:0048052)	5	0	.87	-	 < 0.01	4.18E-01
oligosaccharide catabolic process (GO:0009313)	1	0	.17	-	 < 0.01	8.40E-01
oligosaccharide biosynthetic process (GO:0009312)	4	0	.70	-	 < 0.01	4.98E-01
oligosaccharide metabolic process (GO:0009311)	7	0	1.22	-	 < 0.01	2.95E-01
amine catabolic process (GO:0009310)	3	0	.52	-	 < 0.01	5.93E-01
epithelial to mesenchymal transition (GO:0001837)	2	0	.35	-	 < 0.01	7.06E-01
meiosis II (GO:0007135)	14	0	2.44	-	 < 0.01	8.68E-02
synaptonemal complex assembly (GO:0007130)	6	0	1.05	-	 < 0.01	3.51E-01
germ cell proliferation (GO:0036093)	1	0	.17	-	 < 0.01	8.40E-01
protein biotinylation (GO:0009305)	2	0	.35	-	 < 0.01	7.06E-01
rRNA transcription (GO:0009303)	5	0	.87	-	 < 0.01	4.18E-01
homologous chromosome pairing at meiosis (GO:0007129)	7	0	1.22	-	 < 0.01	2.95E-01
snRNA transcription (GO:0009301)	6	0	1.05	-	 < 0.01	3.51E-01
collagen metabolic process (GO:0032963)	2	0	.35	-	 < 0.01	7.06E-01
GDP-fucose import into Golgi lumen (GO:0036085)	1	0	.17	-	 < 0.01	8.40E-01
GDP-fucose import into endoplasmic reticulum lumen (GO:0036084)	1	0	.17	-	 < 0.01	8.40E-01
ectodermal placode morphogenesis (GO:0071697)	4	0	.70	-	 < 0.01	4.98E-01
D-xylose metabolic process (GO:0042732)	1	0	.17	-	 < 0.01	8.40E-01
ectodermal placode development (GO:0071696)	4	0	.70	-	 < 0.01	4.98E-01
maintenance of protein location in extracellular region (GO:0071694)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of cytokine production (GO:0001818)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cytokine production (GO:0001817)	1	0	.17	-	 < 0.01	8.40E-01
meiosis II cytokinesis (GO:0007111)	11	0	1.92	-	 < 0.01	1.47E-01
meiosis I cytokinesis (GO:0007110)	15	0	2.62	-	 < 0.01	7.29E-02
striated muscle myosin thick filament assembly (GO:0071688)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of melanin biosynthetic process (GO:0048022)	1	0	.17	-	 < 0.01	8.40E-01
regulation of melanin biosynthetic process (GO:0048021)	1	0	.17	-	 < 0.01	8.40E-01
membrane addition at site of cytokinesis (GO:0007107)	1	0	.17	-	 < 0.01	8.40E-01
protein O-linked fucosylation (GO:0036066)	2	0	.35	-	 < 0.01	7.06E-01
muscle cell chemotaxis toward tendon cell (GO:0036061)	1	0	.17	-	 < 0.01	8.40E-01
inositol phosphate-mediated signaling (GO:0048016)	1	0	.17	-	 < 0.01	8.40E-01
commissural neuron axon guidance (GO:0071679)	1	0	.17	-	 < 0.01	8.40E-01
ephrin receptor signaling pathway (GO:0048013)	4	0	.70	-	 < 0.01	4.98E-01
olfactory bulb axon guidance (GO:0071678)	1	0	.17	-	 < 0.01	8.40E-01
neurotrophin TRK receptor signaling pathway (GO:0048011)	1	0	.17	-	 < 0.01	8.40E-01
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	29	0	5.06	-	 < 0.01	6.29E-03
nephrocyte diaphragm assembly (GO:0036059)	3	0	.52	-	 < 0.01	5.93E-01
filtration diaphragm assembly (GO:0036058)	4	0	.70	-	 < 0.01	4.98E-01
insulin-like growth factor receptor signaling pathway (GO:0048009)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of transcription by RNA polymerase III (GO:0016480)	2	0	.35	-	 < 0.01	7.06E-01
sequestering of triglyceride (GO:0030730)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of transcription by RNA polymerase I (GO:0016479)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of response to oxidative stress (GO:1902884)	2	0	.35	-	 < 0.01	7.06E-01
TORC2 signaling (GO:0038203)	3	0	.52	-	 < 0.01	5.93E-01
TORC1 signaling (GO:0038202)	5	0	.87	-	 < 0.01	4.18E-01
establishment of mitotic spindle asymmetry (GO:0061867)	2	0	.35	-	 < 0.01	7.06E-01
polarized secretion of basement membrane proteins in epithelium (GO:0061865)	1	0	.17	-	 < 0.01	8.40E-01
basement membrane constituent secretion (GO:0061864)	4	0	.70	-	 < 0.01	4.98E-01
male germline ring canal formation (GO:0030726)	3	0	.52	-	 < 0.01	5.93E-01
testicular fusome organization (GO:0030724)	1	0	.17	-	 < 0.01	8.40E-01
spectrosome organization (GO:0030721)	3	0	.52	-	 < 0.01	5.93E-01
prostaglandin metabolic process (GO:0006693)	1	0	.17	-	 < 0.01	8.40E-01
prostanoid metabolic process (GO:0006692)	1	0	.17	-	 < 0.01	8.40E-01
icosanoid metabolic process (GO:0006690)	1	0	.17	-	 < 0.01	8.40E-01
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	2	0	.35	-	 < 0.01	7.06E-01
regulation of embryonic pattern specification (GO:1902875)	1	0	.17	-	 < 0.01	8.40E-01
P granule organization (GO:0030719)	4	0	.70	-	 < 0.01	4.98E-01
oocyte growth in germarium-derived egg chamber (GO:0030715)	2	0	.35	-	 < 0.01	7.06E-01
sphingomyelin biosynthetic process (GO:0006686)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to endosome (GO:0036010)	2	0	.35	-	 < 0.01	7.06E-01
sphingomyelin metabolic process (GO:0006684)	1	0	.17	-	 < 0.01	8.40E-01
border follicle cell delamination (GO:0030709)	3	0	.52	-	 < 0.01	5.93E-01
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	1	0	.17	-	 < 0.01	8.40E-01
vitelline membrane formation (GO:0030704)	7	0	1.22	-	 < 0.01	2.95E-01
positive regulation of netrin-activated signaling pathway (GO:1902843)	1	0	.17	-	 < 0.01	8.40E-01
regulation of netrin-activated signaling pathway (GO:1902841)	1	0	.17	-	 < 0.01	8.40E-01
cytosolic ciliogenesis (GO:0061824)	1	0	.17	-	 < 0.01	8.40E-01
phosphatidylcholine biosynthetic process (GO:0006656)	1	0	.17	-	 < 0.01	8.40E-01
phosphatidic acid biosynthetic process (GO:0006654)	2	0	.35	-	 < 0.01	7.06E-01
phosphatidylethanolamine biosynthetic process (GO:0006646)	2	0	.35	-	 < 0.01	7.06E-01
triglyceride mobilization (GO:0006642)	3	0	.52	-	 < 0.01	5.93E-01
unsaturated fatty acid biosynthetic process (GO:0006636)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region (GO:0035593)	2	0	.35	-	 < 0.01	7.06E-01
purinergic nucleotide receptor signaling pathway (GO:0035590)	1	0	.17	-	 < 0.01	8.40E-01
G protein-coupled purinergic receptor signaling pathway (GO:0035588)	1	0	.17	-	 < 0.01	8.40E-01
protein retention in ER lumen (GO:0006621)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of cell cycle G1/S phase transition (GO:1902808)	7	0	1.22	-	 < 0.01	2.95E-01
myeloid cell homeostasis (GO:0002262)	1	0	.17	-	 < 0.01	8.40E-01
G2/M transition of mitotic cell cycle (GO:0000086)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)	2	0	.35	-	 < 0.01	7.06E-01
rhythmic excitation (GO:0043179)	1	0	.17	-	 < 0.01	8.40E-01
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	1	0	.17	-	 < 0.01	8.40E-01
acetate ester biosynthetic process (GO:1900620)	1	0	.17	-	 < 0.01	8.40E-01
nucleotide salvage (GO:0043173)	2	0	.35	-	 < 0.01	7.06E-01
L-proline biosynthetic process (GO:0055129)	2	0	.35	-	 < 0.01	7.06E-01
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396)	1	0	.17	-	 < 0.01	8.40E-01
activation of immune response (GO:0002253)	7	0	1.22	-	 < 0.01	2.95E-01
acetate ester metabolic process (GO:1900619)	2	0	.35	-	 < 0.01	7.06E-01
protein localization to lipid droplet (GO:1990044)	1	0	.17	-	 < 0.01	8.40E-01
telomere maintenance via telomere trimming (GO:0090737)	1	0	.17	-	 < 0.01	8.40E-01
DNA repair complex assembly (GO:0090735)	3	0	.52	-	 < 0.01	5.93E-01
NLS-bearing protein import into nucleus (GO:0006607)	9	0	1.57	-	 < 0.01	2.08E-01
N-terminal peptidyl-proline methylation (GO:0035568)	1	0	.17	-	 < 0.01	8.40E-01
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	11	0	1.92	-	 < 0.01	1.47E-01
negative regulation of chromatin binding (GO:0035562)	1	0	.17	-	 < 0.01	8.40E-01
regulation of chromatin binding (GO:0035561)	4	0	.70	-	 < 0.01	4.98E-01
putrescine biosynthetic process from ornithine (GO:0033387)	2	0	.35	-	 < 0.01	7.06E-01
regulation of cardiac muscle contraction (GO:0055117)	3	0	.52	-	 < 0.01	5.93E-01
entry into diapause (GO:0055115)	1	0	.17	-	 < 0.01	8.40E-01
geranyl diphosphate biosynthetic process (GO:0033384)	1	0	.17	-	 < 0.01	8.40E-01
geranyl diphosphate metabolic process (GO:0033383)	1	0	.17	-	 < 0.01	8.40E-01
phospholipid translocation (GO:0045332)	4	0	.70	-	 < 0.01	4.98E-01
induction of bacterial agglutination (GO:0043152)	1	0	.17	-	 < 0.01	8.40E-01
DNA synthesis involved in double-strand break repair via homologous recombination (GO:0043150)	4	0	.70	-	 < 0.01	4.98E-01
integrated stress response signaling (GO:0140467)	2	0	.35	-	 < 0.01	7.06E-01
response to oomycetes (GO:0002239)	1	0	.17	-	 < 0.01	8.40E-01
response to molecule of fungal origin (GO:0002238)	1	0	.17	-	 < 0.01	8.40E-01
pericentric heterochromatin organization (GO:0140462)	2	0	.35	-	 < 0.01	7.06E-01
ribosomal small subunit export from nucleus (GO:0000056)	2	0	.35	-	 < 0.01	7.06E-01
citrulline metabolic process (GO:0000052)	1	0	.17	-	 < 0.01	8.40E-01
regulation of translation by machinery localization (GO:0043143)	1	0	.17	-	 < 0.01	8.40E-01
electron transport coupled proton transport (GO:0015990)	1	0	.17	-	 < 0.01	8.40E-01
defense response to oomycetes (GO:0002229)	1	0	.17	-	 < 0.01	8.40E-01
innate immune response activating cell surface receptor signaling pathway (GO:0002220)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of compound eye photoreceptor development (GO:0045316)	3	0	.52	-	 < 0.01	5.93E-01
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	1	0	.17	-	 < 0.01	8.40E-01
DNA replication, removal of RNA primer (GO:0043137)	1	0	.17	-	 < 0.01	8.40E-01
regulation of hindgut contraction (GO:0043134)	1	0	.17	-	 < 0.01	8.40E-01
activation of innate immune response (GO:0002218)	6	0	1.05	-	 < 0.01	3.51E-01
S-adenosylmethionine cycle (GO:0033353)	3	0	.52	-	 < 0.01	5.93E-01
defense response to insect (GO:0002213)	7	0	1.22	-	 < 0.01	2.95E-01
guanosine tetraphosphate catabolic process (GO:0015971)	1	0	.17	-	 < 0.01	8.40E-01
monoubiquitinated histone H2A deubiquitination (GO:0035522)	2	0	.35	-	 < 0.01	7.06E-01
monoubiquitinated histone deubiquitination (GO:0035521)	2	0	.35	-	 < 0.01	7.06E-01
monoubiquitinated protein deubiquitination (GO:0035520)	2	0	.35	-	 < 0.01	7.06E-01
behavioral defense response (GO:0002209)	3	0	.52	-	 < 0.01	5.93E-01
mitotic spindle elongation (GO:0000022)	9	0	1.57	-	 < 0.01	2.08E-01
guanosine tetraphosphate metabolic process (GO:0015969)	1	0	.17	-	 < 0.01	8.40E-01
diadenosine polyphosphate catabolic process (GO:0015961)	1	0	.17	-	 < 0.01	8.40E-01
histone H2A monoubiquitination (GO:0035518)	4	0	.70	-	 < 0.01	4.98E-01
viral translation (GO:0019081)	1	0	.17	-	 < 0.01	8.40E-01
viral gene expression (GO:0019080)	1	0	.17	-	 < 0.01	8.40E-01
oxidative DNA demethylation (GO:0035511)	1	0	.17	-	 < 0.01	8.40E-01
DNA dealkylation (GO:0035510)	2	0	.35	-	 < 0.01	7.06E-01
regulation of mitotic recombination (GO:0000019)	4	0	.70	-	 < 0.01	4.98E-01
regulation of DNA recombination (GO:0000018)	15	0	2.62	-	 < 0.01	7.29E-02
single strand break repair (GO:0000012)	2	0	.35	-	 < 0.01	7.06E-01
diadenosine polyphosphate metabolic process (GO:0015959)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of GTP cyclohydrolase I activity (GO:0043104)	1	0	.17	-	 < 0.01	8.40E-01
mitochondrial genome maintenance (GO:0000002)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of protein localization to membrane (GO:1905476)	1	0	.17	-	 < 0.01	8.40E-01
sister chromatid biorientation (GO:0031134)	1	0	.17	-	 < 0.01	8.40E-01
cytoskeletal rearrangement involved in phagocytosis, engulfment (GO:0060097)	1	0	.17	-	 < 0.01	8.40E-01
viral life cycle (GO:0019058)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of DNA duplex unwinding (GO:1905463)	1	0	.17	-	 < 0.01	8.40E-01
regulation of DNA duplex unwinding (GO:1905462)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of potassium ion import across plasma membrane (GO:1903288)	1	0	.17	-	 < 0.01	8.40E-01
regulation of potassium ion import (GO:1903286)	1	0	.17	-	 < 0.01	8.40E-01
response to humidity (GO:0009270)	2	0	.35	-	 < 0.01	7.06E-01
mitotic G2 DNA damage checkpoint (GO:0007095)	8	0	1.40	-	 < 0.01	2.48E-01
response to desiccation (GO:0009269)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of signal transduction in absence of ligand (GO:1901099)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of autophagosome maturation (GO:1901098)	3	0	.52	-	 < 0.01	5.93E-01
regulation of autophagosome maturation (GO:1901096)	4	0	.70	-	 < 0.01	4.98E-01
2'-deoxyribonucleotide biosynthetic process (GO:0009265)	2	0	.35	-	 < 0.01	7.06E-01
deoxyribonucleotide catabolic process (GO:0009264)	2	0	.35	-	 < 0.01	7.06E-01
deoxyribonucleotide biosynthetic process (GO:0009263)	4	0	.70	-	 < 0.01	4.98E-01
deoxyribonucleotide metabolic process (GO:0009262)	5	0	.87	-	 < 0.01	4.18E-01
excitatory postsynaptic potential (GO:0060079)	2	0	.35	-	 < 0.01	7.06E-01
ribonucleotide catabolic process (GO:0009261)	5	0	.87	-	 < 0.01	4.18E-01
mitotic nuclear envelope reassembly (GO:0007084)	1	0	.17	-	 < 0.01	8.40E-01
synapse maturation (GO:0060074)	5	0	.87	-	 < 0.01	4.18E-01
sterol transport (GO:0015918)	8	0	1.40	-	 < 0.01	2.48E-01
membrane tubulation (GO:0097749)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446)	1	0	.17	-	 < 0.01	8.40E-01
long-chain fatty acid import into peroxisome (GO:0015910)	1	0	.17	-	 < 0.01	8.40E-01
lipoprotein localization (GO:0044872)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of crystal cell differentiation (GO:0042690)	4	0	.70	-	 < 0.01	4.98E-01
10-formyltetrahydrofolate metabolic process (GO:0009256)	1	0	.17	-	 < 0.01	8.40E-01
septin ring organization (GO:0031106)	1	0	.17	-	 < 0.01	8.40E-01
mitotic chromosome movement towards spindle pole (GO:0007079)	4	0	.70	-	 < 0.01	4.98E-01
dendrite regeneration (GO:0031104)	2	0	.35	-	 < 0.01	7.06E-01
glucan biosynthetic process (GO:0009250)	3	0	.52	-	 < 0.01	5.93E-01
axon regeneration (GO:0031103)	5	0	.87	-	 < 0.01	4.18E-01
neuron projection regeneration (GO:0031102)	7	0	1.22	-	 < 0.01	2.95E-01
long-chain fatty acid transport (GO:0015909)	4	0	.70	-	 < 0.01	4.98E-01
fatty acid transport (GO:0015908)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of histone H3-K4 trimethylation (GO:1905437)	3	0	.52	-	 < 0.01	5.93E-01
regulation of histone H3-K4 trimethylation (GO:1905435)	3	0	.52	-	 < 0.01	5.93E-01
exon-exon junction complex disassembly (GO:1903259)	1	0	.17	-	 < 0.01	8.40E-01
crystal cell differentiation (GO:0042688)	15	0	2.62	-	 < 0.01	7.29E-02
cardioblast cell fate specification (GO:0042685)	3	0	.52	-	 < 0.01	5.93E-01
cardioblast cell fate commitment (GO:0042684)	8	0	1.40	-	 < 0.01	2.48E-01
negative regulation of compound eye cone cell fate specification (GO:0042683)	3	0	.52	-	 < 0.01	5.93E-01
protein lipoylation (GO:0009249)	1	0	.17	-	 < 0.01	8.40E-01
regulation of compound eye cone cell fate specification (GO:0042682)	5	0	.87	-	 < 0.01	4.18E-01
protein localization to postsynapse (GO:0062237)	6	0	1.05	-	 < 0.01	3.51E-01
glucosamine-containing compound catabolic process (GO:1901072)	12	0	2.09	-	 < 0.01	1.23E-01
female meiosis sister chromatid cohesion (GO:0007066)	1	0	.17	-	 < 0.01	8.40E-01
male meiosis sister chromatid cohesion (GO:0007065)	4	0	.70	-	 < 0.01	4.98E-01
mitotic sister chromatid cohesion (GO:0007064)	8	0	1.40	-	 < 0.01	2.48E-01
neuron migration (GO:0001764)	5	0	.87	-	 < 0.01	4.18E-01
regulation of sister chromatid cohesion (GO:0007063)	5	0	.87	-	 < 0.01	4.18E-01
sister chromatid cohesion (GO:0007062)	22	0	3.84	-	 < 0.01	2.14E-02
male meiosis chromosome segregation (GO:0007060)	10	0	1.74	-	 < 0.01	1.75E-01
positive regulation of protein glycosylation (GO:0060050)	2	0	.35	-	 < 0.01	7.06E-01
calcineurin-mediated signaling (GO:0097720)	3	0	.52	-	 < 0.01	5.93E-01
compound eye cone cell fate commitment (GO:0042676)	2	0	.35	-	 < 0.01	7.06E-01
compound eye cone cell differentiation (GO:0042675)	12	0	2.09	-	 < 0.01	1.23E-01
guanosine-containing compound catabolic process (GO:1901069)	2	0	.35	-	 < 0.01	7.06E-01
menaquinone biosynthetic process (GO:0009234)	1	0	.17	-	 < 0.01	8.40E-01
menaquinone metabolic process (GO:0009233)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of viral transcription (GO:0032897)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein glycosylation (GO:0060049)	3	0	.52	-	 < 0.01	5.93E-01
spindle assembly involved in female meiosis II (GO:0007058)	4	0	.70	-	 < 0.01	4.98E-01
spindle assembly involved in male meiosis I (GO:0007054)	1	0	.17	-	 < 0.01	8.40E-01
cell cycle arrest (GO:0007050)	4	0	.70	-	 < 0.01	4.98E-01
ciliary basal body-plasma membrane docking (GO:0097711)	3	0	.52	-	 < 0.01	5.93E-01
melanosome assembly (GO:1903232)	1	0	.17	-	 < 0.01	8.40E-01
nucleotide-sugar biosynthetic process (GO:0009226)	5	0	.87	-	 < 0.01	4.18E-01
sarcosine biosynthetic process (GO:1901054)	1	0	.17	-	 < 0.01	8.40E-01
pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	1	0	.17	-	 < 0.01	8.40E-01
sarcosine catabolic process (GO:1901053)	2	0	.35	-	 < 0.01	7.06E-01
sarcosine metabolic process (GO:1901052)	3	0	.52	-	 < 0.01	5.93E-01
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	2	0	.35	-	 < 0.01	7.06E-01
optic lobe placode formation (GO:0001744)	4	0	.70	-	 < 0.01	4.98E-01
oenocyte differentiation (GO:0001742)	11	0	1.92	-	 < 0.01	1.47E-01
mediolateral intercalation (GO:0060031)	2	0	.35	-	 < 0.01	7.06E-01
cell cycle G2/M phase transition (GO:0044839)	8	0	1.40	-	 < 0.01	2.48E-01
actomyosin contractile ring organization (GO:0044837)	22	0	3.84	-	 < 0.01	2.14E-02
positive regulation of mitotic cohesin loading (GO:1905406)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mitotic cohesin loading (GO:1905405)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of oxidative stress-induced neuron death (GO:1903223)	1	0	.17	-	 < 0.01	8.40E-01
pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	2	0	.35	-	 < 0.01	7.06E-01
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	1	0	.17	-	 < 0.01	8.40E-01
regulation of pattern recognition receptor signaling pathway (GO:0062207)	1	0	.17	-	 < 0.01	8.40E-01
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	1	0	.17	-	 < 0.01	8.40E-01
neurotrophin signaling pathway (GO:0038179)	1	0	.17	-	 < 0.01	8.40E-01
cyclic nucleotide catabolic process (GO:0009214)	1	0	.17	-	 < 0.01	8.40E-01
protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process (GO:1901044)	2	0	.35	-	 < 0.01	7.06E-01
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	1	0	.17	-	 < 0.01	8.40E-01
protein catabolic process in the vacuole (GO:0007039)	1	0	.17	-	 < 0.01	8.40E-01
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of DNA endoreduplication (GO:0032876)	2	0	.35	-	 < 0.01	7.06E-01
convergent extension involved in gastrulation (GO:0060027)	5	0	.87	-	 < 0.01	4.18E-01
convergent extension (GO:0060026)	8	0	1.40	-	 < 0.01	2.48E-01
cannabinoid signaling pathway (GO:0038171)	1	0	.17	-	 < 0.01	8.40E-01
rhythmic synaptic transmission (GO:0060024)	2	0	.35	-	 < 0.01	7.06E-01
formation of cytoplasmic translation initiation complex (GO:0001732)	1	0	.17	-	 < 0.01	8.40E-01
formation of translation preinitiation complex (GO:0001731)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation by host of viral genome replication (GO:0044829)	1	0	.17	-	 < 0.01	8.40E-01
modulation by host of viral genome replication (GO:0044827)	1	0	.17	-	 < 0.01	8.40E-01
regulation of histone H4 acetylation involved in response to DNA damage stimulus (GO:2000873)	1	0	.17	-	 < 0.01	8.40E-01
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	2	0	.35	-	 < 0.01	7.06E-01
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	2	0	.35	-	 < 0.01	7.06E-01
synaptic transmission, glycinergic (GO:0060012)	1	0	.17	-	 < 0.01	8.40E-01
microtubule nucleation (GO:0007020)	11	0	1.92	-	 < 0.01	1.47E-01
positive regulation of oxidative stress-induced cell death (GO:1903209)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of oxidative stress-induced neuron death (GO:1903204)	3	0	.52	-	 < 0.01	5.93E-01
acetylcholine receptor signaling pathway (GO:0095500)	2	0	.35	-	 < 0.01	7.06E-01
regulation of oxidative stress-induced neuron death (GO:1903203)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to water deprivation (GO:0042631)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	1	0	.17	-	 < 0.01	8.40E-01
microtubule depolymerization (GO:0007019)	6	0	1.05	-	 < 0.01	3.51E-01
positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	1	0	.17	-	 < 0.01	8.40E-01
ectodermal cell fate specification (GO:0001715)	1	0	.17	-	 < 0.01	8.40E-01
endodermal cell fate specification (GO:0001714)	2	0	.35	-	 < 0.01	7.06E-01
copper ion export (GO:0060003)	1	0	.17	-	 < 0.01	8.40E-01
ectodermal cell fate determination (GO:0001713)	2	0	.35	-	 < 0.01	7.06E-01
ectodermal cell fate commitment (GO:0001712)	3	0	.52	-	 < 0.01	5.93E-01
endodermal cell fate commitment (GO:0001711)	3	0	.52	-	 < 0.01	5.93E-01
late nucleophagy (GO:0044805)	3	0	.52	-	 < 0.01	5.93E-01
multi-organism membrane organization (GO:0044803)	1	0	.17	-	 < 0.01	8.40E-01
mating plug formation (GO:0042628)	2	0	.35	-	 < 0.01	7.06E-01
CAAX-box protein processing (GO:0071586)	4	0	.70	-	 < 0.01	4.98E-01
detoxification of cadmium ion (GO:0071585)	1	0	.17	-	 < 0.01	8.40E-01
ectoderm formation (GO:0001705)	3	0	.52	-	 < 0.01	5.93E-01
telomere maintenance via telomerase (GO:0007004)	2	0	.35	-	 < 0.01	7.06E-01
nucleolus organization (GO:0007000)	5	0	.87	-	 < 0.01	4.18E-01
zinc ion import across plasma membrane (GO:0071578)	2	0	.35	-	 < 0.01	7.06E-01
ubiquinone-6 biosynthetic process (GO:1901006)	1	0	.17	-	 < 0.01	8.40E-01
ubiquinone-6 metabolic process (GO:1901004)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of steroid hormone secretion (GO:2000833)	1	0	.17	-	 < 0.01	8.40E-01
regulation of steroid hormone secretion (GO:2000831)	2	0	.35	-	 < 0.01	7.06E-01
dense core granule priming (GO:0061789)	1	0	.17	-	 < 0.01	8.40E-01
mitotic cohesin unloading (GO:0061781)	2	0	.35	-	 < 0.01	7.06E-01
mitotic cohesin loading (GO:0061780)	1	0	.17	-	 < 0.01	8.40E-01
regulation of heart morphogenesis (GO:2000826)	2	0	.35	-	 < 0.01	7.06E-01
cohesin unloading (GO:0061774)	2	0	.35	-	 < 0.01	7.06E-01
regulation of mRNA stability involved in response to oxidative stress (GO:2000815)	1	0	.17	-	 < 0.01	8.40E-01
diphosphoinositol polyphosphate metabolic process (GO:0071543)	1	0	.17	-	 < 0.01	8.40E-01
dopaminergic neuron differentiation (GO:0071542)	1	0	.17	-	 < 0.01	8.40E-01
spermine biosynthetic process (GO:0006597)	1	0	.17	-	 < 0.01	8.40E-01
polyamine biosynthetic process (GO:0006596)	4	0	.70	-	 < 0.01	4.98E-01
polyamine metabolic process (GO:0006595)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of synaptic vesicle clustering (GO:2000809)	1	0	.17	-	 < 0.01	8.40E-01
regulation of synaptic vesicle clustering (GO:2000807)	1	0	.17	-	 < 0.01	8.40E-01
ornithine metabolic process (GO:0006591)	4	0	.70	-	 < 0.01	4.98E-01
octopamine biosynthetic process (GO:0006589)	2	0	.35	-	 < 0.01	7.06E-01
serotonin biosynthetic process from tryptophan (GO:0006587)	1	0	.17	-	 < 0.01	8.40E-01
indolalkylamine metabolic process (GO:0006586)	4	0	.70	-	 < 0.01	4.98E-01
melanin biosynthetic process from tyrosine (GO:0006583)	4	0	.70	-	 < 0.01	4.98E-01
acetylcholine catabolic process (GO:0006581)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of transmission of nerve impulse (GO:0051970)	1	0	.17	-	 < 0.01	8.40E-01
semaphorin-plexin signaling pathway (GO:0071526)	2	0	.35	-	 < 0.01	7.06E-01
phospholipid homeostasis (GO:0055091)	1	0	.17	-	 < 0.01	8.40E-01
amino-acid betaine metabolic process (GO:0006577)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	3	0	.52	-	 < 0.01	5.93E-01
tyrosine catabolic process (GO:0006572)	1	0	.17	-	 < 0.01	8.40E-01
tyrosine biosynthetic process (GO:0006571)	1	0	.17	-	 < 0.01	8.40E-01
genetic imprinting (GO:0071514)	1	0	.17	-	 < 0.01	8.40E-01
regulation of response to osmotic stress (GO:0047484)	1	0	.17	-	 < 0.01	8.40E-01
male meiotic chromosome movement towards spindle pole (GO:0016346)	1	0	.17	-	 < 0.01	8.40E-01
meiotic chromosome movement towards spindle pole (GO:0016344)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cell cycle G2/M phase transition (GO:1902751)	5	0	.87	-	 < 0.01	4.18E-01
tryptophan catabolic process (GO:0006569)	2	0	.35	-	 < 0.01	7.06E-01
tryptophan metabolic process (GO:0006568)	4	0	.70	-	 < 0.01	4.98E-01
L-serine biosynthetic process (GO:0006564)	1	0	.17	-	 < 0.01	8.40E-01
L-serine metabolic process (GO:0006563)	2	0	.35	-	 < 0.01	7.06E-01
proline biosynthetic process (GO:0006561)	2	0	.35	-	 < 0.01	7.06E-01
manganese ion homeostasis (GO:0055071)	1	0	.17	-	 < 0.01	8.40E-01
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	1	0	.17	-	 < 0.01	8.40E-01
copper ion homeostasis (GO:0055070)	9	0	1.57	-	 < 0.01	2.08E-01
positive regulation of lamellipodium organization (GO:1902745)	9	0	1.57	-	 < 0.01	2.08E-01
negative regulation of lamellipodium organization (GO:1902744)	1	0	.17	-	 < 0.01	8.40E-01
apoptotic process involved in development (GO:1902742)	12	0	2.09	-	 < 0.01	1.23E-01
second mitotic wave involved in compound eye morphogenesis (GO:0016330)	6	0	1.05	-	 < 0.01	3.51E-01
lipophagy (GO:0061724)	1	0	.17	-	 < 0.01	8.40E-01
S-adenosylmethionine biosynthetic process (GO:0006556)	1	0	.17	-	 < 0.01	8.40E-01
lysine metabolic process (GO:0006553)	1	0	.17	-	 < 0.01	8.40E-01
asymmetric neuroblast division resulting in ganglion mother cell formation (GO:0055060)	2	0	.35	-	 < 0.01	7.06E-01
calcium ion transmembrane transport via low voltage-gated calcium channel (GO:0090676)	1	0	.17	-	 < 0.01	8.40E-01
glycine catabolic process (GO:0006546)	1	0	.17	-	 < 0.01	8.40E-01
glycine biosynthetic process (GO:0006545)	2	0	.35	-	 < 0.01	7.06E-01
glycine metabolic process (GO:0006544)	3	0	.52	-	 < 0.01	5.93E-01
L-glutamate import (GO:0051938)	1	0	.17	-	 < 0.01	8.40E-01
catecholamine transport (GO:0051937)	2	0	.35	-	 < 0.01	7.06E-01
glutamine biosynthetic process (GO:0006542)	2	0	.35	-	 < 0.01	7.06E-01
catecholamine uptake involved in synaptic transmission (GO:0051934)	1	0	.17	-	 < 0.01	8.40E-01
synaptic transmission, GABAergic (GO:0051932)	2	0	.35	-	 < 0.01	7.06E-01
translation reinitiation (GO:0002188)	2	0	.35	-	 < 0.01	7.06E-01
astral spindle assembly involved in male meiosis (GO:0055050)	2	0	.35	-	 < 0.01	7.06E-01
cytoplasmic translational initiation (GO:0002183)	4	0	.70	-	 < 0.01	4.98E-01
reticulophagy (GO:0061709)	2	0	.35	-	 < 0.01	7.06E-01
glutamate catabolic process via 2-oxoglutarate (GO:0006539)	1	0	.17	-	 < 0.01	8.40E-01
purine nucleobase salvage (GO:0043096)	1	0	.17	-	 < 0.01	8.40E-01
cysteine biosynthetic process from serine (GO:0006535)	1	0	.17	-	 < 0.01	8.40E-01
aspartate catabolic process (GO:0006533)	1	0	.17	-	 < 0.01	8.40E-01
aspartate biosynthetic process (GO:0006532)	1	0	.17	-	 < 0.01	8.40E-01
aspartate metabolic process (GO:0006531)	2	0	.35	-	 < 0.01	7.06E-01
astral spindle assembly (GO:0055049)	2	0	.35	-	 < 0.01	7.06E-01
generative cell mitosis (GO:0055047)	1	0	.17	-	 < 0.01	8.40E-01
t-circle formation (GO:0090656)	1	0	.17	-	 < 0.01	8.40E-01
asparagine biosynthetic process (GO:0006529)	1	0	.17	-	 < 0.01	8.40E-01
asparagine metabolic process (GO:0006528)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cellular amino acid metabolic process (GO:0006521)	1	0	.17	-	 < 0.01	8.40E-01
gastric emptying (GO:0035483)	1	0	.17	-	 < 0.01	8.40E-01
gastric motility (GO:0035482)	1	0	.17	-	 < 0.01	8.40E-01
mitochondrial tRNA processing (GO:0090646)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mitochondrial depolarization (GO:0051900)	2	0	.35	-	 < 0.01	7.06E-01
GPI anchor release (GO:0006507)	1	0	.17	-	 < 0.01	8.40E-01
N-terminal protein palmitoylation (GO:0006500)	1	0	.17	-	 < 0.01	8.40E-01
cardiac muscle cell development (GO:0055013)	2	0	.35	-	 < 0.01	7.06E-01
protein palmitoleylation (GO:0045234)	1	0	.17	-	 < 0.01	8.40E-01
regulation of forward locomotion (GO:0043059)	1	0	.17	-	 < 0.01	8.40E-01
cell junction disassembly (GO:0150146)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of BMP secretion (GO:2001285)	1	0	.17	-	 < 0.01	8.40E-01
regulation of BMP secretion (GO:2001284)	2	0	.35	-	 < 0.01	7.06E-01
Roundabout signaling pathway involved in muscle cell chemotaxis toward tendon cell (GO:2001283)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of muscle cell chemotaxis toward tendon cell (GO:2001282)	1	0	.17	-	 < 0.01	8.40E-01
regulation of muscle cell chemotaxis toward tendon cell (GO:2001281)	1	0	.17	-	 < 0.01	8.40E-01
cardiac muscle cell differentiation (GO:0055007)	3	0	.52	-	 < 0.01	5.93E-01
cardiac cell development (GO:0055006)	2	0	.35	-	 < 0.01	7.06E-01
regeneration (GO:0031099)	23	0	4.01	-	 < 0.01	1.80E-02
DNA methylation involved in embryo development (GO:0043045)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272)	3	0	.52	-	 < 0.01	5.93E-01
amino acid adenylylation by nonribosomal peptide synthase (GO:0043042)	1	0	.17	-	 < 0.01	8.40E-01
amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041)	1	0	.17	-	 < 0.01	8.40E-01
dipeptide transmembrane transport (GO:0035442)	1	0	.17	-	 < 0.01	8.40E-01
regulation of nuclear cell cycle DNA replication (GO:0033262)	1	0	.17	-	 < 0.01	8.40E-01
nuclear DNA replication (GO:0033260)	16	0	2.79	-	 < 0.01	6.12E-02
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)	3	0	.52	-	 < 0.01	5.93E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)	3	0	.52	-	 < 0.01	5.93E-01
tRNA aminoacylation (GO:0043039)	3	0	.52	-	 < 0.01	5.93E-01
amino acid activation (GO:0043038)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of semaphorin-plexin signaling pathway (GO:2001262)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of semaphorin-plexin signaling pathway (GO:2001261)	1	0	.17	-	 < 0.01	8.40E-01
regulation of semaphorin-plexin signaling pathway (GO:2001260)	2	0	.35	-	 < 0.01	7.06E-01
maintenance of protein localization in endoplasmic reticulum (GO:0035437)	3	0	.52	-	 < 0.01	5.93E-01
copper ion transmembrane transport (GO:0035434)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of cell-substrate junction organization (GO:0150118)	1	0	.17	-	 < 0.01	8.40E-01
carnitine transport (GO:0015879)	1	0	.17	-	 < 0.01	8.40E-01
regulation of store-operated calcium entry (GO:2001256)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell-substrate junction organization (GO:0150116)	2	0	.35	-	 < 0.01	7.06E-01
establishment of neuroblast polarity (GO:0045200)	2	0	.35	-	 < 0.01	7.06E-01
norepinephrine transport (GO:0015874)	1	0	.17	-	 < 0.01	8.40E-01
dopamine transport (GO:0015872)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of histone deacetylation (GO:0031065)	1	0	.17	-	 < 0.01	8.40E-01
regulation of histone deacetylation (GO:0031063)	1	0	.17	-	 < 0.01	8.40E-01
purine ribonucleotide transport (GO:0015868)	4	0	.70	-	 < 0.01	4.98E-01
ATP transport (GO:0015867)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to cell-cell junction (GO:0150105)	4	0	.70	-	 < 0.01	4.98E-01
ADP transport (GO:0015866)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	1	0	.17	-	 < 0.01	8.40E-01
purine nucleotide transport (GO:0015865)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cellular amine metabolic process (GO:0033239)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cellular amine metabolic process (GO:0033238)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of protein sumoylation (GO:0033234)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein sumoylation (GO:0033233)	1	0	.17	-	 < 0.01	8.40E-01
pre-miRNA processing (GO:0031054)	4	0	.70	-	 < 0.01	4.98E-01
primary miRNA processing (GO:0031053)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	1	0	.17	-	 < 0.01	8.40E-01
dsRNA processing (GO:0031050)	15	0	2.62	-	 < 0.01	7.29E-02
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	1	0	.17	-	 < 0.01	8.40E-01
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	3	0	.52	-	 < 0.01	5.93E-01
glutamate receptor clustering (GO:0097688)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of apoptotic signaling pathway (GO:2001235)	3	0	.52	-	 < 0.01	5.93E-01
maintenance of rDNA (GO:0043007)	1	0	.17	-	 < 0.01	8.40E-01
organic hydroxy compound transport (GO:0015850)	12	0	2.09	-	 < 0.01	1.23E-01
protein localization to presynapse (GO:1905383)	1	0	.17	-	 < 0.01	8.40E-01
heterochromatin assembly by small RNA (GO:0031048)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of response to gamma radiation (GO:2001229)	4	0	.70	-	 < 0.01	4.98E-01
regulation of response to gamma radiation (GO:2001228)	4	0	.70	-	 < 0.01	4.98E-01
histone H3-K36 dimethylation (GO:0097676)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of neuron migration (GO:2001223)	1	0	.17	-	 < 0.01	8.40E-01
monoamine transport (GO:0015844)	3	0	.52	-	 < 0.01	5.93E-01
regulation of neuron migration (GO:2001222)	1	0	.17	-	 < 0.01	8.40E-01
reductive iron assimilation (GO:0033215)	1	0	.17	-	 < 0.01	8.40E-01
myosin II filament organization (GO:0031038)	2	0	.35	-	 < 0.01	7.06E-01
adiponectin-activated signaling pathway (GO:0033211)	1	0	.17	-	 < 0.01	8.40E-01
myosin II filament assembly (GO:0031036)	2	0	.35	-	 < 0.01	7.06E-01
myosin filament assembly (GO:0031034)	8	0	1.40	-	 < 0.01	2.48E-01
myosin filament organization (GO:0031033)	8	0	1.40	-	 < 0.01	2.48E-01
amino-acid betaine transport (GO:0015838)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation by host of viral process (GO:0044794)	1	0	.17	-	 < 0.01	8.40E-01
glyoxal metabolic process (GO:1903189)	2	0	.35	-	 < 0.01	7.06E-01
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	2	0	.35	-	 < 0.01	7.06E-01
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	2	0	.35	-	 < 0.01	7.06E-01
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	2	0	.35	-	 < 0.01	7.06E-01
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	2	0	.35	-	 < 0.01	7.06E-01
interphase microtubule organizing center assembly (GO:0031024)	1	0	.17	-	 < 0.01	8.40E-01
cytosol to endoplasmic reticulum transport (GO:0046967)	1	0	.17	-	 < 0.01	8.40E-01
3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963)	2	0	.35	-	 < 0.01	7.06E-01
proline transport (GO:0015824)	1	0	.17	-	 < 0.01	8.40E-01
modulation by host of viral process (GO:0044788)	1	0	.17	-	 < 0.01	8.40E-01
sensitization (GO:0046960)	1	0	.17	-	 < 0.01	8.40E-01
ornithine transport (GO:0015822)	1	0	.17	-	 < 0.01	8.40E-01
leucine transport (GO:0015820)	3	0	.52	-	 < 0.01	5.93E-01
G1 DNA damage checkpoint (GO:0044783)	2	0	.35	-	 < 0.01	7.06E-01
purine ribonucleoside monophosphate catabolic process (GO:0009169)	2	0	.35	-	 < 0.01	7.06E-01
nucleotide catabolic process (GO:0009166)	8	0	1.40	-	 < 0.01	2.48E-01
deoxyribonucleoside monophosphate metabolic process (GO:0009162)	2	0	.35	-	 < 0.01	7.06E-01
glycine transport (GO:0015816)	1	0	.17	-	 < 0.01	8.40E-01
ciliary transition zone assembly (GO:1905349)	4	0	.70	-	 < 0.01	4.98E-01
ketone body catabolic process (GO:0046952)	1	0	.17	-	 < 0.01	8.40E-01
meiotic DNA integrity checkpoint (GO:0044778)	1	0	.17	-	 < 0.01	8.40E-01
cellular ketone body metabolic process (GO:0046950)	1	0	.17	-	 < 0.01	8.40E-01
gamma-aminobutyric acid transport (GO:0015812)	2	0	.35	-	 < 0.01	7.06E-01
protein localization to cleavage furrow (GO:1905345)	2	0	.35	-	 < 0.01	7.06E-01
mitotic DNA damage checkpoint (GO:0044773)	17	0	2.96	-	 < 0.01	5.14E-02
meiotic cell cycle phase transition (GO:0044771)	3	0	.52	-	 < 0.01	5.93E-01
ribonucleoside monophosphate catabolic process (GO:0009158)	3	0	.52	-	 < 0.01	5.93E-01
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	2	0	.35	-	 < 0.01	7.06E-01
purine deoxyribonucleotide catabolic process (GO:0009155)	1	0	.17	-	 < 0.01	8.40E-01
purine ribonucleotide catabolic process (GO:0009154)	5	0	.87	-	 < 0.01	4.18E-01
purine deoxyribonucleotide metabolic process (GO:0009151)	1	0	.17	-	 < 0.01	8.40E-01
acrosome assembly (GO:0001675)	2	0	.35	-	 < 0.01	7.06E-01
arginine transport (GO:0015809)	1	0	.17	-	 < 0.01	8.40E-01
L-arginine import across plasma membrane (GO:0097638)	1	0	.17	-	 < 0.01	8.40E-01
neutral amino acid transport (GO:0015804)	5	0	.87	-	 < 0.01	4.18E-01
branched-chain amino acid transport (GO:0015803)	3	0	.52	-	 < 0.01	5.93E-01
basic amino acid transport (GO:0015802)	1	0	.17	-	 < 0.01	8.40E-01
multi-organism cellular process (GO:0044764)	1	0	.17	-	 < 0.01	8.40E-01
pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	1	0	.17	-	 < 0.01	8.40E-01
purine nucleoside triphosphate catabolic process (GO:0009146)	1	0	.17	-	 < 0.01	8.40E-01
nucleoside triphosphate catabolic process (GO:0009143)	2	0	.35	-	 < 0.01	7.06E-01
conditioned taste aversion (GO:0001661)	3	0	.52	-	 < 0.01	5.93E-01
pore complex assembly (GO:0046931)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of autophagy of mitochondrion (GO:1903147)	1	0	.17	-	 < 0.01	8.40E-01
nucleoside diphosphate catabolic process (GO:0009134)	1	0	.17	-	 < 0.01	8.40E-01
histone H3-R2 methylation (GO:0034970)	1	0	.17	-	 < 0.01	8.40E-01
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of CREB transcription factor activity (GO:0032793)	1	0	.17	-	 < 0.01	8.40E-01
ribosome disassembly (GO:0032790)	3	0	.52	-	 < 0.01	5.93E-01
mature miRNA 3'-end processing (GO:0044747)	1	0	.17	-	 < 0.01	8.40E-01
pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	4	0	.70	-	 < 0.01	4.98E-01
purine nucleoside monophosphate catabolic process (GO:0009128)	2	0	.35	-	 < 0.01	7.06E-01
nucleoside monophosphate catabolic process (GO:0009125)	3	0	.52	-	 < 0.01	5.93E-01
box C/D snoRNA processing (GO:0034963)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of ATPase activity (GO:0032781)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of cohesin loading (GO:1905309)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cardiac myofibril assembly (GO:1905306)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cardiac myofibril assembly (GO:1905304)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of autophagosome assembly (GO:2000786)	1	0	.17	-	 < 0.01	8.40E-01
regulation of autophagosome assembly (GO:2000785)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of double-strand break repair (GO:2000780)	1	0	.17	-	 < 0.01	8.40E-01
xanthine catabolic process (GO:0009115)	1	0	.17	-	 < 0.01	8.40E-01
purine nucleobase biosynthetic process (GO:0009113)	3	0	.52	-	 < 0.01	5.93E-01
vitamin biosynthetic process (GO:0009110)	6	0	1.05	-	 < 0.01	3.51E-01
DNA methylation or demethylation (GO:0044728)	3	0	.52	-	 < 0.01	5.93E-01
tetrahydrofolylpolyglutamate metabolic process (GO:0046900)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of imaginal disc-derived wing size (GO:0044720)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of actin filament-based movement (GO:1903116)	2	0	.35	-	 < 0.01	7.06E-01
regulation of actin filament-based movement (GO:1903115)	2	0	.35	-	 < 0.01	7.06E-01
hemoglobin biosynthetic process (GO:0042541)	1	0	.17	-	 < 0.01	8.40E-01
lipoate biosynthetic process (GO:0009107)	1	0	.17	-	 < 0.01	8.40E-01
lipoate metabolic process (GO:0009106)	1	0	.17	-	 < 0.01	8.40E-01
p38MAPK cascade (GO:0038066)	3	0	.52	-	 < 0.01	5.93E-01
NIK/NF-kappaB signaling (GO:0038061)	3	0	.52	-	 < 0.01	5.93E-01
hypotonic salinity response (GO:0042539)	1	0	.17	-	 < 0.01	8.40E-01
hyperosmotic salinity response (GO:0042538)	1	0	.17	-	 < 0.01	8.40E-01
benzene-containing compound metabolic process (GO:0042537)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of BMP signaling pathway by negative regulation of BMP secretion (GO:0038056)	1	0	.17	-	 < 0.01	8.40E-01
ubiquitin-dependent SMAD protein catabolic process (GO:0030579)	1	0	.17	-	 < 0.01	8.40E-01
Cajal body organization (GO:0030576)	5	0	.87	-	 < 0.01	4.18E-01
collagen catabolic process (GO:0030574)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of peptidyl-lysine acetylation (GO:2000758)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of peptidyl-lysine acetylation (GO:2000757)	1	0	.17	-	 < 0.01	8.40E-01
regulation of peptidyl-lysine acetylation (GO:2000756)	10	0	1.74	-	 < 0.01	1.75E-01
cellular hypotonic salinity response (GO:0071477)	1	0	.17	-	 < 0.01	8.40E-01
cellular hypotonic response (GO:0071476)	1	0	.17	-	 < 0.01	8.40E-01
cellular hyperosmotic salinity response (GO:0071475)	1	0	.17	-	 < 0.01	8.40E-01
cellular hyperosmotic response (GO:0071474)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to salt stress (GO:0071472)	2	0	.35	-	 < 0.01	7.06E-01
cellular response to osmotic stress (GO:0071470)	3	0	.52	-	 < 0.01	5.93E-01
regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to desiccation (GO:0071465)	1	0	.17	-	 < 0.01	8.40E-01
regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998)	3	0	.52	-	 < 0.01	5.93E-01
response to auditory stimulus (GO:0010996)	5	0	.87	-	 < 0.01	4.18E-01
free ubiquitin chain depolymerization (GO:0010995)	1	0	.17	-	 < 0.01	8.40E-01
ubiquitin recycling (GO:0010992)	2	0	.35	-	 < 0.01	7.06E-01
cellular response to superoxide (GO:0071451)	4	0	.70	-	 < 0.01	4.98E-01
cellular response to oxygen radical (GO:0071450)	4	0	.70	-	 < 0.01	4.98E-01
membrane depolarization (GO:0051899)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of focal adhesion assembly (GO:0051895)	1	0	.17	-	 < 0.01	8.40E-01
regulation of focal adhesion assembly (GO:0051893)	2	0	.35	-	 < 0.01	7.06E-01
cellular response to pheromone (GO:0071444)	1	0	.17	-	 < 0.01	8.40E-01
excitatory synapse assembly (GO:1904861)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of receptor localization to synapse (GO:1902685)	1	0	.17	-	 < 0.01	8.40E-01
netrin-activated signaling pathway (GO:0038007)	2	0	.35	-	 < 0.01	7.06E-01
regulation of receptor localization to synapse (GO:1902683)	1	0	.17	-	 < 0.01	8.40E-01
epidermal growth factor receptor ligand maturation (GO:0038004)	6	0	1.05	-	 < 0.01	3.51E-01
endocrine signaling (GO:0038002)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	5	0	.87	-	 < 0.01	4.18E-01
N-terminal protein myristoylation (GO:0006499)	1	0	.17	-	 < 0.01	8.40E-01
N-terminal protein lipidation (GO:0006498)	2	0	.35	-	 < 0.01	7.06E-01
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	3	0	.52	-	 < 0.01	5.93E-01
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431)	1	0	.17	-	 < 0.01	8.40E-01
regulation of microtubule nucleation (GO:0010968)	1	0	.17	-	 < 0.01	8.40E-01
selenocysteine biosynthetic process (GO:0016260)	2	0	.35	-	 < 0.01	7.06E-01
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	1	0	.17	-	 < 0.01	8.40E-01
C-terminal protein methylation (GO:0006481)	1	0	.17	-	 < 0.01	8.40E-01
N-terminal protein amino acid methylation (GO:0006480)	1	0	.17	-	 < 0.01	8.40E-01
selenocysteine metabolic process (GO:0016259)	2	0	.35	-	 < 0.01	7.06E-01
attachment of GPI anchor to protein (GO:0016255)	3	0	.52	-	 < 0.01	5.93E-01
pyrimidine-containing compound salvage (GO:0008655)	1	0	.17	-	 < 0.01	8.40E-01
chemorepulsion of axon (GO:0061643)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of macroautophagy (GO:0016242)	8	0	1.40	-	 < 0.01	2.48E-01
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067)	8	0	1.40	-	 < 0.01	2.48E-01
regulation of protein complex stability (GO:0061635)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of necrotic cell death (GO:0010940)	3	0	.52	-	 < 0.01	5.93E-01
phosphatidylinositol 3-kinase signaling (GO:0014065)	6	0	1.05	-	 < 0.01	3.51E-01
DNA synthesis involved in DNA replication (GO:0090592)	2	0	.35	-	 < 0.01	7.06E-01
modulation by host of symbiont process (GO:0051851)	2	0	.35	-	 < 0.01	7.06E-01
protein localization to microtubule plus-end (GO:1904825)	1	0	.17	-	 < 0.01	8.40E-01
regulation of necrotic cell death (GO:0010939)	4	0	.70	-	 < 0.01	4.98E-01
lysosomal microautophagy (GO:0016237)	4	0	.70	-	 < 0.01	4.98E-01
establishment of epithelial cell apical/basal polarity (GO:0045198)	5	0	.87	-	 < 0.01	4.18E-01
telomere capping (GO:0016233)	11	0	1.92	-	 < 0.01	1.47E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)	1	0	.17	-	 < 0.01	8.40E-01
translational readthrough (GO:0006451)	2	0	.35	-	 < 0.01	7.06E-01
regulation of translational fidelity (GO:0006450)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of receptor internalization (GO:0002092)	5	0	.87	-	 < 0.01	4.18E-01
regulation of receptor internalization (GO:0002090)	6	0	1.05	-	 < 0.01	3.51E-01
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	1	0	.17	-	 < 0.01	8.40E-01
dsDNA loop formation (GO:0090579)	3	0	.52	-	 < 0.01	5.93E-01
regulation of translational termination (GO:0006449)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of neuron maturation (GO:0014043)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of neuron remodeling (GO:1904800)	1	0	.17	-	 < 0.01	8.40E-01
protein depalmitoylation (GO:0002084)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of isomerase activity (GO:0010912)	2	0	.35	-	 < 0.01	7.06E-01
pyridoxine biosynthetic process (GO:0008615)	1	0	.17	-	 < 0.01	8.40E-01
regulation of isomerase activity (GO:0010911)	2	0	.35	-	 < 0.01	7.06E-01
pyridoxine metabolic process (GO:0008614)	1	0	.17	-	 < 0.01	8.40E-01
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	1	0	.17	-	 < 0.01	8.40E-01
ether lipid biosynthetic process (GO:0008611)	1	0	.17	-	 < 0.01	8.40E-01
phenylalanyl-tRNA aminoacylation (GO:0006432)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of glucose metabolic process (GO:0010907)	4	0	.70	-	 < 0.01	4.98E-01
regulation of striated muscle tissue development (GO:0016202)	5	0	.87	-	 < 0.01	4.18E-01
synaptic target inhibition (GO:0016201)	13	0	2.27	-	 < 0.01	1.03E-01
regulation of Roundabout signaling pathway (GO:0035386)	1	0	.17	-	 < 0.01	8.40E-01
modulation of process of other organism involved in symbiotic interaction (GO:0051817)	2	0	.35	-	 < 0.01	7.06E-01
Roundabout signaling pathway (GO:0035385)	3	0	.52	-	 < 0.01	5.93E-01
neuron death (GO:0070997)	2	0	.35	-	 < 0.01	7.06E-01
neuroblast development (GO:0014019)	19	0	3.31	-	 < 0.01	3.62E-02
alanyl-tRNA aminoacylation (GO:0006419)	1	0	.17	-	 < 0.01	8.40E-01
tRNA aminoacylation for protein translation (GO:0006418)	3	0	.52	-	 < 0.01	5.93E-01
protein localization to microtubule (GO:0035372)	1	0	.17	-	 < 0.01	8.40E-01
oxidative demethylation (GO:0070989)	1	0	.17	-	 < 0.01	8.40E-01
error-free translesion synthesis (GO:0070987)	1	0	.17	-	 < 0.01	8.40E-01
left/right axis specification (GO:0070986)	1	0	.17	-	 < 0.01	8.40E-01
glial cell proliferation (GO:0014009)	3	0	.52	-	 < 0.01	5.93E-01
meiotic sister chromatid segregation (GO:0045144)	8	0	1.40	-	 < 0.01	2.48E-01
basement membrane assembly involved in embryonic body morphogenesis (GO:2001197)	1	0	.17	-	 < 0.01	8.40E-01
tRNA export from nucleus (GO:0006409)	1	0	.17	-	 < 0.01	8.40E-01
RNA import into nucleus (GO:0006404)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of histone ubiquitination (GO:0033184)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cellular response to oxidative stress (GO:1900408)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to endoplasmic reticulum exit site (GO:0070973)	1	0	.17	-	 < 0.01	8.40E-01
smooth septate junction assembly (GO:0090528)	2	0	.35	-	 < 0.01	7.06E-01
actin filament reorganization (GO:0090527)	7	0	1.22	-	 < 0.01	2.95E-01
vesicle tethering involved in exocytosis (GO:0090522)	4	0	.70	-	 < 0.01	4.98E-01
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)	1	0	.17	-	 < 0.01	8.40E-01
nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of ATP biosynthetic process (GO:2001171)	2	0	.35	-	 < 0.01	7.06E-01
UDP-xylose transmembrane transport (GO:0015790)	2	0	.35	-	 < 0.01	7.06E-01
histone H3-K9 demethylation (GO:0033169)	3	0	.52	-	 < 0.01	5.93E-01
conversion of ds siRNA to ss siRNA involved in RNA interference (GO:0033168)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of histone H2B ubiquitination (GO:2001168)	1	0	.17	-	 < 0.01	8.40E-01
UDP-glucuronic acid transmembrane transport (GO:0015787)	1	0	.17	-	 < 0.01	8.40E-01
UDP-glucose transmembrane transport (GO:0015786)	1	0	.17	-	 < 0.01	8.40E-01
epiboly involved in wound healing (GO:0090505)	4	0	.70	-	 < 0.01	4.98E-01
epiboly (GO:0090504)	4	0	.70	-	 < 0.01	4.98E-01
GDP-fucose transmembrane transport (GO:0015783)	2	0	.35	-	 < 0.01	7.06E-01
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	1	0	.17	-	 < 0.01	8.40E-01
Notch receptor processing, ligand-dependent (GO:0035333)	3	0	.52	-	 < 0.01	5.93E-01
regulation of translation at postsynapse (GO:0140245)	1	0	.17	-	 < 0.01	8.40E-01
regulation of translation at synapse (GO:0140243)	1	0	.17	-	 < 0.01	8.40E-01
hippo signaling (GO:0035329)	9	0	1.57	-	 < 0.01	2.08E-01
sucrose transport (GO:0015770)	1	0	.17	-	 < 0.01	8.40E-01
postsynaptic endocytosis (GO:0140239)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	1	0	.17	-	 < 0.01	8.40E-01
regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	1	0	.17	-	 < 0.01	8.40E-01
trehalose catabolic process (GO:0005993)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	2	0	.35	-	 < 0.01	7.06E-01
trehalose biosynthetic process (GO:0005992)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	1	0	.17	-	 < 0.01	8.40E-01
trehalose metabolic process (GO:0005991)	3	0	.52	-	 < 0.01	5.93E-01
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	4	0	.70	-	 < 0.01	4.98E-01
membrane depolarization during action potential (GO:0086010)	3	0	.52	-	 < 0.01	5.93E-01
3'-UTR-mediated mRNA stabilization (GO:0070935)	1	0	.17	-	 < 0.01	8.40E-01
histone H4 deacetylation (GO:0070933)	1	0	.17	-	 < 0.01	8.40E-01
histone H3 deacetylation (GO:0070932)	3	0	.52	-	 < 0.01	5.93E-01
clathrin-dependent synaptic vesicle endocytosis (GO:0150007)	7	0	1.22	-	 < 0.01	2.95E-01
imaginal disc-derived wing hair outgrowth (GO:0035318)	1	0	.17	-	 < 0.01	8.40E-01
scab formation (GO:0035314)	2	0	.35	-	 < 0.01	7.06E-01
wound healing, spreading of epidermal cells (GO:0035313)	3	0	.52	-	 < 0.01	5.93E-01
sucrose biosynthetic process (GO:0005986)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of peptidyl-serine phosphorylation (GO:0033138)	1	0	.17	-	 < 0.01	8.40E-01
wing cell fate specification (GO:0035311)	3	0	.52	-	 < 0.01	5.93E-01
sucrose metabolic process (GO:0005985)	1	0	.17	-	 < 0.01	8.40E-01
notum cell fate specification (GO:0035310)	5	0	.87	-	 < 0.01	4.18E-01
disaccharide metabolic process (GO:0005984)	4	0	.70	-	 < 0.01	4.98E-01
regulation of peptidyl-serine phosphorylation (GO:0033135)	1	0	.17	-	 < 0.01	8.40E-01
siRNA loading onto RISC involved in chromatin silencing by small RNA (GO:0070923)	2	0	.35	-	 < 0.01	7.06E-01
small RNA loading onto RISC (GO:0070922)	9	0	1.57	-	 < 0.01	2.08E-01
negative regulation of endocytic recycling (GO:2001136)	2	0	.35	-	 < 0.01	7.06E-01
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920)	3	0	.52	-	 < 0.01	5.93E-01
regulation of endocytic recycling (GO:2001135)	4	0	.70	-	 < 0.01	4.98E-01
wing and notum subfield formation (GO:0035309)	12	0	2.09	-	 < 0.01	1.23E-01
glycogen biosynthetic process (GO:0005978)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of histone phosphorylation (GO:0033129)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of histone phosphorylation (GO:0033128)	2	0	.35	-	 < 0.01	7.06E-01
regulation of histone phosphorylation (GO:0033127)	3	0	.52	-	 < 0.01	5.93E-01
aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)	1	0	.17	-	 < 0.01	8.40E-01
production of small RNA involved in gene silencing by RNA (GO:0070918)	15	0	2.62	-	 < 0.01	7.29E-02
UV-damage excision repair (GO:0070914)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of hormone secretion (GO:0046887)	8	0	1.40	-	 < 0.01	2.48E-01
positive regulation of hormone biosynthetic process (GO:0046886)	4	0	.70	-	 < 0.01	4.98E-01
regulation of hormone biosynthetic process (GO:0046885)	8	0	1.40	-	 < 0.01	2.48E-01
citrate transport (GO:0015746)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of CENP-A containing nucleosome assembly (GO:1903099)	1	0	.17	-	 < 0.01	8.40E-01
regulation of CENP-A containing nucleosome assembly (GO:1903097)	1	0	.17	-	 < 0.01	8.40E-01
lysine biosynthetic process (GO:0009085)	1	0	.17	-	 < 0.01	8.40E-01
hormone secretion (GO:0046879)	1	0	.17	-	 < 0.01	8.40E-01
quinolinate metabolic process (GO:0046874)	1	0	.17	-	 < 0.01	8.40E-01
taurine transport (GO:0015734)	1	0	.17	-	 < 0.01	8.40E-01
aromatic amino acid family biosynthetic process (GO:0009073)	1	0	.17	-	 < 0.01	8.40E-01
serine family amino acid catabolic process (GO:0009071)	1	0	.17	-	 < 0.01	8.40E-01
carotenoid transport (GO:0046867)	1	0	.17	-	 < 0.01	8.40E-01
tetraterpenoid transport (GO:0046866)	1	0	.17	-	 < 0.01	8.40E-01
terpenoid transport (GO:0046865)	2	0	.35	-	 < 0.01	7.06E-01
isoprenoid transport (GO:0046864)	2	0	.35	-	 < 0.01	7.06E-01
formate transport (GO:0015724)	1	0	.17	-	 < 0.01	8.40E-01
mitochondrial double-strand break repair via homologous recombination (GO:0097552)	1	0	.17	-	 < 0.01	8.40E-01
mitochondrial double-strand break repair (GO:0097551)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of protein localization to plasma membrane (GO:1903077)	1	0	.17	-	 < 0.01	8.40E-01
aspartate family amino acid catabolic process (GO:0009068)	1	0	.17	-	 < 0.01	8.40E-01
monocarboxylic acid transport (GO:0015718)	15	0	2.62	-	 < 0.01	7.29E-02
detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)	2	0	.35	-	 < 0.01	7.06E-01
regulation of modification of synaptic structure (GO:1905244)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of protein lipidation (GO:1903061)	2	0	.35	-	 < 0.01	7.06E-01
pentose-phosphate shunt, oxidative branch (GO:0009051)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein lipidation (GO:1903059)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of eye photoreceptor cell development (GO:0042480)	3	0	.52	-	 < 0.01	5.93E-01
response to protozoan (GO:0001562)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of acetylcholine-gated cation channel activity (GO:1903049)	1	0	.17	-	 < 0.01	8.40E-01
regulation of acetylcholine-gated cation channel activity (GO:1903048)	1	0	.17	-	 < 0.01	8.40E-01
oocyte maturation (GO:0001556)	4	0	.70	-	 < 0.01	4.98E-01
oocyte growth (GO:0001555)	6	0	1.05	-	 < 0.01	3.51E-01
positive regulation of protein export from nucleus (GO:0046827)	1	0	.17	-	 < 0.01	8.40E-01
histone H3-K4 dimethylation (GO:0044648)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of small molecule metabolic process (GO:0062014)	1	0	.17	-	 < 0.01	8.40E-01
mannosylation (GO:0097502)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of cellular response to X-ray (GO:2000685)	2	0	.35	-	 < 0.01	7.06E-01
regulation of cellular response to X-ray (GO:2000683)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of glycoprotein metabolic process (GO:1903020)	2	0	.35	-	 < 0.01	7.06E-01
heteroduplex formation (GO:0030491)	1	0	.17	-	 < 0.01	8.40E-01
regulation of glycoprotein metabolic process (GO:1903018)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of motor neuron apoptotic process (GO:2000672)	1	0	.17	-	 < 0.01	8.40E-01
regulation of motor neuron apoptotic process (GO:2000671)	1	0	.17	-	 < 0.01	8.40E-01
ethanolamine-containing compound metabolic process (GO:0042439)	3	0	.52	-	 < 0.01	5.93E-01
melanin biosynthetic process (GO:0042438)	4	0	.70	-	 < 0.01	4.98E-01
indole-containing compound catabolic process (GO:0042436)	2	0	.35	-	 < 0.01	7.06E-01
indole-containing compound biosynthetic process (GO:0042435)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of protein deubiquitination (GO:1903003)	1	0	.17	-	 < 0.01	8.40E-01
indole-containing compound metabolic process (GO:0042430)	7	0	1.22	-	 < 0.01	2.95E-01
prostaglandin biosynthetic process (GO:0001516)	1	0	.17	-	 < 0.01	8.40E-01
selenocysteine incorporation (GO:0001514)	1	0	.17	-	 < 0.01	8.40E-01
nuclear migration along microtubule (GO:0030473)	1	0	.17	-	 < 0.01	8.40E-01
protein deadenylylation (GO:0044602)	1	0	.17	-	 < 0.01	8.40E-01
serotonin metabolic process (GO:0042428)	2	0	.35	-	 < 0.01	7.06E-01
protein denucleotidylation (GO:0044601)	1	0	.17	-	 < 0.01	8.40E-01
serotonin biosynthetic process (GO:0042427)	2	0	.35	-	 < 0.01	7.06E-01
choline catabolic process (GO:0042426)	1	0	.17	-	 < 0.01	8.40E-01
catecholamine catabolic process (GO:0042424)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	1	0	.17	-	 < 0.01	8.40E-01
norepinephrine biosynthetic process (GO:0042421)	2	0	.35	-	 < 0.01	7.06E-01
dopamine catabolic process (GO:0042420)	2	0	.35	-	 < 0.01	7.06E-01
action potential (GO:0001508)	6	0	1.05	-	 < 0.01	3.51E-01
acetylcholine catabolic process in synaptic cleft (GO:0001507)	1	0	.17	-	 < 0.01	8.40E-01
neurotransmitter uptake (GO:0001504)	3	0	.52	-	 < 0.01	5.93E-01
regulation of sodium ion transmembrane transporter activity (GO:2000649)	2	0	.35	-	 < 0.01	7.06E-01
norepinephrine metabolic process (GO:0042415)	2	0	.35	-	 < 0.01	7.06E-01
cristae formation (GO:0042407)	2	0	.35	-	 < 0.01	7.06E-01
regulation of asymmetric protein localization involved in cell fate determination (GO:1904785)	1	0	.17	-	 < 0.01	8.40E-01
protein myristoylation (GO:0018377)	1	0	.17	-	 < 0.01	8.40E-01
cellular biogenic amine catabolic process (GO:0042402)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of triglyceride catabolic process (GO:0010898)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of triglyceride catabolic process (GO:0010897)	3	0	.52	-	 < 0.01	5.93E-01
regulation of triglyceride catabolic process (GO:0010896)	8	0	1.40	-	 < 0.01	2.48E-01
positive regulation of steroid biosynthetic process (GO:0010893)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of transcription by transcription factor localization (GO:0061586)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of sequestering of triglyceride (GO:0010891)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of sequestering of triglyceride (GO:0010890)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000624)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of protein localization to cell cortex (GO:1904778)	1	0	.17	-	 < 0.01	8.40E-01
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein localization to cell cortex (GO:1904776)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of histone H4-K16 acetylation (GO:2000620)	1	0	.17	-	 < 0.01	8.40E-01
peptidyl-glutamine methylation (GO:0018364)	1	0	.17	-	 < 0.01	8.40E-01
regulation of sequestering of triglyceride (GO:0010889)	6	0	1.05	-	 < 0.01	3.51E-01
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	3	0	.52	-	 < 0.01	5.93E-01
synaptic vesicle budding from endosome (GO:0016182)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	1	0	.17	-	 < 0.01	8.40E-01
mystery cell differentiation (GO:0008583)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of histone H4-K16 acetylation (GO:2000619)	1	0	.17	-	 < 0.01	8.40E-01
regulation of histone H4-K16 acetylation (GO:2000618)	2	0	.35	-	 < 0.01	7.06E-01
regulation of histone H3-K9 acetylation (GO:2000615)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of macroautophagy by TORC1 signaling (GO:1904766)	2	0	.35	-	 < 0.01	7.06E-01
lipid transport involved in lipid storage (GO:0010877)	1	0	.17	-	 < 0.01	8.40E-01
targeting of mRNA for destruction involved in RNA interference (GO:0030423)	3	0	.52	-	 < 0.01	5.93E-01
production of siRNA involved in RNA interference (GO:0030422)	12	0	2.09	-	 < 0.01	1.23E-01
termination of mitochondrial transcription (GO:0006393)	2	0	.35	-	 < 0.01	7.06E-01
transcription initiation from mitochondrial promoter (GO:0006391)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cell division (GO:0051781)	8	0	1.40	-	 < 0.01	2.48E-01
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	2	0	.35	-	 < 0.01	7.06E-01
protein geranylgeranylation (GO:0018344)	5	0	.87	-	 < 0.01	4.18E-01
protein farnesylation (GO:0018343)	1	0	.17	-	 < 0.01	8.40E-01
protein prenylation (GO:0018342)	5	0	.87	-	 < 0.01	4.18E-01
cellular response to fructose stimulus (GO:0071332)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of triglyceride biosynthetic process (GO:0010868)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of triglyceride biosynthetic process (GO:0010867)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of serine-type peptidase activity (GO:1902573)	1	0	.17	-	 < 0.01	8.40E-01
regulation of triglyceride biosynthetic process (GO:0010866)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of serine-type peptidase activity (GO:1902572)	1	0	.17	-	 < 0.01	8.40E-01
regulation of serine-type peptidase activity (GO:1902571)	2	0	.35	-	 < 0.01	7.06E-01
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	1	0	.17	-	 < 0.01	8.40E-01
transcription initiation from RNA polymerase III promoter (GO:0006384)	3	0	.52	-	 < 0.01	5.93E-01
adenosine to inosine editing (GO:0006382)	5	0	.87	-	 < 0.01	4.18E-01
response to redox state (GO:0051775)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to cAMP (GO:0071320)	2	0	.35	-	 < 0.01	7.06E-01
mRNA cleavage (GO:0006379)	7	0	1.22	-	 < 0.01	2.95E-01
mRNA splice site selection (GO:0006376)	3	0	.52	-	 < 0.01	5.93E-01
7-methylguanosine mRNA capping (GO:0006370)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of secondary metabolite biosynthetic process (GO:1900377)	1	0	.17	-	 < 0.01	8.40E-01
regulation of secondary metabolite biosynthetic process (GO:1900376)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)	4	0	.70	-	 < 0.01	4.98E-01
regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)	4	0	.70	-	 < 0.01	4.98E-01
visual learning (GO:0008542)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of RNA interference (GO:1900370)	1	0	.17	-	 < 0.01	8.40E-01
dopamine uptake (GO:0090494)	1	0	.17	-	 < 0.01	8.40E-01
catecholamine uptake (GO:0090493)	1	0	.17	-	 < 0.01	8.40E-01
termination of RNA polymerase I transcription (GO:0006363)	1	0	.17	-	 < 0.01	8.40E-01
transcription initiation from RNA polymerase I promoter (GO:0006361)	2	0	.35	-	 < 0.01	7.06E-01
meiotic sister chromatid cohesion, centromeric (GO:0051754)	4	0	.70	-	 < 0.01	4.98E-01
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315)	1	0	.17	-	 < 0.01	8.40E-01
glycoside catabolic process (GO:0016139)	2	0	.35	-	 < 0.01	7.06E-01
glycoside metabolic process (GO:0016137)	2	0	.35	-	 < 0.01	7.06E-01
regulation of RNA interference (GO:1900368)	1	0	.17	-	 < 0.01	8.40E-01
telomere maintenance via telomere lengthening (GO:0010833)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of mRNA polyadenylation (GO:1900364)	3	0	.52	-	 < 0.01	5.93E-01
regulation of mRNA polyadenylation (GO:1900363)	4	0	.70	-	 < 0.01	4.98E-01
purine nucleotide-sugar transmembrane transport (GO:0090480)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of centrosome duplication (GO:0010826)	1	0	.17	-	 < 0.01	8.40E-01
carotene catabolic process (GO:0016121)	1	0	.17	-	 < 0.01	8.40E-01
myeloid cell development (GO:0061515)	1	0	.17	-	 < 0.01	8.40E-01
regulation of gene expression by genetic imprinting (GO:0006349)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to cilium (GO:0061512)	6	0	1.05	-	 < 0.01	3.51E-01
chromatin silencing at telomere (GO:0006348)	4	0	.70	-	 < 0.01	4.98E-01
carotene metabolic process (GO:0016119)	1	0	.17	-	 < 0.01	8.40E-01
carotenoid metabolic process (GO:0016116)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cell-substrate adhesion (GO:0010812)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cell-substrate adhesion (GO:0010811)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of viral genome replication (GO:0045071)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of viral genome replication (GO:0045070)	1	0	.17	-	 < 0.01	8.40E-01
nucleosome disassembly (GO:0006337)	1	0	.17	-	 < 0.01	8.40E-01
DNA replication-dependent nucleosome assembly (GO:0006335)	1	0	.17	-	 < 0.01	8.40E-01
regulation of Malpighian tubule size (GO:0035298)	4	0	.70	-	 < 0.01	4.98E-01
regulation of Malpighian tubule diameter (GO:0035297)	3	0	.52	-	 < 0.01	5.93E-01
determination of wing disc primordium (GO:0035294)	1	0	.17	-	 < 0.01	8.40E-01
specification of segmental identity, intercalary segment (GO:0035291)	1	0	.17	-	 < 0.01	8.40E-01
tetraterpenoid metabolic process (GO:0016108)	1	0	.17	-	 < 0.01	8.40E-01
sesquiterpenoid biosynthetic process (GO:0016106)	1	0	.17	-	 < 0.01	8.40E-01
regulation of viral genome replication (GO:0045069)	5	0	.87	-	 < 0.01	4.18E-01
diterpenoid biosynthetic process (GO:0016102)	1	0	.17	-	 < 0.01	8.40E-01
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280)	1	0	.17	-	 < 0.01	8.40E-01
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of transposon integration (GO:0070896)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of transposon integration (GO:0070895)	1	0	.17	-	 < 0.01	8.40E-01
transcytosis (GO:0045056)	2	0	.35	-	 < 0.01	7.06E-01
regulation of transposon integration (GO:0070894)	2	0	.35	-	 < 0.01	7.06E-01
protein retention in Golgi apparatus (GO:0045053)	1	0	.17	-	 < 0.01	8.40E-01
protein insertion into ER membrane by GPI attachment sequence (GO:0045052)	1	0	.17	-	 < 0.01	8.40E-01
mRNA cleavage involved in gene silencing by miRNA (GO:0035279)	1	0	.17	-	 < 0.01	8.40E-01
miRNA mediated inhibition of translation (GO:0035278)	1	0	.17	-	 < 0.01	8.40E-01
mitotic recombination (GO:0006312)	5	0	.87	-	 < 0.01	4.18E-01
intraspecies interaction between organisms (GO:0051703)	6	0	1.05	-	 < 0.01	3.51E-01
interaction with symbiont (GO:0051702)	2	0	.35	-	 < 0.01	7.06E-01
interaction with host (GO:0051701)	1	0	.17	-	 < 0.01	8.40E-01
protein insertion into ER membrane (GO:0045048)	2	0	.35	-	 < 0.01	7.06E-01
apoptotic DNA fragmentation (GO:0006309)	9	0	1.57	-	 < 0.01	2.08E-01
DNA dealkylation involved in DNA repair (GO:0006307)	1	0	.17	-	 < 0.01	8.40E-01
DNA methylation (GO:0006306)	2	0	.35	-	 < 0.01	7.06E-01
DNA alkylation (GO:0006305)	2	0	.35	-	 < 0.01	7.06E-01
protein O-linked mannosylation (GO:0035269)	2	0	.35	-	 < 0.01	7.06E-01
DNA modification (GO:0006304)	4	0	.70	-	 < 0.01	4.98E-01
protein mannosylation (GO:0035268)	2	0	.35	-	 < 0.01	7.06E-01
double-strand break repair via nonhomologous end joining (GO:0006303)	5	0	.87	-	 < 0.01	4.18E-01
multicellular organism growth (GO:0035264)	11	0	1.92	-	 < 0.01	1.47E-01
genital disc sexually dimorphic development (GO:0035263)	5	0	.87	-	 < 0.01	4.18E-01
external genitalia morphogenesis (GO:0035261)	1	0	.17	-	 < 0.01	8.40E-01
internal genitalia morphogenesis (GO:0035260)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of glycogen metabolic process (GO:0070875)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	3	0	.52	-	 < 0.01	5.93E-01
quaternary ammonium group transport (GO:0015697)	1	0	.17	-	 < 0.01	8.40E-01
vitamin A biosynthetic process (GO:0035238)	1	0	.17	-	 < 0.01	8.40E-01
ionotropic glutamate receptor signaling pathway (GO:0035235)	3	0	.52	-	 < 0.01	5.93E-01
plasma membrane copper ion transport (GO:0015679)	1	0	.17	-	 < 0.01	8.40E-01
DNA replication proofreading (GO:0045004)	5	0	.87	-	 < 0.01	4.18E-01
copper ion import (GO:0015677)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.17	-	 < 0.01	8.40E-01
oxygen transport (GO:0015671)	1	0	.17	-	 < 0.01	8.40E-01
regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.17	-	 < 0.01	8.40E-01
determination of genital disc primordium (GO:0035225)	10	0	1.74	-	 < 0.01	1.75E-01
gas transport (GO:0015669)	1	0	.17	-	 < 0.01	8.40E-01
basement membrane assembly (GO:0070831)	6	0	1.05	-	 < 0.01	3.51E-01
positive regulation of integrin-mediated signaling pathway (GO:2001046)	2	0	.35	-	 < 0.01	7.06E-01
regulation of integrin-mediated signaling pathway (GO:2001044)	2	0	.35	-	 < 0.01	7.06E-01
regulation of vesicle size (GO:0097494)	3	0	.52	-	 < 0.01	5.93E-01
clypeo-labral disc development (GO:0035213)	5	0	.87	-	 < 0.01	4.18E-01
spermathecum morphogenesis (GO:0035211)	3	0	.52	-	 < 0.01	5.93E-01
heterochromatin maintenance (GO:0070829)	2	0	.35	-	 < 0.01	7.06E-01
chromatin maintenance (GO:0070827)	4	0	.70	-	 < 0.01	4.98E-01
dendrite extension (GO:0097484)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of hemocyte proliferation (GO:0035208)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of hemocyte proliferation (GO:0035207)	6	0	1.05	-	 < 0.01	3.51E-01
positive regulation of lamellocyte differentiation (GO:0035205)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of lamellocyte differentiation (GO:0035204)	9	0	1.57	-	 < 0.01	2.08E-01
regulation of lamellocyte differentiation (GO:0035203)	11	0	1.92	-	 < 0.01	1.47E-01
export across plasma membrane (GO:0140115)	5	0	.87	-	 < 0.01	4.18E-01
hydrogen sulfide biosynthetic process (GO:0070814)	1	0	.17	-	 < 0.01	8.40E-01
hydrogen sulfide metabolic process (GO:0070813)	1	0	.17	-	 < 0.01	8.40E-01
regulation of viral transcription (GO:0046782)	1	0	.17	-	 < 0.01	8.40E-01
regulation of response to drug (GO:2001023)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of response to DNA damage stimulus (GO:2001022)	5	0	.87	-	 < 0.01	4.18E-01
neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)	2	0	.35	-	 < 0.01	7.06E-01
axo-dendritic protein transport (GO:0099640)	2	0	.35	-	 < 0.01	7.06E-01
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	2	0	.35	-	 < 0.01	7.06E-01
epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013)	8	0	1.40	-	 < 0.01	2.48E-01
positive regulation of lysosomal protein catabolic process (GO:1905167)	1	0	.17	-	 < 0.01	8.40E-01
regulation of lysosomal protein catabolic process (GO:1905165)	1	0	.17	-	 < 0.01	8.40E-01
neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	2	0	.35	-	 < 0.01	7.06E-01
endosome to plasma membrane protein transport (GO:0099638)	3	0	.52	-	 < 0.01	5.93E-01
neurotransmitter receptor transport (GO:0099637)	7	0	1.22	-	 < 0.01	2.95E-01
protein localization to postsynaptic specialization membrane (GO:0099633)	2	0	.35	-	 < 0.01	7.06E-01
peripheral nervous system neuron axonogenesis (GO:0048936)	2	0	.35	-	 < 0.01	7.06E-01
peripheral nervous system neuron development (GO:0048935)	10	0	1.74	-	 < 0.01	1.75E-01
peripheral nervous system neuron differentiation (GO:0048934)	10	0	1.74	-	 < 0.01	1.75E-01
neurotransmitter receptor diffusion trapping (GO:0099628)	2	0	.35	-	 < 0.01	7.06E-01
lysosomal protein catabolic process (GO:1905146)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to acetylcholine (GO:1905145)	2	0	.35	-	 < 0.01	7.06E-01
response to acetylcholine (GO:1905144)	2	0	.35	-	 < 0.01	7.06E-01
[2Fe-2S] cluster assembly (GO:0044571)	2	0	.35	-	 < 0.01	7.06E-01
plasmatocyte differentiation (GO:0042387)	12	0	2.09	-	 < 0.01	1.23E-01
regulation of neurotransmitter receptor activity (GO:0099601)	4	0	.70	-	 < 0.01	4.98E-01
regulation of axo-dendritic protein transport (GO:1905126)	1	0	.17	-	 < 0.01	8.40E-01
vitamin K metabolic process (GO:0042373)	2	0	.35	-	 < 0.01	7.06E-01
vitamin K biosynthetic process (GO:0042371)	1	0	.17	-	 < 0.01	8.40E-01
histone H4-K20 trimethylation (GO:0034773)	2	0	.35	-	 < 0.01	7.06E-01
histone H4-K20 dimethylation (GO:0034772)	1	0	.17	-	 < 0.01	8.40E-01
histone H4-K20 methylation (GO:0034770)	2	0	.35	-	 < 0.01	7.06E-01
basement membrane disassembly (GO:0034769)	3	0	.52	-	 < 0.01	5.93E-01
water-soluble vitamin biosynthetic process (GO:0042364)	4	0	.70	-	 < 0.01	4.98E-01
fat-soluble vitamin biosynthetic process (GO:0042362)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of iron ion transmembrane transport (GO:0034761)	2	0	.35	-	 < 0.01	7.06E-01
viral entry into host cell (GO:0046718)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)	1	0	.17	-	 < 0.01	8.40E-01
regulation of iron ion transmembrane transport (GO:0034759)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of iron ion transport (GO:0034758)	2	0	.35	-	 < 0.01	7.06E-01
regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)	1	0	.17	-	 < 0.01	8.40E-01
regulation of iron ion transport (GO:0034756)	2	0	.35	-	 < 0.01	7.06E-01
'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	1	0	.17	-	 < 0.01	8.40E-01
GDP-L-fucose biosynthetic process (GO:0042350)	2	0	.35	-	 < 0.01	7.06E-01
membrane disassembly (GO:0030397)	2	0	.35	-	 < 0.01	7.06E-01
movement in host environment (GO:0052126)	1	0	.17	-	 < 0.01	8.40E-01
insecticide catabolic process (GO:0046701)	6	0	1.05	-	 < 0.01	3.51E-01
positive regulation of ATP-dependent microtubule motor activity, minus-end-directed (GO:2000579)	1	0	.17	-	 < 0.01	8.40E-01
regulation of ATP-dependent microtubule motor activity, minus-end-directed (GO:2000577)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of microtubule motor activity (GO:2000576)	2	0	.35	-	 < 0.01	7.06E-01
regulation of microtubule motor activity (GO:2000574)	5	0	.87	-	 < 0.01	4.18E-01
chorion-containing eggshell pattern formation (GO:0030381)	10	0	1.74	-	 < 0.01	1.75E-01
histone H3-K79 methylation (GO:0034729)	1	0	.17	-	 < 0.01	8.40E-01
piecemeal microautophagy of the nucleus (GO:0034727)	4	0	.70	-	 < 0.01	4.98E-01
DNA replication-dependent nucleosome organization (GO:0034723)	1	0	.17	-	 < 0.01	8.40E-01
histone H3-K4 demethylation, trimethyl-H3-K4-specific (GO:0034721)	2	0	.35	-	 < 0.01	7.06E-01
guanine nucleotide transport (GO:0001408)	1	0	.17	-	 < 0.01	8.40E-01
iron incorporation into metallo-sulfur cluster (GO:0018283)	1	0	.17	-	 < 0.01	8.40E-01
metal incorporation into metallo-sulfur cluster (GO:0018282)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell projection size (GO:0032536)	2	0	.35	-	 < 0.01	7.06E-01
regulation of follicle cell microvillus length (GO:0032533)	1	0	.17	-	 < 0.01	8.40E-01
regulation of microvillus length (GO:0032532)	1	0	.17	-	 < 0.01	8.40E-01
regulation of follicle cell microvillus organization (GO:0032531)	1	0	.17	-	 < 0.01	8.40E-01
regulation of microvillus organization (GO:0032530)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of protein import into nucleus (GO:0042308)	3	0	.52	-	 < 0.01	5.93E-01
protein N-linked glycosylation via asparagine (GO:0018279)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of metalloendopeptidase activity (GO:1904684)	1	0	.17	-	 < 0.01	8.40E-01
regulation of metalloendopeptidase activity (GO:1904683)	1	0	.17	-	 < 0.01	8.40E-01
follicle cell microvillus organization (GO:0032529)	3	0	.52	-	 < 0.01	5.93E-01
regulation of ubiquinone biosynthetic process (GO:0010795)	1	0	.17	-	 < 0.01	8.40E-01
polyprenol biosynthetic process (GO:0016094)	1	0	.17	-	 < 0.01	8.40E-01
polyprenol metabolic process (GO:0016093)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mRNA export from nucleus (GO:0010793)	1	0	.17	-	 < 0.01	8.40E-01
hematopoietic stem cell homeostasis (GO:0061484)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of somatic stem cell division (GO:1904677)	2	0	.35	-	 < 0.01	7.06E-01
regulation of somatic stem cell division (GO:1904675)	2	0	.35	-	 < 0.01	7.06E-01
synaptic vesicle targeting (GO:0016080)	8	0	1.40	-	 < 0.01	2.48E-01
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	8	0	1.40	-	 < 0.01	2.48E-01
meiotic DNA double-strand break formation involved in reciprocal meiotic recombination (GO:0010780)	1	0	.17	-	 < 0.01	8.40E-01
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	3	0	.52	-	 < 0.01	5.93E-01
DNA damage response, signal transduction by p53 class mediator (GO:0030330)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of ubiquitin protein ligase activity (GO:1904668)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of ubiquitin protein ligase activity (GO:1904667)	2	0	.35	-	 < 0.01	7.06E-01
regulation of ubiquitin protein ligase activity (GO:1904666)	5	0	.87	-	 < 0.01	4.18E-01
cellular response to carbon dioxide (GO:0071244)	2	0	.35	-	 < 0.01	7.06E-01
cellular response to ammonium ion (GO:0071242)	2	0	.35	-	 < 0.01	7.06E-01
tRNA catabolic process (GO:0016078)	5	0	.87	-	 < 0.01	4.18E-01
meiotic DNA repair synthesis involved in reciprocal meiotic recombination (GO:0010778)	1	0	.17	-	 < 0.01	8.40E-01
snoRNA catabolic process (GO:0016077)	1	0	.17	-	 < 0.01	8.40E-01
snRNA catabolic process (GO:0016076)	1	0	.17	-	 < 0.01	8.40E-01
nucleotide-excision repair, DNA gap filling (GO:0006297)	2	0	.35	-	 < 0.01	7.06E-01
ATP generation from poly-ADP-D-ribose (GO:1990966)	1	0	.17	-	 < 0.01	8.40E-01
nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	2	0	.35	-	 < 0.01	7.06E-01
stabilization of membrane potential (GO:0030322)	5	0	.87	-	 < 0.01	4.18E-01
establishment of ER localization (GO:0051686)	1	0	.17	-	 < 0.01	8.40E-01
pyrimidine dimer repair (GO:0006290)	2	0	.35	-	 < 0.01	7.06E-01
establishment of Golgi localization (GO:0051683)	3	0	.52	-	 < 0.01	5.93E-01
protein O-linked glycosylation via threonine (GO:0018243)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to leucine (GO:0071233)	2	0	.35	-	 < 0.01	7.06E-01
protein O-linked glycosylation via serine (GO:0018242)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of protein localization to synapse (GO:1902474)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein localization to synapse (GO:1902473)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of sodium ion transport (GO:0010766)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of sodium ion transport (GO:0010765)	1	0	.17	-	 < 0.01	8.40E-01
regulation of light-activated channel activity (GO:0016061)	1	0	.17	-	 < 0.01	8.40E-01
base-excision repair, gap-filling (GO:0006287)	2	0	.35	-	 < 0.01	7.06E-01
base-excision repair, AP site formation (GO:0006285)	2	0	.35	-	 < 0.01	7.06E-01
base-excision repair (GO:0006284)	10	0	1.74	-	 < 0.01	1.75E-01
transcription-coupled nucleotide-excision repair (GO:0006283)	1	0	.17	-	 < 0.01	8.40E-01
response to rotenone (GO:1904647)	2	0	.35	-	 < 0.01	7.06E-01
maintenance of membrane potential in photoreceptor cell by rhodopsin mediated signaling (GO:0016058)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to cell leading edge (GO:1902463)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cGMP-mediated signaling (GO:0010753)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cGMP-mediated signaling (GO:0010752)	1	0	.17	-	 < 0.01	8.40E-01
premeiotic DNA replication (GO:0006279)	1	0	.17	-	 < 0.01	8.40E-01
RNA-dependent DNA biosynthetic process (GO:0006278)	2	0	.35	-	 < 0.01	7.06E-01
deoxynucleotide transport (GO:0030302)	1	0	.17	-	 < 0.01	8.40E-01
cholesterol transport (GO:0030301)	6	0	1.05	-	 < 0.01	3.51E-01
DNA replication termination (GO:0006274)	1	0	.17	-	 < 0.01	8.40E-01
lagging strand elongation (GO:0006273)	1	0	.17	-	 < 0.01	8.40E-01
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	0	.35	-	 < 0.01	7.06E-01
leading strand elongation (GO:0006272)	7	0	1.22	-	 < 0.01	2.95E-01
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	5	0	.87	-	 < 0.01	4.18E-01
DNA strand elongation involved in DNA replication (GO:0006271)	12	0	2.09	-	 < 0.01	1.23E-01
DNA replication initiation (GO:0006270)	22	0	3.84	-	 < 0.01	2.14E-02
establishment of centrosome localization (GO:0051660)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of stem cell population maintenance (GO:1902459)	1	0	.17	-	 < 0.01	8.40E-01
replicative senescence (GO:0090399)	1	0	.17	-	 < 0.01	8.40E-01
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267)	7	0	1.22	-	 < 0.01	2.95E-01
mitochondrial DNA replication (GO:0006264)	4	0	.70	-	 < 0.01	4.98E-01
protein carboxylation (GO:0018214)	2	0	.35	-	 < 0.01	7.06E-01
protein kinase A signaling (GO:0010737)	1	0	.17	-	 < 0.01	8.40E-01
viral process (GO:0016032)	2	0	.35	-	 < 0.01	7.06E-01
phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of DNA-directed DNA polymerase activity (GO:1900264)	4	0	.70	-	 < 0.01	4.98E-01
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	2	0	.35	-	 < 0.01	7.06E-01
regulation of DNA-directed DNA polymerase activity (GO:1900262)	4	0	.70	-	 < 0.01	4.98E-01
phagosome maturation involved in apoptotic cell clearance (GO:0090386)	2	0	.35	-	 < 0.01	7.06E-01
phagosome-lysosome fusion (GO:0090385)	3	0	.52	-	 < 0.01	5.93E-01
phagosome acidification (GO:0090383)	1	0	.17	-	 < 0.01	8.40E-01
Golgi localization (GO:0051645)	4	0	.70	-	 < 0.01	4.98E-01
peptidyl-methionine modification (GO:0018206)	2	0	.35	-	 < 0.01	7.06E-01
peptidyl-histidine modification (GO:0018202)	1	0	.17	-	 < 0.01	8.40E-01
peptidyl-glycine modification (GO:0018201)	1	0	.17	-	 < 0.01	8.40E-01
double-strand break repair involved in meiotic recombination (GO:1990918)	2	0	.35	-	 < 0.01	7.06E-01
pyrimidine nucleotide catabolic process (GO:0006244)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cytoplasmic translational elongation (GO:1900247)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of synaptic vesicle endocytosis (GO:1900244)	4	0	.70	-	 < 0.01	4.98E-01
regulation of synaptic vesicle endocytosis (GO:1900242)	7	0	1.22	-	 < 0.01	2.95E-01
regulation of proteasome assembly (GO:0090364)	2	0	.35	-	 < 0.01	7.06E-01
salt aversion (GO:0035199)	3	0	.52	-	 < 0.01	5.93E-01
production of miRNAs involved in gene silencing by miRNA (GO:0035196)	10	0	1.74	-	 < 0.01	1.75E-01
dTMP biosynthetic process (GO:0006231)	1	0	.17	-	 < 0.01	8.40E-01
TMP biosynthetic process (GO:0006230)	1	0	.17	-	 < 0.01	8.40E-01
larval central nervous system remodeling (GO:0035193)	6	0	1.05	-	 < 0.01	3.51E-01
nuclear cortical migration (GO:0035192)	1	0	.17	-	 < 0.01	8.40E-01
nuclear axial expansion (GO:0035191)	3	0	.52	-	 < 0.01	5.93E-01
syncytial nuclear migration (GO:0035190)	7	0	1.22	-	 < 0.01	2.95E-01
heteroduplex formation involved in double-strand break repair via synthesis-dependent strand annealing (GO:0010709)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mitotic cytokinesis (GO:1902412)	1	0	.17	-	 < 0.01	8.40E-01
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705)	1	0	.17	-	 < 0.01	8.40E-01
dUMP biosynthetic process (GO:0006226)	1	0	.17	-	 < 0.01	8.40E-01
hatching (GO:0035188)	4	0	.70	-	 < 0.01	4.98E-01
hatching behavior (GO:0035187)	3	0	.52	-	 < 0.01	5.93E-01
UMP biosynthetic process (GO:0006222)	1	0	.17	-	 < 0.01	8.40E-01
histamine uptake (GO:0051615)	1	0	.17	-	 < 0.01	8.40E-01
larval wandering behavior (GO:0035180)	2	0	.35	-	 < 0.01	7.06E-01
serotonin uptake (GO:0051610)	1	0	.17	-	 < 0.01	8.40E-01
translesion synthesis (GO:0019985)	5	0	.87	-	 < 0.01	4.18E-01
assembly of actomyosin apparatus involved in mitotic cytokinesis (GO:1902407)	3	0	.52	-	 < 0.01	5.93E-01
actomyosin contractile ring contraction (GO:0000916)	10	0	1.74	-	 < 0.01	1.75E-01
actomyosin contractile ring assembly (GO:0000915)	14	0	2.44	-	 < 0.01	8.68E-02
larval foraging behavior (GO:0035177)	1	0	.17	-	 < 0.01	8.40E-01
histamine transport (GO:0051608)	3	0	.52	-	 < 0.01	5.93E-01
social behavior (GO:0035176)	6	0	1.05	-	 < 0.01	3.51E-01
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	15	0	2.62	-	 < 0.01	7.29E-02
5-methylcytosine catabolic process (GO:0006211)	1	0	.17	-	 < 0.01	8.40E-01
thymine catabolic process (GO:0006210)	1	0	.17	-	 < 0.01	8.40E-01
hemocyte proliferation (GO:0035172)	6	0	1.05	-	 < 0.01	3.51E-01
lamellocyte differentiation (GO:0035171)	4	0	.70	-	 < 0.01	4.98E-01
response to electrical stimulus (GO:0051602)	1	0	.17	-	 < 0.01	8.40E-01
lymph gland crystal cell differentiation (GO:0035170)	8	0	1.40	-	 < 0.01	2.48E-01
exocyst localization (GO:0051601)	4	0	.70	-	 < 0.01	4.98E-01
lymph gland plasmatocyte differentiation (GO:0035169)	7	0	1.22	-	 < 0.01	2.95E-01
larval lymph gland hemocyte differentiation (GO:0035168)	13	0	2.27	-	 < 0.01	1.03E-01
dGTP catabolic process (GO:0006203)	1	0	.17	-	 < 0.01	8.40E-01
embryonic crystal cell differentiation (GO:0035165)	3	0	.52	-	 < 0.01	5.93E-01
embryonic hemocyte differentiation (GO:0035163)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of locomotion involved in locomotory behavior (GO:0090327)	1	0	.17	-	 < 0.01	8.40E-01
regulation of locomotion involved in locomotory behavior (GO:0090325)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of dendritic spine development (GO:0060999)	2	0	.35	-	 < 0.01	7.06E-01
regulation of dendritic spine development (GO:0060998)	3	0	.52	-	 < 0.01	5.93E-01
fusion cell fate specification (GO:0035156)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of terminal cell fate specification, open tracheal system (GO:0035155)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of protein deacetylation (GO:0090312)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein deacetylation (GO:0090311)	1	0	.17	-	 < 0.01	8.40E-01
homogentisate metabolic process (GO:1901999)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of meiotic cell cycle phase transition (GO:1901995)	2	0	.35	-	 < 0.01	7.06E-01
neurotransmitter receptor internalization (GO:0099590)	2	0	.35	-	 < 0.01	7.06E-01
cell migration involved in heart development (GO:0060973)	1	0	.17	-	 < 0.01	8.40E-01
left/right pattern formation (GO:0060972)	1	0	.17	-	 < 0.01	8.40E-01
lipid droplet formation (GO:0140042)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of protein acetylation (GO:1901985)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of protein acetylation (GO:1901984)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein acetylation (GO:1901983)	10	0	1.74	-	 < 0.01	1.75E-01
regulation of translation at postsynapse, modulating synaptic transmission (GO:0099578)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cell cycle checkpoint (GO:1901978)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cell cycle checkpoint (GO:1901977)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell cycle checkpoint (GO:1901976)	3	0	.52	-	 < 0.01	5.93E-01
cGMP transport (GO:0070731)	1	0	.17	-	 < 0.01	8.40E-01
cyclic nucleotide transport (GO:0070729)	1	0	.17	-	 < 0.01	8.40E-01
homeostasis of number of cells within a tissue (GO:0048873)	3	0	.52	-	 < 0.01	5.93E-01
chemical synaptic transmission, postsynaptic (GO:0099565)	2	0	.35	-	 < 0.01	7.06E-01
cellular lipid biosynthetic process (GO:0097384)	1	0	.17	-	 < 0.01	8.40E-01
operant conditioning (GO:0035106)	2	0	.35	-	 < 0.01	7.06E-01
stem cell fate determination (GO:0048867)	23	0	4.01	-	 < 0.01	1.80E-02
response to mercury ion (GO:0046689)	3	0	.52	-	 < 0.01	5.93E-01
response to copper ion (GO:0046688)	4	0	.70	-	 < 0.01	4.98E-01
trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	1	0	.17	-	 < 0.01	8.40E-01
trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	1	0	.17	-	 < 0.01	8.40E-01
trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	1	0	.17	-	 < 0.01	8.40E-01
response to DDT (GO:0046680)	8	0	1.40	-	 < 0.01	2.48E-01
sensory neuron axon guidance (GO:0097374)	4	0	.70	-	 < 0.01	4.98E-01
protein O-GlcNAcylation via threonine (GO:0097370)	1	0	.17	-	 < 0.01	8.40E-01
brain morphogenesis (GO:0048854)	6	0	1.05	-	 < 0.01	3.51E-01
trans-synaptic signaling by nitric oxide (GO:0099548)	1	0	.17	-	 < 0.01	8.40E-01
regulation of translation at synapse, modulating synaptic transmission (GO:0099547)	1	0	.17	-	 < 0.01	8.40E-01
trans-synaptic signaling by soluble gas (GO:0099543)	1	0	.17	-	 < 0.01	8.40E-01
trans-synaptic signaling by endocannabinoid (GO:0099542)	1	0	.17	-	 < 0.01	8.40E-01
trans-synaptic signaling by lipid (GO:0099541)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of compound eye retinal cell programmed cell death (GO:0046672)	9	0	1.57	-	 < 0.01	2.08E-01
positive regulation of retinal cell programmed cell death (GO:0046670)	9	0	1.57	-	 < 0.01	2.08E-01
positive regulation of cardioblast proliferation (GO:1905062)	1	0	.17	-	 < 0.01	8.40E-01
axon extension involved in axon guidance (GO:0048846)	7	0	1.22	-	 < 0.01	2.95E-01
negative regulation of axon extension involved in axon guidance (GO:0048843)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of axon extension involved in axon guidance (GO:0048842)	2	0	.35	-	 < 0.01	7.06E-01
regulation of axon extension involved in axon guidance (GO:0048841)	6	0	1.05	-	 < 0.01	3.51E-01
compound eye retinal cell programmed cell death (GO:0046667)	9	0	1.57	-	 < 0.01	2.08E-01
retinal cell programmed cell death (GO:0046666)	11	0	1.92	-	 < 0.01	1.47E-01
positive regulation of presynaptic cytosolic calcium concentration (GO:0099533)	1	0	.17	-	 < 0.01	8.40E-01
dorsal closure, leading edge cell differentiation (GO:0046663)	2	0	.35	-	 < 0.01	7.06E-01
protein localization to heterochromatin (GO:0097355)	1	0	.17	-	 < 0.01	8.40E-01
prenylation (GO:0097354)	5	0	.87	-	 < 0.01	4.18E-01
cardiac cell fate determination (GO:0060913)	3	0	.52	-	 < 0.01	5.93E-01
cardiac cell fate specification (GO:0060912)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of metallopeptidase activity (GO:1905050)	1	0	.17	-	 < 0.01	8.40E-01
cardiac cell fate commitment (GO:0060911)	12	0	2.09	-	 < 0.01	1.23E-01
presynaptic dense core vesicle exocytosis (GO:0099525)	1	0	.17	-	 < 0.01	8.40E-01
folic acid metabolic process (GO:0046655)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of metallopeptidase activity (GO:1905049)	1	0	.17	-	 < 0.01	8.40E-01
regulation of metallopeptidase activity (GO:1905048)	2	0	.35	-	 < 0.01	7.06E-01
synaptic vesicle transport along microtubule (GO:0099517)	4	0	.70	-	 < 0.01	4.98E-01
erythrocyte development (GO:0048821)	1	0	.17	-	 < 0.01	8.40E-01
actin filament-based transport (GO:0099515)	10	0	1.74	-	 < 0.01	1.75E-01
synaptic vesicle cytoskeletal transport (GO:0099514)	4	0	.70	-	 < 0.01	4.98E-01
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911)	1	0	.17	-	 < 0.01	8.40E-01
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910)	1	0	.17	-	 < 0.01	8.40E-01
diadenosine hexaphosphate catabolic process (GO:1901909)	1	0	.17	-	 < 0.01	8.40E-01
diadenosine hexaphosphate metabolic process (GO:1901908)	1	0	.17	-	 < 0.01	8.40E-01
diadenosine pentaphosphate catabolic process (GO:1901907)	1	0	.17	-	 < 0.01	8.40E-01
diadenosine pentaphosphate metabolic process (GO:1901906)	1	0	.17	-	 < 0.01	8.40E-01
error-prone translesion synthesis (GO:0042276)	3	0	.52	-	 < 0.01	5.93E-01
detection of peptidoglycan (GO:0032499)	1	0	.17	-	 < 0.01	8.40E-01
female genitalia morphogenesis (GO:0048807)	4	0	.70	-	 < 0.01	4.98E-01
imaginal disc-derived female genitalia morphogenesis (GO:0048804)	4	0	.70	-	 < 0.01	4.98E-01
notum morphogenesis (GO:0048802)	3	0	.52	-	 < 0.01	5.93E-01
antennal joint morphogenesis (GO:0048801)	1	0	.17	-	 < 0.01	8.40E-01
detection of molecule of fungal origin (GO:0032491)	1	0	.17	-	 < 0.01	8.40E-01
detection of molecule of bacterial origin (GO:0032490)	2	0	.35	-	 < 0.01	7.06E-01
cap2 mRNA methylation (GO:0097310)	1	0	.17	-	 < 0.01	8.40E-01
DNA protection (GO:0042262)	1	0	.17	-	 < 0.01	8.40E-01
regulation of Cdc42 protein signal transduction (GO:0032489)	1	0	.17	-	 < 0.01	8.40E-01
Cdc42 protein signal transduction (GO:0032488)	2	0	.35	-	 < 0.01	7.06E-01
regulation of Rap protein signal transduction (GO:0032487)	1	0	.17	-	 < 0.01	8.40E-01
cap1 mRNA methylation (GO:0097309)	1	0	.17	-	 < 0.01	8.40E-01
protein kinase D signaling (GO:0089700)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cAMP-dependent protein kinase activity (GO:2000481)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	1	0	.17	-	 < 0.01	8.40E-01
intestinal cholesterol absorption (GO:0030299)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of centrosome cycle (GO:0046606)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of mitotic centrosome separation (GO:0046604)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mitotic centrosome separation (GO:0046602)	3	0	.52	-	 < 0.01	5.93E-01
regulation of cAMP-dependent protein kinase activity (GO:2000479)	2	0	.35	-	 < 0.01	7.06E-01
maintenance of polarity of follicular epithelium (GO:0042248)	2	0	.35	-	 < 0.01	7.06E-01
establishment of planar polarity of follicular epithelium (GO:0042247)	2	0	.35	-	 < 0.01	7.06E-01
tissue regeneration (GO:0042246)	16	0	2.79	-	 < 0.01	6.12E-02
endoplasmic reticulum calcium ion homeostasis (GO:0032469)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of cytokinesis (GO:0032467)	2	0	.35	-	 < 0.01	7.06E-01
formation of extrachromosomal circular DNA (GO:0001325)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of excitatory postsynaptic potential (GO:2000463)	1	0	.17	-	 < 0.01	8.40E-01
retinol transport (GO:0034633)	1	0	.17	-	 < 0.01	8.40E-01
age-dependent response to reactive oxygen species (GO:0001315)	1	0	.17	-	 < 0.01	8.40E-01
maintenance of gastrointestinal epithelium (GO:0030277)	7	0	1.22	-	 < 0.01	2.95E-01
regulation of glutamate receptor clustering (GO:0106104)	1	0	.17	-	 < 0.01	8.40E-01
entry into host (GO:0044409)	1	0	.17	-	 < 0.01	8.40E-01
symbiotic process (GO:0044403)	3	0	.52	-	 < 0.01	5.93E-01
peptidyl-asparagine modification (GO:0018196)	4	0	.70	-	 < 0.01	4.98E-01
phospholipase C-activating rhodopsin mediated signaling pathway (GO:0030265)	1	0	.17	-	 < 0.01	8.40E-01
apoptotic nuclear changes (GO:0030262)	9	0	1.57	-	 < 0.01	2.08E-01
cellular modified amino acid catabolic process (GO:0042219)	3	0	.52	-	 < 0.01	5.93E-01
terpene metabolic process (GO:0042214)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of protein import (GO:1904590)	3	0	.52	-	 < 0.01	5.93E-01
melanosome organization (GO:0032438)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of translation, ncRNA-mediated (GO:0040033)	1	0	.17	-	 < 0.01	8.40E-01
lipid glycosylation (GO:0030259)	2	0	.35	-	 < 0.01	7.06E-01
IRES-dependent viral translational initiation (GO:0075522)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of protein neddylation (GO:2000435)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein neddylation (GO:2000434)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000433)	1	0	.17	-	 < 0.01	8.40E-01
response to glycoprotein (GO:1904587)	2	0	.35	-	 < 0.01	7.06E-01
establishment of protein localization to chromatin (GO:0071169)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to chromatin (GO:0071168)	5	0	.87	-	 < 0.01	4.18E-01
protein nucleotidylation (GO:0018175)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of intracellular mRNA localization (GO:1904582)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of intracellular mRNA localization (GO:1904581)	1	0	.17	-	 < 0.01	8.40E-01
DNA replication preinitiation complex assembly (GO:0071163)	2	0	.35	-	 < 0.01	7.06E-01
Malpighian tubule tip cell differentiation (GO:0061382)	5	0	.87	-	 < 0.01	4.18E-01
skeletal muscle myosin thick filament assembly (GO:0030241)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of cell cycle arrest (GO:0071158)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell cycle arrest (GO:0071156)	1	0	.17	-	 < 0.01	8.40E-01
lysosome localization (GO:0032418)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of exodeoxyribonuclease activity (GO:1902394)	1	0	.17	-	 < 0.01	8.40E-01
regulation of exodeoxyribonuclease activity (GO:1902392)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of growth rate (GO:0040010)	1	0	.17	-	 < 0.01	8.40E-01
response to methylmercury (GO:0051597)	1	0	.17	-	 < 0.01	8.40E-01
detection of glucose (GO:0051594)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of neurotransmitter transport (GO:0051590)	3	0	.52	-	 < 0.01	5.93E-01
resolution of mitotic recombination intermediates (GO:0071140)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cellular carbohydrate metabolic process (GO:0010676)	4	0	.70	-	 < 0.01	4.98E-01
AMP catabolic process (GO:0006196)	2	0	.35	-	 < 0.01	7.06E-01
purine nucleotide catabolic process (GO:0006195)	6	0	1.05	-	 < 0.01	3.51E-01
dopamine uptake involved in synaptic transmission (GO:0051583)	1	0	.17	-	 < 0.01	8.40E-01
resolution of recombination intermediates (GO:0071139)	1	0	.17	-	 < 0.01	8.40E-01
histone H4-R3 methylation (GO:0043985)	1	0	.17	-	 < 0.01	8.40E-01
histone H4-K12 acetylation (GO:0043983)	2	0	.35	-	 < 0.01	7.06E-01
histone H4-K8 acetylation (GO:0043982)	4	0	.70	-	 < 0.01	4.98E-01
histone H4-K5 acetylation (GO:0043981)	3	0	.52	-	 < 0.01	5.93E-01
ectodermal cell differentiation (GO:0010668)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of mRNA catabolic process (GO:1902373)	2	0	.35	-	 < 0.01	7.06E-01
regulation of tRNA catabolic process (GO:1902370)	1	0	.17	-	 < 0.01	8.40E-01
erythrocyte differentiation (GO:0030218)	1	0	.17	-	 < 0.01	8.40E-01
pupal chitin-based cuticle development (GO:0008364)	1	0	.17	-	 < 0.01	8.40E-01
cell chemotaxis involved in Malpighian tubule morphogenesis (GO:0061352)	1	0	.17	-	 < 0.01	8.40E-01
IMP biosynthetic process (GO:0006188)	1	0	.17	-	 < 0.01	8.40E-01
extracellular matrix disassembly (GO:0022617)	3	0	.52	-	 < 0.01	5.93E-01
DNA strand elongation (GO:0022616)	12	0	2.09	-	 < 0.01	1.23E-01
heparin biosynthetic process (GO:0030210)	1	0	.17	-	 < 0.01	8.40E-01
dormancy process (GO:0022611)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of histone H3-K9 methylation (GO:0051574)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of histone H3-K4 methylation (GO:0051571)	5	0	.87	-	 < 0.01	4.18E-01
regulation of histone H3-K9 methylation (GO:0051570)	5	0	.87	-	 < 0.01	4.18E-01
histone H3-K27 acetylation (GO:0043974)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of RNA catabolic process (GO:1902369)	2	0	.35	-	 < 0.01	7.06E-01
histone H3-K18 acetylation (GO:0043971)	1	0	.17	-	 < 0.01	8.40E-01
histone H3-K9 acetylation (GO:0043970)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of clathrin-dependent endocytosis (GO:1900186)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of protein localization to nucleus (GO:1900181)	3	0	.52	-	 < 0.01	5.93E-01
multicellular organism adhesion to substrate (GO:0022609)	2	0	.35	-	 < 0.01	7.06E-01
GMP biosynthetic process (GO:0006177)	1	0	.17	-	 < 0.01	8.40E-01
multicellular organism adhesion (GO:0022608)	2	0	.35	-	 < 0.01	7.06E-01
heparin metabolic process (GO:0030202)	2	0	.35	-	 < 0.01	7.06E-01
regulation of histone H3-K4 methylation (GO:0051569)	6	0	1.05	-	 < 0.01	3.51E-01
cAMP biosynthetic process (GO:0006171)	7	0	1.22	-	 < 0.01	2.95E-01
histone H2A acetylation (GO:0043968)	5	0	.87	-	 < 0.01	4.18E-01
mitochondrial calcium ion homeostasis (GO:0051560)	2	0	.35	-	 < 0.01	7.06E-01
histone biotinylation (GO:0071110)	2	0	.35	-	 < 0.01	7.06E-01
larval walking behavior (GO:0008346)	1	0	.17	-	 < 0.01	8.40E-01
cell rearrangement involved in Malpighian tubule morphogenesis (GO:0061334)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of mitochondrial DNA replication (GO:0090297)	2	0	.35	-	 < 0.01	7.06E-01
Malpighian tubule bud morphogenesis (GO:0061332)	3	0	.52	-	 < 0.01	5.93E-01
regulation of mitochondrial DNA replication (GO:0090296)	2	0	.35	-	 < 0.01	7.06E-01
adenine salvage (GO:0006168)	1	0	.17	-	 < 0.01	8.40E-01
epithelial cell proliferation involved in Malpighian tubule morphogenesis (GO:0061331)	8	0	1.40	-	 < 0.01	2.48E-01
protein adenylylation (GO:0018117)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cAMP-mediated signaling (GO:0043951)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of cAMP-mediated signaling (GO:0043950)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of epithelial cell migration (GO:0010633)	2	0	.35	-	 < 0.01	7.06E-01
anterior Malpighian tubule development (GO:0061327)	11	0	1.92	-	 < 0.01	1.47E-01
female germline ring canal stabilization (GO:0008335)	5	0	.87	-	 < 0.01	4.18E-01
garland nephrocyte differentiation (GO:0061321)	3	0	.52	-	 < 0.01	5.93E-01
pericardial nephrocyte differentiation (GO:0061320)	9	0	1.57	-	 < 0.01	2.08E-01
positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282)	1	0	.17	-	 < 0.01	8.40E-01
basic amino acid transmembrane transport (GO:1990822)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of apoptotic process involved in morphogenesis (GO:1902339)	2	0	.35	-	 < 0.01	7.06E-01
regulation of apoptotic process involved in morphogenesis (GO:1902337)	2	0	.35	-	 < 0.01	7.06E-01
nephrocyte differentiation (GO:0061319)	12	0	2.09	-	 < 0.01	1.23E-01
renal filtration cell differentiation (GO:0061318)	12	0	2.09	-	 < 0.01	1.23E-01
canonical Wnt signaling pathway involved in heart development (GO:0061316)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of peptide hormone secretion (GO:0090277)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	2	0	.35	-	 < 0.01	7.06E-01
cell surface receptor signaling pathway involved in heart development (GO:0061311)	1	0	.17	-	 < 0.01	8.40E-01
guanine catabolic process (GO:0006147)	1	0	.17	-	 < 0.01	8.40E-01
purine nucleobase catabolic process (GO:0006145)	2	0	.35	-	 < 0.01	7.06E-01
purine nucleobase metabolic process (GO:0006144)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of lipophagy (GO:1904503)	1	0	.17	-	 < 0.01	8.40E-01
methyl-branched fatty acid biosynthetic process (GO:1902321)	1	0	.17	-	 < 0.01	8.40E-01
DNA strand renaturation involved in double-strand break repair (GO:0061306)	1	0	.17	-	 < 0.01	8.40E-01
G2/MI transition of meiotic cell cycle (GO:0008315)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of BMP secretion (GO:1900144)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mRNA stability involved in response to stress (GO:0010610)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	1	0	.17	-	 < 0.01	8.40E-01
endoplasmic reticulum tubular network membrane organization (GO:1990809)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	2	0	.35	-	 < 0.01	7.06E-01
behavioral response to nicotine (GO:0035095)	1	0	.17	-	 < 0.01	8.40E-01
exonucleolytic catabolism of deadenylated mRNA (GO:0043928)	5	0	.87	-	 < 0.01	4.18E-01
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation by host of viral transcription (GO:0043922)	1	0	.17	-	 < 0.01	8.40E-01
nuclear cell cycle DNA replication initiation (GO:1902315)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	1	0	.17	-	 < 0.01	8.40E-01
female germline ring canal formation, actin assembly (GO:0008302)	3	0	.52	-	 < 0.01	5.93E-01
regulation of cell proliferation involved in imaginal disc-derived wing morphogenesis (GO:0090256)	2	0	.35	-	 < 0.01	7.06E-01
establishment of apical/basal cell polarity (GO:0035089)	7	0	1.22	-	 < 0.01	2.95E-01
siRNA loading onto RISC involved in RNA interference (GO:0035087)	5	0	.87	-	 < 0.01	4.18E-01
regulation of glutamine family amino acid metabolic process (GO:0000820)	1	0	.17	-	 < 0.01	8.40E-01
heat shock-mediated polytene chromosome puffing (GO:0035080)	8	0	1.40	-	 < 0.01	2.48E-01
positive regulation of sodium ion transmembrane transport (GO:1902307)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of sodium ion transmembrane transport (GO:1902306)	1	0	.17	-	 < 0.01	8.40E-01
regulation of sodium ion transmembrane transport (GO:1902305)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of protein autophosphorylation (GO:0031954)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein autophosphorylation (GO:0031952)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of histone H4 acetylation (GO:0090241)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of histone H4 acetylation (GO:0090240)	1	0	.17	-	 < 0.01	8.40E-01
regulation of gluconeogenesis (GO:0006111)	1	0	.17	-	 < 0.01	8.40E-01
regulation of glycolytic process (GO:0006110)	2	0	.35	-	 < 0.01	7.06E-01
adenine nucleotide transport (GO:0051503)	3	0	.52	-	 < 0.01	5.93E-01
lysine biosynthetic process via aminoadipic acid (GO:0019878)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of multi-organism process (GO:0043902)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of histone H4 acetylation (GO:0090239)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of histone H3-K9 trimethylation (GO:1900114)	2	0	.35	-	 < 0.01	7.06E-01
regulation of histone H3-K9 trimethylation (GO:1900112)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of histone H3-K9 dimethylation (GO:1900111)	2	0	.35	-	 < 0.01	7.06E-01
malate metabolic process (GO:0006108)	4	0	.70	-	 < 0.01	4.98E-01
regulation of metaphase plate congression (GO:0090235)	2	0	.35	-	 < 0.01	7.06E-01
oxaloacetate metabolic process (GO:0006107)	1	0	.17	-	 < 0.01	8.40E-01
regulation of kinetochore assembly (GO:0090234)	1	0	.17	-	 < 0.01	8.40E-01
succinate metabolic process (GO:0006105)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of spindle checkpoint (GO:0090232)	1	0	.17	-	 < 0.01	8.40E-01
regulation of spindle checkpoint (GO:0090231)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of histone acetylation (GO:0035067)	1	0	.17	-	 < 0.01	8.40E-01
regulation of centromere complex assembly (GO:0090230)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of chromatin silencing at telomere (GO:0031940)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of histone acetylation (GO:0035066)	3	0	.52	-	 < 0.01	5.93E-01
regulation of histone acetylation (GO:0035065)	10	0	1.74	-	 < 0.01	1.75E-01
regulation of histone H3-K9 dimethylation (GO:1900109)	2	0	.35	-	 < 0.01	7.06E-01
intralumenal vesicle formation (GO:0070676)	1	0	.17	-	 < 0.01	8.40E-01
regulation of chromatin silencing at telomere (GO:0031938)	3	0	.52	-	 < 0.01	5.93E-01
regulation of spindle organization (GO:0090224)	6	0	1.05	-	 < 0.01	3.51E-01
embryonic heart tube anterior/posterior pattern specification (GO:0035054)	3	0	.52	-	 < 0.01	5.93E-01
dorsal vessel heart proper cell fate commitment (GO:0035053)	2	0	.35	-	 < 0.01	7.06E-01
dorsal vessel aortic cell fate commitment (GO:0035052)	1	0	.17	-	 < 0.01	8.40E-01
cardiocyte differentiation (GO:0035051)	23	0	4.01	-	 < 0.01	1.80E-02
embryonic heart tube development (GO:0035050)	24	0	4.19	-	 < 0.01	1.51E-02
thymine metabolic process (GO:0019859)	1	0	.17	-	 < 0.01	8.40E-01
5-methylcytosine metabolic process (GO:0019857)	1	0	.17	-	 < 0.01	8.40E-01
L-ascorbic acid biosynthetic process (GO:0019853)	2	0	.35	-	 < 0.01	7.06E-01
L-ascorbic acid metabolic process (GO:0019852)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of lipid kinase activity (GO:0090219)	1	0	.17	-	 < 0.01	8.40E-01
TOR signaling (GO:0031929)	9	0	1.57	-	 < 0.01	2.08E-01
positive regulation of lipid kinase activity (GO:0090218)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of establishment of blood-brain barrier (GO:0090212)	1	0	.17	-	 < 0.01	8.40E-01
regulation of establishment of blood-brain barrier (GO:0090210)	3	0	.52	-	 < 0.01	5.93E-01
pronuclear migration (GO:0035046)	4	0	.70	-	 < 0.01	4.98E-01
sperm aster formation (GO:0035044)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of triglyceride metabolic process (GO:0090209)	4	0	.70	-	 < 0.01	4.98E-01
nonfunctional rRNA decay (GO:0070651)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of triglyceride metabolic process (GO:0090208)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of triglyceride metabolic process (GO:0090207)	12	0	2.09	-	 < 0.01	1.23E-01
gene looping (GO:0090202)	3	0	.52	-	 < 0.01	5.93E-01
female pronucleus assembly (GO:0035038)	2	0	.35	-	 < 0.01	7.06E-01
sperm-egg recognition (GO:0035036)	1	0	.17	-	 < 0.01	8.40E-01
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	4	0	.70	-	 < 0.01	4.98E-01
leading edge cell differentiation (GO:0035026)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of Rho protein signal transduction (GO:0035024)	1	0	.17	-	 < 0.01	8.40E-01
cytoskeletal matrix organization at active zone (GO:0048789)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of nucleus size (GO:0097298)	2	0	.35	-	 < 0.01	7.06E-01
regulation of post-translational protein modification (GO:1901873)	1	0	.17	-	 < 0.01	8.40E-01
establishment of glial blood-brain barrier (GO:0060857)	14	0	2.44	-	 < 0.01	8.68E-02
adult chitin-based cuticle pattern formation (GO:0035018)	1	0	.17	-	 < 0.01	8.40E-01
establishment of blood-brain barrier (GO:0060856)	16	0	2.79	-	 < 0.01	6.12E-02
elongation of arista core (GO:0035015)	2	0	.35	-	 < 0.01	7.06E-01
establishment of pole plasm mRNA localization (GO:0046595)	1	0	.17	-	 < 0.01	8.40E-01
maintenance of pole plasm mRNA location (GO:0046594)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of muscle tissue development (GO:1901862)	1	0	.17	-	 < 0.01	8.40E-01
regulation of muscle tissue development (GO:1901861)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of melanization defense response (GO:0035009)	3	0	.52	-	 < 0.01	5.93E-01
quinolinate biosynthetic process (GO:0019805)	1	0	.17	-	 < 0.01	8.40E-01
mesenchymal cell differentiation (GO:0048762)	2	0	.35	-	 < 0.01	7.06E-01
pigment granule organization (GO:0048753)	12	0	2.09	-	 < 0.01	1.23E-01
compound eye corneal lens morphogenesis (GO:0048750)	1	0	.17	-	 < 0.01	8.40E-01
centromeric sister chromatid cohesion (GO:0070601)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of RNA polymerase I regulatory region sequence-specific DNA binding (GO:1901840)	1	0	.17	-	 < 0.01	8.40E-01
muscle fiber development (GO:0048747)	10	0	1.74	-	 < 0.01	1.75E-01
regulation of RNA polymerase I regulatory region sequence-specific DNA binding (GO:1901839)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901837)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835)	1	0	.17	-	 < 0.01	8.40E-01
regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834)	1	0	.17	-	 < 0.01	8.40E-01
posterior mRNA localization involved in anterior/posterior axis specification (GO:0060814)	2	0	.35	-	 < 0.01	7.06E-01
anterior mRNA localization involved in anterior/posterior axis specification (GO:0060813)	1	0	.17	-	 < 0.01	8.40E-01
cardiac muscle tissue development (GO:0048738)	8	0	1.40	-	 < 0.01	2.48E-01
haltere morphogenesis (GO:0048735)	2	0	.35	-	 < 0.01	7.06E-01
regulation of peroxisome size (GO:0044375)	1	0	.17	-	 < 0.01	8.40E-01
chromosome attachment to the nuclear envelope (GO:0097240)	2	0	.35	-	 < 0.01	7.06E-01
proboscis development (GO:0048728)	5	0	.87	-	 < 0.01	4.18E-01
cellular response to toxic substance (GO:0097237)	6	0	1.05	-	 < 0.01	3.51E-01
xenobiotic catabolic process (GO:0042178)	6	0	1.05	-	 < 0.01	3.51E-01
macropinocytosis (GO:0044351)	1	0	.17	-	 < 0.01	8.40E-01
guanine deglycation, glyoxal removal (GO:0106046)	2	0	.35	-	 < 0.01	7.06E-01
guanine deglycation (GO:0106044)	2	0	.35	-	 < 0.01	7.06E-01
sodium-dependent phosphate transport (GO:0044341)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of intracellular cholesterol transport (GO:0032385)	1	0	.17	-	 < 0.01	8.40E-01
regulation of intracellular cholesterol transport (GO:0032383)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of intracellular sterol transport (GO:0032382)	1	0	.17	-	 < 0.01	8.40E-01
regulation of intracellular sterol transport (GO:0032380)	1	0	.17	-	 < 0.01	8.40E-01
ceramide catabolic process (GO:0046514)	2	0	.35	-	 < 0.01	7.06E-01
activation of cysteine-type endopeptidase activity (GO:0097202)	1	0	.17	-	 < 0.01	8.40E-01
lipoprotein catabolic process (GO:0042159)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of intracellular lipid transport (GO:0032379)	1	0	.17	-	 < 0.01	8.40E-01
regulation of intracellular lipid transport (GO:0032377)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cholesterol transport (GO:0032376)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of sterol transport (GO:0032373)	1	0	.17	-	 < 0.01	8.40E-01
collagen fibril organization (GO:0030199)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of lipid transport (GO:0032370)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of pupariation (GO:0106024)	2	0	.35	-	 < 0.01	7.06E-01
glycerol ether biosynthetic process (GO:0046504)	1	0	.17	-	 < 0.01	8.40E-01
regulation of pupariation (GO:0106023)	3	0	.52	-	 < 0.01	5.93E-01
protoporphyrinogen IX metabolic process (GO:0046501)	2	0	.35	-	 < 0.01	7.06E-01
S-adenosylmethionine metabolic process (GO:0046500)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of reactive oxygen species metabolic process (GO:2000379)	2	0	.35	-	 < 0.01	7.06E-01
regulation of transcription involved in anterior/posterior axis specification (GO:0044324)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of reactive oxygen species metabolic process (GO:2000378)	1	0	.17	-	 < 0.01	8.40E-01
strand invasion (GO:0042148)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373)	2	0	.35	-	 < 0.01	7.06E-01
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371)	2	0	.35	-	 < 0.01	7.06E-01
late meiotic recombination nodule assembly (GO:0042140)	1	0	.17	-	 < 0.01	8.40E-01
intracellular cholesterol transport (GO:0032367)	5	0	.87	-	 < 0.01	4.18E-01
intracellular sterol transport (GO:0032366)	5	0	.87	-	 < 0.01	4.18E-01
axis elongation (GO:0003401)	5	0	.87	-	 < 0.01	4.18E-01
intracellular lipid transport (GO:0032365)	7	0	1.22	-	 < 0.01	2.95E-01
wound healing, spreading of cells (GO:0044319)	4	0	.70	-	 < 0.01	4.98E-01
protein K6-linked deubiquitination (GO:0044313)	1	0	.17	-	 < 0.01	8.40E-01
early meiotic recombination nodule assembly (GO:0042139)	1	0	.17	-	 < 0.01	8.40E-01
meiotic DNA double-strand break formation (GO:0042138)	3	0	.52	-	 < 0.01	5.93E-01
neurotransmitter biosynthetic process (GO:0042136)	4	0	.70	-	 < 0.01	4.98E-01
neurotransmitter catabolic process (GO:0042135)	1	0	.17	-	 < 0.01	8.40E-01
neurotransmitter metabolic process (GO:0042133)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of hormone biosynthetic process (GO:0032353)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of hormone metabolic process (GO:0032352)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of hormone metabolic process (GO:0032351)	5	0	.87	-	 < 0.01	4.18E-01
regulation of hormone metabolic process (GO:0032350)	10	0	1.74	-	 < 0.01	1.75E-01
regulation of DNA-dependent DNA replication initiation (GO:0030174)	3	0	.52	-	 < 0.01	5.93E-01
protein polyglycylation (GO:0018094)	3	0	.52	-	 < 0.01	5.93E-01
postsynaptic actin cytoskeleton organization (GO:0098974)	1	0	.17	-	 < 0.01	8.40E-01
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	2	0	.35	-	 < 0.01	7.06E-01
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	2	0	.35	-	 < 0.01	7.06E-01
mitochondrial unfolded protein response (GO:0034514)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of phospholipid biosynthetic process (GO:0071073)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to ciliary transition zone (GO:1904491)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of phospholipid biosynthetic process (GO:0071072)	1	0	.17	-	 < 0.01	8.40E-01
regulation of phospholipid biosynthetic process (GO:0071071)	2	0	.35	-	 < 0.01	7.06E-01
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	2	0	.35	-	 < 0.01	7.06E-01
neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968)	2	0	.35	-	 < 0.01	7.06E-01
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	2	0	.35	-	 < 0.01	7.06E-01
molybdopterin cofactor biosynthetic process (GO:0032324)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of lamellipodium assembly (GO:0010593)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of lamellipodium assembly (GO:0010592)	9	0	1.57	-	 < 0.01	2.08E-01
sphingolipid catabolic process (GO:0030149)	3	0	.52	-	 < 0.01	5.93E-01
spermidine biosynthetic process (GO:0008295)	2	0	.35	-	 < 0.01	7.06E-01
torso signaling pathway (GO:0008293)	20	0	3.49	-	 < 0.01	3.04E-02
acetylcholine biosynthetic process (GO:0008292)	1	0	.17	-	 < 0.01	8.40E-01
acetylcholine metabolic process (GO:0008291)	2	0	.35	-	 < 0.01	7.06E-01
anterograde axonal transport of mitochondrion (GO:0098957)	1	0	.17	-	 < 0.01	8.40E-01
receptor diffusion trapping (GO:0098953)	2	0	.35	-	 < 0.01	7.06E-01
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299)	7	0	1.22	-	 < 0.01	2.95E-01
cell cycle DNA replication maintenance of fidelity (GO:1902298)	1	0	.17	-	 < 0.01	8.40E-01
DNA strand elongation involved in cell cycle DNA replication (GO:1902296)	1	0	.17	-	 < 0.01	8.40E-01
miRNA metabolic process (GO:0010586)	3	0	.52	-	 < 0.01	5.93E-01
cell cycle DNA replication initiation (GO:1902292)	5	0	.87	-	 < 0.01	4.18E-01
neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of stress fiber assembly (GO:0051497)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of stress fiber assembly (GO:0051496)	5	0	.87	-	 < 0.01	4.18E-01
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049)	2	0	.35	-	 < 0.01	7.06E-01
regulation of AMPA receptor activity (GO:2000311)	2	0	.35	-	 < 0.01	7.06E-01
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048)	2	0	.35	-	 < 0.01	7.06E-01
polyadenylation-dependent mRNA catabolic process (GO:0071047)	2	0	.35	-	 < 0.01	7.06E-01
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)	6	0	1.05	-	 < 0.01	3.51E-01
peptidyl-lysine biotinylation (GO:0018054)	2	0	.35	-	 < 0.01	7.06E-01
histone mRNA catabolic process (GO:0071044)	1	0	.17	-	 < 0.01	8.40E-01
CUT metabolic process (GO:0071043)	3	0	.52	-	 < 0.01	5.93E-01
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	2	0	.35	-	 < 0.01	7.06E-01
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	2	0	.35	-	 < 0.01	7.06E-01
icosanoid secretion (GO:0032309)	3	0	.52	-	 < 0.01	5.93E-01
antisense RNA transcript catabolic process (GO:0071041)	1	0	.17	-	 < 0.01	8.40E-01
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040)	1	0	.17	-	 < 0.01	8.40E-01
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	2	0	.35	-	 < 0.01	7.06E-01
neuron projection extension involved in neuron projection guidance (GO:1902284)	7	0	1.22	-	 < 0.01	2.95E-01
positive regulation of nuclear cell cycle DNA replication (GO:0010571)	1	0	.17	-	 < 0.01	8.40E-01
anterograde dendritic transport (GO:0098937)	2	0	.35	-	 < 0.01	7.06E-01
dendritic transport (GO:0098935)	2	0	.35	-	 < 0.01	7.06E-01
semaphorin-plexin signaling pathway involved in regulation of photoreceptor cell axon guidance (GO:2000305)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of synaptic vesicle exocytosis (GO:2000302)	1	0	.17	-	 < 0.01	8.40E-01
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039)	1	0	.17	-	 < 0.01	8.40E-01
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of neuronal action potential (GO:1904456)	1	0	.17	-	 < 0.01	8.40E-01
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037)	1	0	.17	-	 < 0.01	8.40E-01
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036)	1	0	.17	-	 < 0.01	8.40E-01
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	5	0	.87	-	 < 0.01	4.18E-01
CUT catabolic process (GO:0071034)	3	0	.52	-	 < 0.01	5.93E-01
nuclear retention of pre-mRNA at the site of transcription (GO:0071033)	5	0	.87	-	 < 0.01	4.18E-01
regulation of double-strand break repair via homologous recombination (GO:0010569)	2	0	.35	-	 < 0.01	7.06E-01
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	2	0	.35	-	 < 0.01	7.06E-01
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030)	2	0	.35	-	 < 0.01	7.06E-01
regulation of ketone biosynthetic process (GO:0010566)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of glycoprotein biosynthetic process (GO:0010560)	2	0	.35	-	 < 0.01	7.06E-01
postsynaptic signal transduction (GO:0098926)	2	0	.35	-	 < 0.01	7.06E-01
acetate metabolic process (GO:0006083)	1	0	.17	-	 < 0.01	8.40E-01
retrograde trans-synaptic signaling by endocannabinoid (GO:0098921)	1	0	.17	-	 < 0.01	8.40E-01
retrograde trans-synaptic signaling by lipid (GO:0098920)	1	0	.17	-	 < 0.01	8.40E-01
nuclear ncRNA surveillance (GO:0071029)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of glycoprotein biosynthetic process (GO:0010559)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	6	0	1.05	-	 < 0.01	3.51E-01
cellular detoxification (GO:1990748)	6	0	1.05	-	 < 0.01	3.51E-01
peptidyl-lysine dimethylation (GO:0018027)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of neuromuscular synaptic transmission (GO:1900075)	4	0	.70	-	 < 0.01	4.98E-01
uronic acid metabolic process (GO:0006063)	1	0	.17	-	 < 0.01	8.40E-01
sorbitol catabolic process (GO:0006062)	2	0	.35	-	 < 0.01	7.06E-01
sorbitol metabolic process (GO:0006060)	2	0	.35	-	 < 0.01	7.06E-01
monopolar spindle attachment to meiosis I kinetochore (GO:0051455)	1	0	.17	-	 < 0.01	8.40E-01
intracellular pH elevation (GO:0051454)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of calcium ion transmembrane transport (GO:1904427)	1	0	.17	-	 < 0.01	8.40E-01
myoblast migration (GO:0051451)	2	0	.35	-	 < 0.01	7.06E-01
myoblast proliferation (GO:0051450)	3	0	.52	-	 < 0.01	5.93E-01
N-terminal peptidyl-proline dimethylation (GO:0018016)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of transposition (GO:0010530)	1	0	.17	-	 < 0.01	8.40E-01
hexitol metabolic process (GO:0006059)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of ceramide biosynthetic process (GO:1900060)	1	0	.17	-	 < 0.01	8.40E-01
N-acetylneuraminate metabolic process (GO:0006054)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of ubiquitin-protein transferase activity (GO:0051444)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of ubiquitin-protein transferase activity (GO:0051443)	3	0	.52	-	 < 0.01	5.93E-01
N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009)	1	0	.17	-	 < 0.01	8.40E-01
N-terminal peptidyl-glycine N-myristoylation (GO:0018008)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of transposition (GO:0010529)	22	0	3.84	-	 < 0.01	2.14E-02
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	1	0	.17	-	 < 0.01	8.40E-01
regulation of transposition (GO:0010528)	24	0	4.19	-	 < 0.01	1.51E-02
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of transposition, RNA-mediated (GO:0010526)	5	0	.87	-	 < 0.01	4.18E-01
regulation of transposition, RNA-mediated (GO:0010525)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of calcium ion transport into cytosol (GO:0010524)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231)	1	0	.17	-	 < 0.01	8.40E-01
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926)	2	0	.35	-	 < 0.01	7.06E-01
lipid droplet transport along microtubule (GO:0031887)	4	0	.70	-	 < 0.01	4.98E-01
UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of histone exchange (GO:1900051)	1	0	.17	-	 < 0.01	8.40E-01
N-acetylglucosamine catabolic process (GO:0006046)	1	0	.17	-	 < 0.01	8.40E-01
N-acetylglucosamine metabolic process (GO:0006044)	5	0	.87	-	 < 0.01	4.18E-01
glucosamine catabolic process (GO:0006043)	1	0	.17	-	 < 0.01	8.40E-01
glucosamine metabolic process (GO:0006041)	1	0	.17	-	 < 0.01	8.40E-01
karyogamy (GO:0000741)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of nitric oxide metabolic process (GO:1904407)	1	0	.17	-	 < 0.01	8.40E-01
ketone body metabolic process (GO:1902224)	1	0	.17	-	 < 0.01	8.40E-01
regulation of histone exchange (GO:1900049)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of phosphatidylinositol biosynthetic process (GO:0010513)	1	0	.17	-	 < 0.01	8.40E-01
spermidine metabolic process (GO:0008216)	2	0	.35	-	 < 0.01	7.06E-01
regulation of spindle assembly (GO:0090169)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of phosphatidylinositol biosynthetic process (GO:0010511)	1	0	.17	-	 < 0.01	8.40E-01
spermine metabolic process (GO:0008215)	1	0	.17	-	 < 0.01	8.40E-01
estrogen metabolic process (GO:0008210)	1	0	.17	-	 < 0.01	8.40E-01
DNA catabolic process, endonucleolytic (GO:0000737)	11	0	1.92	-	 < 0.01	1.47E-01
Golgi ribbon formation (GO:0090161)	1	0	.17	-	 < 0.01	8.40E-01
chitin catabolic process (GO:0006032)	11	0	1.92	-	 < 0.01	1.47E-01
DNA strand renaturation (GO:0000733)	2	0	.35	-	 < 0.01	7.06E-01
strand displacement (GO:0000732)	1	0	.17	-	 < 0.01	8.40E-01
DNA synthesis involved in DNA repair (GO:0000731)	10	0	1.74	-	 < 0.01	1.75E-01
DNA recombinase assembly (GO:0000730)	3	0	.52	-	 < 0.01	5.93E-01
androgen metabolic process (GO:0008209)	1	0	.17	-	 < 0.01	8.40E-01
cellular sphingolipid homeostasis (GO:0090156)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of sphingolipid biosynthetic process (GO:0090155)	1	0	.17	-	 < 0.01	8.40E-01
microtubule nucleation by microtubule organizing center (GO:0051418)	7	0	1.22	-	 < 0.01	2.95E-01
inositol biosynthetic process (GO:0006021)	1	0	.17	-	 < 0.01	8.40E-01
telomere maintenance via recombination (GO:0000722)	2	0	.35	-	 < 0.01	7.06E-01
microtubule nucleation by interphase microtubule organizing center (GO:0051415)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	2	0	.35	-	 < 0.01	7.06E-01
regulation of substrate adhesion-dependent cell spreading (GO:1900024)	2	0	.35	-	 < 0.01	7.06E-01
membrane fission (GO:0090148)	3	0	.52	-	 < 0.01	5.93E-01
photoreactive repair (GO:0000719)	1	0	.17	-	 < 0.01	8.40E-01
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	1	0	.17	-	 < 0.01	8.40E-01
nucleotide-excision repair, DNA damage recognition (GO:0000715)	2	0	.35	-	 < 0.01	7.06E-01
D-ribose metabolic process (GO:0006014)	1	0	.17	-	 < 0.01	8.40E-01
galactose metabolic process (GO:0006012)	4	0	.70	-	 < 0.01	4.98E-01
resolution of meiotic recombination intermediates (GO:0000712)	9	0	1.57	-	 < 0.01	2.08E-01
UDP-glucose metabolic process (GO:0006011)	1	0	.17	-	 < 0.01	8.40E-01
meiotic DNA repair synthesis (GO:0000711)	3	0	.52	-	 < 0.01	5.93E-01
neuron apoptotic process (GO:0051402)	2	0	.35	-	 < 0.01	7.06E-01
protection from non-homologous end joining at telomere (GO:0031848)	3	0	.52	-	 < 0.01	5.93E-01
epithelial cell-cell adhesion (GO:0090136)	9	0	1.57	-	 < 0.01	2.08E-01
meiotic DNA recombinase assembly (GO:0000707)	1	0	.17	-	 < 0.01	8.40E-01
fucose metabolic process (GO:0006004)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of eating behavior (GO:1903999)	1	0	.17	-	 < 0.01	8.40E-01
regulation of eating behavior (GO:1903998)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of dendrite development (GO:1900006)	2	0	.35	-	 < 0.01	7.06E-01
cell-cell recognition (GO:0009988)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of serine-type endopeptidase activity (GO:1900005)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of serine-type endopeptidase activity (GO:1900004)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of neuron projection regeneration (GO:0070571)	1	0	.17	-	 < 0.01	8.40E-01
regulation of serine-type endopeptidase activity (GO:1900003)	2	0	.35	-	 < 0.01	7.06E-01
transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification (GO:0060799)	2	0	.35	-	 < 0.01	7.06E-01
transforming growth factor beta receptor signaling pathway involved in primary germ layer cell fate commitment (GO:0060797)	2	0	.35	-	 < 0.01	7.06E-01
protein localization to cell division site (GO:0072741)	2	0	.35	-	 < 0.01	7.06E-01
ectodermal placode formation (GO:0060788)	4	0	.70	-	 < 0.01	4.98E-01
regulation of cell differentiation involved in tissue homeostasis (GO:0060786)	2	0	.35	-	 < 0.01	7.06E-01
regulation of apoptosis involved in tissue homeostasis (GO:0060785)	1	0	.17	-	 < 0.01	8.40E-01
cytoskeleton-dependent cytoplasmic transport, nurse cell to oocyte (GO:0019749)	2	0	.35	-	 < 0.01	7.06E-01
regulation of isoprenoid metabolic process (GO:0019747)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of glial cell migration (GO:1903977)	2	0	.35	-	 < 0.01	7.06E-01
regulation of glial cell migration (GO:1903975)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of signal transduction by p53 class mediator (GO:1901798)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell-substrate junction assembly (GO:0090109)	2	0	.35	-	 < 0.01	7.06E-01
rDNA condensation (GO:0070550)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of lipid catabolic process (GO:0050996)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of lipid catabolic process (GO:0050995)	5	0	.87	-	 < 0.01	4.18E-01
regulation of lipid catabolic process (GO:0050994)	10	0	1.74	-	 < 0.01	1.75E-01
antifungal humoral response (GO:0019732)	3	0	.52	-	 < 0.01	5.93E-01
arachidonate transport (GO:1903963)	3	0	.52	-	 < 0.01	5.93E-01
histone H3-K36 demethylation (GO:0070544)	3	0	.52	-	 < 0.01	5.93E-01
polarity specification of dorsal/ventral axis (GO:0009951)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)	1	0	.17	-	 < 0.01	8.40E-01
sprouting of injured axon (GO:0048682)	4	0	.70	-	 < 0.01	4.98E-01
polarity specification of anterior/posterior axis (GO:0009949)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of axon regeneration (GO:0048681)	1	0	.17	-	 < 0.01	8.40E-01
proximal/distal axis specification (GO:0009946)	3	0	.52	-	 < 0.01	5.93E-01
execution phase of apoptosis (GO:0097194)	11	0	1.92	-	 < 0.01	1.47E-01
foraging behavior (GO:0060756)	1	0	.17	-	 < 0.01	8.40E-01
detection of mechanical stimulus involved in sensory perception of touch (GO:0050976)	4	0	.70	-	 < 0.01	4.98E-01
response to methyl methanesulfonate (GO:0072702)	1	0	.17	-	 < 0.01	8.40E-01
protein kinase C signaling (GO:0070528)	2	0	.35	-	 < 0.01	7.06E-01
collateral sprouting of injured axon (GO:0048674)	3	0	.52	-	 < 0.01	5.93E-01
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	1	0	.17	-	 < 0.01	8.40E-01
S-adenosylhomocysteine metabolic process (GO:0046498)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of TORC2 signaling (GO:1903940)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of heterochromatin organization (GO:0120262)	2	0	.35	-	 < 0.01	7.06E-01
detection of chemical stimulus involved in sensory perception of pain (GO:0050968)	1	0	.17	-	 < 0.01	8.40E-01
collateral sprouting (GO:0048668)	3	0	.52	-	 < 0.01	5.93E-01
glyoxylate metabolic process (GO:0046487)	2	0	.35	-	 < 0.01	7.06E-01
ether lipid metabolic process (GO:0046485)	1	0	.17	-	 < 0.01	8.40E-01
hydrocarbon catabolic process (GO:0120253)	1	0	.17	-	 < 0.01	8.40E-01
establishment or maintenance of cytoskeleton polarity involved in gastrulation (GO:0003380)	3	0	.52	-	 < 0.01	5.93E-01
phosphatidic acid metabolic process (GO:0046473)	3	0	.52	-	 < 0.01	5.93E-01
hormone transport (GO:0009914)	1	0	.17	-	 < 0.01	8.40E-01
intestinal epithelial structure maintenance (GO:0060729)	7	0	1.22	-	 < 0.01	2.95E-01
phosphatidylcholine metabolic process (GO:0046470)	2	0	.35	-	 < 0.01	7.06E-01
establishment of cell polarity involved in gastrulation cell migration (GO:0003379)	3	0	.52	-	 < 0.01	5.93E-01
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of pigment cell differentiation (GO:0050941)	1	0	.17	-	 < 0.01	8.40E-01
dynamin family protein polymerization involved in membrane fission (GO:0003373)	3	0	.52	-	 < 0.01	5.93E-01
establishment or maintenance of cytoskeleton polarity involved in ameboidal cell migration (GO:0003371)	3	0	.52	-	 < 0.01	5.93E-01
membrane lipid catabolic process (GO:0046466)	3	0	.52	-	 < 0.01	5.93E-01
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193)	1	0	.17	-	 < 0.01	8.40E-01
response to photoperiod, blue light (GO:0009906)	1	0	.17	-	 < 0.01	8.40E-01
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192)	1	0	.17	-	 < 0.01	8.40E-01
fasciculation of motor neuron axon (GO:0097156)	4	0	.70	-	 < 0.01	4.98E-01
fasciculation of sensory neuron axon (GO:0097155)	1	0	.17	-	 < 0.01	8.40E-01
regulation of receptor clustering (GO:1903909)	1	0	.17	-	 < 0.01	8.40E-01
establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of muscle organ development (GO:0048636)	6	0	1.05	-	 < 0.01	3.51E-01
regulation of pigment cell differentiation (GO:0050932)	1	0	.17	-	 < 0.01	8.40E-01
pigment cell differentiation (GO:0050931)	2	0	.35	-	 < 0.01	7.06E-01
RNA polymerase I preinitiation complex assembly (GO:0001188)	1	0	.17	-	 < 0.01	8.40E-01
short-chain fatty acid metabolic process (GO:0046459)	1	0	.17	-	 < 0.01	8.40E-01
prostanoid biosynthetic process (GO:0046457)	1	0	.17	-	 < 0.01	8.40E-01
icosanoid biosynthetic process (GO:0046456)	1	0	.17	-	 < 0.01	8.40E-01
dihydrofolate metabolic process (GO:0046452)	1	0	.17	-	 < 0.01	8.40E-01
sulfur compound catabolic process (GO:0044273)	2	0	.35	-	 < 0.01	7.06E-01
induction of negative chemotaxis (GO:0050929)	1	0	.17	-	 < 0.01	8.40E-01
protein localization to phagophore assembly site (GO:0034497)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of negative chemotaxis (GO:0050924)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cilium beat frequency (GO:0003356)	1	0	.17	-	 < 0.01	8.40E-01
myoblast development (GO:0048627)	2	0	.35	-	 < 0.01	7.06E-01
regulation of negative chemotaxis (GO:0050923)	1	0	.17	-	 < 0.01	8.40E-01
myoblast fate specification (GO:0048626)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of chemotaxis (GO:0050922)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of chemotaxis (GO:0050921)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of cilium movement (GO:0003353)	2	0	.35	-	 < 0.01	7.06E-01
myoblast fate commitment (GO:0048625)	3	0	.52	-	 < 0.01	5.93E-01
regulation of cilium movement (GO:0003352)	2	0	.35	-	 < 0.01	7.06E-01
post-embryonic digestive tract morphogenesis (GO:0048621)	1	0	.17	-	 < 0.01	8.40E-01
transcriptional start site selection at RNA polymerase II promoter (GO:0001174)	1	0	.17	-	 < 0.01	8.40E-01
DNA-templated transcriptional start site selection (GO:0001173)	1	0	.17	-	 < 0.01	8.40E-01
sensory perception of sweet taste (GO:0050916)	13	0	2.27	-	 < 0.01	1.03E-01
sensory perception of salty taste (GO:0050914)	3	0	.52	-	 < 0.01	5.93E-01
embryonic foregut morphogenesis (GO:0048617)	3	0	.52	-	 < 0.01	5.93E-01
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	1	0	.17	-	 < 0.01	8.40E-01
L-glutamine biosynthetic process (GO:1901704)	1	0	.17	-	 < 0.01	8.40E-01
detection of calcium ion (GO:0005513)	1	0	.17	-	 < 0.01	8.40E-01
U5 snRNA 3'-end processing (GO:0034476)	2	0	.35	-	 < 0.01	7.06E-01
U2 snRNA 3'-end processing (GO:0034474)	1	0	.17	-	 < 0.01	8.40E-01
U1 snRNA 3'-end processing (GO:0034473)	2	0	.35	-	 < 0.01	7.06E-01
oocyte fate commitment (GO:0048600)	2	0	.35	-	 < 0.01	7.06E-01
axon ensheathment in central nervous system (GO:0032291)	3	0	.52	-	 < 0.01	5.93E-01
neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118)	1	0	.17	-	 < 0.01	8.40E-01
neurexin clustering involved in presynaptic membrane assembly (GO:0097115)	1	0	.17	-	 < 0.01	8.40E-01
AMPA glutamate receptor clustering (GO:0097113)	2	0	.35	-	 < 0.01	7.06E-01
gamma-aminobutyric acid receptor clustering (GO:0097112)	1	0	.17	-	 < 0.01	8.40E-01
regulation of catecholamine metabolic process (GO:0042069)	3	0	.52	-	 < 0.01	5.93E-01
lipid digestion (GO:0044241)	1	0	.17	-	 < 0.01	8.40E-01
long-term strengthening of neuromuscular junction (GO:0042062)	2	0	.35	-	 < 0.01	7.06E-01
postsynaptic density assembly (GO:0097107)	1	0	.17	-	 < 0.01	8.40E-01
postsynaptic density organization (GO:0097106)	2	0	.35	-	 < 0.01	7.06E-01
regulation of dopamine metabolic process (GO:0042053)	2	0	.35	-	 < 0.01	7.06E-01
cardioblast migration to the midline involved in heart rudiment formation (GO:0003319)	1	0	.17	-	 < 0.01	8.40E-01
cell migration to the midline involved in heart development (GO:0003318)	1	0	.17	-	 < 0.01	8.40E-01
heart rudiment formation (GO:0003315)	1	0	.17	-	 < 0.01	8.40E-01
heart rudiment morphogenesis (GO:0003314)	1	0	.17	-	 < 0.01	8.40E-01
heart rudiment development (GO:0003313)	1	0	.17	-	 < 0.01	8.40E-01
myeloid cell differentiation (GO:0030099)	1	0	.17	-	 < 0.01	8.40E-01
protein repair (GO:0030091)	3	0	.52	-	 < 0.01	5.93E-01
cardiac muscle atrophy (GO:0014899)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of signaling receptor activity (GO:2000272)	4	0	.70	-	 < 0.01	4.98E-01
striated muscle atrophy (GO:0014891)	1	0	.17	-	 < 0.01	8.40E-01
metal incorporation into metallo-molybdopterin complex (GO:0042040)	1	0	.17	-	 < 0.01	8.40E-01
Wnt signaling pathway involved in heart development (GO:0003306)	1	0	.17	-	 < 0.01	8.40E-01
IMP salvage (GO:0032264)	1	0	.17	-	 < 0.01	8.40E-01
purine nucleotide salvage (GO:0032261)	2	0	.35	-	 < 0.01	7.06E-01
muscle atrophy (GO:0014889)	1	0	.17	-	 < 0.01	8.40E-01
striated muscle adaptation (GO:0014888)	1	0	.17	-	 < 0.01	8.40E-01
cardiac muscle adaptation (GO:0014887)	1	0	.17	-	 < 0.01	8.40E-01
regulation of myofibril size (GO:0014881)	1	0	.17	-	 < 0.01	8.40E-01
secretory granule localization (GO:0032252)	1	0	.17	-	 < 0.01	8.40E-01
AMP salvage (GO:0044209)	1	0	.17	-	 < 0.01	8.40E-01
'de novo' AMP biosynthetic process (GO:0044208)	2	0	.35	-	 < 0.01	7.06E-01
neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	2	0	.35	-	 < 0.01	7.06E-01
peptide hormone secretion (GO:0030072)	1	0	.17	-	 < 0.01	8.40E-01
postsynaptic neurotransmitter receptor internalization (GO:0098884)	1	0	.17	-	 < 0.01	8.40E-01
'de novo' UMP biosynthetic process (GO:0044205)	1	0	.17	-	 < 0.01	8.40E-01
synapse pruning (GO:0098883)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of male germ cell proliferation (GO:2000255)	1	0	.17	-	 < 0.01	8.40E-01
regulation of male germ cell proliferation (GO:2000254)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of actin cytoskeleton reorganization (GO:2000251)	1	0	.17	-	 < 0.01	8.40E-01
nuclear-transcribed mRNA catabolic process, exonucleolytic, 5'-3' (GO:0034428)	1	0	.17	-	 < 0.01	8.40E-01
post-translational protein acetylation (GO:0034421)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of nucleobase-containing compound transport (GO:0032240)	1	0	.17	-	 < 0.01	8.40E-01
neurotransmitter receptor transport to plasma membrane (GO:0098877)	2	0	.35	-	 < 0.01	7.06E-01
regulation of actin cytoskeleton reorganization (GO:2000249)	3	0	.52	-	 < 0.01	5.93E-01
activation of store-operated calcium channel activity (GO:0032237)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of actin filament bundle assembly (GO:0032233)	6	0	1.05	-	 < 0.01	3.51E-01
negative regulation of actin filament bundle assembly (GO:0032232)	1	0	.17	-	 < 0.01	8.40E-01
cellular oxidant detoxification (GO:0098869)	5	0	.87	-	 < 0.01	4.18E-01
protein depalmitoleylation (GO:1990697)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of ecdysteroid biosynthetic process (GO:0045998)	4	0	.70	-	 < 0.01	4.98E-01
vesicle transport along actin filament (GO:0030050)	10	0	1.74	-	 < 0.01	1.75E-01
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853)	1	0	.17	-	 < 0.01	8.40E-01
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852)	1	0	.17	-	 < 0.01	8.40E-01
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	1	0	.17	-	 < 0.01	8.40E-01
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	19	0	3.31	-	 < 0.01	3.62E-02
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402)	2	0	.35	-	 < 0.01	7.06E-01
regulation of synaptic transmission, dopaminergic (GO:0032225)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of synaptic transmission, cholinergic (GO:0032224)	2	0	.35	-	 < 0.01	7.06E-01
regulation of synaptic transmission, cholinergic (GO:0032222)	7	0	1.22	-	 < 0.01	2.95E-01
actin filament fragmentation (GO:0030043)	1	0	.17	-	 < 0.01	8.40E-01
intestinal lipid absorption (GO:0098856)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of smooth muscle contraction (GO:0045987)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of smooth muscle contraction (GO:0045986)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of protein localization to cell periphery (GO:1904376)	1	0	.17	-	 < 0.01	8.40E-01
actin filament reorganization involved in cell cycle (GO:0030037)	5	0	.87	-	 < 0.01	4.18E-01
regulation of establishment of bipolar cell polarity (GO:0061172)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of mitotic cell cycle, embryonic (GO:0045977)	4	0	.70	-	 < 0.01	4.98E-01
regulation of translation, ncRNA-mediated (GO:0045974)	1	0	.17	-	 < 0.01	8.40E-01
regulation of gastrulation (GO:0010470)	6	0	1.05	-	 < 0.01	3.51E-01
negative regulation of juvenile hormone biosynthetic process (GO:0045968)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of ecdysteroid metabolic process (GO:0045966)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of dopamine metabolic process (GO:0045963)	1	0	.17	-	 < 0.01	8.40E-01
kinetochore organization (GO:0051383)	7	0	1.22	-	 < 0.01	2.95E-01
kinetochore assembly (GO:0051382)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of protein catabolic process in the vacuole (GO:1904352)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein catabolic process in the vacuole (GO:1904350)	1	0	.17	-	 < 0.01	8.40E-01
regulation of signaling receptor activity (GO:0010469)	7	0	1.22	-	 < 0.01	2.95E-01
3'-UTR-mediated mRNA destabilization (GO:0061158)	1	0	.17	-	 < 0.01	8.40E-01
mRNA destabilization (GO:0061157)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of heart rate (GO:0010460)	2	0	.35	-	 < 0.01	7.06E-01
protein maturation by protein folding (GO:0022417)	1	0	.17	-	 < 0.01	8.40E-01
regulation of skeletal muscle contraction (GO:0014819)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of mitotic recombination (GO:0045951)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of mitotic recombination (GO:0045950)	3	0	.52	-	 < 0.01	5.93E-01
muscle cell migration (GO:0014812)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of dopaminergic neuron differentiation (GO:1904340)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of heart rate (GO:0010459)	3	0	.52	-	 < 0.01	5.93E-01
exit from mitosis (GO:0010458)	1	0	.17	-	 < 0.01	8.40E-01
centriole-centriole cohesion (GO:0010457)	4	0	.70	-	 < 0.01	4.98E-01
histone H3-K36 methylation (GO:0010452)	3	0	.52	-	 < 0.01	5.93E-01
cellular potassium ion homeostasis (GO:0030007)	5	0	.87	-	 < 0.01	4.18E-01
modulation of excitatory postsynaptic potential (GO:0098815)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of translational initiation (GO:0045947)	3	0	.52	-	 < 0.01	5.93E-01
neurotransmitter reuptake (GO:0098810)	2	0	.35	-	 < 0.01	7.06E-01
regulation of dopaminergic neuron differentiation (GO:1904338)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of steroid metabolic process (GO:0045940)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of muscle contraction (GO:0045933)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of muscle contraction (GO:0045932)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of oxidoreductase activity (GO:0051354)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of lyase activity (GO:0051350)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein deubiquitination (GO:0090085)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of juvenile hormone metabolic process (GO:0045928)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of female receptivity (GO:0045925)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of fatty acid metabolic process (GO:0045922)	1	0	.17	-	 < 0.01	8.40E-01
box C/D snoRNA metabolic process (GO:0033967)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of ribosome biogenesis (GO:0090071)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of catecholamine metabolic process (GO:0045914)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of carbohydrate metabolic process (GO:0045913)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of DNA recombination (GO:0045911)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of DNA recombination (GO:0045910)	12	0	2.09	-	 < 0.01	1.23E-01
positive regulation of microtubule nucleation (GO:0090063)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of translational fidelity (GO:0045903)	1	0	.17	-	 < 0.01	8.40E-01
choline metabolic process (GO:0019695)	1	0	.17	-	 < 0.01	8.40E-01
deoxyribose phosphate metabolic process (GO:0019692)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of pericentric heterochromatin assembly (GO:0090053)	1	0	.17	-	 < 0.01	8.40E-01
regulation of pericentric heterochromatin assembly (GO:0090052)	2	0	.35	-	 < 0.01	7.06E-01
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316)	1	0	.17	-	 < 0.01	8.40E-01
chromosome decondensation (GO:0051312)	1	0	.17	-	 < 0.01	8.40E-01
male meiosis chromosome separation (GO:0051308)	1	0	.17	-	 < 0.01	8.40E-01
meiotic chromosome separation (GO:0051307)	11	0	1.92	-	 < 0.01	1.47E-01
mitotic sister chromatid separation (GO:0051306)	5	0	.87	-	 < 0.01	4.18E-01
chromosome movement towards spindle pole (GO:0051305)	5	0	.87	-	 < 0.01	4.18E-01
chromosome separation (GO:0051304)	20	0	3.49	-	 < 0.01	3.04E-02
photoreceptor cell fate determination (GO:0043703)	6	0	1.05	-	 < 0.01	3.51E-01
NAD catabolic process (GO:0019677)	1	0	.17	-	 < 0.01	8.40E-01
GDP-mannose metabolic process (GO:0019673)	1	0	.17	-	 < 0.01	8.40E-01
nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of steroid hormone biosynthetic process (GO:0090031)	4	0	.70	-	 < 0.01	4.98E-01
regulation of steroid hormone biosynthetic process (GO:0090030)	4	0	.70	-	 < 0.01	4.98E-01
tRNA-guanine transglycosylation (GO:0101030)	1	0	.17	-	 < 0.01	8.40E-01
mitotic nuclear membrane organization (GO:0101024)	1	0	.17	-	 < 0.01	8.40E-01
plus-end specific microtubule depolymerization (GO:0070462)	1	0	.17	-	 < 0.01	8.40E-01
regulation of morphogenesis of a branching structure (GO:0060688)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of compound eye retinal cell apoptotic process (GO:1901694)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of compound eye retinal cell apoptotic process (GO:1901693)	1	0	.17	-	 < 0.01	8.40E-01
regulation of compound eye retinal cell apoptotic process (GO:1901692)	2	0	.35	-	 < 0.01	7.06E-01
intestinal absorption (GO:0050892)	1	0	.17	-	 < 0.01	8.40E-01
P granule assembly (GO:1903863)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of dendrite extension (GO:1903861)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of protein localization to chromatin (GO:0120187)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of protein localization to chromatin (GO:0120186)	1	0	.17	-	 < 0.01	8.40E-01
salivary gland cavitation (GO:0060662)	1	0	.17	-	 < 0.01	8.40E-01
endocrine process (GO:0050886)	2	0	.35	-	 < 0.01	7.06E-01
short-chain fatty acid catabolic process (GO:0019626)	1	0	.17	-	 < 0.01	8.40E-01
regulation of dendrite extension (GO:1903859)	1	0	.17	-	 < 0.01	8.40E-01
musculoskeletal movement (GO:0050881)	3	0	.52	-	 < 0.01	5.93E-01
nucleotide transmembrane transport (GO:1901679)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of post-embryonic development (GO:0048581)	2	0	.35	-	 < 0.01	7.06E-01
regulation of post-embryonic development (GO:0048580)	5	0	.87	-	 < 0.01	4.18E-01
regulation of mitotic spindle assembly (GO:1901673)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of torso signaling pathway (GO:0120177)	7	0	1.22	-	 < 0.01	2.95E-01
positive regulation of torso signaling pathway (GO:0120176)	2	0	.35	-	 < 0.01	7.06E-01
regulation of torso signaling pathway (GO:0120175)	9	0	1.57	-	 < 0.01	2.08E-01
synaptic vesicle clustering (GO:0097091)	2	0	.35	-	 < 0.01	7.06E-01
multicellular organismal movement (GO:0050879)	3	0	.52	-	 < 0.01	5.93E-01
catechol-containing compound catabolic process (GO:0019614)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	1	0	.17	-	 < 0.01	8.40E-01
methyl-branched fatty acid metabolic process (GO:0097089)	1	0	.17	-	 < 0.01	8.40E-01
butyrate metabolic process (GO:0019605)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to cold (GO:0070417)	1	0	.17	-	 < 0.01	8.40E-01
magnesium ion transmembrane transport (GO:1903830)	1	0	.17	-	 < 0.01	8.40E-01
deoxyribose phosphate catabolic process (GO:0046386)	2	0	.35	-	 < 0.01	7.06E-01
deoxyribose phosphate biosynthetic process (GO:0046385)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633)	1	0	.17	-	 < 0.01	8.40E-01
regulation of microtubule-based movement (GO:0060632)	5	0	.87	-	 < 0.01	4.18E-01
arginine transmembrane transport (GO:1903826)	1	0	.17	-	 < 0.01	8.40E-01
regulation of actomyosin contractile ring localization (GO:1901648)	2	0	.35	-	 < 0.01	7.06E-01
chemosensory jump behavior (GO:0007636)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein deneddylation (GO:0060625)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of ecdysone receptor-mediated signaling pathway (GO:0120143)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of ecdysone receptor-mediated signaling pathway (GO:0120142)	1	0	.17	-	 < 0.01	8.40E-01
pattern orientation (GO:0007633)	1	0	.17	-	 < 0.01	8.40E-01
regulation of ecdysone receptor-mediated signaling pathway (GO:0120141)	2	0	.35	-	 < 0.01	7.06E-01
S-adenosylmethionine catabolic process (GO:0050843)	1	0	.17	-	 < 0.01	8.40E-01
GDP-L-fucose metabolic process (GO:0046368)	3	0	.52	-	 < 0.01	5.93E-01
flight behavior (GO:0007629)	13	0	2.27	-	 < 0.01	1.03E-01
grooming behavior (GO:0007625)	3	0	.52	-	 < 0.01	5.93E-01
regulation of cardioblast proliferation (GO:0003264)	1	0	.17	-	 < 0.01	8.40E-01
glycine import across plasma membrane (GO:1903804)	1	0	.17	-	 < 0.01	8.40E-01
butyrate catabolic process (GO:0046359)	1	0	.17	-	 < 0.01	8.40E-01
L-leucine import across plasma membrane (GO:1903801)	3	0	.52	-	 < 0.01	5.93E-01
disaccharide catabolic process (GO:0046352)	1	0	.17	-	 < 0.01	8.40E-01
disaccharide biosynthetic process (GO:0046351)	2	0	.35	-	 < 0.01	7.06E-01
tube lumen cavitation (GO:0060605)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of viral process (GO:0048525)	5	0	.87	-	 < 0.01	4.18E-01
amino sugar catabolic process (GO:0046348)	12	0	2.09	-	 < 0.01	1.23E-01
protein linear polyubiquitination (GO:0097039)	2	0	.35	-	 < 0.01	7.06E-01
regulation of membrane lipid distribution (GO:0097035)	4	0	.70	-	 < 0.01	4.98E-01
regulation of steroid biosynthetic process (GO:0050810)	4	0	.70	-	 < 0.01	4.98E-01
octopamine metabolic process (GO:0046333)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of synaptic transmission (GO:0050806)	20	0	3.49	-	 < 0.01	3.04E-02
ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)	1	0	.17	-	 < 0.01	8.40E-01
regulation of ribonucleoprotein complex localization (GO:2000197)	1	0	.17	-	 < 0.01	8.40E-01
maintenance of actomyosin contractile ring localization (GO:0032189)	1	0	.17	-	 < 0.01	8.40E-01
septin cytoskeleton organization (GO:0032185)	2	0	.35	-	 < 0.01	7.06E-01
energy homeostasis (GO:0097009)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of glial cell apoptotic process (GO:0034352)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of glial cell apoptotic process (GO:0034351)	1	0	.17	-	 < 0.01	8.40E-01
regulation of glial cell apoptotic process (GO:0034350)	2	0	.35	-	 < 0.01	7.06E-01
protein deglycation, glyoxal removal (GO:0036529)	2	0	.35	-	 < 0.01	7.06E-01
protein deglycation (GO:0036525)	2	0	.35	-	 < 0.01	7.06E-01
regulation of branching morphogenesis of a nerve (GO:2000172)	1	0	.17	-	 < 0.01	8.40E-01
glial cell apoptotic process (GO:0034349)	2	0	.35	-	 < 0.01	7.06E-01
mRNA cleavage involved in gene silencing (GO:0098795)	1	0	.17	-	 < 0.01	8.40E-01
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169)	1	0	.17	-	 < 0.01	8.40E-01
extracellular matrix assembly (GO:0085029)	13	0	2.27	-	 < 0.01	1.03E-01
pre-mRNA cleavage required for polyadenylation (GO:0098789)	4	0	.70	-	 < 0.01	4.98E-01
mRNA cleavage involved in mRNA processing (GO:0098787)	4	0	.70	-	 < 0.01	4.98E-01
protein alpha-1,2-demannosylation (GO:0036508)	1	0	.17	-	 < 0.01	8.40E-01
protein demannosylation (GO:0036507)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cilium-dependent cell motility (GO:2000155)	2	0	.35	-	 < 0.01	7.06E-01
response to mitochondrial depolarisation (GO:0098780)	1	0	.17	-	 < 0.01	8.40E-01
regulation of ubiquitin-specific protease activity (GO:2000152)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of DNA-templated transcription, initiation (GO:2000143)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	2	0	.35	-	 < 0.01	7.06E-01
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	6	0	1.05	-	 < 0.01	3.51E-01
negative regulation of protein tyrosine kinase activity (GO:0061099)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of protein tyrosine kinase activity (GO:0061098)	1	0	.17	-	 < 0.01	8.40E-01
regulation of protein tyrosine kinase activity (GO:0061097)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	1	0	.17	-	 < 0.01	8.40E-01
primary alcohol biosynthetic process (GO:0034309)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of octopamine signaling pathway (GO:2000130)	1	0	.17	-	 < 0.01	8.40E-01
regulation of sequestering of zinc ion (GO:0061088)	3	0	.52	-	 < 0.01	5.93E-01
regulation of octopamine signaling pathway (GO:2000128)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of octopamine or tyramine signaling pathway (GO:2000127)	1	0	.17	-	 < 0.01	8.40E-01
regulation of octopamine or tyramine signaling pathway (GO:2000125)	1	0	.17	-	 < 0.01	8.40E-01
regulation of muscle hypertrophy (GO:0014743)	1	0	.17	-	 < 0.01	8.40E-01
tricellular tight junction assembly (GO:1904274)	1	0	.17	-	 < 0.01	8.40E-01
COP9 signalosome assembly (GO:0010387)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of flagellated sperm motility (GO:1902093)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of sister chromatid cohesion (GO:0045875)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of sevenless signaling pathway (GO:0045874)	8	0	1.40	-	 < 0.01	2.48E-01
establishment of meiotic spindle orientation (GO:0051296)	2	0	.35	-	 < 0.01	7.06E-01
nuclear pore complex assembly (GO:0051292)	4	0	.70	-	 < 0.01	4.98E-01
skeletal muscle atrophy (GO:0014732)	1	0	.17	-	 < 0.01	8.40E-01
detection of pheromone (GO:0043695)	7	0	1.22	-	 < 0.01	2.95E-01
temperature compensation of the circadian clock (GO:0010378)	5	0	.87	-	 < 0.01	4.18E-01
regulation of response to nutrient levels (GO:0032107)	3	0	.52	-	 < 0.01	5.93E-01
regulation of response to extracellular stimulus (GO:0032104)	3	0	.52	-	 < 0.01	5.93E-01
UDP-N-acetylglucosamine transmembrane transport (GO:1990569)	2	0	.35	-	 < 0.01	7.06E-01
maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded (GO:0008071)	1	0	.17	-	 < 0.01	8.40E-01
maternal determination of dorsal/ventral axis, ovarian follicular epithelium, germ-line encoded (GO:0008070)	2	0	.35	-	 < 0.01	7.06E-01
protein homotetramerization (GO:0051289)	3	0	.52	-	 < 0.01	5.93E-01
macromolecule depalmitoylation (GO:0098734)	2	0	.35	-	 < 0.01	7.06E-01
cellular response to salt (GO:1902075)	1	0	.17	-	 < 0.01	8.40E-01
response to salt (GO:1902074)	1	0	.17	-	 < 0.01	8.40E-01
dorsal/ventral axis specification, ovarian follicular epithelium (GO:0008069)	14	0	2.44	-	 < 0.01	8.68E-02
positive regulation of peptidoglycan recognition protein signaling pathway (GO:0061059)	6	0	1.05	-	 < 0.01	3.51E-01
positive regulation of pole plasm oskar mRNA localization (GO:0045856)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of pole plasm oskar mRNA localization (GO:0045855)	1	0	.17	-	 < 0.01	8.40E-01
pH elevation (GO:0045852)	1	0	.17	-	 < 0.01	8.40E-01
innate immune response-activating signal transduction (GO:0002758)	4	0	.70	-	 < 0.01	4.98E-01
response to trehalose (GO:0010353)	3	0	.52	-	 < 0.01	5.93E-01
eye pigment granule organization (GO:0008057)	11	0	1.92	-	 < 0.01	1.47E-01
immune response-activating signal transduction (GO:0002757)	4	0	.70	-	 < 0.01	4.98E-01
sodium ion import across plasma membrane (GO:0098719)	2	0	.35	-	 < 0.01	7.06E-01
cell surface pattern recognition receptor signaling pathway (GO:0002752)	1	0	.17	-	 < 0.01	8.40E-01
female courtship behavior (GO:0008050)	2	0	.35	-	 < 0.01	7.06E-01
female gonad morphogenesis (GO:0061040)	1	0	.17	-	 < 0.01	8.40E-01
mitochondrial tricarboxylic acid transmembrane transport (GO:1990546)	1	0	.17	-	 < 0.01	8.40E-01
leucine import across plasma membrane (GO:0098713)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of striated muscle tissue development (GO:0045843)	1	0	.17	-	 < 0.01	8.40E-01
oscillatory muscle contraction (GO:0014703)	1	0	.17	-	 < 0.01	8.40E-01
protein homooligomerization (GO:0051260)	13	0	2.27	-	 < 0.01	1.03E-01
endodermal digestive tract morphogenesis (GO:0061031)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of membrane potential (GO:0045837)	1	0	.17	-	 < 0.01	8.40E-01
meiotic spindle midzone assembly (GO:0051257)	3	0	.52	-	 < 0.01	5.93E-01
mitotic spindle midzone assembly (GO:0051256)	3	0	.52	-	 < 0.01	5.93E-01
spindle midzone assembly (GO:0051255)	6	0	1.05	-	 < 0.01	3.51E-01
negative regulation of lipid metabolic process (GO:0045833)	12	0	2.09	-	 < 0.01	1.23E-01
mitochondrial fragmentation involved in apoptotic process (GO:0043653)	2	0	.35	-	 < 0.01	7.06E-01
establishment of endothelial barrier (GO:0061028)	1	0	.17	-	 < 0.01	8.40E-01
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of isoprenoid metabolic process (GO:0045827)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of heart contraction (GO:0045822)	3	0	.52	-	 < 0.01	5.93E-01
nucleoside bisphosphate catabolic process (GO:0033869)	1	0	.17	-	 < 0.01	8.40E-01
regulation of NADP metabolic process (GO:1902031)	1	0	.17	-	 < 0.01	8.40E-01
snRNA import into nucleus (GO:0061015)	1	0	.17	-	 < 0.01	8.40E-01
pyrimidine nucleotide import into mitochondrion (GO:1990519)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of glycogen catabolic process (GO:0045819)	3	0	.52	-	 < 0.01	5.93E-01
maintenance of RNA location (GO:0051237)	3	0	.52	-	 < 0.01	5.93E-01
piRNA biosynthetic process (GO:1990511)	5	0	.87	-	 < 0.01	4.18E-01
spindle elongation (GO:0051231)	11	0	1.92	-	 < 0.01	1.47E-01
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	7	0	1.22	-	 < 0.01	2.95E-01
polyadenylation-dependent RNA catabolic process (GO:0043633)	7	0	1.22	-	 < 0.01	2.95E-01
ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630)	1	0	.17	-	 < 0.01	8.40E-01
L-arginine transport (GO:1902023)	1	0	.17	-	 < 0.01	8.40E-01
regulation of hydrogen peroxide metabolic process (GO:0010310)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of dendritic spine morphogenesis (GO:0061003)	1	0	.17	-	 < 0.01	8.40E-01
regulation of dendritic spine morphogenesis (GO:0061001)	1	0	.17	-	 < 0.01	8.40E-01
mitotic DNA replication maintenance of fidelity (GO:1990505)	1	0	.17	-	 < 0.01	8.40E-01
ncRNA polyadenylation (GO:0043629)	1	0	.17	-	 < 0.01	8.40E-01
histone H3-K4 trimethylation (GO:0080182)	2	0	.35	-	 < 0.01	7.06E-01
regulation of cilium-dependent cell motility (GO:1902019)	2	0	.35	-	 < 0.01	7.06E-01
regulation of cilium assembly (GO:1902017)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle (GO:0031660)	1	0	.17	-	 < 0.01	8.40E-01
glycine receptor clustering (GO:0072579)	1	0	.17	-	 < 0.01	8.40E-01
neurotransmitter-gated ion channel clustering (GO:0072578)	5	0	.87	-	 < 0.01	4.18E-01
glucuronate metabolic process (GO:0019585)	1	0	.17	-	 < 0.01	8.40E-01
fatty acid transmembrane transport (GO:1902001)	1	0	.17	-	 < 0.01	8.40E-01
homogentisate catabolic process (GO:1902000)	1	0	.17	-	 < 0.01	8.40E-01
release of sequestered calcium ion into cytosol (GO:0051209)	2	0	.35	-	 < 0.01	7.06E-01
regulation of nitric oxide metabolic process (GO:0080164)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of nervous system process (GO:0031645)	1	0	.17	-	 < 0.01	8.40E-01
regulation of fertilization (GO:0080154)	1	0	.17	-	 < 0.01	8.40E-01
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798)	1	0	.17	-	 < 0.01	8.40E-01
regulation of asymmetric cell division (GO:0009786)	3	0	.52	-	 < 0.01	5.93E-01
ERK1 and ERK2 cascade (GO:0070371)	2	0	.35	-	 < 0.01	7.06E-01
zymogen activation (GO:0031638)	3	0	.52	-	 < 0.01	5.93E-01
multicellular organismal iron ion homeostasis (GO:0060586)	2	0	.35	-	 < 0.01	7.06E-01
puparial adhesion (GO:0007594)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of cellular response to alcohol (GO:1905958)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cellular response to alcohol (GO:1905957)	2	0	.35	-	 < 0.01	7.06E-01
arginine catabolic process to ornithine (GO:0019547)	1	0	.17	-	 < 0.01	8.40E-01
arginine catabolic process to glutamate (GO:0019544)	1	0	.17	-	 < 0.01	8.40E-01
intestinal epithelial cell development (GO:0060576)	1	0	.17	-	 < 0.01	8.40E-01
cell fate specification involved in pattern specification (GO:0060573)	8	0	1.40	-	 < 0.01	2.48E-01
morphogenesis of an epithelial bud (GO:0060572)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of peptide hormone processing (GO:0060570)	1	0	.17	-	 < 0.01	8.40E-01
pyridine-containing compound catabolic process (GO:0072526)	1	0	.17	-	 < 0.01	8.40E-01
CAAX-box protein maturation (GO:0080120)	4	0	.70	-	 < 0.01	4.98E-01
oxalate transport (GO:0019532)	1	0	.17	-	 < 0.01	8.40E-01
postsynaptic cytoskeleton organization (GO:0099188)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of fat cell proliferation (GO:0070346)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of fat cell proliferation (GO:0070345)	1	0	.17	-	 < 0.01	8.40E-01
retrograde synaptic vesicle transport (GO:0048491)	1	0	.17	-	 < 0.01	8.40E-01
regulation of fat cell proliferation (GO:0070344)	2	0	.35	-	 < 0.01	7.06E-01
anterograde synaptic vesicle transport (GO:0048490)	4	0	.70	-	 < 0.01	4.98E-01
regulation of peptide hormone processing (GO:0060568)	1	0	.17	-	 < 0.01	8.40E-01
response to fructose (GO:0009750)	1	0	.17	-	 < 0.01	8.40E-01
apoptotic process involved in morphogenesis (GO:0060561)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of microfilament motor activity (GO:0120080)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of germ cell proliferation (GO:1905938)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of germ cell proliferation (GO:1905937)	1	0	.17	-	 < 0.01	8.40E-01
regulation of germ cell proliferation (GO:1905936)	2	0	.35	-	 < 0.01	7.06E-01
DNA demethylation (GO:0080111)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell fate determination (GO:1905933)	1	0	.17	-	 < 0.01	8.40E-01
D-gluconate metabolic process (GO:0019521)	1	0	.17	-	 < 0.01	8.40E-01
aldonic acid metabolic process (GO:0019520)	1	0	.17	-	 < 0.01	8.40E-01
regulation of postsynapse organization (GO:0099175)	3	0	.52	-	 < 0.01	5.93E-01
postsynaptic modulation of chemical synaptic transmission (GO:0099170)	1	0	.17	-	 < 0.01	8.40E-01
cell aging (GO:0007569)	3	0	.52	-	 < 0.01	5.93E-01
fatty acid derivative transport (GO:1901571)	3	0	.52	-	 < 0.01	5.93E-01
regulation of chitin-based cuticle tanning (GO:0007564)	1	0	.17	-	 < 0.01	8.40E-01
RNA destabilization (GO:0050779)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of dendrite morphogenesis (GO:0050774)	3	0	.52	-	 < 0.01	5.93E-01
fatty acid derivative catabolic process (GO:1901569)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of phosphatidate phosphatase activity (GO:1903741)	1	0	.17	-	 < 0.01	8.40E-01
synaptic signaling by nitric oxide (GO:0099163)	1	0	.17	-	 < 0.01	8.40E-01
glycolate biosynthetic process (GO:0046295)	2	0	.35	-	 < 0.01	7.06E-01
formaldehyde catabolic process (GO:0046294)	1	0	.17	-	 < 0.01	8.40E-01
response to camptothecin (GO:1901563)	2	0	.35	-	 < 0.01	7.06E-01
formaldehyde metabolic process (GO:0046292)	1	0	.17	-	 < 0.01	8.40E-01
detection of hexose stimulus (GO:0009732)	1	0	.17	-	 < 0.01	8.40E-01
detection of sucrose stimulus (GO:0009731)	1	0	.17	-	 < 0.01	8.40E-01
regulation of juvenile hormone biosynthetic process (GO:0007557)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of necrotic cell death (GO:0060547)	1	0	.17	-	 < 0.01	8.40E-01
detection of carbohydrate stimulus (GO:0009730)	1	0	.17	-	 < 0.01	8.40E-01
regulation of juvenile hormone metabolic process (GO:0007556)	3	0	.52	-	 < 0.01	5.93E-01
regulation of ecdysteroid secretion (GO:0007555)	2	0	.35	-	 < 0.01	7.06E-01
regulation of ecdysteroid biosynthetic process (GO:0007554)	4	0	.70	-	 < 0.01	4.98E-01
regulation of ecdysteroid metabolic process (GO:0007553)	5	0	.87	-	 < 0.01	4.18E-01
G1 to G0 transition (GO:0070314)	1	0	.17	-	 < 0.01	8.40E-01
regulation of phosphatidate phosphatase activity (GO:1903730)	1	0	.17	-	 < 0.01	8.40E-01
sex determination, primary response to X:A ratio (GO:0007541)	3	0	.52	-	 < 0.01	5.93E-01
sex determination, establishment of X:A ratio (GO:0007540)	3	0	.52	-	 < 0.01	5.93E-01
regulation of plasma membrane organization (GO:1903729)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of phospholipid metabolic process (GO:1903727)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of phospholipid metabolic process (GO:1903726)	1	0	.17	-	 < 0.01	8.40E-01
regulation of phospholipid metabolic process (GO:1903725)	2	0	.35	-	 < 0.01	7.06E-01
PERK-mediated unfolded protein response (GO:0036499)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of vacuole organization (GO:0044090)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of lipoprotein metabolic process (GO:0050747)	2	0	.35	-	 < 0.01	7.06E-01
regulation of lipoprotein metabolic process (GO:0050746)	2	0	.35	-	 < 0.01	7.06E-01
changes to DNA methylation involved in embryo development (GO:1901538)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of DNA demethylation (GO:1901537)	1	0	.17	-	 < 0.01	8.40E-01
regulation of DNA demethylation (GO:1901535)	1	0	.17	-	 < 0.01	8.40E-01
establishment of synaptic specificity at neuromuscular junction (GO:0007529)	3	0	.52	-	 < 0.01	5.93E-01
larval visceral muscle development (GO:0007523)	9	0	1.57	-	 < 0.01	2.08E-01
muscle cell fate determination (GO:0007521)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	5	0	.87	-	 < 0.01	4.18E-01
regulation of hemopoiesis (GO:1903706)	12	0	2.09	-	 < 0.01	1.23E-01
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	1	0	.17	-	 < 0.01	8.40E-01
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	6	0	1.05	-	 < 0.01	3.51E-01
enterocyte differentiation (GO:1903703)	1	0	.17	-	 < 0.01	8.40E-01
hemocyte development (GO:0007516)	7	0	1.22	-	 < 0.01	2.95E-01
cardioblast cell fate determination (GO:0007510)	3	0	.52	-	 < 0.01	5.93E-01
terpene catabolic process (GO:0046247)	1	0	.17	-	 < 0.01	8.40E-01
adult fat body development (GO:0007505)	2	0	.35	-	 < 0.01	7.06E-01
larval fat body development (GO:0007504)	2	0	.35	-	 < 0.01	7.06E-01
fat body development (GO:0007503)	7	0	1.22	-	 < 0.01	2.95E-01
digestive tract mesoderm development (GO:0007502)	5	0	.87	-	 < 0.01	4.18E-01
mesodermal cell fate specification (GO:0007501)	5	0	.87	-	 < 0.01	4.18E-01
regulation of endocrine process (GO:0044060)	3	0	.52	-	 < 0.01	5.93E-01
TRAIL-activated apoptotic signaling pathway (GO:0036462)	1	0	.17	-	 < 0.01	8.40E-01
detection of maltose stimulus (GO:0034289)	1	0	.17	-	 < 0.01	8.40E-01
detection of disaccharide stimulus (GO:0034288)	1	0	.17	-	 < 0.01	8.40E-01
detection of monosaccharide stimulus (GO:0034287)	1	0	.17	-	 < 0.01	8.40E-01
response to maltose (GO:0034286)	1	0	.17	-	 < 0.01	8.40E-01
embryonic heart tube formation (GO:0003144)	2	0	.35	-	 < 0.01	7.06E-01
embryonic heart tube morphogenesis (GO:0003143)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of cytokine secretion (GO:0050710)	1	0	.17	-	 < 0.01	8.40E-01
ether biosynthetic process (GO:1901503)	1	0	.17	-	 < 0.01	8.40E-01
intermembrane lipid transfer (GO:0120009)	1	0	.17	-	 < 0.01	8.40E-01
regulation of digestive system process (GO:0044058)	3	0	.52	-	 < 0.01	5.93E-01
cap mRNA methylation (GO:0036451)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cytokine secretion (GO:0050707)	1	0	.17	-	 < 0.01	8.40E-01
regulation of appetite (GO:0032098)	1	0	.17	-	 < 0.01	8.40E-01
regulation of response to food (GO:0032095)	3	0	.52	-	 < 0.01	5.93E-01
calcium import into the mitochondrion (GO:0036444)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of GTPase activity (GO:0034260)	1	0	.17	-	 < 0.01	8.40E-01
indolalkylamine catabolic process (GO:0046218)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of deoxyribonuclease activity (GO:0032077)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of nuclease activity (GO:0032075)	1	0	.17	-	 < 0.01	8.40E-01
regulation of deoxyribonuclease activity (GO:0032070)	1	0	.17	-	 < 0.01	8.40E-01
snoRNA splicing (GO:0034247)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)	5	0	.87	-	 < 0.01	4.18E-01
maintenance of protein location in cell cortex (GO:0032065)	1	0	.17	-	 < 0.01	8.40E-01
postsynaptic specialization assembly (GO:0098698)	1	0	.17	-	 < 0.01	8.40E-01
regulation of tRNA stability (GO:0036415)	1	0	.17	-	 < 0.01	8.40E-01
conversion of ds siRNA to ss siRNA (GO:0036404)	1	0	.17	-	 < 0.01	8.40E-01
regulation of non-canonical Wnt signaling pathway (GO:2000050)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of chromatin assembly or disassembly (GO:0045798)	2	0	.35	-	 < 0.01	7.06E-01
G protein-coupled serotonin receptor signaling pathway (GO:0098664)	2	0	.35	-	 < 0.01	7.06E-01
regulation of stem cell population maintenance (GO:2000036)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of pyruvate dehydrogenase activity (GO:1904184)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of pyruvate dehydrogenase activity (GO:1904183)	1	0	.17	-	 < 0.01	8.40E-01
amyloid-beta formation (GO:0034205)	3	0	.52	-	 < 0.01	5.93E-01
regulation of pyruvate dehydrogenase activity (GO:1904182)	2	0	.35	-	 < 0.01	7.06E-01
lipid translocation (GO:0034204)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of insulin secretion (GO:0032024)	5	0	.87	-	 < 0.01	4.18E-01
positive regulation of determination of dorsal identity (GO:2000017)	1	0	.17	-	 < 0.01	8.40E-01
regulation of determination of dorsal identity (GO:2000015)	1	0	.17	-	 < 0.01	8.40E-01
tetrahydrofolate interconversion (GO:0035999)	2	0	.35	-	 < 0.01	7.06E-01
response to silver ion (GO:0010272)	1	0	.17	-	 < 0.01	8.40E-01
box C/D snoRNA 3'-end processing (GO:0000494)	1	0	.17	-	 < 0.01	8.40E-01
box C/D snoRNP assembly (GO:0000492)	3	0	.52	-	 < 0.01	5.93E-01
small nucleolar ribonucleoprotein complex assembly (GO:0000491)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of adenylate cyclase activity (GO:0045762)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of DNA damage checkpoint (GO:2000002)	1	0	.17	-	 < 0.01	8.40E-01
regulation of DNA damage checkpoint (GO:2000001)	1	0	.17	-	 < 0.01	8.40E-01
vitamin transport (GO:0051180)	1	0	.17	-	 < 0.01	8.40E-01
endodermal cell differentiation (GO:0035987)	3	0	.52	-	 < 0.01	5.93E-01
SCF complex assembly (GO:0010265)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of action potential (GO:0045759)	1	0	.17	-	 < 0.01	8.40E-01
meiotic sister chromatid cohesion (GO:0051177)	8	0	1.40	-	 < 0.01	2.48E-01
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	1	0	.17	-	 < 0.01	8.40E-01
maintenance of DNA repeat elements (GO:0043570)	3	0	.52	-	 < 0.01	5.93E-01
aggrephagy (GO:0035973)	1	0	.17	-	 < 0.01	8.40E-01
peptidyl-histidine dephosphorylation (GO:0035971)	1	0	.17	-	 < 0.01	8.40E-01
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	2	0	.35	-	 < 0.01	7.06E-01
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	2	0	.35	-	 < 0.01	7.06E-01
peptidyl-threonine autophosphorylation (GO:1990443)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	9	0	1.57	-	 < 0.01	2.08E-01
hemoglobin metabolic process (GO:0020027)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	1	0	.17	-	 < 0.01	8.40E-01
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	2	0	.35	-	 < 0.01	7.06E-01
COPI-coated vesicle budding (GO:0035964)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of DNA repair (GO:0045739)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of DNA repair (GO:0045738)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	2	0	.35	-	 < 0.01	7.06E-01
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of striated muscle cell differentiation (GO:0051155)	2	0	.35	-	 < 0.01	7.06E-01
regulation of translational initiation in response to stress (GO:0043558)	3	0	.52	-	 < 0.01	5.93E-01
regulation of striated muscle cell differentiation (GO:0051153)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)	1	0	.17	-	 < 0.01	8.40E-01
regulation of phosphatidylinositol 3-kinase activity (GO:0043551)	3	0	.52	-	 < 0.01	5.93E-01
regulation of lipid kinase activity (GO:0043550)	3	0	.52	-	 < 0.01	5.93E-01
mitotic recombination-dependent replication fork processing (GO:1990426)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of muscle cell differentiation (GO:0051149)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of muscle cell differentiation (GO:0051148)	1	0	.17	-	 < 0.01	8.40E-01
regulation of muscle cell differentiation (GO:0051147)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of glycogen biosynthetic process (GO:0045725)	1	0	.17	-	 < 0.01	8.40E-01
rRNA 2'-O-methylation (GO:0000451)	1	0	.17	-	 < 0.01	8.40E-01
response to lithium ion (GO:0010226)	1	0	.17	-	 < 0.01	8.40E-01
response to UV-B (GO:0010224)	1	0	.17	-	 < 0.01	8.40E-01
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of glycogen biosynthetic process (GO:0045719)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of fatty acid biosynthetic process (GO:0045717)	1	0	.17	-	 < 0.01	8.40E-01
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	2	0	.35	-	 < 0.01	7.06E-01
chaperone-mediated protein complex assembly (GO:0051131)	1	0	.17	-	 < 0.01	8.40E-01
intra-S DNA damage checkpoint (GO:0031573)	7	0	1.22	-	 < 0.01	2.95E-01
G2 DNA damage checkpoint (GO:0031572)	8	0	1.40	-	 < 0.01	2.48E-01
mitotic G1 DNA damage checkpoint (GO:0031571)	2	0	.35	-	 < 0.01	7.06E-01
embryonic brain development (GO:1990403)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of actin nucleation (GO:0051127)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of actin nucleation (GO:0051126)	4	0	.70	-	 < 0.01	4.98E-01
regulation of actin nucleation (GO:0051125)	9	0	1.57	-	 < 0.01	2.08E-01
regulation of myosin II filament assembly (GO:0043520)	1	0	.17	-	 < 0.01	8.40E-01
arginine catabolic process to proline (GO:0019493)	1	0	.17	-	 < 0.01	8.40E-01
actomyosin contractile ring maintenance (GO:0031566)	2	0	.35	-	 < 0.01	7.06E-01
mitophagy (GO:0000423)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	1	0	.17	-	 < 0.01	8.40E-01
regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	1	0	.17	-	 < 0.01	8.40E-01
branchiomotor neuron axon guidance (GO:0021785)	1	0	.17	-	 < 0.01	8.40E-01
glial cell development (GO:0021782)	32	0	5.58	-	 < 0.01	3.72E-03
glial cell fate commitment (GO:0021781)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of histone H3-K36 methylation (GO:0000416)	1	0	.17	-	 < 0.01	8.40E-01
regulation of histone H3-K36 methylation (GO:0000414)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of JUN kinase activity (GO:0043507)	4	0	.70	-	 < 0.01	4.98E-01
skeletal muscle adaptation (GO:0043501)	1	0	.17	-	 < 0.01	8.40E-01
muscle adaptation (GO:0043500)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of oogenesis (GO:1905881)	1	0	.17	-	 < 0.01	8.40E-01
pigment cell development (GO:0070285)	1	0	.17	-	 < 0.01	8.40E-01
regulation of oogenesis (GO:1905879)	2	0	.35	-	 < 0.01	7.06E-01
glycine decarboxylation via glycine cleavage system (GO:0019464)	1	0	.17	-	 < 0.01	8.40E-01
extracellular matrix constituent secretion (GO:0070278)	4	0	.70	-	 < 0.01	4.98E-01
plus-end directed microtubule sliding (GO:0031535)	1	0	.17	-	 < 0.01	8.40E-01
minus-end directed microtubule sliding (GO:0031534)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of border follicle cell migration (GO:1903687)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of epithelial cell-cell adhesion involved in epithelium migration (GO:1903683)	1	0	.17	-	 < 0.01	8.40E-01
regulation of epithelial cell-cell adhesion involved in epithelium migration (GO:1903681)	1	0	.17	-	 < 0.01	8.40E-01
ectoderm and mesoderm interaction (GO:0007499)	2	0	.35	-	 < 0.01	7.06E-01
anterior midgut development (GO:0007496)	3	0	.52	-	 < 0.01	5.93E-01
visceral mesoderm-endoderm interaction involved in midgut development (GO:0007495)	1	0	.17	-	 < 0.01	8.40E-01
endodermal cell fate determination (GO:0007493)	1	0	.17	-	 < 0.01	8.40E-01
sternite morphogenesis (GO:0007491)	1	0	.17	-	 < 0.01	8.40E-01
tergite morphogenesis (GO:0007490)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of pentose-phosphate shunt (GO:1905857)	1	0	.17	-	 < 0.01	8.40E-01
tryptophan catabolic process to acetyl-CoA (GO:0019442)	1	0	.17	-	 < 0.01	8.40E-01
tryptophan catabolic process to kynurenine (GO:0019441)	1	0	.17	-	 < 0.01	8.40E-01
maintenance of imaginal histoblast diploidy (GO:0007489)	1	0	.17	-	 < 0.01	8.40E-01
imaginal disc-derived female genitalia development (GO:0007486)	7	0	1.22	-	 < 0.01	2.95E-01
haltere disc morphogenesis (GO:0007481)	3	0	.52	-	 < 0.01	5.93E-01
removal of superoxide radicals (GO:0019430)	4	0	.70	-	 < 0.01	4.98E-01
postsynaptic specialization organization (GO:0099084)	2	0	.35	-	 < 0.01	7.06E-01
pericentric heterochromatin assembly (GO:0031508)	2	0	.35	-	 < 0.01	7.06E-01
heterochromatin assembly (GO:0031507)	8	0	1.40	-	 < 0.01	2.48E-01
UV protection (GO:0009650)	3	0	.52	-	 < 0.01	5.93E-01
acetyl-CoA biosynthetic process from acetate (GO:0019427)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of spindle assembly (GO:1905832)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of epithelial cell proliferation (GO:0050680)	3	0	.52	-	 < 0.01	5.93E-01
mesectoderm development (GO:0048383)	5	0	.87	-	 < 0.01	4.18E-01
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	5	0	.87	-	 < 0.01	4.18E-01
pyruvate transmembrane transport (GO:1901475)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of digestive system process (GO:0060457)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of digestive system process (GO:0060456)	1	0	.17	-	 < 0.01	8.40E-01
R2/R5 cell fate commitment (GO:0007463)	1	0	.17	-	 < 0.01	8.40E-01
mRNA methylation (GO:0080009)	4	0	.70	-	 < 0.01	4.98E-01
R1/R6 cell fate commitment (GO:0007462)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of hindgut contraction (GO:0060450)	1	0	.17	-	 < 0.01	8.40E-01
regulation of epithelial cell proliferation (GO:0050678)	3	0	.52	-	 < 0.01	5.93E-01
epithelial cell proliferation (GO:0050673)	8	0	1.40	-	 < 0.01	2.48E-01
synaptic vesicle tethering involved in synaptic vesicle exocytosis (GO:0099069)	1	0	.17	-	 < 0.01	8.40E-01
response to red or far red light (GO:0009639)	2	0	.35	-	 < 0.01	7.06E-01
cold acclimation (GO:0009631)	4	0	.70	-	 < 0.01	4.98E-01
dolichol biosynthetic process (GO:0019408)	1	0	.17	-	 < 0.01	8.40E-01
hexitol catabolic process (GO:0019407)	2	0	.35	-	 < 0.01	7.06E-01
regulation of dorsal/ventral axon guidance (GO:1905815)	1	0	.17	-	 < 0.01	8.40E-01
aldehyde catabolic process (GO:0046185)	2	0	.35	-	 < 0.01	7.06E-01
determination of imaginal disc primordium (GO:0007445)	11	0	1.92	-	 < 0.01	1.47E-01
positive regulation of synapse pruning (GO:1905808)	2	0	.35	-	 < 0.01	7.06E-01
regulation of synapse pruning (GO:1905806)	2	0	.35	-	 < 0.01	7.06E-01
D-gluconate catabolic process (GO:0046177)	1	0	.17	-	 < 0.01	8.40E-01
aldonic acid catabolic process (GO:0046176)	1	0	.17	-	 < 0.01	8.40E-01
oenocyte development (GO:0007438)	8	0	1.40	-	 < 0.01	2.48E-01
salivary gland boundary specification (GO:0007432)	11	0	1.92	-	 < 0.01	1.47E-01
response to symbiotic bacterium (GO:0009609)	1	0	.17	-	 < 0.01	8.40E-01
response to symbiont (GO:0009608)	5	0	.87	-	 < 0.01	4.18E-01
secondary branching, open tracheal system (GO:0007429)	3	0	.52	-	 < 0.01	5.93E-01
epithelial cell fate determination, open tracheal system (GO:0007425)	3	0	.52	-	 < 0.01	5.93E-01
pre-replicative complex assembly (GO:0036388)	7	0	1.22	-	 < 0.01	2.95E-01
stomatogastric nervous system development (GO:0007421)	2	0	.35	-	 < 0.01	7.06E-01
NAD-cap decapping (GO:0110155)	1	0	.17	-	 < 0.01	8.40E-01
vesicle tethering (GO:0099022)	4	0	.70	-	 < 0.01	4.98E-01
heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of response to alcohol (GO:1901421)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of response to alcohol (GO:1901420)	1	0	.17	-	 < 0.01	8.40E-01
sodium ion export across plasma membrane (GO:0036376)	5	0	.87	-	 < 0.01	4.18E-01
acylglycerol transport (GO:0034196)	1	0	.17	-	 < 0.01	8.40E-01
regulation of response to alcohol (GO:1901419)	3	0	.52	-	 < 0.01	5.93E-01
positive regulation of response to ethanol (GO:1901418)	1	0	.17	-	 < 0.01	8.40E-01
regulation of response to ethanol (GO:1901416)	1	0	.17	-	 < 0.01	8.40E-01
neuronal dense core vesicle exocytosis (GO:0099011)	1	0	.17	-	 < 0.01	8.40E-01
ecdysis, chitin-based cuticle (GO:0018990)	17	0	2.96	-	 < 0.01	5.14E-02
glial cell fate determination (GO:0007403)	3	0	.52	-	 < 0.01	5.93E-01
ganglion mother cell fate determination (GO:0007402)	7	0	1.22	-	 < 0.01	2.95E-01
neuroblast fate determination (GO:0007400)	18	0	3.14	-	 < 0.01	4.31E-02
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409)	1	0	.17	-	 < 0.01	8.40E-01
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)	1	0	.17	-	 < 0.01	8.40E-01
histone H2A-K119 monoubiquitination (GO:0036353)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of myotube cell migration (GO:0110125)	2	0	.35	-	 < 0.01	7.06E-01
regulation of myotube cell migration (GO:0110123)	2	0	.35	-	 < 0.01	7.06E-01
myotube cell migration (GO:0110122)	2	0	.35	-	 < 0.01	7.06E-01
detection of carbon dioxide (GO:0003031)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of compound eye photoreceptor cell differentiation (GO:0110117)	3	0	.52	-	 < 0.01	5.93E-01
recycling endosome to Golgi transport (GO:0071955)	1	0	.17	-	 < 0.01	8.40E-01
xanthine metabolic process (GO:0046110)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of imaginal disc-derived wing vein specification (GO:0110109)	1	0	.17	-	 < 0.01	8.40E-01
voluntary skeletal muscle contraction (GO:0003010)	1	0	.17	-	 < 0.01	8.40E-01
skeletal muscle contraction (GO:0003009)	2	0	.35	-	 < 0.01	7.06E-01
vitamin A transport (GO:0071938)	1	0	.17	-	 < 0.01	8.40E-01
replication fork reversal (GO:0071932)	1	0	.17	-	 < 0.01	8.40E-01
octopamine signaling pathway (GO:0071927)	1	0	.17	-	 < 0.01	8.40E-01
endocannabinoid signaling pathway (GO:0071926)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of cohesin loading (GO:0071923)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cohesin loading (GO:0071922)	4	0	.70	-	 < 0.01	4.98E-01
cohesin loading (GO:0071921)	2	0	.35	-	 < 0.01	7.06E-01
protein localization to M-band (GO:0036309)	1	0	.17	-	 < 0.01	8.40E-01
detection of external biotic stimulus (GO:0098581)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	1	0	.17	-	 < 0.01	8.40E-01
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	1	0	.17	-	 < 0.01	8.40E-01
hyperosmotic response (GO:0006972)	1	0	.17	-	 < 0.01	8.40E-01
hypotonic response (GO:0006971)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of toll-like receptor signaling pathway (GO:0034122)	1	0	.17	-	 < 0.01	8.40E-01
regulation of toll-like receptor signaling pathway (GO:0034121)	1	0	.17	-	 < 0.01	8.40E-01
epithelium regeneration (GO:1990399)	5	0	.87	-	 < 0.01	4.18E-01
homotypic cell-cell adhesion (GO:0034109)	1	0	.17	-	 < 0.01	8.40E-01
erythrocyte homeostasis (GO:0034101)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of glial cell differentiation (GO:0045687)	2	0	.35	-	 < 0.01	7.06E-01
regulation of glial cell differentiation (GO:0045685)	2	0	.35	-	 < 0.01	7.06E-01
presynaptic active zone assembly (GO:1904071)	1	0	.17	-	 < 0.01	8.40E-01
regulation of striated muscle contraction (GO:0006942)	5	0	.87	-	 < 0.01	4.18E-01
regulation of smooth muscle contraction (GO:0006940)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of R7 cell differentiation (GO:0045678)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of helicase activity (GO:0051097)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of helicase activity (GO:0051096)	1	0	.17	-	 < 0.01	8.40E-01
regulation of helicase activity (GO:0051095)	2	0	.35	-	 < 0.01	7.06E-01
G protein-coupled receptor signaling pathway involved in social behavior (GO:1904068)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	2	0	.35	-	 < 0.01	7.06E-01
protein kinase B signaling (GO:0043491)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of locomotor rhythm (GO:1904060)	1	0	.17	-	 < 0.01	8.40E-01
embryonic body morphogenesis (GO:0010172)	2	0	.35	-	 < 0.01	7.06E-01
mRNA 5'-splice site recognition (GO:0000395)	2	0	.35	-	 < 0.01	7.06E-01
RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	1	0	.17	-	 < 0.01	8.40E-01
spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of myoblast differentiation (GO:0045663)	1	0	.17	-	 < 0.01	8.40E-01
spliceosomal complex disassembly (GO:0000390)	2	0	.35	-	 < 0.01	7.06E-01
RNA stabilization (GO:0043489)	2	0	.35	-	 < 0.01	7.06E-01
regulation of myoblast differentiation (GO:0045661)	2	0	.35	-	 < 0.01	7.06E-01
nuclear envelope disassembly (GO:0051081)	2	0	.35	-	 < 0.01	7.06E-01
cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	9	0	1.57	-	 < 0.01	2.08E-01
mRNA 3'-splice site recognition (GO:0000389)	1	0	.17	-	 < 0.01	8.40E-01
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388)	1	0	.17	-	 < 0.01	8.40E-01
spliceosomal snRNP assembly (GO:0000387)	14	0	2.44	-	 < 0.01	8.68E-02
meiotic nuclear envelope disassembly (GO:0051078)	2	0	.35	-	 < 0.01	7.06E-01
alternative mRNA splicing, via spliceosome (GO:0000380)	1	0	.17	-	 < 0.01	8.40E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	11	0	1.92	-	 < 0.01	1.47E-01
phagocytosis, recognition (GO:0006910)	2	0	.35	-	 < 0.01	7.06E-01
protein K11-linked deubiquitination (GO:0035871)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of extent of heterochromatin assembly (GO:0033697)	2	0	.35	-	 < 0.01	7.06E-01
dihydropteridine metabolic process (GO:0051067)	1	0	.17	-	 < 0.01	8.40E-01
pinocytosis (GO:0006907)	1	0	.17	-	 < 0.01	8.40E-01
vesicle targeting (GO:0006903)	12	0	2.09	-	 < 0.01	1.23E-01
vesicle coating (GO:0006901)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	2	0	.35	-	 < 0.01	7.06E-01
nucleotide-excision repair, DNA incision (GO:0033683)	5	0	.87	-	 < 0.01	4.18E-01
negative regulation of lipid biosynthetic process (GO:0051055)	6	0	1.05	-	 < 0.01	3.51E-01
negative regulation of DNA metabolic process (GO:0051053)	14	0	2.44	-	 < 0.01	8.68E-02
regulation of cellular respiration (GO:0043457)	1	0	.17	-	 < 0.01	8.40E-01
regulation of pentose-phosphate shunt (GO:0043456)	1	0	.17	-	 < 0.01	8.40E-01
chromatin disassembly (GO:0031498)	1	0	.17	-	 < 0.01	8.40E-01
generation of catalytic spliceosome for second transesterification step (GO:0000350)	1	0	.17	-	 < 0.01	8.40E-01
arginine catabolic process to proline via ornithine (GO:0010121)	1	0	.17	-	 < 0.01	8.40E-01
generation of catalytic spliceosome for first transesterification step (GO:0000349)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of transcription involved in meiotic cell cycle (GO:0051039)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of transcription involved in meiotic cell cycle (GO:0051038)	1	0	.17	-	 < 0.01	8.40E-01
regulation of transcription involved in meiotic cell cycle (GO:0051037)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of plasmatocyte differentiation (GO:0045615)	1	0	.17	-	 < 0.01	8.40E-01
regulation of endosome size (GO:0051036)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of plasmatocyte differentiation (GO:0045614)	9	0	1.57	-	 < 0.01	2.08E-01
regulation of plasmatocyte differentiation (GO:0045613)	11	0	1.92	-	 < 0.01	1.47E-01
response to red light (GO:0010114)	2	0	.35	-	 < 0.01	7.06E-01
regulation of transposition, DNA-mediated (GO:0000337)	6	0	1.05	-	 < 0.01	3.51E-01
negative regulation of transposition, DNA-mediated (GO:0000335)	6	0	1.05	-	 < 0.01	3.51E-01
minus-end-directed organelle transport along microtubule (GO:0072385)	1	0	.17	-	 < 0.01	8.40E-01
minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.17	-	 < 0.01	8.40E-01
glucuronoside catabolic process (GO:0019391)	1	0	.17	-	 < 0.01	8.40E-01
modulation of process of other organism (GO:0035821)	2	0	.35	-	 < 0.01	7.06E-01
actin filament severing (GO:0051014)	5	0	.87	-	 < 0.01	4.18E-01
microtubule severing (GO:0051013)	4	0	.70	-	 < 0.01	4.98E-01
glucuronoside metabolic process (GO:0019389)	1	0	.17	-	 < 0.01	8.40E-01
galactose catabolic process (GO:0019388)	2	0	.35	-	 < 0.01	7.06E-01
nerve maturation (GO:0021682)	3	0	.52	-	 < 0.01	5.93E-01
establishment of protein localization to chromosome (GO:0070199)	1	0	.17	-	 < 0.01	8.40E-01
synaptonemal complex disassembly (GO:0070194)	2	0	.35	-	 < 0.01	7.06E-01
synaptonemal complex organization (GO:0070193)	11	0	1.92	-	 < 0.01	1.47E-01
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	1	0	.17	-	 < 0.01	8.40E-01
regulation of cell-cell adhesion mediated by integrin (GO:0033632)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of cell adhesion mediated by integrin (GO:0033630)	2	0	.35	-	 < 0.01	7.06E-01
regulation of extent of heterochromatin assembly (GO:0031454)	2	0	.35	-	 < 0.01	7.06E-01
negative regulation of heterochromatin assembly (GO:0031452)	2	0	.35	-	 < 0.01	7.06E-01
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786)	3	0	.52	-	 < 0.01	5.93E-01
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784)	3	0	.52	-	 < 0.01	5.93E-01
kynurenine metabolic process (GO:0070189)	3	0	.52	-	 < 0.01	5.93E-01
egg coat formation (GO:0035803)	7	0	1.22	-	 < 0.01	2.95E-01
regulation of cell adhesion mediated by integrin (GO:0033628)	4	0	.70	-	 < 0.01	4.98E-01
N-terminal peptidyl-methionine acetylation (GO:0017196)	2	0	.35	-	 < 0.01	7.06E-01
detection of virus (GO:0009597)	3	0	.52	-	 < 0.01	5.93E-01
detection of biotic stimulus (GO:0009595)	4	0	.70	-	 < 0.01	4.98E-01
response to oxygen radical (GO:0000305)	4	0	.70	-	 < 0.01	4.98E-01
negative regulation of mRNA 3'-end processing (GO:0031441)	4	0	.70	-	 < 0.01	4.98E-01
response to superoxide (GO:0000303)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of exonuclease activity (GO:1905779)	1	0	.17	-	 < 0.01	8.40E-01
regulation of exonuclease activity (GO:1905777)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of DNA helicase activity (GO:1905775)	1	0	.17	-	 < 0.01	8.40E-01
regulation of DNA helicase activity (GO:1905774)	1	0	.17	-	 < 0.01	8.40E-01
pyridine nucleotide catabolic process (GO:0019364)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of autophagy of mitochondrion (GO:1903599)	3	0	.52	-	 < 0.01	5.93E-01
peptidyl-glutamic acid carboxylation (GO:0017187)	2	0	.35	-	 < 0.01	7.06E-01
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183)	1	0	.17	-	 < 0.01	8.40E-01
peptidyl-diphthamide metabolic process (GO:0017182)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of SMAD protein signal transduction (GO:0060391)	3	0	.52	-	 < 0.01	5.93E-01
regulation of SMAD protein signal transduction (GO:0060390)	3	0	.52	-	 < 0.01	5.93E-01
rescue of stalled ribosome (GO:0072344)	3	0	.52	-	 < 0.01	5.93E-01
pathway-restricted SMAD protein phosphorylation (GO:0060389)	1	0	.17	-	 < 0.01	8.40E-01
suture of dorsal opening (GO:0007396)	1	0	.17	-	 < 0.01	8.40E-01
dorsal closure, spreading of leading edge cells (GO:0007395)	9	0	1.57	-	 < 0.01	2.08E-01
axonogenesis involved in innervation (GO:0060385)	2	0	.35	-	 < 0.01	7.06E-01
dolichol metabolic process (GO:0019348)	1	0	.17	-	 < 0.01	8.40E-01
modified amino acid transport (GO:0072337)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of endosome to plasma membrane protein transport (GO:1905751)	1	0	.17	-	 < 0.01	8.40E-01
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	5	0	.87	-	 < 0.01	4.18E-01
signal transduction by p53 class mediator (GO:0072331)	6	0	1.05	-	 < 0.01	3.51E-01
posterior compartment specification (GO:0007388)	1	0	.17	-	 < 0.01	8.40E-01
specification of segmental identity, abdomen (GO:0007385)	4	0	.70	-	 < 0.01	4.98E-01
specification of segmental identity, antennal segment (GO:0007383)	2	0	.35	-	 < 0.01	7.06E-01
specification of segmental identity, maxillary segment (GO:0007382)	2	0	.35	-	 < 0.01	7.06E-01
specification of segmental identity, labial segment (GO:0007381)	2	0	.35	-	 < 0.01	7.06E-01
regulation of endosome to plasma membrane protein transport (GO:1905749)	1	0	.17	-	 < 0.01	8.40E-01
phenol-containing compound catabolic process (GO:0019336)	4	0	.70	-	 < 0.01	4.98E-01
positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	3	0	.52	-	 < 0.01	5.93E-01
regulation of Golgi to plasma membrane protein transport (GO:0042996)	3	0	.52	-	 < 0.01	5.93E-01
microtubule bundle formation involved in mitotic spindle midzone assembly (GO:1903562)	1	0	.17	-	 < 0.01	8.40E-01
synaptic vesicle budding (GO:0070142)	5	0	.87	-	 < 0.01	4.18E-01
cephalic furrow formation (GO:0007376)	1	0	.17	-	 < 0.01	8.40E-01
flight (GO:0060361)	9	0	1.57	-	 < 0.01	2.08E-01
vesicle uncoating (GO:0072319)	1	0	.17	-	 < 0.01	8.40E-01
clathrin coat disassembly (GO:0072318)	1	0	.17	-	 < 0.01	8.40E-01
sequestering of actin monomers (GO:0042989)	2	0	.35	-	 < 0.01	7.06E-01
amyloid precursor protein catabolic process (GO:0042987)	3	0	.52	-	 < 0.01	5.93E-01
pentose metabolic process (GO:0019321)	2	0	.35	-	 < 0.01	7.06E-01
amyloid precursor protein metabolic process (GO:0042982)	4	0	.70	-	 < 0.01	4.98E-01
insecticide metabolic process (GO:0017143)	7	0	1.22	-	 < 0.01	2.95E-01
response to ammonium ion (GO:0060359)	2	0	.35	-	 < 0.01	7.06E-01
terminal region determination (GO:0007362)	15	0	2.62	-	 < 0.01	7.29E-02
protein localization to microtubule end (GO:1905725)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to aldehyde (GO:0110096)	1	0	.17	-	 < 0.01	8.40E-01
cellular detoxification of aldehyde (GO:0110095)	1	0	.17	-	 < 0.01	8.40E-01
guanine metabolic process (GO:0046098)	1	0	.17	-	 < 0.01	8.40E-01
establishment of protein localization to postsynaptic membrane (GO:1903540)	2	0	.35	-	 < 0.01	7.06E-01
posterior abdomen determination (GO:0007359)	1	0	.17	-	 < 0.01	8.40E-01
zygotic specification of dorsal/ventral axis (GO:0007352)	2	0	.35	-	 < 0.01	7.06E-01
inositol phosphorylation (GO:0052746)	1	0	.17	-	 < 0.01	8.40E-01
clathrin coat assembly (GO:0048268)	4	0	.70	-	 < 0.01	4.98E-01
protein localization to postsynaptic membrane (GO:1903539)	4	0	.70	-	 < 0.01	4.98E-01
determination of ventral identity (GO:0048264)	1	0	.17	-	 < 0.01	8.40E-01
determination of dorsal identity (GO:0048263)	2	0	.35	-	 < 0.01	7.06E-01
nucleologenesis (GO:0017126)	1	0	.17	-	 < 0.01	8.40E-01
determination of dorsal/ventral asymmetry (GO:0048262)	5	0	.87	-	 < 0.01	4.18E-01
plasma membrane phospholipid scrambling (GO:0017121)	3	0	.52	-	 < 0.01	5.93E-01
adenine biosynthetic process (GO:0046084)	1	0	.17	-	 < 0.01	8.40E-01
adenine metabolic process (GO:0046083)	1	0	.17	-	 < 0.01	8.40E-01
response to L-canavanine (GO:1901354)	2	0	.35	-	 < 0.01	7.06E-01
dUTP catabolic process (GO:0046081)	1	0	.17	-	 < 0.01	8.40E-01
dUTP metabolic process (GO:0046080)	1	0	.17	-	 < 0.01	8.40E-01
regulation of preblastoderm mitotic cell cycle (GO:0007347)	1	0	.17	-	 < 0.01	8.40E-01
pronuclear fusion (GO:0007344)	4	0	.70	-	 < 0.01	4.98E-01
egg activation (GO:0007343)	7	0	1.22	-	 < 0.01	2.95E-01
vesicle-mediated intercellular transport (GO:0110077)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of apical constriction involved in ventral furrow formation (GO:0110074)	2	0	.35	-	 < 0.01	7.06E-01
regulation of apical constriction involved in ventral furrow formation (GO:0110073)	2	0	.35	-	 < 0.01	7.06E-01
mRNA stabilization (GO:0048255)	2	0	.35	-	 < 0.01	7.06E-01
lipoprotein transport (GO:0042953)	1	0	.17	-	 < 0.01	8.40E-01
negative regulation of blood circulation (GO:1903523)	3	0	.52	-	 < 0.01	5.93E-01
lauric acid metabolic process (GO:0048252)	1	0	.17	-	 < 0.01	8.40E-01
dUMP metabolic process (GO:0046078)	1	0	.17	-	 < 0.01	8.40E-01
iron import into the mitochondrion (GO:0048250)	1	0	.17	-	 < 0.01	8.40E-01
dTMP metabolic process (GO:0046073)	1	0	.17	-	 < 0.01	8.40E-01
binding of sperm to zona pellucida (GO:0007339)	1	0	.17	-	 < 0.01	8.40E-01
dGTP metabolic process (GO:0046070)	1	0	.17	-	 < 0.01	8.40E-01
positive regulation of store-operated calcium channel activity (GO:1901341)	1	0	.17	-	 < 0.01	8.40E-01
interstrand cross-link repair (GO:0036297)	10	0	1.74	-	 < 0.01	1.75E-01
regulation of centriole-centriole cohesion (GO:0030997)	1	0	.17	-	 < 0.01	8.40E-01
cellular response to increased oxygen levels (GO:0036295)	1	0	.17	-	 < 0.01	8.40E-01
DNA rewinding (GO:0036292)	2	0	.35	-	 < 0.01	7.06E-01
syncytial embryo cellularization (GO:0110069)	2	0	.35	-	 < 0.01	7.06E-01
cGMP catabolic process (GO:0046069)	1	0	.17	-	 < 0.01	8.40E-01
regulation of store-operated calcium channel activity (GO:1901339)	1	0	.17	-	 < 0.01	8.40E-01
D-amino acid transport (GO:0042940)	1	0	.17	-	 < 0.01	8.40E-01
SAGA complex assembly (GO:0036285)	1	0	.17	-	 < 0.01	8.40E-01
dipeptide transport (GO:0042938)	1	0	.17	-	 < 0.01	8.40E-01
regulation of mitotic spindle checkpoint (GO:1903504)	2	0	.35	-	 < 0.01	7.06E-01
protein localization to adherens junction (GO:0071896)	3	0	.52	-	 < 0.01	5.93E-01
negative regulation of oskar mRNA translation (GO:0007319)	7	0	1.22	-	 < 0.01	2.95E-01
regulation of nucleosome density (GO:0060303)	1	0	.17	-	 < 0.01	8.40E-01
maternal specification of dorsal/ventral axis, oocyte, germ-line encoded (GO:0007311)	5	0	.87	-	 < 0.01	4.18E-01
